{"id":12,"date":"2019-03-28T04:44:40","date_gmt":"2019-03-27T19:44:40","guid":{"rendered":"http:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/?page_id=12"},"modified":"2026-02-03T11:54:00","modified_gmt":"2026-02-03T02:54:00","slug":"research","status":"publish","type":"page","link":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/research\/","title":{"rendered":"\u7814\u7a76\u30fb\u696d\u7e3e"},"content":{"rendered":"\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%;\">\n    <h2 class=\"contents_title\">\u81e8\u5e8a\u7814\u7a76<\/h2>\n  <\/dt>\n  <dd style=\"margin-top: 12px; font-size:1.05em; line-height:1.7;\">\n    \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\u6559\u5ba4\u3067\u306f\u3001\u4ee5\u4e0b\u306e\u9818\u57df\u3092\u7814\u7a76\u306e\u67f1\u3068\u3057\u3066\u6d3b\u52d5\u3057\u3066\u3044\u308b\u3002\n    \u52a0\u3048\u3066\u3001\u672c\u6559\u5ba4\u3067\u306f\u5927\u5b66\u9662\u751f\u306e\u5b66\u4f4d\u53d6\u5f97\u306b\u5411\u3051\u305f\u7814\u7a76\u6307\u5c0e\u3092\u884c\u3063\u3066\u304a\u308a\u3001\n    \u533b\u5b66\u90e84\u5e74\u751f\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30ea\u30b5\u30fc\u30c1\u30af\u30e9\u30fc\u30af\u30b7\u30c3\u30d7\u3082\u6bce\u5e74\u53d7\u3051\u5165\u308c\u3066\u3044\u308b\u3002\n    \u81e8\u5e8a\u7814\u7a76\u306e\u7acb\u6848\u304b\u3089\u89e3\u6790\u3001\u767a\u8868\u306b\u81f3\u308b\u307e\u3067\u4e00\u8cab\u3057\u305f\u7814\u7a76\u6559\u80b2\u3092\u5b9f\u8df5\u3057\u3066\u304a\u308a\u3001\n    \u3053\u308c\u3089\u306e\u7d99\u7d9a\u7684\u306a\u6559\u80b2\u30fb\u7814\u7a76\u6307\u5c0e\u306e\u6210\u679c\u3068\u3057\u3066\u3001\n    \u5b66\u4f1a\u8cde\u3084\u5b66\u751f\u8868\u5f70\uff08\u533b\u5b66\u90e8\u9577\u8cde\u3001YCU Student Award \u306a\u3069\uff09\u306e\u53d7\u8cde\u8005\u3092\u8f29\u51fa\u3057\u3066\u3044\u308b\u3002\n    <br><br>\n    <ul style=\"margin-top:12px; padding-left:1.2em;\">\n      <li>\u2460 \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad<\/li>\n      <li>\u2461 \u6838\u533b\u5b66\uff08\u60aa\u6027\u816b\u760d\u306a\u3069\uff09<\/li>\n      <li>\u2462 \u753b\u50cf\u4e0b\u6cbb\u7642\uff08Interventional Radiology\uff1aIVR\uff09<\/li>\n      <li>\u2463 \u795e\u7d4c\u653e\u5c04\u7dda<\/li>\n      <li>\u2464 \u30e1\u30bf\u89e3\u6790\u30fbSystematic Review<\/li>\n      <li>\u2465 \u4eba\u5de5\u77e5\u80fd\u7814\u7a76<\/li>\n    <\/ul>\n  <\/dd>\n<\/dl>\n\n\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2460 \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\uff08CT\u30fbMRI\u30fb\u6838\u533b\u5b66\uff09\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\n    \u5fc3\u81d3CT\u304a\u3088\u3073\u5fc3\u81d3MRI\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u3092\u57fa\u76e4\u306b\u3001\u5faa\u74b0\u5668\u75be\u60a3\u306e\u8a3a\u65ad\u3001\u75c5\u614b\u89e3\u660e\u3001\u306a\u3089\u3073\u306b\u4e88\u5f8c\u8a55\u4fa1\u306b\u95a2\u3059\u308b\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u308b\u3002\n    \u4e3b\u306b\u865a\u8840\u6027\u5fc3\u75be\u60a3\u3001\u5fc3\u7b4b\u75c7\u3001\u5fc3\u4e0d\u5168\u3092\u5bfe\u8c61\u3068\u3057\u3001\u51a0\u52d5\u8108\u5f62\u614b\u8a55\u4fa1\u306b\u52a0\u3048\u3066\u3001\u5fc3\u7b4b\u6027\u72b6\u89e3\u6790\u3001\u5fc3\u7b4b\u8840\u6d41\u8a55\u4fa1\u3001\u51a0\u5faa\u74b0\u6a5f\u80fd\u8a55\u4fa1\u306a\u3069\u3092\u7d71\u5408\u7684\u306b\u89e3\u6790\u3059\u308b\u3053\u3068\u3067\u3001\n    \u5f62\u614b\u8a55\u4fa1\u306b\u3068\u3069\u307e\u3089\u306a\u3044\u6a5f\u80fd\u7684\u30fb\u75c5\u614b\u7684\u7406\u89e3\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    \u307e\u305f\u3001CT\u304a\u3088\u3073MRI\u306b\u3088\u308b\u5b9a\u91cf\u6307\u6a19\u3092\u7528\u3044\u305f\u30ea\u30b9\u30af\u5c64\u5225\u5316\u3084\u6cbb\u7642\u52b9\u679c\u4e88\u6e2c\u306b\u95a2\u3059\u308b\u691c\u8a0e\u3092\u901a\u3058\u3066\u3001\n    \u65e5\u5e38\u8a3a\u7642\u3078\u306e\u5fdc\u7528\u3092\u898b\u636e\u3048\u305f\u81e8\u5e8a\u7684\u6709\u7528\u6027\u306e\u78ba\u7acb\u3092\u91cd\u8996\u3057\u3066\u3044\u308b\u3002\n    <br>\uff08\u6307\u5c0e\u6559\u54e1\uff1a\u5b87\u90fd\u5bae\u6559\u6388\u30fb\u52a0\u85e4\u771f\u543e\u51c6\u6559\u6388\uff09\n  <\/dd>\n<\/dl>\n\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%; margin-top: 16px;\">\n    <h3 style=\"font-size: 1.05em;\">\u7814\u7a76\u30c6\u30fc\u30de<\/h3>\n  <\/dt>\n\n  <!-- MRI -->\n  <dt style=\"width: 100%; margin-top: 12px;\">\n    <h4 style=\"font-size: 0.95em;\"><strong>\u3010MRI\u3011<\/strong><\/h4>\n  <\/dt>\n  <dd style=\"margin-top: 4px; margin-bottom: 4px; font-size: 0.9em; line-height: 1.55;\">\n    <ul style=\"margin: 0; padding-left: 1.1em;\">\n      <li>\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306b\u304a\u3051\u308b\u85ac\u5264\u8ca0\u8377 Perfusion MRI \u306b\u3088\u308b\u75c5\u614b\u8a55\u4fa1<\/li>\n      <li>\u5fc3\u4e0d\u5168\u60a3\u8005\u306b\u304a\u3051\u308b MRI-ECV\uff08extracellular volume fraction\uff09\u3092\u7528\u3044\u305f\u75c5\u614b\u89e3\u660e<\/li>\n      <li>MRI \u306b\u3088\u308b\u5fc3\u7b4b\u8840\u6d41\u30fb\u51a0\u52d5\u8108\u8840\u6d41\u4e88\u5099\u80fd\uff08CFR: coronary flow reserve\uff09\u306e\u5b9a\u91cf\u8a55\u4fa1<\/li>\n      <li>\u8ca0\u8377 Perfusion MRI \u3092\u7528\u3044\u305f coronary flow capacity \u306e\u8a55\u4fa1<\/li>\n    <\/ul>\n  <\/dd>\n\n  <!-- CT\uff08MRI\u3068\u306e\u9593\u9694\u3092\u8a70\u3081\u308b\uff09 -->\n  <dt style=\"width: 100%; margin-top: 6px;\">\n    <h4 style=\"font-size: 0.95em;\"><strong>\u3010CT\u3011<\/strong><\/h4>\n  <\/dt>\n  <dd style=\"margin-top: 4px; margin-bottom: 4px; font-size: 0.9em; line-height: 1.55;\">\n    <ul style=\"margin: 0; padding-left: 1.1em;\">\n      <li>\u5fc3\u7b4b CT-ECV \u306b\u3088\u308b\u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u975e\u4fb5\u8972\u7684\u691c\u51fa<\/li>\n      <li>\u8ca0\u8377 perfusion CTP \u306b\u3088\u308b\u5fc3\u7b4b\u865a\u8840\u306e\u5b9a\u91cf\u7684\u8a55\u4fa1<\/li>\n      <li>\u51a0\u52d5\u8108\u5468\u56f2\u8102\u80aa\u7d44\u7e54\uff08PCAT\uff09\u306e\u8a08\u6e2c\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u306e\u958b\u767a<\/li>\n    <\/ul>\n  <\/dd>\n\n  <!-- \u305d\u306e\u4ed6 -->\n  <dt style=\"width: 100%; margin-top: 8px;\">\n    <h4 style=\"font-size: 0.95em;\"><strong>\u3010\u305d\u306e\u4ed6\u3011<\/strong><\/h4>\n  <\/dt>\n  <dd style=\"margin-top: 4px; font-size: 0.9em; line-height: 1.55;\">\n    <ul style=\"margin: 0; padding-left: 1.1em;\">\n      <li>\u6df1\u5c64\u5b66\u7fd2\uff08DLR\uff09\u3092\u7528\u3044\u305f\u5faa\u74b0\u5668\u753b\u50cf\u306e\u753b\u8cea\u5411\u4e0a\u306b\u95a2\u3059\u308b\u7814\u7a76<\/li>\n      <li>\u4eba\u5de5\u77e5\u80fd\u3068\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u3092\u7528\u3044\u305f\u5e0c\u5c11\u5fc3\u7b4b\u75be\u60a3\u306e\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76<\/li>\n    <\/ul>\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-1-1024x576.jpg\" alt=\"\" class=\"wp-image-1813\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-1-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-1-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-1-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-1.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%; margin-top: 18px;\">\n    <h3>\u4f4d\u76f8\u5dee\u30b7\u30cdMRI\u306b\u3088\u308b\u51a0\u52d5\u8108\u8840\u6d41\u4e88\u5099\u80fd\uff08CFR\uff09\u306e\u8a55\u4fa1<\/h3>\n  <\/dt>\n\n  <dd style=\"margin-top: 12px;\">\n    <p>\n      \u4f4d\u76f8\u5dee\u30b7\u30cdMRI\uff08Phase-contrast cine MRI\uff09\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u8840\u6d41\u4e88\u5099\u80fd\uff08coronary flow reserve, CFR\uff09\u306e\u8a55\u4fa1\u306f\u3001\n      \u51a0\u9759\u8108\u6d1e\u8840\u6d41\u3092\u5b9a\u91cf\u7684\u306b\u8a08\u6e2c\u3059\u308b\u3053\u3068\u3067\u3001\u5fc3\u7b4b\u5168\u4f53\u306e\u51a0\u5faa\u74b0\u6a5f\u80fd\u3092\u975e\u4fb5\u8972\u7684\u306b\u8a55\u4fa1\u53ef\u80fd\u306a\u624b\u6cd5\u3067\u3042\u308b\u3002\n      \u5b89\u9759\u6642\u304a\u3088\u3073\u85ac\u5264\u8ca0\u8377\u6642\u306e\u51a0\u9759\u8108\u6d1e\u8840\u6d41\u91cf\u304b\u3089\u7b97\u51fa\u3055\u308c\u308bCFR\u306f\u3001\u51a0\u52d5\u8108\u72ed\u7a84\u306e\u6709\u7121\u306b\u3068\u3069\u307e\u3089\u305a\u3001\n      \u5fae\u5c0f\u5faa\u74b0\u969c\u5bb3\u3092\u542b\u3081\u305f\u5305\u62ec\u7684\u306a\u51a0\u5faa\u74b0\u6a5f\u80fd\u3092\u53cd\u6620\u3059\u308b\u6307\u6a19\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u73fe\u6642\u70b9\u3067\u306e\u6709\u7528\u6027<\/strong><br>\n      \u3053\u308c\u307e\u3067\u306e\u7814\u7a76\u306b\u3088\u308a\u3001\u4f4d\u76f8\u5dee\u30b7\u30cdMRI\u3067\u8a55\u4fa1\u3055\u308c\u305fCFR\u306f\u3001\n      \u65e2\u77e5\u307e\u305f\u306f\u7591\u3044\u51a0\u52d5\u8108\u75be\u60a3\u60a3\u8005\u306b\u304a\u3044\u3066\u5fc3\u8840\u7ba1\u30a4\u30d9\u30f3\u30c8\u306e\u4e88\u6e2c\u56e0\u5b50\u3068\u306a\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u308b\u3002\n      \u9020\u5f71\u5264\u3092\u7528\u3044\u305a\u3001\u5358\u4e00\u65ad\u9762\u306e\u64ae\u50cf\u3067\u8a55\u4fa1\u53ef\u80fd\u3067\u3042\u308b\u70b9\u306f\u3001\n      \u814e\u6a5f\u80fd\u4f4e\u4e0b\u4f8b\u3084\u7e70\u308a\u8fd4\u3057\u691c\u67fb\u304c\u5fc5\u8981\u306a\u75c7\u4f8b\u306b\u304a\u3044\u3066\u3082\u9069\u7528\u53ef\u80fd\u6027\u304c\u9ad8\u304f\u3001\n      \u5b89\u5168\u304b\u3064\u518d\u73fe\u6027\u306e\u9ad8\u3044\u4e88\u5f8c\u6307\u6a19\u3068\u3057\u3066\u81e8\u5e8a\u7684\u610f\u7fa9\u3092\u6709\u3059\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fbINOCA\u8a55\u4fa1\u3078\u306e\u5fdc\u7528<\/strong><br>\n      \u8fd1\u5e74\u6ce8\u76ee\u3055\u308c\u3066\u3044\u308bINOCA\uff08ischemia with non-obstructive coronary arteries\uff09\u306b\u304a\u3044\u3066\u306f\u3001\n      \u51a0\u52d5\u8108\u306b\u6709\u610f\u72ed\u7a84\u3092\u8a8d\u3081\u306a\u3044\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u865a\u8840\u75c7\u72b6\u3092\u5448\u3059\u308b\u75c7\u4f8b\u304c\u591a\u304f\u3001\n      \u51a0\u5fae\u5c0f\u5faa\u74b0\u969c\u5bb3\u306e\u8a55\u4fa1\u304c\u91cd\u8981\u306a\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u308b\u3002\n      \u4f4d\u76f8\u5dee\u30b7\u30cdMRI\u306b\u3088\u308bCFR\u8a55\u4fa1\u306f\u3001\u5fc3\u7b4b\u5168\u4f53\u306e\u8840\u6d41\u5fdc\u7b54\u3092\u53cd\u6620\u3059\u308b\u3053\u3068\u304b\u3089\u3001\n      INOCA\u306b\u304a\u3051\u308b\u75c5\u614b\u89e3\u660e\u3084\u30ea\u30b9\u30af\u5c64\u5225\u5316\u306b\u6709\u7528\u306a\u975e\u4fb5\u8972\u7684\u8a55\u4fa1\u6cd5\u3068\u306a\u308a\u5f97\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u4eca\u5f8c\u306e\u5c55\u671b<\/strong><br>\n      \u4eca\u5f8c\u306f\u3001\u30b9\u30c8\u30ec\u30b9\u30d1\u30fc\u30d5\u30e5\u30fc\u30b8\u30e7\u30f3MRI\u3084\u5fc3\u7b4b\u7d44\u7e54\u6027\u72b6\u8a55\u4fa1\uff08T1 mapping\u3001ECV\uff09\u3068\u306e\u7d71\u5408\u89e3\u6790\u306b\u3088\u308a\u3001\n      \u51a0\u5faa\u74b0\u6a5f\u80fd\u3068\u5fc3\u7b4b\u969c\u5bb3\u306e\u95a2\u9023\u3092\u5305\u62ec\u7684\u306b\u8a55\u4fa1\u3059\u308b\u30a2\u30d7\u30ed\u30fc\u30c1\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n      \u307e\u305f\u3001CFR\u5358\u72ec\u8a55\u4fa1\u306b\u3068\u3069\u307e\u3089\u305a\u3001\u51a0\u52d5\u8108\u8840\u6d41\u91cf\u3068\u5fc3\u7b4b\u8840\u6d41\u6307\u6a19\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\n      \u51a0\u8840\u6d41capacity\u8a55\u4fa1\u3078\u306e\u767a\u5c55\u306b\u3088\u308a\u3001\u3088\u308a\u7cbe\u7dfb\u306a\u30ea\u30b9\u30af\u5c64\u5225\u5316\u304a\u3088\u3073\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u3078\u306e\u5fdc\u7528\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n<p style=\"margin-top: 12px; font-size: 0.9em; color: #555;\">\n      Kato S. et al. J Am Coll Cardiol, 2017; 70:869-879\n    <\/p>\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-2-1024x576.jpg\" alt=\"\" class=\"wp-image-1827\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-2-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-2-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-2-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528-2.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%; margin-top: 18px;\">\n    <h3>\u6df1\u5c64\u5b66\u7fd2\uff08DLR\uff09\u306b\u3088\u308b\u51a0\u52d5\u8108CT\u306e\u753b\u8cea\u6539\u5584<\/h3>\n  <\/dt>\n\n  <dd style=\"margin-top: 12px;\">\n    <p>\n      \u51a0\u52d5\u8108CT\uff08coronary CT angiography: CCTA\uff09\u306f\u3001\u51a0\u52d5\u8108\u72ed\u7a84\u3092\u975e\u4fb5\u8972\u7684\u306b\u8a55\u4fa1\u3067\u304d\u308b\u691c\u67fb\u3068\u3057\u3066\u5e83\u304f\u7528\u3044\u3089\u308c\u3066\u3044\u308b\u3002\n      \u4e00\u65b9\u3067\u3001\u7a7a\u9593\u5206\u89e3\u80fd\u3084\u753b\u50cf\u30ce\u30a4\u30ba\u306e\u5236\u7d04\u306b\u3088\u308a\u3001\u7279\u306b\u8efd\u5ea6\u304b\u3089\u4e2d\u7b49\u5ea6\u72ed\u7a84\u306b\u304a\u3044\u3066\u306f\u72ed\u7a84\u306e\u904e\u5927\u8a55\u4fa1\u304c\u751f\u3058\u3084\u3059\u304f\u3001\n      \u8a3a\u65ad\u7cbe\u5ea6\u306e\u5411\u4e0a\u304c\u8ab2\u984c\u3068\u3055\u308c\u3066\u3044\u308b\u3002\n      \u672c\u7814\u7a76\u3067\u306f\u3001\u6df1\u5c64\u5b66\u7fd2\u3092\u7528\u3044\u305f\u753b\u50cf\u518d\u69cb\u6210\u6cd5\uff08deep learning-based reconstruction: DLR\uff09\u3001\n      \u7279\u306b<strong>\u7b2c2\u4e16\u4ee3DLR<\/strong>\u304c\u51a0\u52d5\u8108CT\u306e\u753b\u8cea\u304a\u3088\u3073\u72ed\u7a84\u8a55\u4fa1\u80fd\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u3092\u691c\u8a0e\u3057\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u7814\u7a76\u306e\u6982\u8981<\/strong><br>\n      \u975e\u77f3\u7070\u5316\u30d7\u30e9\u30fc\u30af\u3092\u6709\u3059\u308b\u6bb5\u968e\u7684\u72ed\u7a84\u30e2\u30c7\u30eb\u3092\u5099\u3048\u305f\u8840\u7ba1\u30d5\u30a1\u30f3\u30c8\u30e0\u3092\u7528\u3044\u3001\n      320\u5217\u691c\u51fa\u5668CT\u3067\u64ae\u5f71\u3092\u884c\u3063\u305f\u3002\n      \u753b\u50cf\u518d\u69cb\u6210\u6cd5\u3068\u3057\u3066\u3001\u5f93\u6765\u306e\u9010\u6b21\u8fd1\u4f3c\u518d\u69cb\u6210\uff08HIR\uff09\u3001\n      \u30e2\u30c7\u30eb\u30d9\u30fc\u30b9\u9010\u6b21\u8fd1\u4f3c\u518d\u69cb\u6210\uff08MBIR\uff09\u3001\n      \u5f93\u6765\u4e16\u4ee3DLR\u3001\n      \u304a\u3088\u3073\u7b2c2\u4e16\u4ee3DLR\u3092\u7528\u3044\u3001\u5b9a\u91cf\u7684\u304a\u3088\u3073\u8996\u899a\u7684\u306a\u753b\u8cea\u8a55\u4fa1\u3092\u884c\u3063\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u4e3b\u306a\u7d50\u679c<\/strong><br>\n      \u7b2c2\u4e16\u4ee3DLR\u3067\u306f\u3001\u753b\u50cf\u30ce\u30a4\u30ba\u304c\u6700\u3082\u4f4e\u6e1b\u3055\u308c\u3001\n      \u8840\u7ba1\u5185\u8154\u3068\u80cc\u666f\u3068\u306e\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\u30fb\u30ce\u30a4\u30ba\u6bd4\uff08CNR\uff09\u304a\u3088\u3073\n      \u8840\u7ba1\u5883\u754c\u306e\u7acb\u3061\u4e0a\u304c\u308a\u3092\u793a\u3059edge rise slope\uff08ERS\uff09\u304c\u6709\u610f\u306b\u5411\u4e0a\u3057\u305f\u3002\n      \u307e\u305f\u3001\u7c92\u72b6\u6027\u3001\u8840\u7ba1\u306e\u30b7\u30e3\u30fc\u30d7\u30cd\u30b9\u3001\u5185\u8154\u306e\u8996\u8a8d\u6027\u3068\u3044\u3063\u305f\u8996\u899a\u8a55\u4fa1\u306b\u304a\u3044\u3066\u3082\u3001\n      \u7b2c2\u4e16\u4ee3DLR\u304c\u4ed6\u306e\u518d\u69cb\u6210\u6cd5\u3088\u308a\u9ad8\u3044\u8a55\u4fa1\u3092\u793a\u3057\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u81e8\u5e8a\u7684\u610f\u7fa9<\/strong><br>\n      \u7b2c2\u4e16\u4ee3DLR\u306f\u3001\u51a0\u52d5\u8108\u5185\u8154\u306e\u63cf\u51fa\u80fd\u3092\u5927\u304d\u304f\u6539\u5584\u3057\u3001\n      \u51a0\u52d5\u8108\u72ed\u7a84\u306e\u5b9a\u91cf\u8a55\u4fa1\u306e\u4fe1\u983c\u6027\u5411\u4e0a\u306b\u5bc4\u4e0e\u3059\u308b\u53ef\u80fd\u6027\u304c\u793a\u3055\u308c\u305f\u3002\n      \u7279\u306b\u8efd\u5ea6\u304b\u3089\u4e2d\u7b49\u5ea6\u72ed\u7a84\u306b\u304a\u3051\u308b\u904e\u5927\u8a55\u4fa1\u306e\u6291\u5236\u3084\u3001\n      \u3088\u308a\u6b63\u78ba\u306a\u30ea\u30b9\u30af\u8a55\u4fa1\u3078\u306e\u5fdc\u7528\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u4eca\u5f8c\u306e\u5c55\u671b<\/strong><br>\n      \u4eca\u5f8c\u306f\u3001\u81e8\u5e8a\u75c7\u4f8b\u306b\u304a\u3051\u308b\u8a3a\u65ad\u80fd\u3084\u4e88\u5f8c\u4e88\u6e2c\u80fd\u3078\u306e\u5f71\u97ff\u3092\u691c\u8a3c\u3059\u308b\u3068\u3068\u3082\u306b\u3001\n      \u88ab\u3070\u304f\u4f4e\u6e1b\u30d7\u30ed\u30c8\u30b3\u30eb\u3068\u306e\u4f75\u7528\u3084\u4ed6\u306e\u753b\u50cf\u89e3\u6790\u6280\u8853\u3068\u306e\u7d71\u5408\u306b\u3088\u308a\u3001\n      \u51a0\u52d5\u8108CT\u8a3a\u65ad\u306e\u3055\u3089\u306a\u308b\u7cbe\u5ea6\u5411\u4e0a\u3078\u306e\u5c55\u958b\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 12px; font-size: 0.9em; color: #555;\">\n      Sawamura S. et al. Quantitative Imaging in Medicine and Surgery, 2024; 14:2870\u20132883\n    <\/p>\n  <\/dd>\n<\/dl>\n\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2461 \u6838\u533b\u5b66\uff08\u60aa\u6027\u816b\u760d\u306a\u3069\uff09\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\nPET\u304a\u3088\u3073SPECT\u3092\u7528\u3044\u305f\u6838\u533b\u5b66\u753b\u50cf\u3092\u57fa\u76e4\u3068\u3057\u3066\u3001\u60aa\u6027\u816b\u760d\u3092\u306f\u3058\u3081\u3068\u3059\u308b\u5404\u7a2e\u75be\u60a3\u306e\u8a3a\u65ad\u3001\u75c5\u52e2\u8a55\u4fa1\u3001\u306a\u3089\u3073\u306b\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u308b\u3002\u816b\u760d\u306e\u4ee3\u8b1d\u6d3b\u6027\u3084\u751f\u7269\u5b66\u7684\u7279\u6027\u3092\u975e\u4fb5\u8972\u7684\u306b\u53ef\u8996\u5316\u3067\u304d\u308b\u6838\u533b\u5b66\u753b\u50cf\u306e\u7279\u6027\u3092\u6d3b\u304b\u3057\u3001\u81e8\u5e8a\u73fe\u5834\u306b\u304a\u3051\u308b\u610f\u601d\u6c7a\u5b9a\u306b\u76f4\u7d50\u3059\u308b\u60c5\u5831\u306e\u5275\u51fa\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n\u7279\u306b\u3001SUV\u306a\u3069\u306e\u5b9a\u91cf\u6307\u6a19\u3084\u753b\u50cf\u7531\u6765\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306b\u7740\u76ee\u3057\u3001\u64ae\u50cf\u6761\u4ef6\u3084\u89e3\u6790\u624b\u6cd5\u306b\u3088\u308b\u3070\u3089\u3064\u304d\u306e\u5f71\u97ff\u3092\u8003\u616e\u3057\u306a\u304c\u3089\u3001\u305d\u306e\u518d\u73fe\u6027\u30fb\u59a5\u5f53\u6027\u304a\u3088\u3073\u81e8\u5e8a\u7684\u6709\u7528\u6027\u3092\u4f53\u7cfb\u7684\u306b\u691c\u8a3c\u3057\u3066\u3044\u308b\u3002\u307e\u305f\u3001\u6cbb\u7642\u524d\u5f8c\u306e\u7d4c\u6642\u7684\u5909\u5316\u3084\u4ed6\u306e\u81e8\u5e8a\u60c5\u5831\u3068\u306e\u7d71\u5408\u89e3\u6790\u3092\u901a\u3058\u3066\u3001\u6cbb\u7642\u53cd\u5fdc\u6027\u306e\u8a55\u4fa1\u3084\u65e9\u671f\u52b9\u679c\u5224\u5b9a\u306e\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u3082\u691c\u8a0e\u3092\u9032\u3081\u3066\u3044\u308b\u3002\n\u3053\u308c\u3089\u306e\u77e5\u898b\u3092\u901a\u3058\u3066\u3001\u5358\u306a\u308b\u753b\u50cf\u8a3a\u65ad\u7cbe\u5ea6\u306e\u5411\u4e0a\u306b\u3068\u3069\u307e\u3089\u305a\u3001\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u306e\u6700\u9069\u5316\u3001\u4e88\u5f8c\u4e88\u6e2c\u3001\u3055\u3089\u306b\u306f\u500b\u3005\u306e\u60a3\u8005\u306b\u5fdc\u3058\u305f\u6cbb\u7642\u6226\u7565\u306e\u69cb\u7bc9\u3092\u652f\u63f4\u3059\u308b\u500b\u5225\u5316\u533b\u7642\u3078\u306e\u8ca2\u732e\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    <br>\uff08\u6307\u5c0e\u6559\u54e1\uff1a\u77f3\u6e21\u7fa9\u4e4b\u8b1b\u5e2b\uff09\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_3-1024x576.jpg\" alt=\"\" class=\"wp-image-1847\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_3-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_3-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_3-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_3.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%; margin-top: 18px;\">\n    <h3>AMPA\u53d7\u5bb9\u4f53\u306e\u53ef\u8996\u5316\u306b\u95a2\u3059\u308b\u7814\u7a76<\/h3>\n  <\/dt>\n\n  <dd style=\"margin-top: 12px;\">\n    <p>\n      \u4e2d\u67a2\u795e\u7d4c\u7cfb\u306e\u60c5\u5831\u4f1d\u9054\u3092\u62c5\u3046\u30b7\u30ca\u30d7\u30b9\u6a5f\u80fd\u306f\u3001\u8133\u75be\u60a3\u306e\u75c5\u614b\u7406\u89e3\u306b\u304a\u3044\u3066\u6975\u3081\u3066\u91cd\u8981\u3067\u3042\u308b\u3002\n      \u4e2d\u3067\u3082\u3001\u8208\u596e\u6027\u30b7\u30ca\u30d7\u30b9\u306b\u767a\u73fe\u3059\u308bAMPA\u53d7\u5bb9\u4f53\u306f\u3001\u795e\u7d4c\u6d3b\u52d5\u3084\u53ef\u5851\u6027\u3068\u5bc6\u63a5\u306b\u95a2\u4e0e\u3057\u3066\u3044\u308b\u304c\u3001\n      \u3053\u308c\u307e\u3067\u30d2\u30c8\u751f\u4f53\u8133\u306b\u304a\u3044\u3066\u76f4\u63a5\u53ef\u8996\u5316\u3059\u308b\u3053\u3068\u306f\u56f0\u96e3\u3067\u3042\u3063\u305f\u3002\n      \u672c\u7814\u7a76\u3067\u306f\u3001\u300c<strong>\u898b\u3048\u306a\u3044\u3082\u306e\u3092\u53ef\u8996\u5316\u3059\u308b<\/strong>\u300d\u3053\u3068\u3092\u76ee\u6a19\u306b\u3001\n      AMPA\u53d7\u5bb9\u4f53\u306e\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u7814\u7a76\u4f53\u5236\u3068\u30a2\u30d7\u30ed\u30fc\u30c1<\/strong><br>\n      \u57fa\u790e\u7814\u7a76\uff08\u751f\u7406\u5b66\uff09\u304a\u3088\u3073\u81e8\u5e8a\u79d1\uff08\u8133\u795e\u7d4c\u5916\u79d1\u30fb\u653e\u5c04\u7dda\u6cbb\u7642\u79d1\uff09\u3068\u5bc6\u306b\u9023\u643a\u3057\u3001\n      \u5206\u5b50\u30ec\u30d9\u30eb\u306e\u75c5\u614b\u3092\u81e8\u5e8a\u753b\u50cf\u3068\u3057\u3066\u6349\u3048\u308b\u30c8\u30e9\u30f3\u30b9\u30ec\u30fc\u30b7\u30e7\u30ca\u30eb\u30ea\u30b5\u30fc\u30c1\u3092\u63a8\u9032\u3057\u3066\u3044\u308b\u3002\n      \u751f\u7406\u5b66\u7814\u7a76\u5ba4\u3068\u306e\u5171\u540c\u7814\u7a76\u306b\u3088\u308a\u3001AMPA\u53d7\u5bb9\u4f53\u306b\u7279\u7570\u7684\u306b\u7d50\u5408\u3059\u308b\n      \u65b0\u898fPET\u30d7\u30ed\u30fc\u30d6\u3092\u958b\u767a\u3057\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fbAMPA\u53d7\u5bb9\u4f53\u306e\u53ef\u8996\u5316\uff08\u4e16\u754c\u521d\uff09<\/strong><br>\n      \u672c\u7814\u7a76\u306b\u3088\u308a\u3001\u8208\u596e\u6027\u30b7\u30ca\u30d7\u30b9\u306b\u304a\u3051\u308bAMPA\u53d7\u5bb9\u4f53\u306e\u5206\u5e03\u3092\u3001\n      PET\u3092\u7528\u3044\u3066\u30d2\u30c8\u751f\u4f53\u8133\u3067\u53ef\u8996\u5316\u3059\u308b\u3053\u3068\u306b\u4e16\u754c\u3067\u521d\u3081\u3066\u6210\u529f\u3057\u305f\u3002\n      \u3053\u306e\u6210\u679c\u306f\u3001\u795e\u7d4c\u6d3b\u52d5\u306e\u5206\u5b50\u57fa\u76e4\u3092\u751f\u4f53\u5185\u3067\u8a55\u4fa1\u53ef\u80fd\u3068\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\n      \u795e\u7d4c\u5909\u6027\u75be\u60a3\u3001\u3066\u3093\u304b\u3093\u3001\u7cbe\u795e\u75be\u60a3\u306a\u3069\u3001\u5e45\u5e83\u3044\u4e2d\u67a2\u795e\u7d4c\u75be\u60a3\u306e\u75c5\u614b\u89e3\u660e\u3078\u306e\u5fdc\u7528\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u8133\u816b\u760d\uff08Glioblastoma\uff09\u3078\u306e\u81e8\u5e8a\u5fdc\u7528<\/strong><br>\n      \u3055\u3089\u306b\u3001\u8133\u795e\u7d4c\u5916\u79d1\u304a\u3088\u3073\u653e\u5c04\u7dda\u6cbb\u7642\u79d1\u3068\u9023\u643a\u3057\u3001\n      \u60aa\u6027\u8133\u816b\u760d\u3067\u3042\u308b\u81a0\u82bd\u816b\uff08glioblastoma\uff09\u3092\u5bfe\u8c61\u3068\u3057\u305f\u81e8\u5e8a\u5fdc\u7528\u7814\u7a76\u3092\u9032\u3081\u3066\u3044\u308b\u3002\n      \u30a2\u30df\u30ce\u9178PET\u30d7\u30ed\u30fc\u30d6\u3067\u3042\u308b <strong><sup>18<\/sup>F-fluciclovine<\/strong> \u3092\u7528\u3044\u308b\u3053\u3068\u3067\u3001\n      \u816b\u760d\u306e\u4ee3\u8b1d\u6d3b\u6027\u3084\u6d78\u6f64\u7bc4\u56f2\u3092\u8a55\u4fa1\u3057\u3001\n      \u624b\u8853\u8a08\u753b\u3084\u653e\u5c04\u7dda\u6cbb\u7642\u8a08\u753b\u3078\u306e\u5fdc\u7528\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u81e8\u5e8a\u7684\u610f\u7fa9\u3068\u4eca\u5f8c\u306e\u5c55\u671b<\/strong><br>\n      \u5206\u5b50\u30ec\u30d9\u30eb\u306e\u795e\u7d4c\u30fb\u816b\u760d\u75c5\u614b\u3092\u753b\u50cf\u3068\u3057\u3066\u6349\u3048\u308b\u672c\u7814\u7a76\u306f\u3001\n      \u5f93\u6765\u306e\u5f62\u614b\u753b\u50cf\u3067\u306f\u8a55\u4fa1\u56f0\u96e3\u3067\u3042\u3063\u305f\u6a5f\u80fd\u7684\u30fb\u751f\u7269\u5b66\u7684\u60c5\u5831\u3092\u63d0\u4f9b\u3059\u308b\u3002\n      \u4eca\u5f8c\u306f\u3001\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u3084\u4e88\u5f8c\u4e88\u6e2c\u3078\u306e\u5fdc\u7528\u3092\u542b\u3081\u3001\n      \u7cbe\u5bc6\u533b\u7642\uff08precision medicine\uff09\u3078\u306e\u767a\u5c55\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 12px; font-size: 0.9em; color: #555;\">\n      Miyazaki T, et al. Visualization of AMPA receptors in living human brain with positron emission tomography.\n      <em>Nature Medicine<\/em> 2020; 26:281\u2013288.\n    <\/p>\n  <\/dd>\n<\/dl>\n\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2462 \u753b\u50cf\u4e0b\u6cbb\u7642\uff08Interventional Radiology\uff1aIVR\uff09\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\n    \u8840\u7ba1\u5185\u6cbb\u7642\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u753b\u50cf\u4e0b\u6cbb\u7642\uff08IVR\uff09\u3092\u57fa\u76e4\u306b\u3001\u96e3\u6cbb\u6027\u75c5\u614b\u306b\u5bfe\u3059\u308b\u4f4e\u4fb5\u8972\u304b\u3064\u5b89\u5168\u306a\u6cbb\u7642\u6226\u7565\u306e\u78ba\u7acb\u3092\u76ee\u6307\u3057\u305f\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u308b\u3002\n    \u975e\u4ee3\u511f\u6027\u809d\u786c\u5909\u306b\u5bfe\u3059\u308b\u8179\u8154\u9759\u8108\u30b7\u30e3\u30f3\u30c8\uff08PVS\uff09\u7559\u7f6e\u5f8c\u306e\u5faa\u74b0\u52d5\u614b\u5909\u5316\u3084\u5408\u4f75\u75c7\u306b\u95a2\u3059\u308b\u691c\u8a0e\u3067\u306f\u3001\n    BNP\u3001\u5fc3\u80f8\u90ed\u6bd4\u3001\u51dd\u56fa\u7cfb\u30de\u30fc\u30ab\u30fc\u306a\u3069\u306e\u7d4c\u6642\u7684\u8a55\u4fa1\u306b\u52a0\u3048\u3001\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7CT\u3092\u7528\u3044\u305f\u5305\u62ec\u7684\u89e3\u6790\u306b\u3088\u308a\u3001\n    \u6cbb\u7642\u52b9\u679c\u304a\u3088\u3073\u30ea\u30b9\u30af\u4e88\u6e2c\u306e\u81e8\u5e8a\u7684\u6709\u7528\u6027\u3092\u660e\u3089\u304b\u306b\u3057\u3066\u3044\u308b\u3002\n    <br><br>\n    \u307e\u305f\u3001Budd-Chiari\u75c7\u5019\u7fa4\u306b\u4f34\u3046\u4e0b\u5927\u9759\u8108\u9589\u585e\u306b\u5bfe\u3057\u3066\u306f\u3001\n    \u8fd1\u4f4d\u7aef\u3092\u6539\u826f\u3057\u305f\u30ac\u30a4\u30c9\u30ef\u30a4\u30e4\u30fc\u3092\u7528\u3044\u305fSharp recanalization\u624b\u6280\u3092\u5fdc\u7528\u3057\u3001\n    \u7279\u6b8a\u30c7\u30d0\u30a4\u30b9\u3092\u7528\u3044\u305a\u306b\u6bb5\u968e\u7684\u30d0\u30eb\u30fc\u30f3\u62e1\u5f35\u3092\u884c\u3046\u3053\u3068\u3067\u3001\n    \u7dda\u7dad\u5316\u75c5\u5909\u306b\u5bfe\u3057\u3066\u3082\u5b89\u5168\u304b\u3064\u8cbb\u7528\u5bfe\u52b9\u679c\u306b\u512a\u308c\u305f\u8840\u7ba1\u518d\u5efa\u3092\u53ef\u80fd\u3068\u3059\u308b\u6cbb\u7642\u6cd5\u3092\u63d0\u6848\u3057\u3066\u3044\u308b\u3002\n    <br><br>\n    \u3055\u3089\u306b\u3001\u814e\u7d30\u80de\u304c\u3093\u306b\u5bfe\u3059\u308b\u30ab\u30c6\u30fc\u30c6\u30eb\u6cbb\u7642\uff08\u52d5\u8108\u585e\u6813\u8853\u30fb\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u6cbb\u7642\uff09\u306b\u95a2\u3059\u308b\u7814\u7a76\u306b\u3082\u53d6\u308a\u7d44\u307f\u3001\n    \u753b\u50cf\u6240\u898b\u3068\u6cbb\u7642\u52b9\u679c\u3001\u5408\u4f75\u75c7\u3068\u306e\u95a2\u9023\u3092\u691c\u8a0e\u3059\u308b\u3053\u3068\u3067\u3001\n    \u500b\u5225\u5316\u6cbb\u7642\u304a\u3088\u3073IVR\u306e\u9069\u5fdc\u6700\u9069\u5316\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    <br>\n    \uff08\u62c5\u5f53\u6559\u54e1\uff1a\u5c0f\u5c71\u65b0\u543e \u8b1b\u5e2b\uff09\n  <\/dd>\n<\/dl>\n\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c911-1024x576.jpg\" alt=\"\" class=\"wp-image-1902\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c911-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c911-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c911-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c911.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c912-1024x576.jpg\" alt=\"\" class=\"wp-image-1903\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c912-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c912-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c912-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u30b9\u30e9\u30a4\u30c912.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2463 \u795e\u7d4c\u653e\u5c04\u7dda\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\n    \u8133\u795e\u7d4c\u5916\u79d1\u3068\u306e\u9023\u643a\u306e\u3082\u3068\u3001\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u3084\u81a0\u82bd\u816b\u306a\u3069\u306e\u8133\u816b\u760d\u3092\u5bfe\u8c61\u3068\u3057\u305f\u6838\u533b\u5b66\u753b\u50cf\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u308b\u3002\n    PET\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u6a5f\u80fd\u753b\u50cf\u3092\u7528\u3044\u3066\u3001\u816b\u760d\u306e\u751f\u7269\u5b66\u7684\u7279\u6027\u8a55\u4fa1\u3001\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u3001\u9451\u5225\u8a3a\u65ad\u3078\u306e\u5fdc\u7528\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    <br><br>\n    \u3055\u3089\u306b\u3001\u795e\u5948\u5ddd\u770c\u7acb\u3053\u3069\u3082\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u3068\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u306e\u9023\u643a\u4f53\u5236\u306e\u3082\u3068\u3001MR fingerprinting\uff08MRF\uff09\u3092\u7528\u3044\u305f\u65b0\u751f\u5150\u8133\u306e\u5b9a\u91cfMRI\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u308b\u3002\n    \u6b63\u5e38\u8133\u767a\u9054\u306b\u4f34\u3046T1\u5024\u3001T2\u5024\u306a\u3069\u306e\u5b9a\u91cf\u5024\u5909\u5316\u3092\u660e\u3089\u304b\u306b\u3057\u3001\u53c2\u7167\u5024\uff08\u30ce\u30fc\u30de\u30eb\u30c7\u30fc\u30bf\uff09\u306e\u6574\u5099\u3092\u9032\u3081\u3066\u3044\u308b\u3002\n    \u52a0\u3048\u3066\u3001\u4f4e\u9178\u7d20\u6027\u865a\u8840\u6027\u8133\u75c7\u3084\u4ee3\u8b1d\u6027\u75be\u60a3\u306a\u3069\u65b0\u751f\u5150\u671f\u306b\u8133\u640d\u50b7\u3092\u6765\u3059\u75be\u60a3\u3092\u5bfe\u8c61\u306b\u3001\n    \u5b9a\u91cf\u7684\u753b\u50cf\u6307\u6a19\u306b\u57fa\u3065\u304f\u8a3a\u65ad\u652f\u63f4\u30fb\u91cd\u75c7\u5ea6\u8a55\u4fa1\u306e\u78ba\u7acb\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    <br>\uff08\u6307\u5c0e\u6559\u54e1\uff1a\u52a0\u85e4\u4e9c\u7d50\u7f8e\u52a9\u6559\uff09\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_7-1024x576.jpg\" alt=\"\" class=\"wp-image-1869\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_7-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_7-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_7-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_7.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2464 \u30e1\u30bf\u89e3\u6790\u30fbsystematic review\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\n    \u753b\u50cf\u8a3a\u65ad\u9818\u57df\u306b\u304a\u3051\u308b\u8a3a\u65ad\u80fd\u3001\u4e88\u5f8c\u4e88\u6e2c\u80fd\u3001\u6cbb\u7642\u52b9\u679c\u306b\u95a2\u3059\u308b systematic review \u304a\u3088\u3073\u30e1\u30bf\u89e3\u6790\u3092\u7a4d\u6975\u7684\u306b\u884c\u3063\u3066\u3044\u308b\u3002\n    \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u3084\u6838\u533b\u5b66\u5206\u91ce\u3092\u4e2d\u5fc3\u306b\u3001\u9ad8\u3044\u30a8\u30d3\u30c7\u30f3\u30b9\u30ec\u30d9\u30eb\u3092\u6709\u3059\u308b\u7814\u7a76\u6210\u679c\u3092\u767a\u4fe1\u3057\u3001\n    \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3084\u81e8\u5e8a\u610f\u601d\u6c7a\u5b9a\u306b\u8cc7\u3059\u308b\u30a8\u30d3\u30c7\u30f3\u30b9\u5275\u51fa\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u3002\n    <br>\uff08\u6307\u5c0e\u6559\u54e1\uff1a\u52a0\u85e4\u771f\u543e\u51c6\u6559\u6388\uff09\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_1-1024x576.jpg\" alt=\"\" class=\"wp-image-1848\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_1-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_1-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_1-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_1.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_4-1024x576.jpg\" alt=\"\" class=\"wp-image-1853\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_4-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_4-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_4-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_4.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width: 100%; margin-top: 18px;\">\n    <h3>CT-ECV\uff08extracellular volume fraction\uff09\u306b\u3088\u308b\u5fc3\u7b4b\u7dda\u7dad\u5316\u8a55\u4fa1\u306e\u30e1\u30bf\u89e3\u6790<\/h3>\n  <\/dt>\n\n  <dd style=\"margin-top: 12px;\">\n    <p>\n      \u5fc3\u7b4b\u306e\u7dda\u7dad\u5316\u306f\u3001\u591a\u304f\u306e\u5fc3\u75be\u60a3\u306b\u5171\u901a\u3059\u308b\u91cd\u8981\u306a\u75c5\u614b\u57fa\u76e4\u3067\u3042\u308a\u3001\n      \u305d\u306e\u5b9a\u91cf\u8a55\u4fa1\u306f\u8a3a\u65ad\u3084\u91cd\u75c7\u5ea6\u8a55\u4fa1\u3001\u4e88\u5f8c\u4e88\u6e2c\u306b\u304a\u3044\u3066\u91cd\u8981\u3067\u3042\u308b\u3002\n      \u5fc3\u81d3MRI\u306b\u3088\u308bECV\uff08extracellular volume fraction\uff09\u8a55\u4fa1\u306f\u5e83\u304f\u7528\u3044\u3089\u308c\u3066\u3044\u308b\u304c\u3001\n      \u8fd1\u5e74\u3067\u306f<strong>\u9020\u5f71CT\u3092\u7528\u3044\u305fECV\u8a55\u4fa1\uff08CT-ECV\uff09<\/strong>\u306e\u6709\u7528\u6027\u3082\u5831\u544a\u3055\u308c\u3066\u3044\u308b\u3002\n      \u672c\u7814\u7a76\u3067\u306f\u3001CT-ECV\u306e\u81e8\u5e8a\u7684\u4fa1\u5024\u3092\u660e\u3089\u304b\u306b\u3059\u308b\u305f\u3081\u3001\n      \u7cfb\u7d71\u7684\u30ec\u30d3\u30e5\u30fc\u304a\u3088\u3073\u30e1\u30bf\u89e3\u6790\u3092\u884c\u3063\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u7814\u7a76\u306e\u6982\u8981<\/strong><br>\n      PubMed\u3001Web of Science\u3001Cochrane Library\u3001EMBASE\u3092\u7528\u3044\u3066\u6587\u732e\u691c\u7d22\u3092\u884c\u3044\u3001\n      \u5fc3\u8840\u7ba1\u75be\u60a3\u306b\u304a\u3051\u308bCT-ECV\u3092\u8a55\u4fa1\u3057\u305f\u65e2\u5831\u7814\u7a76\u3092\u7d71\u5408\u89e3\u6790\u3057\u305f\u3002\n      \u7279\u306b\u3001\u5065\u5e38\u7fa4\u3001\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u3001\u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u304a\u3051\u308b\n      CT-ECV\u5024\u306e\u5dee\u7570\u3092\u4e3b\u8981\u89e3\u6790\u3068\u3057\u3066\u691c\u8a0e\u3057\u305f\u3002\n      \u3055\u3089\u306b\u3001\u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u8a3a\u65ad\u306b\u304a\u3051\u308bCT-ECV\u306e\u8a3a\u65ad\u80fd\u306b\u3064\u3044\u3066\u3082\u89e3\u6790\u3092\u884c\u3063\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u4e3b\u306a\u7d50\u679c<\/strong><br>\n      \u7d71\u5408\u89e3\u6790\u306e\u7d50\u679c\u3001CT-ECV\u306f\u5065\u5e38\u7fa4\u3068\u6bd4\u8f03\u3057\u3066\u5927\u52d5\u8108\u5f01\u72ed\u7a84\u75c7\u3067\u6709\u610f\u306b\u4e0a\u6607\u3057\u3001\n      \u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u3067\u306f\u3055\u3089\u306b\u8457\u660e\u306a\u4e0a\u6607\u3092\u793a\u3057\u305f\u3002\n      \u307e\u305f\u3001CT-ECV\u306f\u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u8a3a\u65ad\u306b\u304a\u3044\u3066\u9ad8\u3044\u611f\u5ea6\u304a\u3088\u3073\u7279\u7570\u5ea6\u3092\u793a\u3057\u3001\n      \u8a3a\u65ad\u7cbe\u5ea6\u306e\u9ad8\u3055\u304c\u78ba\u8a8d\u3055\u308c\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u81e8\u5e8a\u7684\u610f\u7fa9<\/strong><br>\n      CT-ECV\u306f\u3001\u65e5\u5e38\u8a3a\u7642\u3067\u5e83\u304f\u884c\u308f\u308c\u3066\u3044\u308b\u5fc3\u81d3CT\u691c\u67fb\u306b\u4ed8\u52a0\u7684\u89e3\u6790\u3068\u3057\u3066\u5c0e\u5165\u53ef\u80fd\u3067\u3042\u308a\u3001\n      \u975e\u4fb5\u8972\u7684\u306b\u5fc3\u7b4b\u7dda\u7dad\u5316\u3092\u5b9a\u91cf\u8a55\u4fa1\u3067\u304d\u308b\u70b9\u304c\u5927\u304d\u306a\u5229\u70b9\u3067\u3042\u308b\u3002\n      \u7279\u306b\u3001\u7d4c\u30ab\u30c6\u30fc\u30c6\u30eb\u7684\u5927\u52d5\u8108\u5f01\u7f6e\u63db\u8853\uff08TAVR\uff09\u524d\u306e\u8853\u524dCT\u306b\u304a\u3044\u3066\u3001\n      \u5fc3\u81d3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u3084\u9451\u5225\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u793a\u3055\u308c\u305f\u3002\n    <\/p>\n\n    <p style=\"margin-top: 10px;\">\n      <strong>\u30fb\u4eca\u5f8c\u306e\u5c55\u671b<\/strong><br>\n      \u4eca\u5f8c\u306f\u3001MRI\u3068\u306e\u76f4\u63a5\u6bd4\u8f03\u3084\u4e88\u5f8c\u3068\u306e\u95a2\u9023\u3092\u691c\u8a0e\u3059\u308b\u524d\u5411\u304d\u7814\u7a76\u3092\u901a\u3058\u3066\u3001\n      CT-ECV\u306e\u81e8\u5e8a\u7684\u4f4d\u7f6e\u3065\u3051\u3092\u3055\u3089\u306b\u660e\u78ba\u5316\u3059\u308b\u3053\u3068\u304c\u671f\u5f85\u3055\u308c\u308b\u3002\n      \u307e\u305f\u3001\u5408\u6210ECV\uff08synthetic ECV\uff09\u306a\u3069\u306e\u65b0\u305f\u306a\u624b\u6cd5\u306e\u5c0e\u5165\u306b\u3088\u308a\u3001\n      \u9020\u5f71\u6761\u4ef6\u3084\u64ae\u50cf\u30d7\u30ed\u30c8\u30b3\u30eb\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8a55\u4fa1\u6cd5\u3078\u306e\u767a\u5c55\u3082\u671f\u5f85\u3055\u308c\u308b\u3002\n    <\/p>\n\n    <p style=\"margin-top: 12px; font-size: 0.9em; color: #555;\">\n      Kato S, Misumi Y, Utsunomiya D, et al. JACC: Cardiovascular Imaging, 2024; 17:516\u2013528\n    <\/p>\n  <\/dd>\n<\/dl>\n\n\n\n<dl class=\"contents_list flex_box\">\n  <dt style=\"width:100%; margin-top:18px; border-left:6px solid #c62828; padding-left:12px;\">\n    <h3 style=\"font-size:1.25em; font-weight:600; margin:0; background:none; border:none;\">\n      \u2465 \u4eba\u5de5\u77e5\u80fd\u7814\u7a76\n    <\/h3>\n  <\/dt>\n  <dd style=\"margin-top:12px; font-size:1.05em; line-height:1.7; margin-left:0;\">\n    Deep learning \u306a\u3069\u306e\u4eba\u5de5\u77e5\u80fd\u6280\u8853\u3092\u7528\u3044\u305f\u753b\u50cf\u89e3\u6790\u7814\u7a76\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u3002\n    \u5177\u4f53\u7684\u306b\u306f\u3001\u9593\u8cea\u6027\u80ba\u708e\u306b\u304a\u3051\u308b\u7dda\u7dad\u5316\u306e\u5b9a\u91cf\u5316\u3092\u76ee\u7684\u3068\u3057\u305f\u753b\u50cf\u89e3\u6790\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u306e\u958b\u767a\u3084\u3001\n    \u753b\u50cf\u8aad\u5f71\u6642\u306e\u8996\u7dda\u8a08\u6e2c\uff08eye-tracking\uff09\u30c7\u30fc\u30bf\u3092\u6d3b\u7528\u3057\u305f\u8aad\u5f71\u884c\u52d5\u89e3\u6790\u3092\u884c\u3063\u3066\u3044\u308b\u3002\n    \u3053\u308c\u3089\u306e\u7814\u7a76\u3092\u901a\u3058\u3066\u3001\u8a3a\u65ad\u7cbe\u5ea6\u306e\u5411\u4e0a\u306e\u307f\u306a\u3089\u305a\u3001\u6559\u80b2\u30fb\u8aad\u5f71\u652f\u63f4\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u5fdc\u7528\u3092\u76ee\u6307\u3057\u3066\u3044\u308b\u3002\n    \u672c\u5206\u91ce\u306f\u6bd4\u8f03\u7684\u65b0\u3057\u3044\u7814\u7a76\u9818\u57df\u3067\u3042\u308b\u305f\u3081\u3001\u7279\u5b9a\u306e\u6307\u5c0e\u6559\u54e1\u3092\u8a2d\u3051\u305a\u3001\u533b\u5c40\u54e1\u304c\u9023\u643a\u30fb\u5354\u529b\u3057\u3066\u7814\u7a76\u3092\u63a8\u9032\u3057\u3066\u3044\u308b\u3002\n  <\/dd>\n<\/dl>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u533b\u5c40HP\u7528_6-1024x576.jpg\" alt=\"\" class=\"wp-image-1894\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u533b\u5c40HP\u7528_6-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u533b\u5c40HP\u7528_6-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u533b\u5c40HP\u7528_6-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/02\/\u533b\u5c40HP\u7528_6.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_6-1024x576.jpg\" alt=\"\" class=\"wp-image-1857\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_6-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_6-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_6-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_6.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_5-1-1024x576.jpg\" alt=\"\" class=\"wp-image-1859\" srcset=\"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_5-1-1024x576.jpg 1024w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_5-1-300x169.jpg 300w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_5-1-768x432.jpg 768w, https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wordpress\/wp-content\/uploads\/2026\/01\/\u533b\u5c40HP\u7528_5-1.jpg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading contents_title\">\u696d\u7e3e\u30ea\u30b9\u30c8<\/h2>\n\n\n\n<div class=\"changeElem_btn_content\"><button class=\"change_elem_btn list_btn\">2024\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2023\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2022\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2021\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2020\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2019\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2018\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2017\u5e74<\/button><br><button class=\"change_elem_btn list_btn\">2016\u5e74<\/button><\/div>\n\n\n\n<p class=\"has-text-align-center\">2017\u5e74\u307e\u3067\u306f\u653e\u5c04\u7dda\u6cbb\u7642\u79d1\u306e\u696d\u7e3e\u3082\u8a18\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<p><!-- ====== 2024\u5e74 ====== --><\/p>\n\n\n\n<div id=\"panel_2024\" class=\"change_elem_panel\" style=\"display: block;\"><!-- \u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff1a\u539f\u8457\u8ad6\u6587\uff08\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080\uff09 -->\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Aoki R, Kobayashi Y, Nakajima K, Kamide H, Miwa H, Tsuchiya H, Oishi R, Inoue A, Irie S, Misumi Y, Mochizuki H, Magami S, Sugimori K, Sekikawa Z, Utsunomiya D: Transarterial and Transvenous Approach for the Embolization of Arteriovenous Fistula between the Hepatic Arteries and Inferior Vena Cava Associated with Liver Abscess Due to Cholangitis. Interv Radiol, 9\uff082\uff09: 69\uff0d73, 2024.<\/dd>\n<dd>Aoki R: Resuscitative Endovascular Balloon Occlusion of the Aorta in Patients With Exsanguinating Hemorrhage. JAMA, 331\uff0811\uff09: 979, 2024.<\/dd>\n<dd>Aoki R, Iwasawa T, Utsunomiya D, Yamakawa H, Kitamura H, Baba T, Ogura T: Interstitial lung disease associated with anti-aminoacyl-tRNA synthetase syndrome: quantitative evaluation of CT after initial treatment and long-term follow-up. Acta Radiol, 65\uff0811\uff09: 1332\uff0d1340, 2024.<\/dd>\n<dd>Azuma M, Kato S, Sawamura S, Fukui K, Takizawa R, Nakayama N, Ito M, Hibi K, Utsunomiya D: Prevalence of cardiac amyloidosis in atrial fibrillation: a CMR study prior to catheter ablation. Heart Vessels, 40\uff082\uff09: 131\uff0d139, 2024.<\/dd>\n<dd>Enokizono M, Kurokawa R, Yagishita A, Nakata Y, Koyasu S, Nihira H, Kuwashima S, Aida N, Kono T, Mori H: Clinical and neuroimaging review of monogenic cerebral small vessel disease from the prenatal to adolescent developmental stage. Jpn J Radiol, 42\uff082\uff09: 109\uff0d125, 2024.<\/dd>\n<dd>Fujita R, Iwasawa T, Aoki T, Iwao Y, Ogura T, Utsunomiya D: Detection of the usual interstitial pneumonia pattern in chest CT: effect of computer-aided diagnosis on radiologist diagnostic performance. Acta Radiol, 65\uff083\uff09: 259\uff0d266, 2024. doi: 10.1177\/0284185120902393.<\/dd>\n<dd>Ikeda S, Ogura T, Kato T, Kenmotsu H, Agemi Y, Tokito T, Ito K, Isomoto K, Takiguchi Y, Yoneshima Y, Yokoyama T, Harada T, Tanzawa S, Kobayashi N, Iwasawa T, Misumi T, Okamoto H: Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc, 21\uff084\uff09: 635\uff0d643, 2024.<\/dd>\n<dd>Kagimoto M, Kato S, Takizawa R, Kodama S, Suzurikawa K, Azuma M, Nakayama N, Iguchi K, Fukui K, Ito M, Iwasawa T, Kino T, Utsunomiya D: Hyperenhancement of LA Wall by Three-Dimensional High-Resolution Late Gadolinium-Enhanced MRI and Recurrence of AF After Catheter Ablation. J Clin Med, 13\uff0823\uff09: 7357, 2024.<\/dd>\n<dd>Kato K, Goto H, Tanaka M, Suzuki T, Toyoda Y, Shinkai M, Kitagawa N, Nishi T, Kigasawa H, Kurosawa K, Aida N, Yoshimi A, Noda A, Ito Y, Seki M, Takita J, Nagahara N, Tsuchida M, Tanaka Y: Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell Line. Genes Chromosomes Cancer, 63\uff0810\uff09: e23276, 2024.<\/dd>\n<dd>Kato S, Misumi Y, Horita N, Yamamoto K, Utsunomiya D: Clinical Utility of Computed Tomography-Derived Myocardial Extracellular Volume Fraction: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging, 17\uff085\uff09: 516\uff0d528, 2024. doi: 10.1016\/j.jcmg.2023.10.008.<\/dd>\n<dd>Kato S, Kitai T, Utsunomiya D, Azuma M, Fukui K, Hagiwara E, Ogura T, Ishibashi Y, Okada T, Kitakata H, Shiraishi Y, Torii S, Ohashi K, Takamatsu K, Yokoyama A, Hirata K, Matsue Y, Node K: Myocardial Injury by COVID-19 Infection Assessed by Cardiovascular Magnetic Resonance Imaging &#8211; A Prospective Multicenter Study. Circ J, 88\uff089\uff09: 1450\uff0d1458, 2024. doi: 10.1253\/circj.CJ-23-0729.<\/dd>\n<dd>Kato S: Reply: Computed Tomography Extracellular Volume Measurement in Healthy Participants. JACC Cardiovasc Imaging, 17\uff084\uff09: 464, 2024. doi: 10.1016\/j.jcmg.2024.02.006.<\/dd>\n<dd>Kato S, Azuma M, Kodama S, Horita N, Utsunomiya D: Catheter ablation of atrial fibrillation improves outcomes in heart failure: An updated meta-analysis. ESC Heart Fail, 11\uff085\uff09: 3449\uff0d3452, 2024. doi: 10.1002\/ehf2.14919.<\/dd>\n<dd>Kato S, Azuma M, Horita N, Utsunomiya D: Monitoring the Efficacy of Tafamidis in ATTR Cardiac Amyloidosis by MRI-ECV: A Systematic Review and Meta-Analysis. Tomography, 10\uff088\uff09: 1303\uff0d1311, 2024.<\/dd>\n<dd>Kato S, Azuma M: Reply: Exploring the link between COVID-19 and coronary spasm. J Cardiol Cases, 30\uff083\uff09: 102, 2024.<\/dd>\n<dd>Kato S, Azuma M, Horita N, Utsunomiya D: Prognostic significance of CAD-RADS for patients with suspected coronary artery disease: A systematic review and meta-analysis. Radiology Advances, 1\uff081\uff09: umae007, 2024.<\/dd>\n<dd>Kawaguchi Y, Kato S, Horita N, Utsunomiya D: Value of dynamic computed tomography myocardial perfusion in CAD: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging, 25\uff0812\uff09: 1675\uff0d1685, 2024. doi: 10.1093\/ehjci\/jeae118.<\/dd>\n<dd>Koike Y, Motohashi K, Kato S: Safety and Effectiveness of Endovascular Treatment of Complications Associated with Persistent Sciatic Artery: A Qualitative Systematic Review. J Vasc Interv Radiol, 35\uff088\uff09: 1117\uff0d1126, 2024. doi: 10.1016\/j.jvir.2024.04.013.<\/dd>\n<dd>Koyama S, Nogami A, Yoneda M, Cheng S, Koike Y, Takeuchi Y, Iwaki M, Kobayashi T, Saito S, Utsunomiya D, Nakajima: Chronological course and clinical features after Denver peritoneovenous shunt placement in decompensated liver cirrhosis. Tomography, 10\uff083\uff09: 471\uff0d479, 2024. doi: 10.3390\/tomography10040036.<\/dd>\n<dd>Kuninaka H, Usumoto Y, Tanabe M, Ogawa N, Mukai M, Nasu A, Maeda K, Fuke C, Sawamura S, Yamashiro T, Utsunomiya D, Ihama Y: Distinguishing true from pseudo hematoma in the cervical spinal canal using postmortem computed tomography. Leg Med\uff08Tokyo\uff09, 66: 102358, 2024. doi: 10.1016\/j.legalmed.2023.102358.<\/dd>\n<dd>Kurita Y, Utsunomiya D, Kubota K, Koyama S, Hasegawa S, Hosono K, Irie K, Suzuki Y, Maeda S, Kobayashi N, Ichikawa Y, Endo I, Nakajima A: Diagnostic value of contrast-enhanced dual-energy computed tomography in the pancreatic parenchymal and delayed phases for pancreatic cancer. Tomography, 10\uff0810\uff09: 1591\uff0d1604, 2024. doi: 10.3390\/tomography10100117.<\/dd>\n<dd>Kuroda Y, Naruto T, Tsuyusaki Y, Kato A, Aida N, Kurosawa K: Role of TOE1 variants at the nuclear localization motif in pontocerebellar hypoplasia 7. J Hum Genet, 67\uff087\uff09: 349\uff0d355, 2024.<\/dd>\n<dd>Morioka T, Kato S, Onoma A, Izumi T, Sakano T, Ishikawa E, Sawamura S, Yasuda N, Nagase H, Utsunomiya D: Improvement of Quantification of Myocardial Synthetic ECV with Second-Generation Deep Learning Reconstruction. J Cardiovasc Dev Dis, 11\uff0810\uff09: 304, 2024.<\/dd>\n<dd>Murakami H, Enomoto Y, Kumaki T, Aida N, Kurosawa K: Nanopore long-read sequencing analysis reveals ZIC1 dysregulation caused by a de novo 3q inversion with a breakpoint located 7 kb downstream of ZIC1. J Hum Genet, 69\uff081\uff09: 47\uff0d52, 2024.<\/dd>\n<dd>Nakaigawa N, Hasumi H, Utsunomiya D, Yoshida K, Ishiwata Y, Oka T, Hayward C, Makiyama K: Evaluation of PET\/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma\uff08Zirdac-JP\uff09. Jpn J Clin Oncol, 54\uff088\uff09: 873\uff0d879, 2024. doi: 10.1093\/jjco\/hyae075.<\/dd>\n<dd>Nishiyama K, Baba T, Oda T, Sekine A, Niwa T, Yamada S, Kaburaki S, Nagasawa R, Okudela K, Takemura T, Iwasawa T, Mineshita M, Ogura T: Bilateral Pneumothorax after a Transbronchial Lung Cryobiopsy for Interstitial Lung Disease. Intern Med, 63\uff086\uff09: 839\uff0d842, 2024.<\/dd>\n<dd>Sakurai Y, Iwasaki F, Hirose A, Matsumoto N, Miyagawa N, Keino D, Yokosuka T, Hamanoue S, Yanagimachi M, Shiomi M, Goto S, Tanaka M, Tanaka Y, Nozawa K, Goto H: Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study. J Pediatr Hematol Oncol, 46\uff085\uff09: 233\uff0d240, 2024.<\/dd>\n<dd>Sawamura S, Kato S, Funama Y, Oda S, Mochizuki H, Inagaki S, Takeuchi Y, Morioka T, Izumi T, Ota Y, Kawagoe H, Cheng S, Nakayama N, Fukui K, Tsutsumi T, Iwasawa T, Utsunomiya D: Evaluation of four computed tomography reconstruction algorithms using a coronary artery phantom. Quant Imaging Med Surg, 14\uff084\uff09: 2870\uff0d2883, 2024. doi: 10.21037\/qims-23-1204.<\/dd>\n<dd>Sekii R, Kato S, Horita N, Utsunomiya D: Prognostic role of late gadolinium-enhanced MRI in confirmed and suspected cardiac sarcoidosis: meta-analysis. Int J Cardiovasc Imaging, 40\uff088\uff09: 1797\uff0d1807, 2024.<\/dd>\n<dd>Takahashi Y, Iijima T, Ishidera Y, Imai Y, Mizushima T, Utsunomiya D, Kobayashi N, Ichikawa Y, Kato S, Harada J, Miyagi: Primary small bowel adenocarcinoma with metastatic ovarian tumor in a pregnant woman. Case Rep Oncol, 17\uff081\uff09: 882\uff0d890, 2024. doi: 10.1159\/000540524.<\/dd>\n<dd>Tanigaki T, Kato S, Azuma M, Nitta M, Horita N, Utsunomiya D: Right ventricular myocardial fibrosis evaluated by extracellular volume fraction by magnetic resonance imaging in patients with repaired tetralogy of Fallot: a meta-analysis. Heart Vessels, 39\uff084\uff09: 349\uff0d358, 2024. doi: 10.1007\/s00380-023-02332-y.<\/dd>\n<dd>Terauchi M, Yamashiro T, Sawamura S, Koyama S, Nakaigawa N, Kondo K, Hasumi H, Makiyama K, Utsunomiya D: Combining transarterial embolization and percutaneous cryoablation for early-stage renal cell carcinoma: embolization materials and impacts of tumor size. Tomography, 10\uff0811\uff09: 1767\uff0d1779, 2024. doi: 10.3390\/tomography10110130.<\/dd>\n<dd>Uehara T, Seki E, Nonoda Y, Kumaki T, Tsuyusaki Y, Aida N, Enomoto Y, Ishikura K, Kurosawa K: Two siblings with acute necrotizing encephalopathy associated with variants of LARS1. Am J Med Genet A, 194\uff0811\uff09: e63803, 2024.<\/dd>\n<dd>Zenjiro S, Kamide H, Kobayashi Y, Terauchi M: Multiple delayed-onset metachronous ileal stenoses after transcatheter arterial embolisation using N-butyl-2-cyanoacrylate for upper gastrointestinal bleeding: Factors of complication and importance of plain CT evaluations. BJR Case Rep, 10\uff086\uff09: uaae042, 2024.<\/dd>\n<dd>Ninomiya K, Nakaza E, Yamashiro T, Abe T, Ikematsu N, Nagama H, Kakazu K, Fukasawa M: Shaken adult syndrome due to ocean wave: an autopsy case. Forensic Sci Med Pathol, 20\uff081\uff09: 233\uff0d238, 2024. doi: 10.1007\/s12024-023-00699-y.<\/dd>\n<dd>\u5e73\u5c71\u9ebb\u5229\u5b50\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c\u9752\u6728\u3000\u4eae\uff0c\u9752\u6728\u3000\u6df3\uff0c\u795e\u6238\u7f8e\u6709\u5e0c\uff0c\u82b3\u8cc0\u3000\u6681\uff0c\u9ad8\u4e0b\u5553\u660e\uff0c\u5c71\u57ce\u6052\u96c4\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff0c\u8352\u4e95\u5b8f\u96c5\uff0c\u6fa4\u4f4f\u77e5\u679d: \u80ba\u764c\u80f8\u819c\u6d78\u6f64\u306e\u8853\u524d\u8a55\u4fa1\u306b\u304a\u3051\u308b4DCT\u53ca\u3073\u80f8\u819c\u7652\u7740\u89e3\u6790\u30bd\u30d5\u30c8\u306e\u6709\u7528\u6027\u306e\u8a55\u4fa1\uff0e\u6a2a\u6d5c\u533b\u5b66\uff0c75\uff084\uff09: 535\uff0d540\uff0c2024\uff0e<\/dd>\n<\/dl>\n<p><!-- \u7dcf\u8aac --><\/p>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff5c\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff0c\u77f3\u7530\u548c\u53f2\uff0c\u9ad8\u68a8\u79c0\u4e00\u90ce: \u5fc3\u81d3\u5f01\u819c\u75c7\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c\uff0c153\uff081\uff09: 257\uff0d258\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u3089\u5b66\u3076\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\uff0e\u753b\u50cf\u8a3a\u65ad\uff0c44\uff086\uff09: 606\uff0d612\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u75c7\u4f8b\u304b\u3089\u5b66\u3076\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad \u5fc3\u7b4b\u6897\u585e\uff0e\u753b\u50cf\u8a3a\u65ad\uff0c44\uff081\uff09: 22\uff0d23\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u75c7\u4f8b\u304b\u3089\u5b66\u3076\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad \u51a0\u52d5\u8108\u5468\u56f2\u8102\u80aa\u6e1b\u5f31\u6307\u6570\uff0e\u753b\u50cf\u8a3a\u65ad\uff0c44\uff081\uff09: 34\uff0d35\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u75c7\u4f8b\u304b\u3089\u5b66\u3076\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad \u5fc3\u7b4b\u708e\uff0e\u753b\u50cf\u8a3a\u65ad\uff0c44\uff081\uff09: 66\uff0d67\uff0c2024\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306b\u304a\u3051\u308bDLR\u306e\u6709\u7528\u6027\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c40\uff081\uff09: 1485\uff0d1491\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e\uff0c\u76f8\u7530\u5178\u5b50: \u65b0\u751f\u5150\u306e\u982d\u90e8\u753b\u50cf\u8a3a\u65ad\u306e\u30a8\u30c3\u30bb\u30f3\u30b7\u30e3\u30eb\uff0d\u6b63\u5e38\u89e3\u5256\u3068\u4e3b\u8981\u75c5\u614b\uff0d\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c40\uff0810\uff09: 1170\uff0d1179\uff0c2024\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u75c7\u5019\u5b66\u306b\u5fdc\u3058\u305f\u753b\u50cf\u691c\u67fb\u306e\u9078\u629e 3 \u80f8\u90e8 \u547c\u5438\u56f0\u96e3\uff0e\u65e5\u672c\u533b\u5e2b\u4f1a\u96d1\u8a8c\uff0c153\uff08\u7279\u5225\u53f71\uff09: S147\uff0dS149\uff0c2024\uff0e<\/dd>\n<dd>\u4e0a\u51fa\u6d69\u4e4b\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3MRI\u306b\u3088\u308b\u5fc3\u7b4b\u30b9\u30c8\u30ec\u30a4\u30f3\u89e3\u6790\uff0e\u65e5\u72ec\u533b\u5831\uff0c67\uff084\uff09: 45\uff0d52\uff0c2023\uff0e<\/dd>\n<\/dl>\n<p><!-- \u8457\u66f8 --><\/p>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff5c\u8457\u66f8<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u8a3a\u65ad\uff0e\u75c7\u4f8b\u304b\u3089\u5b66\u3076\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad\uff0eGakken\u79c0\u6f64\u793e\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u75be\u60a3\u306eCT\u3068MRI\u3000\u5fc3\u7b4b\u75be\u60a3\u3000\u9069\u5fdc\u3068\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\uff0e\u533b\u5b66\u66f8\u9662\uff0c254-258\uff0c2024\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e: \u81e8\u5e8a\u753b\u50cf\uff0e\u7d76\u5bfe\u82e6\u624b\u5206\u91ce\u306b\u3057\u306a\u3044 \u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c1170-1179\uff0c2024\uff0e<\/dd>\n<dd>\u5800\u6c5f\u6167\u4e00\uff0c\u5ca1\u90e8\u54f2\u5f66\uff0c\u52a0\u85e4\u5927\u6cb3\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: CT-like MRI\u306b\u3088\u308b\u8171\u306e\u8a55\u4fa1 \u81e8\u5e8a\u30b9\u30dd\u30fc\u30c4\u533b\u5b66 2024\u5e748\u6708 \u30b9\u30dd\u30fc\u30c4\u533b\u5b66\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\uff0d\u5c0f\u5150\u306e\u88ab\u66dd\u4f4e\u6e1b\u3092\u76ee\u6307\u3059\u53d6\u308a\u7d44\u307f\uff0d\uff0e\u6587\u5149\u5802\uff0c806-810\uff0c2024\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u3000CT\u306b\u304a\u3051\u308b\u9020\u5f71\u5264\u306e\u6295\u4e0e\u3068\u5b89\u5168\u7ba1\u7406 CT\u7528\u9020\u5f71\u5264\u3092\u6295\u4e0e\u6642\u306b\u6ce8\u610f\u304c\u5fc5\u8981\u306a\u75c5\u614b \u5c0f\u5150\uff0eMEDICAL VIEW\uff0c242-245\uff0c2024\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u3000CT\u306b\u304a\u3051\u308b\u9020\u5f71\u5264\u306e\u6295\u4e0e\u3068\u5b89\u5168\u7ba1\u7406 CT\u7528\u9020\u5f71\u5264\u3092\u6295\u4e0e\u6642\u306b\u6ce8\u610f\u304c\u5fc5\u8981\u306a\u75c5\u614b \u6388\u4e73\u5a66\uff0eMEDICAL VIEW\uff0c246\uff0c2024\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u3000CT\u306b\u304a\u3051\u308b\u9020\u5f71\u5264\u306e\u6295\u4e0e\u3068\u5b89\u5168\u7ba1\u7406 CT\u7528\u9020\u5f71\u5264\u3092\u6295\u4e0e\u6642\u306b\u6ce8\u610f\u304c\u5fc5\u8981\u306a\u75c5\u614b \u598a\u5a20\u3042\u308b\u3044\u306f\u598a\u5a20\u306e\u53ef\u80fd\u6027\u304c\u3042\u308b\u5973\u6027\uff0eMEDICAL VIEW\uff0c247-248\uff0c2024\uff0e<\/dd>\n<dd>\u5c0f\u5c71\u65b0\u543e: \u7814\u4fee\u533b\u30fb\u7dcf\u5408\u8a3a\u7642\u533b\u306e\u305f\u3081\u306e\u304c\u3093\u5316\u5b66\u7642\u6cd5\u30d5\u30a1\u30fc\u30b9\u30c8\u30bf\u30c3\u30c1\uff0e\u3058\u307b\u3046\uff0c348-356\uff0c2024\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff0c\u7532\u7530\u82f1\u91cc\u5b50\uff0c\u4e95\u4e0a\u54f2\u5175: \u547c\u5438\u5668\u75be\u60a3\u8a3a\u65ad\u91cd\u8981\u306aCT\u6240\u898b \u547c\u5438\u5668\u8a3a\u7642\u30a8\u30c3\u30bb\u30f3\u30b7\u30e3\u30eb\uff08\u7b2c1\u7248\uff09\uff0e\u682a\u5f0f\u4f1a\u793e\u5357\u6c5f\u5802\uff0c235-257\uff0c2024\uff0e<\/dd>\n<\/dl>\n<p><!-- \u5b66\u4f1a\u7b49\u767a\u8868 --><\/p>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff5c\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Iwasawa T, Sawazumi T, Matsumura M, Takemura T, Aoki R, Yasuda H, Otoshi R, Baba T, and Ogura T: Clinicopathological correlation of multiple cystic lesions in the lung. RSNA 2024\uff0c\u30b7\u30ab\u30b4\uff0c2024\uff0c12\uff0e<\/dd>\n<dd>Yamashiro T, Moriya H: Evaluations of pulmonary function for the separated right\/left lungs and five lobes by dynamic-ventilation CT. 11th International Workshop on Pulmonary Functional Imaging, Otsu, 2024, 8.<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e: Motion Detection in Neonatal MR Fingerprinting: Enhancing Reliability in T1 and T2 values\uff0eIMRM2024\uff0c\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\uff0c2024\uff0c5\uff0e<\/dd>\n<dd>Azuma M, Kato S, Yuki S, Takizawa R, Saigo S, Iguchi K, Nakayama N, Fukui K, Iwasawa T, Ishii S, Sawamura S, Utsunomiya D, Hibi K: Prevalence of Cardiac Amyloidosis in Patients with Atrial Fibrillation Treated with Catheter Ablation: A Study using Cardiac Magnetic Resonance\uff0e\u7b2c88\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u795e\u6238\uff0c2024\uff0c3\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad-CT,MRI\u306e\u8aad\u5f71\uff0e\u7b2c10\u56deRadiology Today in Setouchi\uff0c\u677e\u5c71\uff0c2024\uff0c1\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad\u3068\u5411\u304d\u5408\u3046\uff0e\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668MRI\u306e\u30c8\u30d4\u30c3\u30af\u3068\u8ab2\u984c\uff0e\u7b2c12\u56deMRI\u5faa\u74b0\u5668\u64ae\u5f71\u7814\u7a76\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u9069\u5207\u306a\u753b\u50cf\u8a3a\u65ad\u3068\u653e\u5c04\u7dda\u79d1\u306e\u4ed5\u7d44\u307f\u3065\u304f\u308a\uff0eAdvanced Life Science Meeting\uff0c\u6a2a\u6d5c\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u8a3a\u65ad\u306e\u30c8\u30d4\u30c3\u30af\u30b9\uff5e\u8a3a\u7642\u306b\u6d3b\u304b\u3059MRI\uff0cCT\uff0cSPECT\uff0e\u6a2a\u9808\u8cc0\u30a8\u30ea\u30a2 \u30d0\u30a4\u30a8\u30eb\u753b\u50cf\u8a3a\u65ad\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff0c\u6a2a\u9808\u8cc0\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u8a3a\u65ad\u306b\u304a\u3051\u308b\u5076\u767a\u6240\u898b\u306e\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\uff0e\u5e83\u5cf6\u753b\u50cf\u8a3a\u65ad\u8b1b\u6f14\u4f1a\uff0c\u5e83\u5cf6\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\u518d\u8003\u30fc\u6280\u8853\u8a3a\u7642\u306e\u878d\u5408\u304c\u3082\u305f\u3089\u3059\u3082\u306e\uff0e\u7b2c23\u56de\u9ad8\u901f\u3089\u305b\u3093CT\u7814\u7a76\u4f1a\uff0c\u76db\u5ca1\uff0c2024\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u6700\u65b0\u306e\u5fc3\u81d3CT\u6280\u8853: \u5fc3\u7b4b\u8a55\u4fa1\u306e\u6700\u524d\u7dda\uff0eGlobal Standard CT Symposium 2024\uff0c\u6771\u4eac\uff0c2024\uff0c8\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u51a0\u52d5\u8108CT\uff0eJCR \u30df\u30c3\u30c9\u30a6\u30a3\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc\uff0c\u4ed9\u53f0\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5faa\u74b0\u5668\u9818\u57df\u306e\u753b\u50cf\u8a3a\u65adup-date\uff0e\u6a2a\u6d5c\u5e02\u5927\u5927\u5b66\u9662 \u533b\u7406\u9023\u643a\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0c7\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u9032\u5316\u3059\u308b\u653e\u5c04\u7dda\u753b\u50cf\u6280\u8853\uff0d\u6700\u65b0\u306e\u8a3a\u65ad\u30a2\u30d7\u30ed\u30fc\u30c1\uff0d\uff0e\u30a2\u30eb\u30ca\u30a4\u30e9\u30e0\u793e\u5185\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u7b4b\u306e\u30de\u30c3\u30d4\u30f3\u30b0\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u75c7\u306e\u8a3a\u65ad\uff0eRadiology Update \u5b66\u8853\u8b1b\u6f14\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u9032\u5316\u3059\u308b\u653e\u5c04\u7dda\u753b\u50cf\u6280\u8853\u3000\u6700\u65b0\u306e\u8a3a\u65ad\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u795e\u5948\u5dddATTR-CM\u30a6\u30a7\u30d6\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0c3\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3 \u81d3 MRI \u306b\u3088\u308b\u5fc3\u7b4b\u708e\u306e\u8a3a\u65ad Pearls and Pitfalls\uff0e\u95a2\u6771\u5fc3\u81d3MRI\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI: \u5fc3\u7b4b\u75c7\u8a3a\u65ad\u3092\u30b7\u30f3\u30d7\u30eb\u306b\uff01 JCR \u30df\u30c3\u30c9\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc\uff0c\u6d5c\u677e\uff0c2024\uff0c7\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5c02\u9580\u5bb6\u3067\u306a\u304f\u3066\u3082\u30b3\u30b3\u3060\u3051\u306f\u77e5\u3063\u3066\u3066\u307b\u3057\u3044\u6700\u8fd1\u306e\u8a71\u984c: \u5fc3\u5927\u8840\u7ba1\u9818\u57df\uff0e\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u9032\u5316\u3059\u308b\u653e\u5c04\u7dda\u753b\u50cf\u6280\u8853 \u6700\u65b0\u306e\u8a3a\u65ad\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c1\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u518d\u69cb\u6210\u6280\u8853\u3092\u7528\u3044\u305fCT\/MR\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u3068\u305d\u306e\u6d3b\u7528\u8853\uff0e\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c1\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u8a3a\u65ad\uff0c\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u306b\u304a\u3051\u308b\u5fc3\u81d3MRI\u306e\u91cd\u8981\u6027\uff0e\u65e5\u672c\u6838\u533b\u5b66\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI\u306e\u6700\u8fd1\u306e\u8a71\u984c\uff0e\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c7\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: REVORAS\u3092\u7528\u3044\u305f\u5305\u62ec\u7684\u51a0\u52d5\u8108\u89e3\u6790: \u5fc3\u8840\u7ba1\u30a4\u30d9\u30f3\u30c8\u30ea\u30b9\u30af\u3092\u63b4\u3080\uff0eBeyond Angiography Japan \u2169\u2169\u2167\uff0c\u795e\u6238\uff0c2024\uff0c3\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: Perfusion MRI\uff0eBeyond Angiography Japan \u2169\u2169\u2167\uff0c\u795e\u6238\uff0c2024\uff0c3\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u6700\u524d\u7dda\uff0e\u5faa\u74b0\u5668\u753b\u50cf\u7814\u7a76\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c8\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI\u306e\u9032\u6b69\u3068\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u65b0\u5c55\u958b\uff0e\u795e\u5948\u5dddMRI\u6280\u8853\u7814\u7a76\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3CT\u6d3b\u7528\u8853\uff5e\u51a0\u52d5\u8108\u304b\u3089\u5fc3\u7b4b\u307e\u3067\u306e\u5305\u62ec\u7684\u306a\u8a55\u4fa1\uff5e\uff0e\u6a2a\u9808\u8cc0\u30a8\u30ea\u30a2 \u30d0\u30a4\u30a8\u30eb\u753b\u50cf\u8a3a\u65ad\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff0c\u6a2a\u9808\u8cc0\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI: \u5faa\u74b0\u5668\u8a3a\u7642\u3067\u306e\u6d3b\u7528\u6cd5\u3068pitfall\uff0e\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: CT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8a55\u4fa1\u306e\u6700\u65b0\u52d5\u5411\u3068\u4eca\u5f8c\u306e\u5c55\u671b\uff0e\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a \u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c12\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\u306e\u6700\u524d\u7dda\uff0e\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09\uff0c\u795e\u6238\uff0c2024\uff0c3\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: Feature Tracking\u306b\u3088\u308bGLS\u306e\u6b63\u5e38\u7bc4\u56f2\u306f\u3042\u308b\u304b\uff1f SCMR Japan WG seminar\uff0c\u6771\u4eac\uff0c2024\uff0c8\uff0e<\/dd>\n<dd>\u6771 \u771f\u4f0a\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u798f\u4e95\u548c\u6a39\uff0c\u5ca1\u7530\u8208\u9020\uff0c\u65e5\u6bd4 \u6f54\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: Dynamic Myocardial CT Perfusion\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u30e1\u30bf\u30a2\u30ca\u30ea\u30b7\u30b9\uff0e\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c1\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e: Sj\u00f6gren-Larsson\u75c7\u5019\u7fa4\u306e3\u4f8b\uff0e\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff0c\u3055\u3044\u305f\u307e\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e: TUBB4A\u907a\u4f1d\u5b50\u75c5\u7684\u30d0\u30ea\u30a2\u30f3\u30c8\u306b\u3088\u308b\u907a\u4f1d\u6027\u75d9\u6027\u9ebb\u75fa\u306e\u4e00\u4f8b\uff0e\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e: \u65b0\u751f\u5150\u3078\u306eMR Fingerprinting\u306e\u5fdc\u7528\u3068\u8ab2\u984c\uff0d\u4f53\u52d5\u306b\u3088\u308b\u5b9a\u91cf\u5024\u3078\u306e\u5f71\u97ff\uff0d\uff0e\u7b2c18\u56de\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u4eac\u90fd\uff0c2024\uff0c10\uff0e<\/dd>\n<dd>\u68ee\u8c37\u307f\u3069\u308a: \u5341\u4e8c\u6307\u8178\u6f70\u760d\u51fa\u8840\u306b\u5bfe\u3057\u53f3\u809d\u52d5\u8108\u306b\u7559\u7f6e\u3057\u305f\u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u304c\u7d049\u304b\u6708\u5f8c\u306b\u6d88\u5931\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c35\u56de\u95a2\u6771IVR\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c7\uff0e<\/dd>\n<dd>\u68ee\u8c37\u307f\u3069\u308a: \u89e3\u5256\u524dCT\u3067\u690e\u5f13\u6839\u30b9\u30af\u30ea\u30e5\u30fc\u629c\u53bb\u306b\u3088\u308b\u53f3\u7dcf\u8178\u9aa8\u9759\u8108\u640d\u50b7\u3092\u63a8\u6e2c\u3057\u6cd5\u533b\u89e3\u5256\u306b\u3088\u308b\u8fc5\u901f\u306a\u6b7b\u56e0\u306e\u540c\u5b9a\u306b\u5bc4\u4e0e\u3057\u305f\u4e00\u4f8b\uff0e\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u7b2c461\u56de\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: AI\u6280\u8853\u306b\u3088\u308b\u80f8\u90e8\u9818\u57df\u306e\u65b0\u305f\u306a\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c43\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: Thoracic Manifestations of Rheumatoid Arthritis\uff0e\u7b2c82\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u795e\u6238\u7f8e\u6709\u5e0c: \u524d\u7e26\u9694\u30c7\u30b9\u30e2\u30a4\u30c9\u578b\u7dda\u7dad\u816b\u75c7\u306e\u4e00\u4f8b\uff0e\u7b2c38\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u798f\u5ca1\uff0c2024\uff0c10\uff0e<\/dd>\n<dd>\u91dd\u91d1\u88d5\u5e73: \u80c3\u9759\u8108\u7624\u306b\u5bfe\u3059\u308bB-RTO\u3092\u65bd\u884c\u3057\u305f\u7fcc\u65e5\u306b\u518d\u7834\u88c2\u3092\u6765\u305f\u3057\uff0c\u51fa\u8840\u6027\u30b7\u30e7\u30c3\u30af\u306b\u3088\u308a\u6b7b\u4ea1\u3057\u305f\u4e00\u4f8b\uff0e\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7b2c64\u56de\u4f8b\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c10\uff0e<\/dd>\n<dd>\u771f\u4e0a \u85ab: \u8853\u524d\u8a3a\u65ad\u306b\u81f3\u3089\u306a\u304b\u3063\u305f\u786c\u5316\u6027\u80ba\u80de\u4e0a\u76ae\u816b\u306e\u4e00\u4f8b\uff0e\u7b2c462\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u9ad8\u5d0e\uff0c2024\uff0c12\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u68ee\u7530\u6709\u9999\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u671f\u306b\u8996\u795e\u7d4c\u840e\u7e2e\u3092\u4f34\u3063\u3066\u521d\u8a3a\u65ad\u3055\u308c\u305f\u6025\u6027\u671f\u306eNMOSD\u306e\u4e00\u4f8b\uff0e\u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u68ee\u7530\u6709\u9999\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50: \u7279\u5fb4\u7684\u306a\u7b4b\u840e\u7e2e\u306e\u5206\u5e03\u304b\u3089\u539f\u56e0\u907a\u4f1d\u5b50\u304c\u63a8\u5bdf\u3067\u304d\u305f\u5148\u5929\u6027\u30df\u30aa\u30d1\u30c1\u30fc\u306e\u4e00\u4f8b\uff0e\u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u9732\u5d0e \u60a0\uff0c\u9ed2\u7530\u53cb\u7d00\u5b50: TUBB4A\u907a\u4f1d\u5b50\u75c5\u7684\u30d0\u30ea\u30a2\u30f3\u30c8\u306b\u3088\u308b\u907a\u4f1d\u6027\u75d9\u6027\u9ebb\u75fa\u306e\u4e00\u4f8b\uff0e\u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u73fe\u5834\u4e3b\u7fa9\uff01\u5c0f\u5150\u304c\u3093\u306e\u753b\u50cf\u8a3a\u65ad\u300eJCCG\u4e2d\u592e\u753b\u50cf\u8a3a\u65ad\u306e\u3042\u3086\u307f\u300f\uff0e\u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u4e2d\u5ddd\u57fa\u751f\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u76f8\u7530\u5178\u5b50: Creation of segmentation model for the corpus callosum and the pons in pediatric head MRI using deep learning\uff0e\u7b2c83\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u3000MRI\u306e\u6d3b\u7528\uff0e\u7b2c52\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff0c\u5e55\u5f35\uff0c2024\uff0c9\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u306e\u7dca\u6025\u982d\u90e8CT\u30fbMRI\uff0e\u7b2c58\u56deRadiology Update Fukuoka\u5b66\u8853\u8b1b\u6f14\u4f1a\uff0c\u798f\u5ca1\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u306e\u8133MRI\u691c\u67fb\uff0e\u7b2c58\u56de\u795e\u5948\u5dddMRI\u6280\u8853\u7814\u7a76\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0c7\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u30ea\u30d5\u30ec\u30c3\u30b7\u30e3\u30fc\u30bb\u30df\u30ca\u30fc \u307e\u305a\u306f\u57fa\u672c\u304b\u3089\uff0d\u82e6\u624b\u610f\u8b58\u306e\u514b\u670d\u306b\u5411\u3051\u3066\uff0d\u9838\u80f8\u90e8\uff0e\u7b2c9\u56de\u80ce\u5150MRI\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c2\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u8a3a\u65ad\uff08\u5c0f\u5150\uff09\u80f8\u90e8\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u79d1\u5c02\u9580\u533b\u4f1a\u30fb\u533b\u4f1a\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u30ec\u30af\u30c1\u30e3\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u6700\u65b0\u6a5f\u80fd\u3068\u30c8\u30e9\u30f3\u30b9\u30b8\u30e5\u30fc\u30b5\u3092\u4f7f\u3044\u3053\u306a\u3059\uff0d\u5c0f\u5150\uff0d\uff0e\u65e5\u672c\u8d85\u97f3\u6ce2\u533b\u5b66\u4f1a\u7b2c97\u56de\u5b66\u8853\u96c6\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c5\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u9020\u5f71\u5264\u306e\u9069\u6b63\u4f7f\u7528\u30fb\u5b89\u5168\u6027\uff5e\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u7acb\u5834\u304b\u3089\uff0e\u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c6\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u5c0f\u5150\u306e\u4e2d\u67a2\u795e\u7d4c\u611f\u67d3\uff0e\u7b2c37\u56deJCR\u30df\u30c3\u30c9\u30a6\u30a3\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc\uff0c\u4ed9\u53f0\uff0c2024\uff0c1\uff0e<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb\uff0c\u9752\u6728 \u4eae\uff0c\u4e2d\u5d8b\u8ce2\u4eba\uff0c\u671b\u6708\u6625\u6d77\uff0c\u4e95\u4e0a\u745b\u88d5\uff0c\u7e04\u7530\u664b\u592a\u90ce\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce: \u76f2\u8178\u764c\u518d\u767a\u306b\u3088\u308b\u5916\u8178\u9aa8\u52d5\u8108\u8178\u7ba1\u763b\u306b\u5bfe\u3057\u3066\u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u3092\u7559\u7f6e\u3057\u6551\u547d\u3067\u304d\u305f\u4e00\u4f8b\uff0e\u7b2c35\u56de\u95a2\u6771IVR\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2024\uff0c11\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff0c\u771f\u934b\u5fb3\u5b50\uff0c\u9688\u4e38\u52a0\u5948\u5b50\uff0c\u6728\u6238 \u6676\uff0c\u5927\u7530\u82f1\u63ee\uff0c\u9752\u6728\u8302\u6a39: Parental leave and shortened working hours due to child rearing in Japanese Radiologists: Results of the 2023 JRS survey\uff0e\u7b2c83\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: CT\u3067\u300c\u9ed2\u3044\u75c5\u5909\u300d\u306b\u306a\u308b\u547c\u5438\u5668\u75be\u60a3: \u6a5f\u80fd\u753b\u50cf\u8a3a\u65ad\u5165\u9580\uff0e\u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u5b50\u80b2\u3066\u306b\u95a2\u3059\u308bJRS\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb\uff082023\u5e74\uff09\u306e\u7d50\u679c\u304b\u3089\u898b\u3048\u308b\u3082\u306e\uff0e\u7b2c83\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u533b\u7642\u306e\u30ea\u30e2\u30fc\u30c8\u5316\u3068\u30c7\u30ea\u30d0\u30ea\u30fc\u5316\uff0e\u7b2c7\u671fYCU\u533b\u7642\u7d4c\u55b6\u30fb\u653f\u7b56\u30d7\u30ed\u30b0\u30e9\u30e0\uff0c\u6a2a\u6d5c\uff0c2024\uff0c8\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u533b\u5e2b\u306e\u50cd\u304d\u65b9\u6539\u97692024: \u3084\u308a\u304c\u3044\u306e\u6f02\u6d41\u3068\u5bfe\u51e6\uff0e\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u30bd\u30fc\u30b7\u30e3\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u7814\u7a76\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c8\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u4e00\u822c\u753b\u50cf\u8a3a\u65ad\u533b\u304c\u8003\u3048\u308b\u30bb\u30e9\u30ce\u30b9\u30c6\u30a3\u30af\u30b9\uff0e\u7b2c64\u56de\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u4f8b\u4f1a\uff0c\u6a2a\u6d5c\uff0c2024\uff0c10\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u4e00\u822c\u753b\u50cf\u8a3a\u65ad\u533b\u304c\u8003\u3048\u308b\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u30bb\u30e9\u30ce\u30b9\u30c6\u30a3\u30af\u30b9\uff0e\u30a6\u30a7\u30d6\u30bb\u30df\u30ca\u30fcPRRT\u8a3a\u7642\u5831\u916c\u306e\u5909\u66f4\u70b9\u3068\u305d\u306e\u5c06\u6765\u6027\uff08WEB\u958b\u50ac\uff09\uff0c2024\uff0c8\uff0e<\/dd>\n<\/dl>\n<p><!-- \u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff1a\u7814\u7a76\u52a9\u6210\u91d1\uff082024\u5e74\u6b04\u306b\u8f09\u3063\u3066\u3044\u308b\u3082\u306e\uff09 --><\/p>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09: \u51a0\u52d5\u8108\u75be\u60a3\u306b\u304a\u3051\u308bMRI\u306e\u51a0\u52d5\u8108\u8840\u6d41\u4e88\u5099\u80fd\u306e\u6709\u7528\u6027\u3092\u691c\u8a3c\u3059\u308b\u524d\u5411\u304d\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u3000\u57fa\u76e4\uff08C\uff09\uff082022-2026\uff09\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u547c\u5438\u5668\u7cfb\u5148\u5929\u7570\u5e38\u75be\u60a3\u306e\u533b\u7642\u6c34\u6e96\u5411\u4e0a\u3068\u79fb\u884c\u671f\u533b\u7642\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb \u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff082023-2025\uff09\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u5c0f\u5150\u4e0a\u8863\u816b\u306b\u5bfe\u3059\u308b\u624b\u8853\u6458\u51fa\u5ea6\u3068\u5206\u5b50\u5b66\u7684\u30de\u30fc\u30ab\u30fc\u3092\u7528\u3044\u305f\u6cbb\u7642\u5c64\u5225\u5316\u306b\u3088\u308b\u96c6\u5b66\u7684\u6cbb\u7642\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u78ba\u7acb\u306b\u5411\u3051\u305f\u7814\u7a76\u958b\u767a\uff0eAMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082023-2025\uff09\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u3073\u307e\u3093\u6027\u5185\u5728\u6027\u6a4b\u30b0\u30ea\u30aa\u30fc\u30de\uff08DIPG\uff09\u306e\u30ec\u30b8\u30b9\u30c8\u30ea\u69cb\u7bc9\u304a\u3088\u3073\u7de9\u548c\u30b1\u30a2\u306e\u5b9f\u614b\u89e3\u660e\u3092\u76ee\u7684\u3068\u3057\u305f\u591a\u65bd\u8a2d\u5171\u540c\u524d\u65b9\u8996\u7684\u89b3\u5bdf\u7814\u7a76\uff0eAMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082023-2025\uff09\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09: 1H-MRS\u3092\u7528\u3044\u305f\u8133\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff08\u5206\uff09: \u65b0\u6280\u8853\u3092\u7528\u3044\u305f\u5c0f\u5150\u8eaf\u5e79\u90e8MRI\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u8aad\u5f71\u652f\u63f4\u80ba\u533a\u57df\u8a8d\u8b58\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u8a55\u4fa1\u7b49\u306e\u696d\u52d9\uff0e\u53d7\u8a17\u7814\u7a76\u4f01\u696d \u5bcc\u58eb\u30d5\u30a4\u30eb\u30e0\u682a\u5f0f\u4f1a\u793e\uff08\u30e1\u30c7\u30a3\u30ab\u30eb\u30b7\u30b9\u30c6\u30e0\u4e8b\u696d\u90e8\uff09\uff082023\uff0c7\uff0c1-2024\uff0c6\uff0c30\uff09\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u753b\u50cf\u30d3\u30e5\u30fc\u30a2\u3068\u9023\u52d5\u3057\u305f\u8aad\u5f71\u30ec\u30dd\u30fc\u30c8\u4f5c\u6210\u306e\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306e\u6539\u5584\u306b\u95a2\u3059\u308b\u8abf\u67fb\uff0e\u53d7\u8a17\u7814\u7a76\u4f01\u696d \u30ad\u30e4\u30ce\u30f3\u30e1\u30c7\u30a3\u30ab\u30eb\u30b7\u30b9\u30c6\u30e0\u30ba\u682a\u5f0f\u4f1a\u793e\uff082023\uff0c9\uff0c28-2024\uff0c3\uff0c31\uff09\uff0e<\/dd>\n<\/dl>\n<p><!-- \u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff1a\u305d\u306e\u4ed6 --><\/p>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\uff5c\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>\u9752\u6728 \u4eae: JJR\u7814\u7a76\u7d99\u7d9a\u5968\u52b1\u8cde\uff0e\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\uff0c2024\uff0c4\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\uff0e\u7d50\u6838\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32024\uff08\u7b2c1\u7248\uff09\uff0e\u682a\u5f0f\u4f1a\u793e\u5357\u6c5f\u5802\uff0c\u6771\u4eac\uff0c2024\uff0e<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<div id=\"panel_2023\" class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Kato S, Horita N, Utsunomiya D: Sodium-glucose cotransporter 2 inhibitors in obese patients with heart failure. Cardiol J, 30\uff081\uff09: 153\uff0d154, 2023. doi: 10.5603\/CJ.a2023.0004.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: Imaging characteristics of myocarditis after mRNA-based COVID-19 vaccination: a meta-analysis. ESC Heart Fail, 10\uff081\uff09: 748\uff0d750, 2023. doi: 10.1002\/ehf2.14236.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: Cardiac magnetic resonance-derived tissue tracking strain in patients with hypertrophic cardiomyopathy. Quant Imaging Med Surg, 13\uff082\uff09: 1235\uff0d1239, 2023. doi: 10.21037\/qims-22-522.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: Sodium-glucose cotransporter 2 inhibitors in Asian patients with heart failure. Chin Med J \uff08Engl\uff09, 136\uff088\uff09: 1004\uff0d1005, 2023. doi: 10.1097\/CM9.0000000000002652.<\/dd>\n<dd>Kato S, Azuma M, Nakayama N, Fukui K, Ito M, Saito N, Horita N, Utsunomiya D: Diagnostic accuracy of whole heart coronary magnetic resonance angiography: a systematic review and meta-analysis. J Cardiovasc Magn Reson, 25\uff081\uff09: 36, 2023. doi: 10.1186\/s12968-023-00949-6.<\/dd>\n<dd>Iwasawa T, Matsushita S, Hirayama M, Baba T, Ogura T: Quantitative Analysis for Lung Disease on Thin-Section CT. Diagnostics\uff08 Basel\uff09, 18\uff0831\uff09: 2988, 2023.<\/dd>\n<dd>Horita N, Kato S, Utsunomiya D: Collider bias and the obesity paradox. Nutr Rev, 81\uff082\uff09: 81231\uff0d81232, 2023. doi: 10.1093\/nutrit\/nuac077.<\/dd>\n<dd>Tanigaki T, Kato S, Azuma M, Ito M, Horita N, Utsunomiya D: Coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance imaging of coronary sinus: a meta-analysis. J Cardiovasc Magn Reson, 25\uff081\uff09: 11, 2023. doi: 10.1186\/s12968-023-00912-5.<\/dd>\n<dd>Nakamura T, Kato S, Fukui K, Kodama S, Azuma M,Kagimoto M, Nakayama N, Iwasawa T, Utsunomiya D: Contrast defect of left atrial appendage on computed tomography is associated with higher risk of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. Heart Vessels, 38\uff083\uff09: 394\uff0d401, 2023. doi: 10.1007\/s00380-022-02166-0.<\/dd>\n<dd>Suyama S, Kato S, Nakaura T, Azuma M, Kodama S, Nakayama N, Fukui K, Utsunomiya D: Machine learning to predict left ventricular reverse remodeling by guidelinedirected medical therapy by utilizing texture feature of extracellular volume fraction in patients with non-ischemic dilated cardiomyopathy. Heart Vessels, 38\uff083\uff09: 361\uff0d370, 2023. doi: 10.1007\/s00380-022-02167-z.<\/dd>\n<dd>Aoki R, Nakajima K, Kobayashi Y, Sakai Y, Kamide H, Yamamoto T, Furugori S, Sawamura S, Terauchi M, Kamiyama K, Ikeda S, Tsuji G, Koyama S, Yoshigi J, Sekikawa Z, Utsunomiya D: Common and uncommon vascular injuries and endovascular treatment associated with pelvic blunt trauma: a real-world experience. Jpn J Radiol, 41\uff083\uff09: 258\uff0d265, 2023. doi: 10.1007\/s11604-022-01355-1.<\/dd>\n<dd>Miyake Y, Tateishi K, Oshima A, Hongo T, Satomi K, Ichimura K, Kato A, Iwashita H, Utsunomiya D, Yamamoto T: A case of midbrain germinoma: A literature review for radiographic and clinical features. Neurooncol Adv, 5\uff081\uff09: vdad043, 2023. doi: 10.1093\/noajnl\/vdad043.<\/dd>\n<dd>Azuma M, Kato S, Murohashi K, Fukui K, Utsunomiya D, Kitamura H, Hagiwara E, Ogura T: Severe multivessel coronary vasospasm in a patient with coronavirus disease 2019. J Cardiol Cases, 28\uff084\uff09: 147\uff0d149, 2023. doi: 10.1016\/j.jccase.2023.05.010.<\/dd>\n<dd>Aoki R, Kobayashi Y, Nawata S, Kamide H, Sekikawa Z, Utsunomiya D: Gastrointestinal bleeding due to the rupture of splenic artery caused by pancreatic carcinoma: A case requiring repeated transcatheter arterial embolization in a short period of time. Interv Radiol\uff08 Higashimatsuyama\uff09, 8 \uff082\uff09: 88\uff0d91, 2023. doi: 10.22575\/interventionalradiolo gy.2022-0034.<\/dd>\n<dd>Imajo K, Saigusa Y, Kobayashi T, Nagai K, Nishida S, Kawamura N, Doi H, Iwaki M, Nogami A, Honda Y, Kessoku T, Ogawa Y, Kirikoshi H, Yasuda S, Toyoda H, Hayashi H, Kokubu S, Utsunomiya D, Takahashi H, Aishima S, Kim BK, Tamaki N, Saito S, Yoneda M, Loomba R, Nakajima A: M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis. Hepatol Res, 53\uff089\uff09: 844\uff0d856, 2023. doi: 10.1111\/hepr.13927.<\/dd>\n<dd>Azuma M, Kato S, Fukui K, Horita N, Utsunomiya D: Microvascular dysfunction in patients with heart failure with preserved ejection fraction: A meta-analysis. Microcirculation, 30\uff087\uff09: e12822, 2023.<\/dd>\n<dd>Aoki R, Kato S, Nakajima K, Sakai J, Yoshida K, Masui H, Ikeda S, Yoshigi J, Utsunomiya D: Superior mesenteric artery embolism associated with Cisplatin-induced aortic thrombosis. BJR Case Rep, 9\uff085\uff09: 20220149, 2023.<\/dd>\n<dd>Kitajima K, Igeta M, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Miyake H, Yamamoto S, Narita M, Daimon T, Yamakado K: Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment-Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index\uff08 J-RAP-BSI\uff09 Trial. Eur J Nucl Med Mol Imaging, 50\uff085\uff09: 1487\uff0d1498. 2023.<\/dd>\n<dd>Yokose M, Takaki S, Saigusa Y, Mihara T, Ishiwata Y, Kato S, Horie K, Goto T: Stomach position evaluated using computed tomography is related to successful post-pyloric enteral feeding tube placement in critically ill patients: a retrospective observational study. J Intensive Care, 11\uff081\uff09: 25, 2023.<\/dd>\n<dd>Kitajima K, Kuyama J, Kawahara T, Suga T, Otani T, Sugawara S, Kono Y, Tamaki Y, Seko-Nitta A, Ishiwata Y, Ito K, Toriihara A, Watanabe S, Hosono M, Miyake H, Yamamoto S, Sasaki R, Narita M, Yamakado K: Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAPBSI Trial. Cancers\uff08 Basel\uff09, 15\uff0810\uff09: 2784, 2023.<\/dd>\n<dd>Baba T, Takemura T, Okudela K, Hebisawa A, Matsushita S, Iwasawa T, Yamakawa H, Nakagawa H, Ogura T: Concordance between transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung disease in the same patients. BMC Pulm Med, 29\uff0823\uff09: 279, 2023.<\/dd>\n<dd>Otoshi R, Sekine A, Muraoka T, Iwasawa T, Takemura T, Matsushita S, Okudela K, Kitamura H, Baba T, Ogura T: Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease. Adv Respir Med, 19\uff0891\uff09: 164\uff0d173, 2023.<\/dd>\n<dd>Haraguchi T, Matsuoka S, Yagihashi K, Matsushita S, Yamashiro T, Kobayashi Y, Mimura H: Quantitative Computed Tomography Analysis of the Longitudinal Change. Between Centrilobular and Paraseptal Emphysema Subtypes: A Retrospective Study. J Comput Assist Tomogr, 47\uff085\uff09: 746\uff0d752, 2023.<\/dd>\n<dd>Iwashita H, Kawabata Y, Hayashi H, Matsushita S, Yamashiro T, Matsumura M, Yoshimura Y, Kataoka T, Mitsui H, Suzuki T, Misumi T, Tanaka T, Ishijima S, Fukuoka J, Iwasawa T, Ogura T, Okudela K: Frequency of subclinical interstitial lung disease in COVID-19 autopsy cases: potential risk factors of severe pneumonia. BMC Pulm Med, 27\uff0823\uff09: 408, 2023.<\/dd>\n<dd>Okubo Y, Sato S, Terao H, Yamamoto Y, Suzuki A, Hasegawa C, Yoshioka E, Ono K, Washimi K, Yokose T, Nakaigawa N, Kishida T, Miyagi Y: Review of the Developing Landscape of Prostate Biopsy and Its Roles in Prostate Cancer Diagnosis and Treatment. Arch Esp Urol, 76\uff089\uff09: 633\uff0d642, 2023.<\/dd>\n<dd>Okubo Y, Sato S, Hasegawa C, Koizumi M, Suzuki T, Yamamoto Y, Yoshioka E, Ono K, Washimi K, Yokose T, Kishida T, Miyagi Y: Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and\/or number of cores. Hum Pathol, 135: 99\uff0d107, 2023.<\/dd>\n<dd>Toda S, Yamamoto Y, Ookubo Y, Hayashi H, Tsunematsu T, Kadoya M, Masudo K, Iwasaki H: Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report. Gland Surg, 12\uff0810\uff09: 1441\uff0d1448, 2023.<\/dd>\n<dd>Kashihara T, Mori T, Nakaichi T, Nakamura S, Ito K, Kurihara H, Kusumoto M, Itami J, Yoshimoto S, Igaki H: Correlation between L-amino acid transporter 1 expression and 4-borono-2-18F-fluoro-phenylalanine accumulation in humans. Cancer Med, 12\uff0821\uff09: 20564\uff0d20572, 2023.<\/dd>\n<dd>Yoshii Y, Matsumoto H, Igarashi C, Tachibana T, Hihara F, Shinada M, Waki A, Yoshida S, Naito K, Ito K, Higashi T, Kurihara H, Ueno M: Process to Remove the Size Variants Contained in the Antibody\u2013Chelator Complex PCTANCAB0 0 1 for Radiolabeling with Copper- 6 4 . Pharmaceuticals, 16\uff0810\uff09: 1341, 2023.<\/dd>\n<dd>Kambe A, Yamamoto Y, Hasegawa C, Kakiuchi A, Kojima D, Hino A, Horikawa A, Doiuchi T, Kurihara H: SMARCA4- deficient tumors in the adrenal gland and small intestines: A rare case report. Radiol Case Rep, 19\uff082\uff09: 794\uff0d797, 2023.<\/dd>\n<dd>Kakiuchi A, Yamamoto Y, Kambe A, Kojima D, Horikawa A, Hino A, Doiuchi T, Kurihara H: SAPHO syndrome with a purely osteolytic form: A case report. Radiol Case Rep, 18 \uff0810\uff09: 3612\uff0d3614, 2023.<\/dd>\n<dd>Aoki J, Yamamoto Y, Horikawa A, Doiuchi T, Hino A, Kojima D, Kurihara H, Washimi K, Katoh H, Hiruma T: Fluorodeoxyglucose positron emission tomography \uff08FDG\/ PET\uff09 shows the effect of carbon-ion radiotherapy\uff08 CIRT\uff09; with pathologic confirmation. Radiol Case Rep, 18\uff085\uff09: 1793\uff0d1795, 2023.<\/dd>\n<dd>Iwashita H, Kawabata Y, Hayashi H, Matsushita S, Yamashiro T, Matsumura M, Yoshimura Y, Kataoka T, Mitsui H, Suzuki T, Misumi T, Tanaka T, Ishijima S, Fukuoka J, Iwasawa T, Ogura T, Okudela K: Frequency of subclinical interstitial lung disease in COVID-19 autopsy cases: potential risk factors of severe pneumonia. BMC Pulm Med, 23\uff081\uff09: 408, 2023.<\/dd>\n<dd>Sekine A, Hagiwara E, Oda T, Muraoka T, Iwasawa T, Ikeda S, Okuda R, Kitamura H, Baba T, Takemura T, Matsumura M, Okudela K, Kumagai E, Chiba S, Motobayashi Y, Ogura T: High prevalence of upper lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis in patients with round atelectasis. Respir Investig, 61\uff086\uff09: 738\uff0d745, 2023.<\/dd>\n<dd>Okuda R, Takemura T, Misumi T, Nagasawa R, Iwasawa T, Baba T, Hagiwara E, Ogura T: Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. Respiration, 102\uff089\uff09: 803\uff0d 812, 2023.<\/dd>\n<dd>Baba T, Takemura T, Okudela K, Hebisawa A, Matsushita S, Iwasawa T, Yamakawa H, Nakagawa H, Ogura T: Concordance between transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung disease in the same patients. BMC Pulm Med, 23\uff081\uff09: 279, 2023.<\/dd>\n<dd>Otoshi R, Sekine A, Muraoka T, Iwasawa T, Takemura T, Matsushita S, Okudela K, Kitamura H, Baba T, Ogura T: Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease. Adv Respir Med, 91\uff082\uff09: 164\uff0d173, 2023.<\/dd>\n<dd>Okuda R, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Arai T, Nakamura Y, Miyamoto A, Miyazaki Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Kuwahira I, Sato S, Kato S, Suzuki T, Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Nukiwa T, Kobayashi K: Design and rationale of the Japanese Idiopathic Interstitial Pneumonias \uff08JIPS\uff09 Registry. Respir Investig, 61\uff081\uff09: 95\uff0d102, 2023.<\/dd>\n<dd>Miyazaki O, Oguma E, Nishikawa M, Tanami Y, Hosokawa T, Kitami M, Aoki H, Hattori S, Motoori K, Watanabe K, Ida K, Hishitani T, Kitamura M, Nozawa K, Takimoto T, Hiyama E: Usefulness of central radiologic review in clinical traials of children with hepatoblastoma. Pediatr Radiol, 53\uff083\uff09: 367\uff0d377, 2023.<\/dd>\n<dd>Enokizono M, Aida N, Yagishita A, Nakata Y, Ideguchi R, Kurokawa R, Kono T, Moritani T, Mori H: Neuroimaging findings of inborn errors of metabolism: urea cycle disorders, aminoacidopathies, and organic acidopathies. Jpn J Radiol, 41\uff087\uff09: 683\uff0d702, 2023.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>Iwasawa T, Matsushita S, Hirayama M, Baba T, Ogura T: Quantitative Analysis for Lung Disease on Thin-Section CT. Diagnostics\uff08 Basel\uff09, 13\uff0818\uff09: 2988, 2023.<\/dd>\n<dd>Iwasawa T: Three-dimensional Ultrashort Echo Time MRI: A More Sensitive Tool for Monitoring Patients with Cystic Fibrosis. Radiology, 308\uff081\uff09: e231367, 2023.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u79d1\u306e\u50cd\u304d\u65b9\uff0e \u30a4\u30f3\u30ca\u30fc\u30d3\u30b8\u30e7\u30f3\uff0c38\uff086\uff09: 12\uff0d14\uff0c2023\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce\uff0c\u5ca1\u7530\u8208\u9020\uff0c\u65e5\u6bd4\u3000\u6f54\uff0c\u5b87\u90fd\u5bae\u5927 \u8f14: \u81e8\u5e8a\u51a0\u52d5\u8108\u75be\u60a3\u5b66- \u51a0\u52d5\u8108\u75be\u60a3\u306e\u6700\u65b0\u6cbb\u7642\u6226\u7565\uff0c\u975e \u4fb5\u8972\u7684\u691c\u67fb\uff087\uff09\u5fc3\u81d3CT\uff0e\u65e5\u672c\u81e8\u5e8a\uff08\u5897\u520a\u53f7\uff09\uff0c81\uff088\uff09: 205 \uff0d211\uff0c2023\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3MRI\u306e\u4eca\u307e\u3067\u3068\u3053\u308c\u304b\u3089\uff0e \u5fc3\u81d3MRI\u306b\u3088\u308b\u5fc3\u7b4b\u7d44\u7e54\u6027\u72b6\u8a55\u4fa1\uff0e\u81e8\u5e8a\u653e\u5c04\u7dda\uff0c38 \uff0813\uff09: 14\uff0d23\uff0c2023\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u7d76\u5bfe\u82e6\u624b\u5206\u91ce\u306b\u3057\u306a\u3044\u3000\u6210\u4eba\u5148\u5929\u6027\u5fc3\u75be\u60a3\u306e \u753b\u50cf\u8a3a\u65ad\u5fc3\u623f\u4e2d\u9694\u6b20\u640d\u75c7\u3068\u5fc3\u5ba4\u4e2d\u9694\u6b20\u640d\u75c7\uff0e\u81e8\u5e8a\u753b \u50cf\uff0c39\uff086\uff09: 622\uff0d630\uff0c2023\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff0c\u571f\u4e95\u5185\u6052\u5b8f\uff0c\u5800\u5ddd\u3000\u6b69: \u5b50\u5bae\u9838\u304c\u3093\u306e\u81e8\u5e8a\u9032 \u884c\u671f\u6c7a\u5b9a\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\u306e\u5f79\u5272\uff0e\u7523\u79d1\u3068\u5a66\u4eba\u79d1\uff0c99 \uff0811\uff09: 1219\uff0d1224\uff0c2023\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5148\u5929\u6027\u56a2\u80de\u6027\u80ba\u75be\u60a3\u306e up to date 3\uff0e\u5206\u985e\u306b \u95a2\u3059\u308b\u6700\u65b0\u306e\u77e5\u898b 1\uff0e\u753b\u50cf\u8a3a\u65ad\u306e\u898b\u5730\u304b\u3089\uff0e\u65e5\u672c\u5916\u79d1 \u5b66\u4f1a\u96d1\u8a8c\uff0c124\uff086\uff09: 478\uff0d484\uff0c2023\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u8457\u66f8<\/h3>\n<\/dt>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80ba\u91ce\u306e\u9650\u5c40\u7684\u306a\u900f\u904e\u6027\u4ea2\u9032\uff08\u5c0f\u8449\u4e2d\u5fc3\u6027\u80ba\u6c17 \u816b\uff09\uff0e\u9f4b\u7530\u5e78\u4e45 \u7de8\uff0e300\u4f8b\u3067\u5b66\u3076\u3000\u8aad\u5f71\u30ec\u30dd\u30fc\u30c8\u306e\u6d41\u5100 \uff08\u7b2c1 \u7248\uff09\uff0e\u682a\u5f0f\u4f1a\u793eGakken\uff0c230\uff0c2023\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80ba\u91ce\u306e\u5168\u4f53\u7684\u306a\u900f\u904e\u6027\u4ea2\u9032\uff08\u91cd\u75c7\u80ba\u6c17\u816b\uff09\uff0e\u9f4b \u7530\u5e78\u4e45 \u7de8\uff0e300\u4f8b\u3067\u5b66\u3076\u3000\u8aad\u5f71\u30ec\u30dd\u30fc\u30c8\u306e\u6d41\u5100\uff08\u7b2c1 \u7248\uff09\uff0e\u682a\u5f0f\u4f1a\u793eGakken\uff0c231\uff0c2023\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u753b\u50cf\u8a3a\u65ad\u3000\u308f\u304b\u308b\uff01\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\uff0e\u682a\u5f0f\u4f1a \u793eGakken\uff0c845\uff0c2023\uff0e<\/dd>\n<dd>\u68ee\u7530\u6709\u9999: \u5373\u6226\u529b\u304c\u8eab\u306b\u3064\u304f\u809d\u80c6\u81b5\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u30e1\u30c7\u30a3 \u30ab\u30eb\u30b5\u30a4\u30a8\u30f3\u30b9\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\uff0c245\uff0d247\uff0c268\uff0d 270\uff0c378\uff0d380\uff0c513\uff0d515\uff0c2023\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e\u5148\u5929\u6027\u80ba\u8449 \u6027\u80ba\u6c17\u816b\uff08CLD\uff09\uff0c\u6c17\u7ba1\u652f\u9589\u9396\u75c7\uff08BA\uff09\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc \u793e\uff0c125\uff0d127\uff0c2023\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e\u6a2a\u7d0b\u7b4b\u8089 \u816b. \u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c279\uff0d281\uff0c2023\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u5bae\u5d5c\u3000\u6cbb: \u5c0f\u5150 \u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e\u8131 \u9ac4\u6027\u75be\u60a3\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c63\uff0d66\uff0c2023\uff0e<\/dd>\n<dd>\u68ee\u7530\u6709\u9999: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e\u65b0\u751f\u5150\u30fb\u4e73\u5150\u3000 \u8133\u5ba4\u5468\u56f2\u767d\u8cea\u8edf\u5316\u75c7\uff08PVL\uff09\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c35\uff0d 37\uff0c2023\uff0e<\/dd>\n<dd>\u68ee\u7530\u6709\u9999: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e\u65b0\u751f\u5150\u30fb\u4e73\u5150\u3000 \u8133\u51fa\u8840\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c38\uff0d41\uff0c2023\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0eMRI\u691c\u67fb\u6642\u306e \u93ae\u9759\u306b\u95a2\u3059\u308b\u5171\u540c\u63d0\u8a00: \u753b\u50cf\u8a3a\u65ad\u5074\u304b\u3089\u307f\u305f\u63d0\u8a00\u306e\u30dd \u30a4\u30f3\u30c8\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c2\uff0d3\uff0c2023\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO\uff0e1H-MR spectroscopy\uff08 1H-MRS\uff09\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c42\uff0d44\uff0c2023\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Yamashiro T, Matsushita S, Utsunomiya D: Prevalence of COVID-19 pneumonia diagnosed by an in-vehicle CT scanner in patients with mild COVID-19 at a special accommodation facility in Japan \uff08winter of 2020-2021\uff09. Asian Congress of Thoracic Imaging, Seoul, 2023, 6.<\/dd>\n<dd>Ohta Y, Iwasawa T, Hirayama M, Aoki R, Nemoto T, Fujii F: Motion artifact correction using a new deep learning reconstruction approach: utility in chest computed tomography. RSNA 2023, Chicago, 2023, 11.<\/dd>\n<dd>Oota Y, Iwasawa T, Nemoto T, Akino N, Fujii K, Matsuura M: Current and Novel Techniques for Artifact Reduction on Chest CT: A Practical Guide for Radiologists. RSNA 2023, Chicago, 2023, 11.<\/dd>\n<dd>Kato A, Aida N, Nozawa K, Utsunomiya D: Imaging finding of brain injury in term of newborns\uff0e\u7b2c82\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04 \u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>Misumi Y, Kato S, Horita N, Utsunomiya D: Clinical Utility of Computed Tomography Derived Extracellular Volume Fraction: A Systematic Review and Meta-analysis\uff0e\u7b2c82\u56de \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u51a0\u52d5\u8108\u75be\u60a3\u306b\u304a\u3051\u308bCT\u30d5\u30a1\u30fc\u30b9\u30c8\u6642\u4ee3\u306e\u5e55 \u958b\u3051\u3068\u4eca\u5f8c\u306e\u5c55\u958b\uff0e\u7b2c82\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c \u6a2a\u6d5c\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u8a3a\u65ad\u306b\u304a\u3051\u308b\u5076\u767a\u6240\u898b\u3078\u306e\u30de\u30cd\u30b8\u30e1\u30f3 \u30c8\u3092\u8003\u3048\u308b\uff0e\u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927 \u4f1a\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u75c5\u306e\u753b\u50cf\u8a3a\u65ad\uff0dCT\uff0cMRI\u306e\u5f79\u5272\uff0e\u7b2c3 \u671f\u30d5\u30a1\u30a4\u30b6\u30fc\u30b0\u30ed\u30fc\u30d0\u30eb\u533b\u5b66\u6559\u80b2\u30d5\u30a1\u30f3\u30c9\u306b\u3088\u308b\u30d7\u30ed \u30b8\u30a7\u30af\u30c8\u8b1b\u6f14\u4f1a\uff08\u662d\u548c\u5927\u5b66\u85e4\u304c\u4e18\u75c5\u9662\u5185\u79d1\u5faa\u74b0\u5668\u4e3b \u50ac\uff09\uff0c\u6771\u4eac\uff0c2023\uff0c12\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff0c\u583a\u3000\u7d50\u6709\uff0c\u52a0\u85e4\u82f1\u660e: \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f \u67d3\u75c7\u3092\u5951\u6a5f\u306b\u767a\u75c7\u3057\u305f\u80ba\u6c34\u816b\u306e\u4e00\u4f8b\uff0e\u7b2c14\u56de\u547c\u5438\u6a5f\u80fd \u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\uff0c\u672d\u5e4c\uff0c2023\uff0c1\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u30fb\u50cd\u304d\u65b9\u6539\u9769\u63a8\u9032\u59d4\u54e1\u4f1a\u52b4\u52d9 \u5f62\u614b\u30a2\u30f3\u30b1\u30fc\u30c8\u3000\u7d50\u679c\u5831\u544a\uff0e\u7b2c59\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66 \u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e04 \u533b\u5e2b\u306e\u50cd\u304d\u65b9\u6539\u97692024 \u30b9\u30bf\u30fc\u30c8\u76f4\u524d\uff08Part1\uff09\uff09\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: MINOCA\u3068\u305d\u306e\u9451\u5225\u75be\u60a3: T2\u30de\u30c3\u30d4\u30f3\u30b0\u306e\u5f79 \u5272\u306f\uff1f SCMR 2023 WG seminar\uff0c\u6771\u4eac\uff0c2023\uff0c8\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5185\u79d1\u533b\u76ee\u7dda\u3067\u307f\u305f\u653e\u5c04\u7dda\u8a3a\u65ad\u533b\u306e\u9b45\u529b\uff0e\u7b2c19 \u56de\u7814\u4fee\u533b\u30fb\u533b\u5b66\u751f\u306e\u305f\u3081\u306e\u653e\u5c04\u7dda\u79d1\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b \u50ac\uff09\uff0c2023\uff0c6\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u7027\u6fa4\u826f\u54c9\uff0c\u798f\u4e95\u548c\u6a39\uff0c\u82b3\u8cc0\u3000\u6681\uff0c\u6fa4\u6751\u99ff\u543e\uff0c \u9752\u6728\u3000\u4eae\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u80ba\u9759\u8108\u9694\u96e2\u8853\u304c\u594f\u529f\u3057\u305f\u4e0b\u80ba \u9759\u8108\u5171\u901a\u7ba1\u3092\u6709\u3059\u308b\u5fc3\u623f\u7d30\u52d5\u306e1 \u4f8b\uff0e\u7b2c97\u56de\u5fc3\u81d3\u8840\u7ba1 \u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u5927\u962a\uff0c2023\uff0c7\uff0e<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u7530\u4e0a\u5e78\u6cbb\uff0c\u5b87\u90fd\u5bae\u5927 \u8f14: \u5c0f\u8133\u306b\u9650\u5c40\u3057\u305f\u7570\u5e38\u3092\u5448\u3057\u305fRhombencephalosynapsis \u306e\u4e00\u4f8b\uff0e\u7b2c52\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c2\uff0e<\/dd>\n<dd>\u6fa4\u6751\u99ff\u543e\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u5c3e\u7530\u6e08\u592a\u90ce\uff0c\u8239\u9593\u82b3\u61b2\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c \u76db\u5ca1\u3000\u7ffc\uff0c\u6cc9\u3000\u654f\u6cbb\uff0c\u5ddd\u8d8a\u535a\u7d00\uff0c\u592a\u7530\u967d\u4e00\u90ce\uff0c\u5824\u3000\u9ad8 \u5fd7\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u8d85\u9ad8\u7cbe\u7d30 CT \u3092\u6559\u5e2b\u753b\u50cf\u3068\u3057\u305fdeeplearning- based reconstruction\uff08 SR-DLR\uff09\u306b\u3088\u308b coronary CTA \u306e\u8996\u8a8d\u6027\u306e\u8a55\u4fa1: \u51a0\u52d5\u8108\u30d5\u30a1\u30f3\u30c8\u30e0\u3092\u7528\u3044\u305f\u691c\u8a0e\uff0e \u7b2c96\u56de\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u677e\u5c71\uff0c2023\uff0c1\uff0e<\/dd>\n<dd>\u5cb8\u672c\u771f\u7531\u5b50\uff0c\u5c71\u57ce\u6052\u96c4\uff0c\u52a0\u85e4\u82f1\u660e\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u80cc\u666f\u56e0 \u5b50\u3092\u8003\u616e\u3057\u305f\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306eCT\u8a3a\u65ad\uff0e\u7b2c 58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u5cb8\u672c\u771f\u7531\u5b50\uff0c\u9ce5\u4e95\u90c1\u7537\uff0c\u5c71\u57ce\u6052\u96c4: \u4e0b\u8178\u9593\u819c\u9759\u8108\u9589\u585e\u306b \u3088\u308b\u91cd\u75c7\u865a\u8840\u6027\u8178\u708e\u306e\u4e00\u4f8b\uff0e\u7b2c33\u56de\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76 \u4f1a\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: CPFE\u306e\u753b\u50cf\u6240\u898b\uff0e\u7b2c42\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771 \u4eac\uff0c2023\uff0c2\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: Smoking-related lung disease\uff0e\u7b2c82\u56de\u65e5\u672c\u533b\u5b66 \u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff0c\u6797\u3000\u3000\u611b\uff0c\u6fa4\u4f4f\u77e5\u679d\uff0c\u5409\u7530\u5b66\u8a89\uff0c\u9752\u6728\u3000\u6df3\uff0c \u5e73\u5c71\u9ebb\u5229\u5b50\uff0c\u99ac\u5834\u667a\u5c1a\uff0c\u5965\u5bfa\u5eb7\u53f8\uff0c\u5c0f\u5009\u9ad8\u5fd7: \u9593\u8cea\u6027 \u80ba\u708e\u306e\u5256\u691c\u80ba\u306eMRI\u3000\u75c5\u7406\u7d44\u7e54\u50cf\u3068\u306e\u6bd4\u8f03\uff0e\u7b2c51\u56de\u65e5 \u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff0c\u8efd\u4e95\u6ca2\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u9032\u884c\u6027\u7dda\u7dad\u5316\u3092\u4f34\u3046\u9593\u8cea\u6027\u80ba\u75be\u60a3\u306e\u8003\u3048\u65b9\uff0e \u7b2c37\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u9752\u6728\u3000\u4eae\uff0c\u82b3\u8cc0\u3000\u6681\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u5409\u5100\u3000\u6df3\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: CT\u304b\u3089Epipericardial fat necrosis\u3092\u7591\u3046\u3082\uff0c\u4e00\u9031\u5f8c\u306b\u81bf \u80f8\u6240\u898b\u3092\u5448\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c97\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76 \u4f1a\uff0c\u5927\u962a\uff0c2023\uff0c7\uff0e<\/dd>\n<dd>\u4e2d\u6751\u6cf0\u4ecb: \u8853\u524d\u8a3a\u65ad\u56f0\u96e3\u3067\u3042\u3063\u305f\u8179\u8154\u5185Inflammatory myofibroblastic tumor \u306e1 \u4f8b\uff0e\u7b2c460\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda \u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c12\uff0e<\/dd>\n<dd>\u4e95\u4e0a\u745b\u88d5: \u80f8\u9aa8\u5727\u8feb\u306b\u3088\u308b\u5185\u80f8\u52d5\u8108\u640d\u50b7\u306b\u5bfe\u3057\u52d5\u8108\u585e\u6813 \u8853\u3092\u8a66\u884c\u5f8c\uff0c\u8133\u6897\u585e\u3092\u767a\u75c7\u3057\u305f1 \u4f8b\uff0e\u7b2c460\u56de\u65e5\u672c\u533b\u5b66 \u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c12\uff0e<\/dd>\n<dd>\u91dd\u91d1\u88d5\u5e73: \u80ba\u816b\u760d\u8840\u6813\u6027\u5fae\u5c0f\u8840\u7ba1\u75c7\u306e1 \u4f8b\uff0e\u7b2c460\u4f1a\u65e5\u672c \u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c12\uff0e<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u4e95\u4e0a\u745b\u88d5\uff0c\u5165\u6c5f\u6c99\u4ee3\uff0c\u4e09\u89d2\u512a\u82b1\uff0c \u671b\u6708\u6625\u6d77\uff0c\u912d\u3000\u4ed5\u5c2d\uff0c\u9752\u6728\u3000\u4eae\uff0c\u79b9\u3000\u54f2\u6f22\uff0c\u95a2\u5ddd\u5584\u4e8c \u90ce: \u96e3\u6cbb\u6027\u6c17\u7ba1\u652f\u539f\u751f\u56a2\u80de\u306b\u5bfe\u3057CV\u30dd\u30fc\u30c8\u3092\u7559\u7f6e\u3059\u308b \u3053\u3068\u3067\u30c9\u30ec\u30ca\u30fc\u30b8\u52b9\u679c\u3092\u7dad\u6301\u3057\u3064\u3064QOL\u5411\u4e0a\u304c\u5f97\u3089\u308c \u305f\u4e00\u4f8b\uff0e\u7b2c34\u56de\u95a2\u6771IVR\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c7\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50:\u30ea\u30d5\u30ec\u30c3\u30b7\u30e3\u30fc\u30b3\u30fc\u30b9\u3000\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c59 \u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u5fb3\u5cf6\uff0c2023\uff0c9\uff0e \u68ee\u7530\u6709\u9999\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50: ACTA2\u907a\u4f1d\u5b50\u4ee5\u4e0a\u306b\u3088\u308b\u591a\u81d3\u5668\u5e73\u6ed1\u7b4b\u6a5f\u80fd\u969c\u5bb3\u75c7\u5019\u7fa4 \u306e\u4e00\u4f8b\uff0e\u7b2c59\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c 2023\uff0c6\uff0e<\/dd>\n<dd>\u68ee\u7530\u6709\u9999: \u5185\u6027\u5668\u8d85\u97f3\u6ce2\u691c\u67fb\u306e\u30dd\u30a4\u30f3\u30c8\uff0e\u7b2c56\u56de\u65e5\u672c\u5c0f \u5150\u5185\u5206\u6ccc\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u30a4\u30f3\u30bf\u30e9\u30af\u30c6\u30a3\u30d6\u30d7\u30ec\u30df\u30a2\u30e0 \u30bb\u30df\u30ca\u30fc\uff09\uff0c\u5927\u5bae\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u5c0f\u5150\u306e\u8131\u9ac4\u75be\u60a3\uff0e\u7b2c82\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a \u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u5c0f\u5150\u306e\u8133\u816b\u760d\uff0e\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7b2c63\u56de\u4f8b \u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150MRI\u306e\u6d3b\u7528: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad\u3092\u304b \u306a\u3048\u308b\u305f\u3081\u306b\uff0e\u7b2c51\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff0c\u8efd\u4e95 \u6ca2\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u795e\u5948\u5ddd\u3053\u3069\u3082\u306e\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u8a3a\u65ad: \u5f62\u614b\u5b66 \u304b\u3089Advanced MR technique\u307e\u3067\uff0e\u7b2c52\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04 \u7dda\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c2\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u795e\u7d4c\u753b\u50cf\u8a3a\u65ad\u306e\u9032\u3081\u65b9\uff0e\u7b2c51\u56de\u65e5\u672c\u5c0f\u5150 \u795e\u7d4c\u5916\u79d1\u5b66\u4f1a\uff0c\u5b87\u90fd\u5bae\uff0c2023\uff0c6\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150MRI\u9069\u6b63\u4f7f\u7528\u3078\u306e\u30ab\u30ae: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b \u50cf\u8a3a\u65ad\u3092\u304b\u306a\u3048\u308b\u305f\u3081\u306b\uff0e\u7b2c59\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66 \u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c6\uff0e<\/dd>\n<dd>\u5e73\u5c71\u9ebb\u5229\u5b50: \u80ba\u764c\u80f8\u819c\u6d78\u6f64\u306e\u8853\u524d\u8a55\u4fa1\u306b\u304a\u3051\u308b4DCT\u53ca\u3073 \u80f8\u819c\u7652\u7740\u30bd\u30d5\u30c8\u306e\u6709\u7528\u6027\u306e\u8a55\u4fa1\uff0e\u7b2c460\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04 \u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c12\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09: \u8aad\u5f71\u652f\u63f4\u80ba\u533a\u57df\u8a8d\u8b58\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306e\u8a55\u4fa1 \u7b49\u306e\u696d\u52d9\uff0e\u53d7\u8a17\u7814\u7a76\u8cbb\uff082023-2024\uff09\uff0c182\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09: \u753b\u50cf\u30d3\u30e5\u30fc\u30a2\u3068\u9023\u52d5\u3057\u305f\u8aad\u5f71\u30ec\u30dd\u30fc\u30c8\u4f5c \u6210\u306e\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306e\u6539\u5584\u306b\u95a2\u3059\u308b\u8abf\u67fb\uff0e\u53d7\u8a17\u7814\u7a76\u8cbb \uff082023-2024\uff09\uff0c66\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09: \u591a\u5206\u91ce\u6a2a\u65ad\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308b\u533b\u7642\u753b\u50cf \u89e3\u6790\uff0e\u5968\u5b66\u5bc4\u9644\u91d1\uff082023-2028\uff09\uff0c27\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09: \u51a0\u52d5\u8108\u75be\u60a3\u306b\u304a\u3051\u308bMRI\u306e\u51a0\u52d5\u8108\u8840\u6d41 \u4e88\u5099\u80fd\u306e\u6709\u7528\u6027\u3092\u691c\u8a3c\u3059\u308b\u524d\u5411\u304d\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76\uff0e\u79d1 \u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082022-2025\uff09\uff0c52\u4e07\u5186\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u5206\uff09: \u81b5\u304c\u3093\u65e9\u671f\u767a\u898b\u30fb\u7cbe\u5bc6\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u3092\u5b9f \u73fe\u3059\u308b\u65b0\u898f\u653e\u5c04\u6027\u6297\u4f53\u533b\u85ac\u3092\u7528\u3044\u305f \u8d85\u97f3\u6ce2\u5185\u8996\u93e1\u30ac\u30a4 \u30c9\u6295\u4e0e\u306b\u3088\u308b\u9769\u65b0\u7684PET\u753b\u50cf\u8a3a\u65ad\u306e\u7b2cI \u76f8\u533b\u5e2b\u4e3b\u5c0e\u6cbb \u9a13AMED\u81e8\u5e8a\u7814\u7a76\uff0e\u6cbb\u9a13\u63a8\u9032\u7814\u7a76\u4e8b\u696d\uff082022-2024\uff09\uff0c 0 \u5186\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u5206\uff09: \u518d\u767a\u30fb\u96e3\u6cbb\u6027\u60aa\u6027\u795e\u7d4c\u81a0\u816b\u306b\u5bfe\u3059\u308b\u6cbb\u7642 \u7528\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM\u306e\u6709\u52b9\u6027\u3092\u691c\u8a3c\u3059\u308b\u7814\u7a76\u958b \u767a\uff0eAMED\u81e8\u5e8a\u7814\u7a76\u30fb\u6cbb\u9a13\u63a8\u9032\u7814\u7a76\u4e8b\u696d\uff082023-2026\uff09\uff0c 130\u4e07\u5186\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u4ee3\uff09: \u96e3\u6cbb\u6027\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u65e5\u672c\u767a\u653e\u5c04\u6027 \u85ac\u526464Cu-ATSM\u306b\u3088\u308b\u65b0\u6cbb\u7642\u6cd5\u958b\u767a\uff0d\u65e9\u671f\u627f\u8a8d\u3092\u76ee \u6307\u3059\u7b2cI \u76f8\u62e1\u5927\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u306e\u5b9f\u65bd\uff0eAMED\u9769\u65b0\u304c\u3093\u30fb \u9818\u57df3 &#8211; 2 \uff082020-2023\uff09\uff0c1,380\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u907a\u4f1d\u75c5\u306ethin slice\u64ae\u50cf\u3068\u4eba\u5de5\u77e5\u80fd\u306b\u3088 \u308b\u78c1\u6c17\u5171\u9cf4\u753b\u50cf\u8a3a\u65ad\u6cd5\u306e\u6a39\u7acb\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa \u76e4\uff08C\uff09\uff082021-2023\uff09\uff0c13\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u547c\u5438\u5668\u7cfb\u5148\u5929\u7570\u5e38\u75be\u60a3\u306e\u533b\u7642\u6c34\u6e96\u5411\u4e0a \u3068\u79fb\u884c\u671f\u533b\u7642\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\uff08\u96e3 \u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09\uff082023-2025\uff09\uff0c30\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u9ac4\u82bd\u816b\uff0c\u975e\u5b9a\u578b\u5947\u5f62\u816b\u69d8\u30e9\u30d6\u30c9\u30a4\u30c9\u816b \u760d\uff0c\u4e0a\u8863\u816b\u306b\u5bfe\u3059\u308b\u6a19\u6e96\u6cbb\u7642\u958b\u767a\u3092\u76ee\u7684\u3068\u3057\u305f\u4ed6\u65bd\u8a2d \u5171\u540c\u7814\u7a76\uff0eAMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d \uff082023-2025\uff09\uff0c13\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u5c0f\u5150\u4e0a\u8863\u816b\u306b\u5bfe\u3059\u308b\u624b\u8853\u6458\u51fa\u5ea6\u3068\u5206\u5b50 \u5b66\u7684\u30de\u30fc\u30ab\u30fc\u3092\u7528\u3044\u305f\u6cbb\u7642\u5c64\u5225\u5316\u306b\u3088\u308b\u96c6\u5b66\u7684\u6cbb\u7642\u306e \u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u78ba\u7acb\u306b\u5411\u3051\u305f\u7814\u7a76\u958b\u767a\uff0eAMED\u9769\u65b0\u7684 \u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082023-2025\uff09\uff0c26\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u3073\u307e\u3093\u6027\u5185\u5728\u6027\u6a4b\u30b0\u30ea\u30aa\u30fc\u30de\uff08DIPG\uff09 \u306e\u30ec\u30b8\u30b9\u30c8\u30ea\u69cb\u7bc9\u304a\u3088\u3073\u7de9\u548c\u30b1\u30a2\u306e\u5b9f\u614b\u89e3\u660e\u3092\u76ee\u7684\u3068 \u3057\u305f\u591a\u65bd\u8a2d\u5171\u540c\u524d\u65b9\u8996\u7684\u89b3\u5bdf\u7814\u7a76\uff0eAMED\u9769\u65b0\u7684\u304c\u3093 \u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082023-2025\uff09\uff0c26\u4e07\u5186\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u4ee3\uff09: 1H-MRS\u6cd5\u3092\u7528\u3044\u305f\u8133\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b \u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1 \uff082022-2023\uff09\uff0c20.8\u4e07\u5186\uff0e<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff08\u4ee3\uff09: \u982d\u90e8MRI arterial spin labeling\uff08ASL\uff09\u753b \u50cf\u3092\u7528\u3044\u305f\u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb \u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1\uff082022-2023\uff09\uff0c19.1\u4e07\u5186\uff0e<\/dd>\n<dd>\u5e73\u5c71\u9ebb\u5229\u5b50\uff08\u4ee3\uff09: 4DCT\u306b\u3088\u308b\u80f8\u819c\u7652\u7740\u306e\u691c\u8a0e\uff0e\u795e\u5948\u5ddd \u770c\u7acb\u5faa\u74b0\u5668\u547c\u5438\u5668\u75c5\u30bb\u30f3\u30bf\u30fc\u5bc4\u9644\u91d1\uff0c78\u4e07\u5186\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>Yamashiro T: Pitfalls of CT-based researches for COPD: Lessons from my own failures and experiences.China-Japan Friendship Hospital Lecture Series\u201aBeijing\u201a2023\u201a7.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u8a3a\u65ad\u3067\u75c5\u6c17\u3092\u8a3a\u308b\uff0e\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u5e02\u6c11 \u8b1b\u5ea7\uff0c\u6a2a\u6d5c\uff0c2023\uff0c2\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u8840\u7ba1\u753b\u50cf\u8a3a\u65ad- \u7dcf\u8ad6\u30fb\u89e3\u5256\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u79d1 \u5c02\u9580\u533b\u4f1a\u30fb\u533b\u4f1a\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c 2023\uff0c5\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80cc\u666f\u75be\u60a3\u3092\u8003\u616e\u3057\u305fCOVID-19\u306eCT\u753b\u50cf\u8a3a \u65ad\uff0e\u7b2c71\u56de\u795e\u5948\u5dddCT\u7814\u7a76\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c3\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u9060\u9694\u753b\u50cf\u8a3a\u65ad\u304b\u3089\u8997\u304f\u300c\u9060\u9694\u533b\u7642\u300d\u306e\u73fe\u5728\u3068 \u672a\u6765\uff0e\u7b2c6 \u671fYCU\u75c5\u9662\u7d4c\u55b6\u30d7\u30ed\u30b0\u30e9\u30e0\uff0c\u6a2a\u6d5c\uff0c2023\uff0c8\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80f8\u90e8X\u7dda\u753b\u50cf\u75c5\u5909\u691c\u51fa\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2CXR-AID \u306e\u4f7f\u7528\u7d4c\u9a13\uff0e\u7b2c64\u56de\u65e5\u672c\u4eba\u9593\u30c9\u30c3\u30af\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff0c\u9ad8 \u5d0e\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u4e2d\u5185\u8033CT\u306e\u8aad\u5f71: \u6b63\u5e38\u89e3\u5256\u3068\u5178\u578b\u7684\u75be\u60a3\u306b\u6163 \u308c\u308b\uff0e\u7b2c63\u56de\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u4f8b\u4f1a\uff0c\u6a2a\u6d5c\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u6700\u524d\u7dda\u8a3a\u65ad\u304b\u3089\u6cbb\u7642\u307e\u3067\u306e\u65b0 \u305f\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u5730\u57df\u3067\u8a3a\u308b\u5faa\u74b0\u5668\u75be\u60a3\u30bb\u30df\u30ca\u30fc\uff0c\u6a2a \u6d5c\uff0c2023\uff0c12\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u6700\u65b0CT\u304a\u3088\u3073MRI\u88c5\u7f6e\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c 42\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2023\uff0c2\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u753b\u50cf\u304b\u3089\u89e3\u660e\uff01\u5fc3\u81d3CT\u304c\u5909\u3048\u308b\u6b21\u4e16\u4ee3\u306e\u5faa\u74b0 \u5668\u8a3a\u7642\uff0e\u7b2c51\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a\uff08\u30e9 \u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09\uff0c\u540d\u53e4\u5c4b\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u5f53\u756a\u4e16\u8a71\u4eba\uff0e\u7b2c14\u56de\u6c60\u6dfb\u30e1\u30e2\u30ea\u30a2\u30eb\u80f8\u90e8\u753b\u50cf \u8a3a\u65ad\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c2023\uff0c8\uff0e<\/dd>\n<dd>\u9752\u6728\u3000\u4eae: \u30a4\u30e1\u30fc\u30b8\u30fb\u30a4\u30f3\u30bf\u30fc\u30d7\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u30fb\u30bb\u30c3\u30b7\u30e7 \u30f3\u6562\u95d8\u8cde\uff0e\u7b2c59\u56de\u8179\u90e8\u6551\u6025\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6c96\u7e04\uff0c2023\uff0c3\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff0c\u51fa\u5ddd\u8f1d\u6d69: \u4e73\u764c\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30c0\u30a4\u30ca\u30df\u30c3\u30af \u9020\u5f71\u3068\u9ad8\u7a7a\u9593\u5206\u89e3\u80fd\u753b\u50cf\u306e\u6709\u7528\u6027\uff0eBayer Radiology\u30b5 \u30a4\u30c8\u30fbSearch Radiology \u75c7\u4f8b\u5831\u544a\uff08WEB\u958b\u50ac\uff09\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff0c\u51fa\u5ddd\u8f1d\u6d69: \u4e0b\u5927\u9759\u8108\u816b\u760d\u6813\u8a3a\u65ad\u306b\u304a\u3051\u308bslow infusion \u9020\u5f71\u3068True FISP\uff083D-SSFP\uff09\u306e\u6709\u7528\u6027\uff0eBayer Radiology\u30b5\u30a4\u30c8\u30fbSearch Radiology \u75c7\u4f8b\u5831\u544a\uff08WEB\u958b \u50ac\uff09\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce: \u8aad\u5f71\u696d\u52d9\u3084IVR\u6642\u3067\u306e\u696d\u52d9\u52b9\u7387\uff0c\u9060\u9694\u8aad\u5f71 \u3084AI\u8a3a\u65ad\uff0c\u50cd\u304d\u65b9\u6539\u9769\u306b\u3064\u3044\u3066\uff0e\u30d0\u30a4\u30a8\u30eb\u85ac\u54c1\u793e\u5185\u52c9 \u5f37\u4f1a\uff0c\u795e\u5948\u5ddd\uff0c2023\uff0c4\uff0e<\/dd>\n<dd>\u9752\u6728\u3000\u4eae: \u30a4\u30e1\u30fc\u30b8\u30fb\u30a4\u30f3\u30bf\u30fc\u30d7\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u30fb\u30bb\u30c3\u30b7\u30e7 \u30f3\u512a\u79c0\u8cde\uff0e\u7b2c59\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c \u5fb3\u5cf6\uff0c2023\uff0c9\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce: \u653e\u5c04\u7dda\u5b89\u5168\u5229\u7528\u306e\u57fa\u790e\uff0e\u795e\u5948\u5ddd\u30ea\u30cf\u30d3\u30ea \u30c6\u30fc\u30b7\u30e7\u30f3\u75c5\u9662\u8b1b\u6f14\uff0c\u795e\u5948\u5ddd\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce: \u4e2d\u5185\u8033CT\u306e\u8aad\u5f71: \u6b63\u5e38\u89e3\u5256\u3068\u5178\u578b\u7684\u75be\u60a3\u306b \u6163\u308c\u308b\uff08\u5ea7\u9577\uff09\uff0e\u795e\u5948\u5ddd\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c63\u56de\u4f8b\u4f1a\uff0c \u795e\u5948\u5ddd\uff0c2023\uff0c10\uff0e<\/dd>\n<dd>\u5c71\u53e3\u552f\u53f2: \u9f3b\u526f\u9f3b\u8154\u306b\u767a\u751f\u3057\u305f\u80de\u5de3\u578b\u6a2a\u7d0b\u7b4b\u8089\u816b\u306e2 \u4f8b\uff0e\u795e\u5948\u5ddd\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c63\u56de\u4f8b\u4f1a\uff0c\u795e\u5948\u5ddd\uff0c 2023\uff0c10\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u30a8\u30c3\u30bb\u30f3\u30b9\uff0e\u753b\u50cf\u8a3a\u65adWEB \u30bb\u30df\u30ca\u30fcIN \u8328\u57ce\uff08WEB\u958b\u50ac\uff09\uff0c2023\uff0c11\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u5185\u5206\u6ccc\u9818\u57df\u306eMRI: \u64ae\u50cf\u6cd5\u304b\u3089MRS\u307e \u3067\uff0eSandoz Medical Seminar\uff08WEB\u958b\u50ac\uff09\uff0c2023\uff0c8\uff0e<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Noritake M, Yamada A, Yamanaka S, Utsunomiya D, Inoue T: Intraductal papilloma with carcinoma of the breast described by dedicated breast 18F-FDG PET. Clin Nucl Med, 47(6): 557-558, 2022.<\/dd>\n<dd>Kudo A, Tateishi U, Yoshimura R, Tsuchiya J, Yokoyama K, Takano S, Kobayashi N, Utsunomiya D, Hata M, Ichikawa Y, Tanabe 1, Hosono M, Kinuya S: Safety and response after peptide receptor radionuclide therapy with 177 Lu-DOTATATE for neuroendocrine tumors in phase 1\/2 prospective Japanese trial. J Hepatobiliary Pancreat Sci, 29(4): 487-499, 2022.<\/dd>\n<dd>Kato S, Azuma M, Fukui K, Kodama S, Nakayama N, Kitamura H, Hagiwara E, Ogura T, Horita N, Namkoong H, Kimura K, Tamura K, Utsunomiya D: Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis. Heart Vessels, 37(9): 1570-1582, 2022.<\/dd>\n<dd>Noguchi T, Ota H, Matsumoto N, Morita Y, Oshita A, Kawasaki E, Kawasaki T, Moriwaki K, Kato S, Fukui K, Hoshi T, Watabe H, Kanaya T, Asaumi Y, Kataoka Y, Otsuka F, Takagi K, Yoneda S, Sawada K, Iwai T, Matama H, Honda S, Fujino M, Miura H, Nishimura K, Takase K: Clinical impact of cardiac magnetic resonance in patients with suspected coronary artery disease associated with chronic kidney disease (AQUAMARINE-CKD study): study. protocol for a randomized controlled trialTrials, 23(1): 904, 2022.<\/dd>\n<dd>Kinoshita M, Kato S, Kodama S, Azuma M, Nakayama N, Fukui K, Saito N, Iwasawa T, Kimura K, Tamura K, Utsunomiya D: Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy. Heart Vessels, 37(9): 1541-1550, 2022.<\/dd>\n<dd>Ishiwata Y, Miura K, Kishimoto M, Nomura K, Sawamura S, Magami S, Ikawa M, Yamashiro T, Utsunomiya D: Comparison of CO-RADS scores based on visual and artificial intelligence assessments in a non-endemic area. Diagnostics (Basel), 12(3): 738, 2022.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients. Am J Cardiol, 172: 159-161, 2022.<\/dd>\n<dd>Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, Kessoku T, Ogawa Y, Takahashi H, Saigusa Y, Yoneda M, Kirikoshi H, Utsunomiya D, Aishima S, Saito S, Nakajima A: Direct comparison of US and MR elastography for staging liver fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol, 20(4): 908-917, 2022.<\/dd>\n<dd>Imajo K, Kessoku T, Honda Y, Hasegawa S, Tomeno W, Ogawa Y, Motosugi U, Saigusa Y, Yoneda M, Kirikoshi H, Yamanaka S, Utsunomiya D, Saito S, Nakajima A: MRI-based quantitative R2* mapping at 3 Tesla reflects hepatic iron overload and pathogenesis in nonalcoholic fatty liver disease patients. J Magn Reson Imaging, 55(1): 111-125, 2022.<\/dd>\n<dd>Nishii T, Funama Y, Kato S, Iwasawa T, Yasuda N, Ota Y, Kawagoe H, Oda S, Tsutsumi T, Utsunomiya D: Comparison of visibility of in-stent restenosis between conventional- and ultra-high spatial resolution computed tomography: coronary arterial phantom study. Jpn J Radiol, 40(3): 279-288, 2022.<\/dd>\n<dd>Kurita Y, Hara K, Kobayashi N, Kuwahara T, Mizuno N, Okuno N, Haba S, Yagi S, Hasegawa S, Sato T, Hosono K, Endo I, Shimizu Y, Niwa Y, Utsunomiya D, Inaba Y, Nakajima A, Kubota K, Ichikawa Y: Detection rate of endoscopic ultrasound and computed tomography in diagnosing pancreatic neuroendocrine neoplasms including small lesions: A multicenter study. J Hepatobiliary Pancreat Sci, 29(8): 950-959, 2022.<\/dd>\n<dd>Sawamura S, Koike Y, Yamamoto T, Terauchi M, Koyama S, Utsunomiya D: The use of viabahn VBX stent-grafts for the treatment of extrahepatic portal vein hemorrhage. Minim Invasive Ther Allied Technol, 31(7): 1066-1069, 2022.<\/dd>\n<dd>Kato S, Utsunomiya D, Horita N, Hoshino M, Kakuta T: Prognostic significance of the perivascular fat attenuation index derived by coronary computed tomography: A meta-analysis. Hellenic J Cardiol, 67: 73-75, 2022.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: Sodium-glucose cotransporter 2 inhibitors in heart failure with chronic kidney disease. ESC Heart Fail, 9(5): 3661-3662, 2022.<\/dd>\n<dd>Kato S, Horita N, Utsunomiya D: The positive impact of coronary computed tomography angiography-based strategies on the clinical outcomes of patients with diabetes mellitus. Eur J Intern Med, 106: 150-151, 2022.<\/dd>\n<dd>Aoki R, Iwasawa T, Saka T, Yamashiro T, Utsunomiya D, Misumi T, Baba T, Ogura T: Effects of automatic deep-learning-based lung analysis on quantification of interstitial lung disease: correlation with pulmonary function test results and prognosis. Diagnostics (Basel), 12(12): 3038, 2022.<\/dd>\n<dd>Muramatsu S, Sato K, Yamashiro T, Doi K: Quantitative measurements of emphysema in ultra-high resolution computed tomography using model-based iterative reconstruction in comparison to that using hybrid iterative reconstruction. Phys Eng Sci Med, 45(1): 115-124, 2022.<\/dd>\n<dd>Tomita H, Yamashiro T, Iida G, Tsubakimoto M, Mimura H, Murayama S: Radiomics analysis for differentiating of cervical lymphadenopathy between cancer of unknown primary and malignant lymphoma on unenhanced computed tomography. Nagoya J Med Sci, 84(2): 269-285, 2022.<\/dd>\n<dd>Kariyasu T, Machida H, Yamashiro T, Fukushima K, Koyanagi M, Yokoyama K, Nishikawa M, Satoh T: Correlation between CT value on lung subtraction CT and radioactive count on perfusion lung single photon emission CT in chronic thromboembolic pulmonary hypertension. Diagnostics, 12(11): 2895, 2022.<\/dd>\n<dd>Muto Y, Sekine A, Hagiwara E, Komatsu S, Baba T, Oda T, Tabata E, Sakayori M, Fukui K, Iwasawa T, Takemura T, Misumi T, Ogura T: Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosis. Respir Investig, 60(40): 543-550, 2022.<\/dd>\n<dd>Ikeda S, Kato T, Kenmotsu H, Ogura T, Sato Y, Hino A, Harada T, Kubota K, Tokito T, Okamoto I, Furuya N, Yokoyama T, Hosokawa S, Iwasawa T, Kasajima R, Miyagi Y, Misumi T, Okamoto H: Atezolizumab for Pretreated Non-Small Cell Lung Cancer with Idiopathic Interstitial Pneumonia: Final Analysis of Phase II AMBITIOUS Study. Oncologist, 27(9): 720-e702, 2022.<\/dd>\n<dd>Sekine A, Matama G, Hagiwara E, Tabata E, Ikeda S, Oda T, Okuda R, Kitamura H, Baba T, Satoh H, Misumi T, Komatsu S, Iwasawa T, Ogura T: Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy. Thorac Cancer, 13(17): 2443-2449, 2022.<\/dd>\n<dd>Inafuku K, Sekine A, Arai H, Hagiwara E, Komatsu S, Iwasawa T, Misumi T, Kikunishi N, Tajiri M, Okudela K, Rino Y, Ogura T: Radiological unilateral pleuroparenchymal fibroelastosis as a notable late complication after lung cancer surgery: incidence and perioperative associated factors. Interact Cardiovasc Thorac Surg, 35(4): ivac223, 2022.<\/dd>\n<dd>Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Hanaoka M, Ogura T: Respiratory lesions in IgG4-related disease: classification using 2019 American College of Rheumatology\/European League Against Rheumatism criteria. ERJ Open Res, 8(3): 00120-2022, 2022.<\/dd>\n<dd>Okuda R, Takemura T, Iwasawa T, Kaburaki S, Baba T, Hagiwara E, Ogura T: Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase. Allergy Asthma Clin Immunol, 18(1): 104, 2022.<\/dd>\n<dd>Kataoka T, Okudela K, Matsumura M, Baba T, Kitamura H, Arai H, Suzuki T, Koike C, Mutsui H, Sekiya M, Sugiyama M, Takemura T, Iwasawa T, Ogura T, Ohashi K: Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia. Oncology letters, 24(1): 225, 2022.<\/dd>\n<dd>Chuma M, Yokoo H, Hiraoka A, Ueda K, Yokoyama T, Tsuji K, Shimada N, Uojima H, Kobayashi S, Hattori N, Okubo T, Atsukawa M, Ishikawa T, Takaguchi K, Tsutsui A, Toyoda H, Tada T, Saito Y, Hirose S, Tanaka T, Takeda K, Otani M, Sekikawa Z, Watanabe T, Hidaka H, Morimoto M, Numata K, Kagawa T, Sakamoto M, Kumada T, Maeda S: Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment. Curr Oncol, 4(29): 3259-3271, 2022\uff0e<\/dd>\n<dd>Furugori S, Abe T, Funabiki T, Sekikawa Z, Takeuchi I: Arterial Embolisation for Trauma Patients with Pelvic Fractures in Emergency Settings: A Nationwide Matched Cohort Study in Japan. Eur J Vasc Endovasc Surg, 64: 234-242\uff0c2022\uff0e<\/dd>\n<dd>Masamichi K, Yamamoto H, Uehara T, Kobayashi Y, Hozumi H, Fujisawa T, Mayamoto A, Kishaba T, Kunishima F, Okamoto M, Kitamura H, Iwakasa T, Matsushita S, Terasaki Y, Kunugi S, Ushiki A, Yasuo M, Suda T, Hanaoka M: prognostic implication of IgG4 and IgG1-positibe cell infiltration in the lung in patients with idiopathic interstitial pneumonia. Scientific Reports, 3(1): 9303, 2022.<\/dd>\n<dd>Yamamoto Y, Hino A, Kurihara H, Kano K, Serizawa I, Katoh H, Hiruma T: Transitional changes of spacer materials used in carbon-ion radiation therapy. Asia Pac J Clin Oncol, 18(5): 442-447, 2022.<\/dd>\n<dd>Okubo Y, Yamamoto Y, Terao H, Suzuki T, Koizumi M, Yoshioka E, Washimi K, Sato S, Yokose T, Kishida T, Miyagi Y: Significance of non-standardized magnetic resonance imaging abnormalities and subsequent targeted prostate cancer biopsy for pathologists: A retrospective observational study. Pathol Res Pract, 240: 154188, 2022.<\/dd>\n<dd>Murayama D, Yamamoto Y, Matsui A, Yasukawa M, Okamoto S, Toda S, Iwasaki H: Lung cavitation in patients with anaplastic thyroid cancer treated with lenvatinib. Gland Surg, 11(6): 963-969, 2022.<\/dd>\n<dd>Okubo Y, Yamamoto Y, Sato S, Yoshioka E, Suzuki M, Washimi K, Osaka K, Suzuki T, Yokose T, Kishida T, Miyagi Y: Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution. Virchows Arch, 480(5): 979-987, 2022.<\/dd>\n<dd>Hihara F, Matsumoto H, Yoshimoto M, Masuko T, Endo Y, Igarashi C, Tachibana T, Shinada M, Zhang MR, Kurosawa G, Sugyo A, Tsuji AB, Higashi T, Kurihara H, Ueno M, Yoshii Y: In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. International journal of molecular sciences, 23(10): 5807, 2022.<\/dd>\n<dd>Igarashi C, Matsumoto H, Takahashi M, Hihara F, Tachibana T, Zhang MR, Kurihara H, Higashi T, Yoshii Y: Identification and quantitative structure\u2013activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM. Nuclear Medicine and Biology, 108-109: 10-15, 2022.<\/dd>\n<dd>Yoshimoto Suzuki Y, Yamanaka J, Miyazaki O, Nozawa K, Ohira M, Kamijo T, Shichino H: Infantile Stage M Neuroblastoma With 11q Deletion, Mimicking Stage MS. J Pediatr Hematol Oncol, 44(3): e779-e781, 2022.<\/dd>\n<dd>Fujii S, Mochizuki K, Usui H, Kitagawa N, Umemoto S, Tanaka M, Tanaka Y, Otani M, Nozawa K, Kurosawa K, Kagami M, Shinkai M: Infantile hepatic hemangioma and hepatic mesenchymal hamartoma in an infant associated with placental mesenchymal dysplasia: a case report. Surg Case Rep, 8(1): 161, 2022.<\/dd>\n<dd>Tomiyasu M, Shibasaki J, Kawaguchi H (AIST), Enokizono M(TMHP), Toyoshima K, Obata T(QST), Aida N: Altered brain metabolite concentration and delayed neurodevelopment in preterm neonates. Pediatric Research, 91: 197\u2013203, 2022.<\/dd>\n<dd>Ikeda A, Tomiyasu M, Yamamoto A, Tsuyusaki Y, Kawai Y, Tanabe M, Tsuji M, Iai M, Aida N, Goto T: Elevation of brain gamma-aminobutyric acid levels is associated with vigabatrin-associated brain abnormalities on magnetic resonance imaging. Epilepsy Res, 181: 106881, 2022.<\/dd>\n<dd>Kumaki T, Enomoto Y, Aida N, Goto T, Kurosawa K: Progression of cerebral and cerebellar atrophy in congenital contractures of limbs and face, hypotonia, and developmental delay. Pediatr Int, 64(1): e14734, 2022.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14:\u5fc3\u81d3\u306e\u89e3\u5256. \u753b\u50cf\u8a3a\u65ad, 42(7): 600-607, 2022.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u3067\u307f\u304b\u3051\u308b\u5076\u767a\u7684\u6240\u898b\u306e\u30de\u30cd\u30b8\u30e1\u30f3\u30c82022 &#8211; \u3042\u306a\u305f\u306a\u3089\u3069\u3046\u66f8\u304f\uff1f \u753b\u50cf\u8a3a\u65ad(\u5897\u520a\u53f7), 42(11): A76-77, 2022.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u3067\u307f\u304b\u3051\u308b\u5076\u767a\u7684\u6240\u898b\u306e\u30de\u30cd\u30b8\u30e1\u30f3\u30c82022 &#8211; \u3042\u306a\u305f\u306a\u3089\u3069\u3046\u66f8\u304f\uff1f \u753b\u50cf\u8a3a\u65ad(\u5897\u520a\u53f7), 42(11): A82-83, 2022.<\/dd>\n<dd>\u6fa4\u6751\u99ff\u543e, \u52a0\u85e4\u771f\u543e, \u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u5927\u8840\u7ba1\u306e\u8853\u5f8c\u5408\u4f75\u75c7. \u81e8\u5e8a\u753b\u50cf, 38(13): 14-23, 2022.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e, \u6771\u3000\u771f\u4f0a, \u5150\u7389\u3000\u7fd4, \u4e2d\u5c71\u5c1a\u8cb4, \u798f\u4e95\u548c\u6a39, \u9f4b\u85e4\u3000\u592e, \u5ca9\u6fa4\u591a\u6075, \u5b87\u90fd\u5bae\u5927\u8f14: MRI\u306b\u3088\u308b\u5fc3\u7b4b\u30b9\u30c8\u30ec\u30a4\u30f3\u89e3\u6790\u306e\u6709\u7528\u6027. \u5fc3\u81d3, 54(1): 23-28, 2022.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u753b\u50cf\u3067\u307f\u304b\u3051\u308b\u5076\u767a\u7684\u6240\u898b\u306e\u30de\u30cd\u30b8\u30e1\u30f3\u30c82022 &#8211; \u3042\u306a\u305f\u306a\u3089\u3069\u3046\u66f8\u304f\uff1f \u753b\u50cf\u8a3a\u65ad(\u5897\u520a\u53f7), 42(11): A80-A81, 2022.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u7279\u6b8a\u306a\u5fc3\u7b4b\u708e\u306eMRI. \u753b\u50cf\u8a3a\u65ad, 42(8): 816-817, 2022.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u3053\u3053\u304c\u77e5\u308a\u305f\u3044, \u201c\u306f\u3058\u3081\u3088\u3046\uff01\u5fc3\u81d3\u306e\u753b\u50cf\u8a3a\u65ad\u201d. \u753b\u50cf\u8a3a\u65ad, 42(13): 1288-1290, 2022.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI\u3000\u8aad\u5f71\u306e\u76ee\u306e\u4ed8\u3051\u3069\u3053\u308d. \u753b\u50cf\u8a3a\u65ad, 42(7): 621-632, 2022.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a \u8efd\u5fae\u306a\u9593\u8cea\u6027\u9670\u5f71. \u753b\u50cf\u8a3a\u65ad(\u5897\u520a\u53f7), 42(11): A60-61, 2022.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075, \u6b66\u6751\u6c11\u5b50: \u904e\u654f\u6027\u80ba\u708e. \u753b\u50cf\u8a3a\u65ad, 42(10): 972-984, 2022.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e, \u77f3\u5ddd\u5e78\u8f14, \u571f\u4e95\u5185\u6052\u5b8f, \u8349\u5207\u5b5d\u8cb4, \u6797\u3000\u667a\u53f2, \u4f50\u85e4\u79c0\u5149: \u8133\u6a5f\u80fd\u753b\u50cf\u306e\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b \uff0d\u8133\u816b\u760d\uff0d. \u81e8\u5e8a\u653e\u5c04\u7dda, 67(13): 1719-1727, 2022.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: 2022\u5e74\u306b\u304a\u3051\u308b\u6838\u533b\u5b66\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u6700\u65b0\u52d5\u5411. Rad Fan, 20(4): 36-41, 2022.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u7279\u96c6\u3000Step up MRI 2022\u3000MRI\u7814\u7a76\u306e\u6700\u65b0\u52d5\u5411\uff06\u9818\u57df\u5225MRI\u6280\u8853\u306e\u81e8\u5e8a\u5fdc\u7528\u3068\u30c8\u30d4\u30c3\u30af\u30b9\u30006\uff0e\u5c0f\u5150\u9818\u57df\u306b\u304a\u3051\u308b\u81e8\u5e8a\u5fdc\u7528\u3068\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u30b9. INNERVISION, 37(9): 62-64, 2022.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u30b3\u30c4, \u80ba\u30fb\u7e26\u9694\u8a55\u4fa1. \u5c0f\u5150\u79d1\u8a3a\u7642, 85: 148-152, 2022.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u30b3\u30c4, \u56a2\u80de\u6027\u80ba\u75be\u60a3. \u5c0f\u5150\u79d1\u8a3a\u7642, 85: 244-249, 2022.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u30b3\u30c4, \u5c0f\u5150\u753b\u50cf\u691c\u67fb\u3092\u9069\u6b63\u306b\u884c\u3046\u305f\u3081\u306b. \u5c0f\u5150\u79d1\u8a3a\u7642, 85: 2-5, 2022.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad\u3092\u76ee\u6307\u3057\u3066. \u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u96d1\u8a8c J Jpn Soc Pediatr Radiol, 38(1): 21\u201328, 2022.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Kato S, Fukui K, Azuma m, Kodama S, Saito N, Yazaki M, Nabeta T, Ito m, Kawaguchi Y, Kudo A, Hiki M, Matsue Y, Ota S, Yamada A, Takakura M, Matsuda A, Matsuzawa Y, Utsunomiya D, Kimura K, Tamura K: Multicenter Registry Evaluating the Utility of Cardiac MRI for Patients with Non-ischemic Heart Failure in Japan: IMAGE-HF registry. \u7b2c86\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(WEB\u958b\u50ac), 2022\uff0c3\uff0e<\/dd>\n<dd>Ishiwata Y, Iizuka H, Horie K, Onoma A, Yamashiro, Ogawa M, Utsunomiya D: Investigation of 123I-FP-CIT SPECT Imaging Time Reduction Using Artificial Intelligence. 35th Annual Congress of the European Association of Nuclear Medicine(WEB\u958b\u50ac), 2022, 10.<\/dd>\n<dd>Iwasawa T, Tsuchiya N, Moriya H, Yanagawa M, Baba T, Ogura T: Evaluation of Airway disease in Rheumatoid arthritis using ultra-high-resolution CT. RSNA 2023, Chicago, 2022, 11.<\/dd>\n<dd>Aida N: Neuroimage findings in neonatal neurological disorders. 6th Azalea Festival Symposium in Peditric Neurology(WEB\u958b\u50ac), 2022, 3.<\/dd>\n<dd>\u4f0a\u85e4\u8ce2\u4e00, \u5ca9\u6fa4\u591a\u6075, \u52a0\u85e4\u771f\u543e, \u5b87\u90fd\u5bae\u5927\u8f14: \u9593\u8cea\u6027\u80ba\u708e\u60a3\u8005\u306eCT\u89e3\u6790\u306b\u304a\u3051\u308b\u80ba\u306e\u7dda\u7dad\u5316\u3068\u53f3\u5fc3\u6a5f\u80fd\u306e\u95a2\u9023\u306e\u691c\u8a0e. \u7b2c94\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 1.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\u306e\u81e8\u5e8a\uff5e\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u30b9\u3092\u3075\u304f\u3081\u3066. \u7b2c70\u56de\u795e\u5948\u5dddCT\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u6280\u8853\u9032\u6b69. \u65e5\u672c\u653e\u5c04\u7dda\u79d1\u5c02\u9580\u533b\u4f1a\u30fb\u533b\u4f1a\u30df\u30c3\u30c9\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc, \u795e\u6238, 2022, 7.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3MRI\u3067\u306a\u306b\u304c\u5206\u304b\u308b\u306e\u304b. \u7b2c85\u56de\u9759\u5ca1\u770cMRI\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 8.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u306e\u753b\u50cf\u8a3a\u65ad: CT, MRI\u306e\u57fa\u672c\u3068\u30c8\u30d4\u30c3\u30af. Kyoto Radiological Science Seminar, \u4eac\u90fd, 2022, 9.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: JCR\u30a2\u30ef\u30fc\uff1a\uff19\u3064\u306e\u653e\u5c04\u7dda\u90e8\u306e\u52e4\u52d9\u7d4c\u9a13\u304b\u3089\u8003\u3048\u308b \u90fd\u5e02\u90e8\u3068\u5730\u65b9\u306e\u4eca\u5f8c\u306e\u76ee\u6a19\u306b\u3064\u3044\u3066.\u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: MDCT\u306e\u6280\u8853\u306e\u6b69\u307f, \u305d\u3057\u3066, \u3053\u308c\u304b\u3089\u306e\u767a\u5c55. \u7b2c41\u56de\u6a2a\u4e09\u3089\u305b\u3093CT\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 10.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u7b4b\u75be\u60a3\u3092\u753b\u50cf\u8a3a\u65ad\u3067\u8a3a\u308b. \u7b2c3\u56deConference of Fabry disease in Kanagawa(WEB\u958b\u50ac), 2022, 10.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u753b\u50cf\u8a3a\u65ad\u306e\u57fa\u672c\u301c\u89e3\u5256\u304b\u3089\u8aad\u5f71\u307e\u3067. \u7b2c30\u56de\u5c71\u967d\u30fb\u5c71\u9670Radiology Update\u5b66\u8853\u8b1b\u6f14\u4f1a(WEB\u958b\u50ac), 2022, 10.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: CT\u642d\u8f09\u8eca\u3092\u7528\u3044\u305f COVID-19 \u5bfe\u7b56\uff1a\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u306e\u53d6\u7d44\u307f\uff0e\u7b2c13\u56de\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 1.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: COVID-19\u80ba\u708e\u306eCT\u8a3a\u65ad\u304b\u3089\u898b\u3048\u3066\u304f\u308b\u3053\u3068\uff0e\u5b9f\u8df5\u529b\u3068\u7814\u7a76\u529b\u3092\u5099\u3048\u305f\u6cd5\u533b\u5b66\u8005\u80b2\u6210\u4e8b\u696d\uff08\u5e73\u621029\u5e74\u5ea6\u6587\u90e8\u79d1\u5b66\u7701\u88dc\u52a9\u91d1\u4e8b\u696d\u3000\u57fa\u790e\u7814\u7a76\u533b\u990a\u6210\u6d3b\u6027\u5316\u30d7\u30ed\u30b0\u30e9\u30e0\uff09\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u30b7\u30ea\u30fc\u30ba(WEB\u958b\u50ac), 2022, 3.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80ba\u306b\u57fa\u790e\u75be\u60a3\u304c\u3042\u308b\u60a3\u8005\u306eCOVID-19\u80ba\u708e\u306eCT\u50cf\uff0e\u7b2c11\u56de\u6551\u6025\u653e\u5c04\u7dda\u30bb\u30df\u30ca\u30fc\u30d7\u30ec\u30df\u30a2\u30e0(WEB\u958b\u50ac), 2022, 5.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u533b\u7642\u5f93\u4e8b\u8005\u3068\u3057\u3066\u306e\u30b3\u30ed\u30ca\u653f\u7b56\u3078\u306e\u8ca2\u732e\uff1a\u753b\u50cf\u8a3a\u65ad\u533b\u304c\u53d6\u308a\u7d44\u3080 COVID-19 \u8a3a\u7642\uff0e\u4ee4\u548c4\u5e74\u5ea6\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u75c5\u9662\u7d4c\u55b6\u30d7\u30ed\u30b0\u30e9\u30e0\u30fbSIMBA\u30fb\u30d8\u30eb\u30b9\u30c7\u30fc\u30bf\u30b5\u30a4\u30a8\u30f3\u30b9\u5c02\u653b\u5408\u540c\u30aa\u30f3\u30e9\u30a4\u30f3\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u6a2a\u6d5c\uff0c2022, 8.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u753b\u50cf\u8a3a\u65ad\u533b\u304c\u898b\u308b\u300c\u30b3\u30ed\u30ca\u798d\u300d\uff1a\u533b\u7642\u30fb\u798f\u7949\u30fb\u884c\u653f\u306e\u89b3\u70b9\u304b\u3089\uff0e\u7b2c5\u56de\u65e5\u672c\u6cd5\u533b\u75c5\u7406\u5b66\u4f1a\u5b66\u8853\u5168\u56fd\u96c6\u4f1a, \u6a2a\u6d5c, 2022, 9.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u80cc\u666f\u56e0\u5b50\u3067\u8aad\u307f\u89e3\u304fCOVID-19\u306e\u80f8\u90e8CT\u50cf. \u7b2c41\u56de\u30d6\u30e9\u30c3\u30b7\u30e5\u30a2\u30c3\u30d7\u30bb\u30df\u30ca\u30fc in Yokohama, \u6a2a\u6d5c, 2022, 9.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u7b2c6\u6ce2, \u7b2c7\u6ce2\u306eCOVID-19\u60a3\u8005\u306eCT\u50cf\uff1a\u6a2a\u6d5c\u306f\u3058\u3081\u75c5\u9662\u3067\u306e\u7d4c\u9a13\u304b\u3089\uff0e\u9999\u5ddd\u770c\u80f8\u90e8CT\u8aad\u5f71\u7814\u7a76\u4f1a\u7279\u5225\u8b1b\u6f14\u4f1a, \u9ad8\u677e, 2022, 10.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u7b2c6\u6ce2\uff0d7\u6ce2\u306eCOVID-19\u306eCT\u50cf\uff1a\u6a2a\u6d5c\u306f\u3058\u3081\u75c5\u9662\uff08\u6a2a\u6d5c\u5e02\u30b3\u30ed\u30ca\u5c02\u9580\u75c5\u9662\uff09\u3067\u306e1000\u4f8b\u306e\u7d4c\u9a13\u304b\u3089\uff0e\u7b2c62\u56de\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u4f8b\u4f1a, \u6a2a\u6d5c\uff0c2022, 10.<\/dd>\n<dd>\u677e\u4e0b\u5f70\u4e00\u90ce: \u80f8\u90e8\u5358\u7d14X\u7dda\u5199\u771f\u3067\u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u4ee3\u8868\u7684\u30b5\u30a4\u30f3. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u677e\u4e0b\u5f70\u4e00\u90ce: \u5358\u7d14\u5199\u771f\u304b\u3089\u59cb\u3081\u308b\u80f8\u90e8\u753b\u50cf\u8a3a\u65ad\u306e\u4e16\u754c. \u795e\u5948\u5ddd\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u8853\u8b1b\u7fd2\u4f1a(WEB\u958b\u50ac), 2022, 11.<\/dd>\n<dd>\u677e\u4e0b\u5f70\u4e00\u90ce: \u80f8\u90e8\u5358\u7d14X\u7dda\u5199\u771f\u8aad\u5f71\u306e\u57fa\u672c\uff5e\u533b\u5e2b\u306f\u3053\u3053\u3092\u898b\u3066\u3044\u308b. \u5ddd\u5d0e\u5e02\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a \u5b9a\u4f8b\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2023, 1.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u3092\u5229\u7528\u3057\u305f\u9593\u8cea\u6027\u80ba\u708e\u306eCT\u306e\u5b9a\u91cf\u8a55\u4fa1\u3068\u305d\u306e\u81e8\u5e8a\u5fdc\u7528. \u7b2c41\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a(WEB\u958b\u50ac), 2022, 1.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u5b9a\u91cf\u5316\u3067\u898b\u3048\u3066\u304f\u308b\u547c\u5438\u5668\u75be\u60a3\u306e\u75c5\u614b. \u7b2c13\u56de\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a, \u798f\u5ca1, 2022, 1.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u80f8\u90e8CT\u8aad\u5f71\u306e\u57fa\u790e\u3000\u9ad8\u7cbe\u7d30CT\u3067\u307f\u308b\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3. \u7b2c62\u56de\u547c\u5438\u5668\u5b66\u4f1a(WEB\u958b\u50ac), 2022, 4.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: COVID-19\u306b\u95a2\u308f\u308b\u753b\u50cf\u8a3a\u65ad\u3000\u80ba\u75c5\u5909\uff12\u3000\u5f8c\u907a\u75c7. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a, \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: Radiomics. \u7b2c2\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u7814\u7a76\u4f1a, \u6771\u4eac, 2022, 10\uff0e<\/dd>\n<dd>\u9ad8\u6728\u91cd\u4eba, \u6885\u6d25\u96c5\u592b, \u77f3\u5ddd\u3000\u516c, \u718a\u8c37\u82f1\u4e4b, \u5e84\u7530\u660c\u9686, \u539f\u7530\u5f18\u79cb, \u91ce\u767b\u306f\u308b\u304b, \u5800\u5207\u3000\u611b, \u7530\u8302\u548c\u6b4c\u5b50, \u5c71\u4e2d\u529f\u4e00, \u5c0f\u6797\u96c4\u4ecb: \u5065\u8a3a\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u3067COVID-19\u80ba\u708e\uff08\u7622\u75d5\uff09\u304c\u7591\u308f\u308c\u305f\u75c7\u4f8b\u306b\u3064\u3044\u3066. \u7b2c50\u56de\u65e5\u672c\u7dcf\u5408\u5065\u8a3a\u533b\u5b66\u4f1a(WEB\u958b\u50ac), 2022, 1.<\/dd>\n<dd>\u671b\u6708\u6625\u6d77, \u5c71\u672c\u3000\u7d71, \u6fa4\u6751\u99ff\u543e, \u5c0f\u5c71\u65b0\u543e, \u5b87\u90fd\u5bae\u5927\u8f14: \u9396\u9aa8\u4e0b\u9759\u8108\u8840\u6813\u75c7\u306b\u3088\u308a\u6cbb\u7642\u53ef\u80fd\u3067\u3042\u3063\u305f\u9838\u90e8\u30ea\u30f3\u30d1\u6f0f\u306e1\u4f8b. \u7b2c458\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u771f\u4e0a\u3000\u85ab\uff1a\u8178\u9593\u819c\u816b\u7624\u3067\u767a\u898b\u3055\u308c\u305f\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u4e00\u4f8b. \u7b2c458\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb, \u4e0a\u51fa\u6d69\u4e4b, \u5927\u5d8b\u667a\u6d0b, \u6c38\u7530\u3000\u5fb9, \u912d\u3000\u4ed5\u582f, \u9ebb\u751f\u771f\u4e8c\u90ce, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u533b\u539f\u6027\u7cbe\u5de3\u52d5\u8108\u640d\u50b7\u306b\u5bfe\u3059\u308bTAE\u3092\u65bd\u884c\u3057\u305f2\u4f8b. \u7b2c33\u56de\u95a2\u6771IVR\u7814\u7a76\u4f1a, \u6771\u4eac, 2022, 8.<\/dd>\n<dd>\u671b\u6708\u6625\u6d77, \u897f\u4e95\u4fca\u6676, \u91ce\u6751\u5e78\u4e00\u90ce, \u963f\u90e8\u3000\u793c, \u5b89\u85e4\u548c\u592b, \u9f4a\u85e4\u516c\u5f66, \u7af9\u6797\u8302\u751f, \u52a0\u85e4\u771f\u543e: \u9aa8\u8ee2\u79fb\u691c\u7d22\u76ee\u7684\u306e\u9aa8\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u306b\u3088\u308a\u65e9\u671f\u767a\u898b\u3067\u304d\u305f\u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u306e1\u4f8b. 2022\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c62\u56de\u4f8b\u4f1a\uff0c\u6a2a\u6d5c, 2022, 10.<\/dd>\n<dd>\u5927\u5d8b\u667a\u6d0b, \u5c71\u53e3\u552f\u53f2, \u6c38\u7530\u3000\u5fb9, \u4e2d\u6751\u6cf0\u4ecb, \u5c0f\u6797\u96c4\u4ecb, \u9ebb\u751f\u771f\u4e8c\u90ce, \u4e09\u6a4b\u8015\u5e73, \u5cb8\u7530\u76f4\u5b5d, \u4e0a\u51fa\u6d69\u4e4b, \u5bfa\u5185\u3000\u5e79, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u8853\u524d\u8a3a\u65ad\u56f0\u96e3\u3067\u3042\u3063\u305f\u809d\u9580\u90e8\u816b\u7624\u306e1\u4f8b. 2022\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c62\u56de\u4f8b\u4f1a\uff0c\u6a2a\u6d5c, 2022, 10.<\/dd>\n<dd>\u6c38\u7530\u3000\u5fb9, \u5c0f\u6797\u96c4\u4ecb, \u5927\u5d8b\u667a\u6d0b, \u4e2d\u6751\u6cf0\u4ecb, \u9ebb\u751f\u771f\u4e8c\u90ce, \u5c71\u53e3\u552f\u53f2, \u4e09\u6a4b\u8015\u5e73, \u5cb8\u7530\u76f4\u5b5d, \u4e0a\u51fa\u6d69\u4e4b, \u5bfa\u5185\u3000\u5e79, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u5b50\u5bae\u817a\u7b4b\u75c7\u306e\u904e\u591a\u6708\u7d4c\u306b\u3088\u308b\u51fa\u8840\u6301\u7d9a\u306b\u5bfe\u3057\u3066UAE\u3092\u65bd\u884c\u3057\u305f1\u4f8b. 2022\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c62\u56de\u4f8b\u4f1a\uff0c\u6a2a\u6d5c, 2022, 10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u5927\u304d\u304f\u9032\u5316\u3057\u305f\u534a\u5c0e\u4f53PET. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(\u30b7\u30f3\u30dd\u30b8\u30a6\u30e02 \u6838\u533b\u5b66\uff5e\u8fd1\u672a\u6765\u6838\u533b\u5b66\u306e\u5411\u304b\u3046\u9053\uff0d\u8a3a\u65ad\u30fb\u6cbb\u7642\u306e\u7cbe\u5ea6\u3092\u3042\u3052\u308b\u6700\u65b0\u624b\u6cd5\uff5e), \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u6838\u533b\u5b66\u6307\u5c0e\u8005\u30b3\u30fc\u30b9\u3000\u816b\u760d\u6838\u533b\u5b66\uff08\u672c\u90a6\u306b\u304a\u3051\u308b\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\uff09. \u7b2c22\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a(WEB\u958b\u50ac), 2022, 5.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u534a\u5c0e\u4f53PET\/CT\u3068\u305d\u306e\u904b\u7528. \u7b2c12\u56de\u6771\u5317FDG-PET\u7814\u7a76\u4f1a, \u4ed9\u53f0, 2022, 7.<\/dd>\n<dd>\u67f4\u7530\u88d5\u53f2: \u4ee4\u548c2\u5e74\u5ea6\u3055\u3044\u305f\u307e\u5e02\u5927\u5bae\u5730\u533a\u4e73\u304c\u3093\u691c\u8a3a\u5831\u544a. \u7b2c57\u56de\u5927\u5bae\u533b\u5b66\u4f1a\u7dcf\u4f1a, \u5927\u5bae, 2022, 3.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u7814\u4fee\u533b\u306b\u77e5\u3063\u3066\u6b32\u3057\u3044\u5c0f\u5150\u982d\u90e8\u6551\u6025\u75be\u60a3\u306e\u30dd\u30a4\u30f3\u30c8. \u7b2c19\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u7814\u4fee\u533b\u306b\u77e5\u3063\u3066\u307b\u3057\u3044\u5c0f\u5150\u982d\u90e8\u816b\u760d\uff08\u30c6\u30f3\u30c8\u4e0a\uff09. \u7b2c19\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca, \u76f8\u7530\u5178\u5b50, \u68ee\u7530\u6709\u9999, \u85e4\u4e95\u88d5\u592a, \u91ce\u6fa4\u4e45\u7f8e\u5b50: \u7b4bMRI\u304b\u3089RYR1\u907a\u4f1d\u5b50\u5909\u7570\u306b\u4f34\u3046\u5148\u5929\u6027\u30df\u30aa\u30d1\u30c1\u30fc\u304c\u793a\u5506\u3055\u308c\u305f1\u4f8b. \u7b2c51\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u6771\u4eac, 2022, 2.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u79c1\u304c\u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u3092\u7406\u89e3\u3059\u308b\u307e\u3067\u306e\u9053\u306e\u308a. \u7b2c51\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u6771\u4eac, 2022, 2.<\/dd>\n<dd>\u68ee\u7530\u6709\u9999, \u91ce\u6fa4\u4e45\u7f8e\u5b50, \u85e4\u4e95\u88d5\u592a, \u85e4\u7530\u548c\u4fca, \u76f8\u7530\u5178\u5b50: \u539f\u767a\u5de3\u306e\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u9ad8\u30ea\u30b9\u30af\u795e\u7d4c\u82bd\u816b\u306e\u4e00\u4f8b. \u7b2c58\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6d66\u5b89, 2022, 6.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff1a\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad. \u7b2c58\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc), \u6d66\u5b89, 2022, 6.<\/dd>\n<dd>\u68ee\u7530\u6709\u9999\uff1a\u5c0f\u5150\u306b\u7279\u5fb4\u7684\u306a\u9aa8\u8edf\u90e8\u5916\u50b7(\u8650\u5f85\u3092\u9664\u304f)\uff0e\u9aa8\u8edf\u90e8\u653e\u5c04\u7dda\u8a3a\u65ad\u30bb\u30df\u30ca\u30fc\uff0c\u9759\u5ca1\uff0c2022\uff0c7.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u30c0\u30a4\u30d0\u30fc\u30b7\u30c6\u30a3\u306e\u6642\u4ee3\uff1a\u3057\u306a\u3084\u304b\u306b\u3057\u305f\u305f\u304b\u306b\u751f\u304d\u307e\u3057\u3087\u3046. \u7b2c42\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7(\u30a4\u30d6\u30cb\u30f3\u30b0\u30bb\u30df\u30ca\u30fc5), \u51fd\u9928, 2022, 7.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff1a\u5c0f\u5150\u56a2\u80de\u6027\u75be\u60a3\u306e\u8a3a\u65ad\u3092\u8003\u3048\u308b\u3000\u753b\u50cf\u8a3a\u65ad. \u7b2c26\u56de\u65e5\u672c\u6c17\u80f8\u30fb\u56a2\u80de\u6027\u80ba\u75be\u60a3\u5b66\u4f1a\u7dcf\u4f1a(\u6559\u80b2\u8b1b\u6f14), \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50:1H-MR spectroscopy for the pediatric brain(1H-MRS\u306e\u5c0f\u5150\u8133\u3067\u306e\u6d3b\u7528). \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a, \u540d\u53e4\u5c4b, 2022, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u4e2d\u67a2\u795e\u7d4c\uff12\u3000\u5c0f\u5150\uff1a\u80ce\u5150\u30fb\u5148\u5929\u5947\u5f62\u3000\u810a\u9ac4\u810a\u690e\u5148\u5929\u6027\u5947\u5f62. \u7b2c58\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff08\u6559\u80b2\u8b1b\u6f14\uff09(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50:\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff1a\u57fa\u672c\u3068Pediatric Neuroradiology\u306e\u697d\u3057\u3055. \u7b2c30\u56de\u5c71\u5f62CT MRI\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: Pediatric Neuroradiology\u3092\u697d\u3057\u3082\u3046\uff01 \u7b2c71\u56de\u4e5d\u5ddeMRI\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff1a\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u653e\u5c04\u7dda\u8a3a\u65ad\u300d. \u7b2c64\u65e5\u672c\u5c0f\u5150\u8840\u6db2\u30fb\u304c\u3093\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2022, 11.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50:\u4e0b\u5782\u4f53\u3068\u4ee3\u8b1d\u75be\u60a3\u306eMRI\u8a3a\u65ad. \u7b2c55\u56de\u65e5\u672c\u5c0f\u5150\u5185\u5206\u6ccc\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c, 2022, 11.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5fc3\u8840\u7ba1I-\u5fc3\u6a5f\u80fd\u89e3\u6790(\u4e00\u822c\u6f14\u984c\u5ea7\u9577\uff09. \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a, \u795e\u5948\u5ddd, 2022, 4.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1aOpening the Future\u2500\u672a\u6765\u3092\u898b\u636e\u3048\u305f\u3053\u308c\u304b\u3089\u306e\u30dd\u30b9\u30c8\u30d7\u30ed\u30bb\u30b7\u30f3\u30b0(\u5171\u50ac\u30bb\u30df\u30ca\u30fc\u5ea7\u9577\uff09. \u7b2c81\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a, \u795e\u5948\u5ddd, 2022, 4.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u73e0\u7389\u306e\u75c7\u4f8b\u304b\u3089\u5b66\u3076\uff5e\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb\u3092\u62bc\u3055\u3048\u305f\u8aad\u5f71\u3092\u5fc3\u304c\u3051\u3066(\u5ea7\u9577\uff09. AIMS Cardiac Imaging(WEB\u958b\u50ac),2022,5.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u6280\u5e2b\u3068\u533b\u5e2b\u306e\u5171\u9cf4\u304b\u3089\u751f\u307e\u308c\u308b\u8a3a\u7642\u306b\u8cc7\u3059\u308b\u753b\u50cf\u8a3a\u65ad\uff08\u5ea7\u9577\uff09. FCA-Webinar in Yokohama(WEB\u958b\u50ac), 2022, 7.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1aCanon\u9ad8\u7cbe\u7d30\u6280\u8853\uff08\u5ea7\u9577\uff09. Global Standard CT Symposium 2022(WEB\u958b\u50ac), 2022, 8.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1aCT\/MRI\u753b\u50cf\u8a3a\u65ad\u3067\u306e\u6700\u65b0\u6280\u8853\u306e\u6d3b\u7528\u6cd5\uff08\u5171\u50ac\u30bb\u30df\u30ca\u30fc\u5ea7\u9577\uff09. \u7b2c58\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5fc3\u81d3\u9818\u57df\u753b\u50cf\u8a3a\u65ad\u306e\u795e\u9ac4\u3092\u8a9e\u308b\uff08\u5ea7\u9577\uff09. \u7b2c50\u56de\u65ad\u5c64\u6620\u50cf\u7814\u7a76\u4f1a, \u6771\u4eac, 2022, 9.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4, \u52a0\u85e4\u82f1\u660e, \u53f6\u8c37\u7531\u4f73, \u9ed2\u6728\u3000\u6df3: \u6a2a\u6d5c\u5e02\u30b3\u30ed\u30ca\u5c02\u9580\u75c5\u9662\u306e\u5b9f\u73fe. \u4ee4\u548c3\u5e74\u5ea6\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u7406\u4e8b\u9577\u30fb\u5b66\u9577\u8868\u5f70\uff08\u6559\u54e1\u90e8\u9580, \u5968\u52b1\u8cde, \u56e3\u4f53\uff09, 2022, 2<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u81d3MRI\u8aad\u5f71\u306e\u57fa\u672c\u3068\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb. AIMS Cardiac Imaging(WEB\u958b\u50ac), 2022, 5.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1aCOVID-19\u306b\u3088\u308b\u5fc3\u7b4b\u969c\u5bb3\u306e\u5fc3MRI\u6240\u898b-\u672c\u90a6\u306b\u304a\u3051\u308b\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76\u306e\u7d50\u679c. \u7b2c12\u56de Multi-modality Cardio Vascular Imaging (MCVI)(WEB\u958b\u50ac), 2022, 11.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1aCOVID-19\u306e\u5fc3\u7b4b\u969c\u5bb3. SCMR Japan WG Seminar 2021, \u4e09\u91cd, 2022, 1.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1aT1\u3068ECV\u306f\u4f55\u3092\u898b\u3066\u3044\u308b\u306e\uff1f SCMR Japan WG Seminar 2022, \u6771\u4eac, 2022, 8.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u81d3MRI\u306e\u7f8e\u3057\u3044\u753b\u50cf\u3092\u64ae\u50cf\u3057, \u8aad\u5f71\u3059\u308b. \u884c\u5fb3\u7dcf\u5408\u75c5\u9662 \u5fc3\u81d3MRI\u52c9\u5f37\u4f1a(WEB\u958b\u50ac), 2022, 2.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u8ca0\u8377MRI\u306b\u3064\u3044\u3066. \u884c\u5fb3\u7dcf\u5408\u75c5\u9662 \u5fc3\u81d3MRI\u52c9\u5f37\u4f1a(WEB\u958b\u50ac), 2022, 3.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u7b4b\u6a5f\u80fd\u89e3\u6790\u304b\u3089\u6027\u72b6\u8a3a\u65ad\u307e\u3067\uff1a\u5fc3\u6a5f\u80fd\u89e3\u6790, LGE, T1\u30de\u30c3\u30d7\u8a55\u4fa1. \u7b2c50\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc), \u540d\u53e4\u5c4b, 2022, 9.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u81d3MRI\u306b\u95a2\u3059\u308b\u6700\u8fd1\u306e\u8a71\u984c. \u30d0\u30a4\u30a8\u30eb\u753b\u50cf\u30bb\u30df\u30ca\u30fc(WEB\u958b\u50ac), 2022, 6.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5faa\u74b0\u5668\u9818\u57df\u306eMRI\u306b\u95a2\u3059\u308b\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u30b9. \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u30bb\u30df\u30ca\u30fc\u2015\u5fc3\u81d3\u9818\u57df\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\u30e2\u30c0\u30ea\u30c6\u30a3\u3092\u5b66\u3076\u2015(WEB\u958b\u50ac), 2022, 11.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5faa\u74b0\u5668\u306e\u753b\u50cf\u8a3a\u65ad\u3092\u5b66\u3076 \u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u5fc3\u81d3MRI\u306e\u30ad\u30db\u30f3. \u7b2c62\u56de\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a(\u6559\u80b2\u8b1b\u6f14), \u6a2a\u6d5c, 2022, 10.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u8840\u7ba1\u75be\u60a3\u306b\u304a\u3051\u308bDLR-MRI\u306e\u6d3b\u7528. \u6771\u6d77\u5faa\u74b0\u5668\u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u30bb\u30df\u30ca\u30fc(WEB\u958b\u50ac), 2022, 7.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5fc3\u8840\u7ba1\u75be\u60a3\u306b\u304a\u3051\u308bDLR-MRI\u306e\u6d3b\u7528. \u7b2c45\u56de\u5ca1\u5c71MRI\u64ae\u50cf\u6280\u8853\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 7.<\/dd>\n<dd>\u677e\u4e0b\u5f70\u4e00\u90ce\uff1a\u30bb\u30c3\u30b7\u30e7\u30f35\uff08\u5ea7\u9577\uff09. \u7b2c36\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u9752\u6728\u3000\u4eae\uff1aJJR\u512a\u79c0\u8ad6\u6587\u8cde\uff0ePulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity, \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a, 2022, 4.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u6551\u6025CT\u306e\u8aad\u5f71\u30dd\u30a4\u30f3\u30c8\uff0e\u30d0\u30a4\u30a8\u30eb\u85ac\u54c1\u793e\u5185\u52c9\u5f37\u4f1a\uff0c\u795e\u5948\u5ddd, 2022, 5.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u7dca\u6025IVR\u306e\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb\uff08\u5ea7\u9577\uff09\uff0eFCA-Webinar in Yokohama(WEB\u958b\u50ac), 2022, 7.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u96e3\u6cbb\u6027, \u9045\u5ef6\u6027\u526f\u4f5c\u7528\u3092\u751f\u3058\u305fNBCA\u585e\u6813\u75c7\u4f8b\uff0e\u6771\u4eac\u30a2\u30f3\u30ae\u30aa\u30fbIVR\u4f1a(WEB\u958b\u50ac), 2022, 10.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u6551\u6025\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\uff1a\u8aad\u5f71\u3067\u62bc\u3055\u3048\u308b\u3079\u304d\u30ef\u30f3\u30dd\u30a4\u30f3\u30c8\uff0eBayer Radiology Online Seminar(WEB\u958b\u50ac), 2022, 11.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u304c\u62bc\u3055\u3048\u3066\u304a\u304f\u3079\u304d\u7dca\u6025\u7570\u5e38\u6240\u898b\u306e\u8aad\u307f\u65b9\uff1a\u57fa\u790e\uff5e\u5fdc\u7528\u307e\u3067\uff0e\u795e\u5948\u5ddd\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a\u6280\u8853\u8b1b\u7fd2\u4f1a\uff0c\u795e\u5948\u5ddd, 2022, 12.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff1a\u5c0f\u5150\uff11\u3000\u982d\u9838\u90e8\u82e6\u624b\u610f\u8b58\u306e\u514b\u670d\uff08\u6559\u80b2\u8b1b\u6f14\u5ea7\u9577\uff09. \u7b2c58\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a(WEB\u958b\u50ac), 2022, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: AYA\u4e16\u4ee3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u6226\u7565\uff08\u6559\u80b2\u8b1b\u6f14\u5ea7\u9577\uff09. \u7b2c58\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u6771\u4eac, 2022, 9<\/dd>\n<dd>\u67f4\u7530\u88d5\u53f2: \u4e73\u764c\u8a3a\u7642\u306b\u304a\u3051\u308b PET\/CT\u691c\u67fb\u306b\u3064\u3044\u3066. \u4ee4\u548c4\u5e74\u5ea6\u7b2c1\u56de\u4e73\u304c\u3093\u691c\u8a3a\u75c7\u4f8b\u691c\u8a0e\u4f1a, \u5927\u5bae, 2022, 6.<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Nakachi T, Kato S, Saito N, Fukui K, Iwasawa T, Endo T, Kosuge M, Utsunomiya D, Kimura K, Tamura K\uff1a Non-invasive evaluation of patients undergoing percutaneous coronary intervention for chronic total occlusion\uff0eJournal of clinical medicine, 10(20)\uff1a4712, 2021.<\/dd>\n<dd>Kato S, Fukui K, Kodama S, Azuma M, Nakayama N, Iwasawa T, Kimura K, Tamura K, Utsunomiya D\uff1aCardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.Journal of cardiovascular magnetic resonance\uff0c23(1): 112\uff0c2021.<\/dd>\n<dd>Nishii T, Funama Y, Kato S, Iwasawa T, Yasuda N, Ota Y, Kawagoe H, Oda S, Tsutsumi T, Utsunomiya D: Comparison of visibility of in-stent restenosis between conventional- and ultra-high spatial resolution computed tomography: coronary arterial phantom study.Japanese journal of radiology\uff0c40(3): 279-288\uff0c2021\uff0e<\/dd>\n<dd>Kobayashi N, Takano S, Ito K, Sugiura M, Ogawa M, Takeda Y, Okubo N, Suzuki A, Tokuhisa M, Kaneta T, Utsunomiya D, Hata M, Inoue T, Hosono M, Kinuya S, Ichikawa Y: Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors. Annals of nuclear medicine, 35(12): 1332-1341\uff0c2021\uff0e<\/dd>\n<dd>Kato S, Fukui K, Kodama S, Azuma M, Nakayama N, Iwasawa T, Kimura K, Tamura K, Utsunomiya D: Prognostic value of resting coronary sinus flow determined by phase-contrast cine cardiovascular magnetic resonance in patients with known or suspected coronary artery disease.Journal of cardiovascular magnetic resonance, 23(1): 97, 2021\uff0e<\/dd>\n<dd>Kato S, Kitamura H, Hayakawa K, Fukui K, Tabata E, Otoshi R, Iwasawa T, Utsunomiya D, Kimura K, Tamura K, Ogura T: Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis.Heart and vessels, 36(8): 1151-1158, 2021\uff0e<\/dd>\n<dd>Azuma M, Kato S, Sekii R, Kodama S, Kinoshita K, Suzurikawa K, Kagimoto M, Nakayama N, Iguchi K, Fukui K, Iwasawa T, Utsunomiya D, Kimura K, Tamura K: Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.The international journal of cardiovascular imaging\uff0c37(8): 2535-2543\uff0c2021\uff0e<\/dd>\n<dd>Azuma M, Kato S, Fukui K, Utsunomiya D, Ogura T: Quantitative pixel-wise analysis of native T1 mapping for identification of cardiac involvement in severe acute respiratory syndrome coronavirus 2 infection. European heart journal cardiovascular imaging\uff0c22(9): e143\uff0c2021\uff0e<\/dd>\n<dd>Aoki R, Kobayashi Y, Nawata S, Kamide H, Yamamoto T, Furugori S, Sekikawa Z, Utsunomiya D: Computed tomography imaging of resuscitative endovascular balloon occlusion of the aorta (REBOA): pearls and pitfalls.Japanese journal of radiology\uff0c39(12): 1133-1140\uff0c2021\uff0e<\/dd>\n<dd>Sugimoto Y, Kato S, Fukui K, Iwasawa T, Utsunomiya D, Kimura K, Tamura K: Impaired coronary flow reserve evaluated by phase-contrast cine magnetic resonance imaging in patients with atrial fibrillations. Heart and vessels, 36(6): 775-781, 2021.<\/dd>\n<dd>Miyake S, Higurashi T, Jono T, Akimoto T, Ogawa F, Oi Y, Tanaka K, Hara Y, Kobayashi N, Kato H, Yamashiro T, Utsunomiya D, Nakajima A, Yamamoto T, Maeda S, Kaneko T, Takeuchi I: Real-world evaluation of a computed tomography-first triage strategy for suspected Coronavirus disease 2019 in outpatients in Japan: An observational cohort study. Medicine, 100(22): e26161, 2021.<\/dd>\n<dd>Imajo K, Kessoku T, Honda Y, Hasegawa S, Tomeno W, Ogawa Y, Motosugi U, Saigusa Y, Yoneda M, Kirikoshi H, Yamanaka S, Utsunomiya D, Saito S, Nakajima A: MRI-based quantitative R2* mapping at 3 Tesla reflects hepatic iron overload and pathogenesis in nonalcoholic fatty liver disease patients. Journal of magnetic resonance imaging\uff0c55(1): 111-125\uff0c2021.<\/dd>\n<dd>Aoki R, Iwasawa T, Hagiwara E, Komatsu S, Utsunomiya D, Ogura T: Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity\uff0eJapanese journal of radiology, 39(5): 451-458\uff0c2021.<\/dd>\n<dd>Kato S, Fukui K, Kodama S, Azuma M, Nakayama N, Kishimoto M, Iwasawa T, Kimura K, Tamura K, Utsunomiya D: Acute myocarditis by immune checkpoint inhibitor identified by quantitative pixel-wise analysis of native T1 mapping. Circulation cardiovascular imaging, 14(5): e012177, 2021.<\/dd>\n<dd>Nishimiya N, Tajima K, Imajo K, Kameda A, Yoshida E, Togashi Y, Aoki K, Inoue T, Nakajima A, Utsunomiya D, Terauchi Y: Effects of canagliflozin on hepatic steatosis, visceral fat and skeletal muscle among patients with type 2 diabetes and non-alcoholic fatty liver disease. Internal medicine, 60(21): 3391-3399\uff0c2021.<\/dd>\n<dd>Kamide H, Kato S, Hayakawa K, Fukui K, Kitamura H, Ogura T, Iwasawa T, Kimura K, Tamura K, Utsunomiya D: Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease. The international journal of cardiovascular imaging, 37(3): 1073-1083\uff0c2021.<\/dd>\n<dd>Yokota Y, Takeda C, Kidoh M, Oda S, Aoki R, Ito K, Morita K, Haraoka K, Yamashita Y, Iizuka H, Kato S, Tsujita K, Ikeda O, Yamashita Y, Utsunomiya D: Effects of deep learning reconstruction technique in high-resolution non-contrast magnetic resonance coronary angiography at a 3-tesla machine. Canadian association of radiologists&#8217; journal, 72(1): 120-127\uff0c2021.<\/dd>\n<dd>Horie K, Ihama Y, Aso S, Kuninaka H, Mochizuki H, Yamashiro T, Kato S, Utsunomiya D: Identification of aortic injury site using postmortem non-contrast computed tomography in road traffic accident. Radiology case reports, 16(1): 5-8\uff0c2021.<\/dd>\n<dd>Ishiwata Y, Kaneta T, Nawata S, Iizuka H, Utsunomiya D: Feasibility of prognosis assessment for cancer of unknown primary origin using texture analysis of 18F-fluorodeoxyglucose PET\/computed tomography images of largest metastatic lymph node. Nuclear medicine communications, 42(1): 86-92\uff0c2021.<\/dd>\n<dd>Hatano M, Miyazaki T, Ishiwata Y, Nakajima W, Arisawa T, Kuroki Y, Kobayashi A, Takada Y, Ogawa M, Kawamura K, Zhang M, Higuchi M, Taguri M, Kimura Y, Takahashi T: Biodistribution and radiation dosimetry of the positron emission tomography probe for AMPA receptor, [11 C]K-2, in healthy human subjects. Scientific Reports, 11(1): 1598, 2021.<\/dd>\n<dd>Sato S, Nagatani Y, Hashimoto M, Nitta N, Hanaoka J, Ushio N, Tsukagoshi S, Uranishi A, Kimoto T, Oshio Y, Mayumi M, Sonoda A, Otani H, Yamashiro T, Moriya H, Murata K, Watanabe Y: Usability of the lateral decubitus position on four-dimensional ultra-low-dose computed tomography for the detection of localized pleural adhesion in the pulmonary apical region. Acta Radiol, 62(4): 462-473, 2021.<\/dd>\n<dd>Akazawa Y, Ganaha A, Higa T, Kondo S, Oyakawa Y, Hirakawa H, Suzuki M, Yamashiro T: Measurement of stapes footplate thickness in otosclerosis by ultra-high-resolution computed tomography.Acta Otolaryngol, 140(11): 899-903, 2021.<\/dd>\n<dd>Ishikawa K, Yamashiro T, Ariga T, Toita T, Kudaka W, Heianna J, Maemoto H, Kusada T, Makino W, Aoki Y, Murayama S: Predictive factors of posttreatment fracture by definitive radiotherapy for uterine cervical cancer. Jpn J Radiol\uff0c39(1): 93-99, 2021.<\/dd>\n<dd>Tsuruoka H, Handa H, Yamashiro T, Nishine H, Inoue T, Mineshita M: Correlation between computed tomographic analysis and pulmonary function measurements in patients with relapsing polychondritis. Respiration, 100(2): 109-115, 2021.<\/dd>\n<dd>Tanaka R, Samei E, Segars WP, Abadi E, Matsumoto I, Tamura M, Takata M, Yamashiro T: Assessment of pleural invasion and adhesion of lung tumors with dynamic chest radiography: A virtual clinical imaging study. Med Phys, 48(4): 1616-1623, 2021.<\/dd>\n<dd>Tomita H, Yamashiro T, Heianna J, Nakasone T, Kobayashi T, Mishiro S, Hirahara D, Takaya E, Mimura H, Murayama S, Kobayashi Y: Deep learning for preoperative diagnosis of metastatic cervical lymph nodes on contrast-enhanced computed tomography in patients with oral squamous cell carcinoma. Cancers,13(4): 600,2021.<\/dd>\n<dd>Tomita H, Yamashiro T, Iida G, Tsubakimoto M, Mimura H, Murayama S: Unenhanced CT texture analysis with machine learning for differentiating between nasopharyngeal cancer and nasopharyngeal malignant lymphoma. Nagoya J Med Sci, 83(1): 135-149, 2021.<\/dd>\n<dd>Tomita H, Yamashiro T, Heianna J, Nakasone T, Kimura Y, Mimura H, Murayama S: Nodal-based radiomics analysis for identifying cervical lymph node metastasis at levels I and II in patients with oral squamous cell carcinoma using contrast-enhanced computed tomography. Eur Radiol, 31(10): 7440-7449, 2021.<\/dd>\n<dd>Nakajima K, Yamaguchi K, Abe T, Taniguchi H, Mizukami S, Sekikawa Z, Takeuchi I: Extravasation and outcomes in computed tomography and angiography in patients with pelvic fractures requiring transcatheter arterial embolization: A single-center observational study.Journal of trauma and acute care surgery, 92(5): 873-879, 2021.<\/dd>\n<dd>Murayama D, Kojima D, Hino A, Yamamoto Y, Doiuchi T, Horikawa A, Kurihara H: A case of bulla formation after treatment for COVID-19 pneumonia. Radiol Case Rep, 16(5): 1162-1164, 2021.<\/dd>\n<dd>Matsumoto H, Watabe T, Igarashi C, Tachibana T, Hihara F, Waki A, Zhang MR, Tashima H, Yamaya T, Ooe K, Shimosegawa E, Hatazawa J, Yoshida S, Naito K, Kurihara H, Ueno M, Ito K, Higashi T, Yoshii Y: Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates. Pharmaceuticals, 14(10): 950, 2021.<\/dd>\n<dd>Murayama D, Yamamoto Y, Matsui A, Yasukawa M, Toda S, Iwasaki H: A case of the accumulation of 131-iodine in the mammary gland after remnant ablation for papillary thyroid carcinoma on lactating period. Radiol Case Rep, 16(5): 3442-3444, 2021.<\/dd>\n<dd>Okubo Y, Sato S, Osaka K, Yamamoto Y, Suzuki T, Ida A, Yoshioka E, Suzuki M, Washimi K, Yokose T, Kishida T, Miyagi Y: Clinicopathological Analysis of the ISUP Grade Group And Other Parameters in Prostate Cancer: Elucidation of Mutual Impact of the Various Parameters. Front Oncol, 11: 695251, 2021.<\/dd>\n<dd>Oda T, Sekine A, Tabata E, Iwasawa T, Takemura T, Ogura T: Comparison of Clinical Characteristics and Outcomes between Idiopathic and Secondary Pleuroparenchymal Fibroelastosis. Clin Med, 10(4): 846, 2021.<\/dd>\n<dd>Sekine A, Oda T, Shintani R, Ikeda S,Baba T, Iwasawa T, Komatsu S, Hagiwara E, Ogura T: Spontaneous regression following endobronchial ultrasound-guided transbronchial needle aspiration in lung cancer patients. Respir Investig, 59(5): 691-695, 2021.<\/dd>\n<dd>Sekine A, Hagiwara E, Iwasawa T, Otoshi R, Tabata E, Shintani R, Okabayashi H, Ikeda S, Oda T, Okuda R, Kitamura H, Baba T, Komatsu S, Ogura T: Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis. Respir Investig, 59(6): 837-844, 2021.<\/dd>\n<dd>Sawazumi T, Baba T, Iwasawa T, Arai H, Matsumura M, Takemura T, Sugiyama M, Sekiya M, Saigusa Y, Ogura T, Inayama Y, Ohashi K, Okudela K: Prognostic impact of HNF4\u03b1 expression in interstitial lung disease. Pathol Int, 72(1): 25-34, 2021.<\/dd>\n<dd>\u5b89\u85e4\u548c\u592b, \u963f\u90e8\u3000\u793c, \u9f4a\u85e4\u516c\u5f66, \u5b87\u6d25\u6728\u7fd4\u5e73, \u67ff\u5185\u3000\u660e: \u53f3\u5c3f\u7ba1\u8d70\u884c\u7570\u5e38\u304a\u3088\u3073\u5927\u52d5\u8108\u524d\u8178\u9aa8\u9759\u8108\u5408\u6d41\u3092\u4f34\u3046\u53f3\u91cd\u8907\u4e0b\u5927\u9759\u8108\u306e\u307e\u308c\u306a1\u4f8b: CT\u6240\u898b\u304a\u3088\u3073\u767a\u751f\u5b66\u76841\u8003\u5bdf. \u81e8\u5e8a\u653e\u5c04\u7dda, 66(3): 281-285, 2021.<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb, \u5e73\u5c71\u9ebb\u5229\u5b50, \u4e2d\u6751\u5143\u7d00, \u5c71\u53e3\u552f\u53f2, \u4e09\u6a4b\u8015\u5e73, \u9752\u6728\u3000\u4eae, \u7e04\u7530\u664b\u592a\u90ce, \u4e0a\u51fa\u6d69\u4e4b, \u897f\u4e95\u4fca\u6676, \u6fa4\u4f4f\u77e5\u679d, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u5375\u5de3\u816b\u760d\u304c\u9451\u5225\u3068\u306a\u3063\u305f\u5b50\u5bae\u5e83\u9593\u819c\u5185\u7b4b\u816b\u306e\u4e00\u4f8b. \u6a2a\u6d5c\u533b\u5b66, 72(1): 27-31, 2021.<\/dd>\n<dd>\u4e2d\u6751\u5143\u7d00, \u5e73\u5c71\u9ebb\u5229\u5b50, \u5c0f\u6797\u96c4\u4ecb, \u5c71\u53e3\u552f\u53f2, \u4e09\u6a4b\u8015\u5e73, \u9752\u6728\u3000\u4eae, \u7e04\u7530\u664b\u592a\u90ce, \u4e0a\u51fa\u6d69\u4e4b, \u897f\u4e95\u4fca\u6676, \u95a2\u5ddd\u5584\u4e8c\u90ce: MRI\u6240\u898b\u304c\u975e\u5178\u578b\u7684\u3067\u3042\u3063\u305f\u815f\u5e73\u6ed1\u7b4b\u816b\u306e\u4e00\u4f8b. \u6a2a\u6d5c\u533b\u5b66, 72(1): 41-45, 2021.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, Utsunomiya D: Imaging of COVID-19: An update of current evidences. Diagnostic and interventional imaging\uff0c102(9): 493-500\uff0c2021\uff0e<\/dd>\n<dd>Kamagata K, Andica C, Kato A, Saito Y, Uchida W, Hatano T, Lukies M, Ogawa T, Takeshige-Amano H, Akashi T, Hagiwara A, Fujita S, Aoki S: Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases. Int J Mol Sci, 22(10): 5216, 2021.<\/dd>\n<dd>Yamakawa H, Ogura T, Kameda H, Kishaba T, Iwasawa T, Takemura T, Kuwano K: Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD). J Clin Med, 10(17): 3816, 2021.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u305f\u3053\u3064\u307c\u75c7\u5019\u7fa4\uff0e\u753b\u50cf\u8a3a\u65ad, 41(5): 430-431,2021.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u51a0\u52d5\u8108\u306e\u8106\u5f31\u30d7\u30e9\u30fc\u30af: \u30ca\u30d7\u30ad\u30f3\u30ea\u30f3\u30b0\u30fb\u30b5\u30a4\u30f3.\u753b\u50cf\u8a3a\u65ad, 41(5): 438-440, 2021.<\/dd>\n<dd>\u4e0a\u51fa\u6d69\u4e4b, \u52a0\u85e4\u771f\u543e, \u6771\u3000\u771f\u4f0a, \u5150\u7389\u3000\u7fd4, \u4e2d\u5c71\u5c1a\u8cb4, \u798f\u4e95\u548c\u6a39, \u9f4b\u85e4\u3000\u592e, \u5ca9\u6fa4\u591a\u6075, \u5b87\u90fd\u5bae\u5927\u8f14: Feature tracking\u6cd5\u306b\u3088\u308b\u5fc3\u7b4b\u30b9\u30c8\u30ec\u30a4\u30f3\u89e3\u6790. INNERVISION, 36(5): 2-6, 2021.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u8d85\u9ad8\u7cbe\u7d30CT\u306e\u6d3b\u7528: \u8033\u5c0f\u9aa8\u5947\u5f62. \u753b\u50cf\u8a3a\u65ad, 41(9): 956-957, 2021\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4, \u5ca9\u6fa4\u591a\u6075: \u9762\u691c\u51fa\u5668CT\u306e\u6d3b\u7528: \u80f8\u819c\u4e0b\u80ba\u764c\u306e\u58c1\u5074\u80f8\u819c\u3078\u306e\u7652\u7740\u6d78\u6f64. \u753b\u50cf\u8a3a\u65ad, 41(9): 946-947, 2021.<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e\uff0c\u85e4\u4e95\u9032\u4e5f: \u982d\u90e8\u9818\u57df\u306b\u6c42\u3081\u3089\u308c\u308b\u30ec\u30dd\u30fc\u30c8\u306e\u66f8\u304d\u65b9\u3000\u8133\u8840\u7ba1\u969c\u5bb3\u306e\u8aad\u5f71\u306e\u30dd\u30a4\u30f3\u30c8. \u81e8\u5e8a\u753b\u50cf, 37(1): 122-127, 2021.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075, \u6b66\u6751\u6c11\u5b50, \u5c0f\u5009\u9ad8\u5fd7: \u9593\u8cea\u6027\u80ba\u75be\u60a3\u306e\u5225\u306e\u9854.\u81e8\u5e8a\u753b\u50cf, 37(2): 271-277, 2021.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075, \u5965\u5bfa\u5eb7\u53f8, \u6b66\u6751\u6c11\u5b50, \u5c0f\u677e\u3000\u8302, \u8429\u539f\u6075\u91cc, \u5c0f\u5009\u9ad8\u5fd7, \u8352\u4e95\u5b8f\u660c, \u7530\u5c3b\u9053\u5f66: \u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u8a3a\u7642\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u79d1\u533b\u306e\u5f79\u5272.\u753b\u50cf\u8a3a\u65ad, 41(7): 697-708\uff0c2021.<\/dd>\n<dd>\u68ee\u7530\u6709\u9999, \u91ce\u6fa4\u4e45\u7f8e\u5b50: \u80f8\u90e8\u5358\u7d14X\u7dda\u5199\u771f\u306e\u8aad\u5f71\u306e\u30dd\u30a4\u30f3\u30c8-\u3068\u304f\u306b\u65b0\u751f\u5150\u30fb\u4e73\u5e7c\u5150\u3067\u306e\u6ce8\u610f\u70b9. \u5c0f\u5150\u5185\u79d1, 53(9): 1362-1368, 2021.<\/dd>\n<dd>\u68ee\u7530\u6709\u9999, \u76f8\u7530\u5178\u5b50: \u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u8133\u7b4b\u75c7\u30fb\u4e73\u9178\u30a2\u30b7\u30c9\u30fc\u30b7\u30b9\u30fb\u8133\u5352\u4e2d\u69d8\u767a\u4f5c\u75c7\u5019\u7fa4 (MELAS). \u8133\u795e\u7d4c\u5916\u79d1, 49(2): 349-355, 2021.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u300c\u6d88\u5316\u7ba1\u91cd\u8907\u75c7\u306e\u3059\u3079\u3066\u300d\u51fa\u751f\u5f8c\u753b\u50cf\u8a3a\u65ad. \u5c0f\u5150\u5916\u79d1, 53(9): 902-907, 2021.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u8457\u66f8<\/h3>\n<\/dt>\n<dd>Iwasawa T: Principle and clinical applications of respiratory motion assessment using 4D computed tomography and magnetic resonance imaging. Pulmonary functional imaging. Springer, 91-106, 2021.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4, \u6211\u90a3\u8987\u7ae0, \u9234\u6728\u5e79\u7537: \u5373\u6226\u529b\u304c\u8eab\u306b\u3064\u304f\u982d\u981a\u90e8\u306e\u753b\u50cf\u8a3a\u65ad. \u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb, 208-210, 336-338, 359-361, 2021.<\/dd>\n<dd>\u52a0\u85e4\u4e9c\u7d50\u7f8e\uff0c\u85e4\u4e95\u9032\u4e5f: \u5373\u6226\u529b\u304c\u8eab\u306b\u3064\u304f\u8133\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\u30b5\u30a4\u30a8\u30f3\u30b9\u30fb\u30a4\u30f3\u30bf\u30fc\u30ca\u30b7\u30e7\u30ca\u30eb\uff0c142-143, 166-167, 309-310,332-333, 443-444, 2021.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u8133\u306e\u767a\u9054\u3068\u7279\u5fb4\/\u5468\u7523\u671f\u969c\u5bb3.\u982d\u90e8\u753b\u50cf\u8a3a\u65ad\u306e\u52d8\u30c9\u30b3\u30edNEO. \u682a\u5f0f\u4f1a\u793e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e, 2021.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Iwasawa T, Fukuda T, Yamada D, Ito Y, Aoki T, Ogura T: Improvement in the diagnostic performance of ultra-high-resolution computed tomography for fibrotic hypersensitivity pneumonitis. RSNA 2021\uff08WEB\u958b\u50ac\uff09, 2021,12.<\/dd>\n<dd>Iwasawa T, Takemura T, Okudela K, Kitamura H, Baba T, Ogura T: Radiological-pathological correlation in non-specific interstitial pneumonia (NSIP), State-of-the-art images by ultra-high-resolution computed tomography. RSNA 2021(WEB\u958b\u50ac), 2021, 12.<\/dd>\n<dd>Aoki R, Kobayashi Y, Nawata S, Kamide H, Hirayama M, Furugori S, Nishii T, Sekikawa Z, Utsunomiya D: Radiological imaging of resuscitative endovascular balloon occlusion of the aorta (REBOA)-Pearls and pitfalls. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Aso S, Ihama Y, Horie K, Kuninaka H, Mochizuki H, Yamashiro T, Kato S, Utsunomiya D: Evaluation of aortic injury on post-mortem CT after road traffic accidents\uff0e\u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Ishiwata Y, Hieda Y, Kishimoto M, Kaki S, Yamada K, Yamashiro T, Utsunomiya D: Qualitative and quantitative study of diagnostic performance of dual energy CT for bone metastases. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Kishimoto M, Ishiwata Y, Yamashiro T, Utsunomiya D: Diagnostic performance of CO-RADS classification of COVID-19 pneumonia on chest CT in non-epidemic area. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Koguchi T, Iwasawa T, Yamashiro T, Tabata E, Baba T, Misumi T, Utsunomiya D, Ogura T: Bronchiectasis in rheumatoid arthritis: Quantitative evaluation using ultra-high-resolution CT and correlation with clinical\/radiological findings. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Nakamura T, Kato S, Fukui K, Kodama S, Azuma M, Iwasawa T, Utsunomiya D: Low enhancement of left atrial appendage on computed tomography and risk of recurrence after ablation in patients with atrial fibrillation. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Morita Y, Nozawa K, Fujii Y, Fujita K, Murata K, Aida N: Comparison of imaging quality in the lung MRI between 3D-USV and PETRA sequences. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2021\uff0c4\uff0e<\/dd>\n<dd>Nakamura M, Kamide H, Kobayashi Y, Yamaguchi T, Mituhashi K, Aoki R, Nawata S, Hirayama M,Nishii T, Sekikawa Z: Transcatheter arterial embolization for gastrointestinal bleeding: comparison of NBCA use and non-use on rebleeding and ischemia. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u533b\u5b66\u4f1a\u7dcf\u4f1a, \u6a2a\u6d5c, 2021, 4.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u306b\u3088\u308bCT\u642d\u8f09\u8eca\u3092\u6d3b\u7528\u3057\u305f\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u80ba\u708e\u306e\u65e9\u671f\u767a\u898b\u30fb\u91cd\u75c7\u5ea6\u8a55\u4fa1\u306e\u610f\u7fa9\uff0e\u7b2c57\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u5927\u962a\uff08WEB\u958b\u50ac\uff09,2021,9.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u897f\u4e95\u4fca\u6676\uff0c\u8239\u9593\u82b3\u61b2\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c\u5b89\u7530\u5c1a\u53f2\uff0c\u592a\u7530\u967d\u4e00\u90ce\uff0c\u5824\u3000\u9ad8\u5fd7\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: \u8d85\u9ad8\u7cbe\u7d30CT\u306e\u51a0\u52d5\u8108\u30b9\u30c6\u30f3\u30c8\u5185\u75c5\u5909\u306e\u8996\u8a8d\u6027\u306e\u8a55\u4fa1: \u51a0\u52d5\u8108\u30d5\u30a1\u30f3\u30c8\u30e0\u3092\u7528\u3044\u305f\u691c\u8a0e\uff0e\u7b2c93\u56de\u65e5\u672c\u5fc3\u81d3\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2021, 7.<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66: \u5468\u7523\u671f\u4f4e\u9178\u7d20\u6027\u865a\u8840\u6027\u8133\u75c7\uff08HIE\uff09\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c57\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 9.<\/dd>\n<dd>\u9752\u6728\u3000\u4eae, \u5ca9\u6fa4\u591a\u6075, \u8429\u539f\u6075\u7406, \u5c0f\u677e\u3000\u8302, \u5c0f\u5009\u9ad9\u5fd7, \u5b87\u90fd\u5bae\u5927\u8f14: COVID-19\u80ba\u708e\u306e\u91cd\u75c7\u5ea6\u3068\u753b\u50cf\u89e3\u6790\u30bd\u30d5\u30c8\u30a6\u30a8\u30a2\u3092\u7528\u3044\u305fCT\u306e\u5b9a\u91cf\u8a55\u4fa1\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c457\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 3.<\/dd>\n<dd>\u82b3\u8cc0\u3000\u6681\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u5c71\u57ce\u6052\u96c4\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff0c\u4e39\u7fbd\u3000\u5d07\uff0c\u5c0f\u5009\u9ad8\u5fd7: \u6210\u4eba\u5f8c\u306b\u767a\u898b\u3055\u308c\u305fCongenital Pulmonary Venous Obstruction\u306e\uff11\u4f8b. \u7b2c35\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(WEB\u958b\u50ac), 2021, 9.<\/dd>\n<dd>\u4f0a\u5ddd\u745e\u5e0c\uff0c\u77f3\u6e21\u7fa9\u4e4b\uff0c\u4e09\u6d66\u8ce2\u592a\u90ce\uff0c\u771f\u4e0a\u3000\u85ab\uff0c\u5cb8\u672c\u771f\u7531\u5b50\uff0c\u5c71\u57ce\u6052\u96c4\uff0c\u5b87\u90fd\u5bae\u5927\u8f14: CT\u306b\u304a\u3051\u308bCO-RADS \u8a55\u4fa1\u3092\u53ef\u80fd\u3068\u3059\u308b\u6df1\u5c64\u5b66\u7fd2\u30e2\u30c7\u30eb\u306e\u69cb\u7bc9\uff0e2021\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c61\u56de\u4f8b\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u67ff\u5185\u3000\u660e\uff0c\u9752\u6728\u3000\u4eae\uff0c\u4e2d\u5d8b\u8ce2\u4eba\uff0c\u9152\u4e95\u5bb9\u5802\uff0c\u6c60\u7530\u3000\u65b0\uff0c\u8fbb\u3000\u53b3\u543e\uff0c\u5409\u5100\u3000\u6df3: \u5927\u5f84\u30d0\u30eb\u30fc\u30f3\u306e\u30de\u30a4\u30af\u30ed\u30d0\u30eb\u30fc\u30f3\u30ab\u30c6\u30fc\u30c6\u30eb\u3092\u7528\u3044\u305fBRTO \u306e\u521d\u671f\u7d4c\u9a13\uff0e2021\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c61\u56de\u4f8b\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb\uff0c\u897f\u4e95\u4fca\u6676\uff0c\u912d\u3000\u4ed5\u582f\uff0c\u9ebb\u751f\u771f\u4e8c\u90ce\uff0c\u5c71\u53e3\u552f\u53f2\uff0c\u4e09\u6a4b\u8015\u5e73\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u5e73\u5c71\u9ebb\u5229\u5b50\uff0c\u5bfa\u5185\u3000\u5e79\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce: \u2000\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u8102\u80aa\u8089\u816b\u306e\u4e00\u4f8b\uff0e2021\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c61\u56de\u4f8b\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb, \u5e73\u5c71\u9ebb\u5229\u5b50, \u4e2d\u6751\u5143\u7d00, \u5c71\u53e3\u552f\u53f2, \u4e09\u6a4b\u8015\u5e73, \u9752\u6728\u3000\u4eae, \u7e04\u7530\u664b\u592a\u90ce, \u4e0a\u51fa\u6d69\u4e4b, \u897f\u4e95\u4fca\u6676, \u6fa4\u4f4f\u77e5\u679d, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u5375\u5de3\u816b\u760d\u304c\u9451\u5225\u3068\u306a\u3063\u305f\u5b50\u5bae\u5e83\u9593\u819c\u5185\u7b4b\u816b\u306e\u4e00\u4f8b. \u7b2c457\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\uff08WEB\u958b\u50ac\uff09,2021\uff0c3.<\/dd>\n<dd>\u4e0a\u51fa\u6d69\u4e4b, \u5c71\u672c\u3000\u7d71, \u9752\u6728\u3000\u4eae, \u7e04\u7530\u664b\u592a\u90ce, \u5c0f\u6797\u96c4\u4ecb, \u53e4\u90e1\u614e\u592a\u90ce, \u6803\u5c3e\u3000\u6893, \u4e2d\u897f\u6c99\u767e\u7406, \u70ad\u8c37\u5d07\u7fa9, \u671b\u6708\u5065\u592a\u90ce, \u95a2\u5ddd\u5584\u4e8c\u90ce: \u7b2c\u4e00\u5b50\u51fa\u7523\u6642\u306bNBCA\u306b\u3066UAE\u3092\u884c\u3063\u305f\u60a3\u8005\u306b\u5bfe\u3057, \u7b2c\u4e8c\u5b50\u51fa\u7523\u6642\u306b\u3082UAE\u3092\u884c\u3063\u305f1\u75c7\u4f8b. \u7b2c50\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff08WEB\u958b\u50ac\uff09,2021, 5.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: COVID-19\u80ba\u708e\u306eCT\u8a3a\u65ad. \u6c60\u6dfb\u30e1\u30e2\u30ea\u30a2\u30eb\u30bb\u30df\u30ca\u30fc(WEB\u958b\u50ac), 2021, 8.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u75c7\u4f8b\u304b\u3089\u5b66\u3076\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u306b\u3088\u308b\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u8a3a\u65ad. \u7b2c40\u56de\u753b\u50cf\u533b\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 2.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u9593\u8cea\u6027\u80ba\u708e\u306e\u753b\u50cf\u8a3a\u65ad. \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09, 2021, 3.<\/dd>\n<dd>\u77e2\u6fa4\u6176\u4e00, \u6b66\u7530\u548c\u6c38, \u6fa4\u7530\u3000\u96c4, \u6e21\u9089\u3000\u7d14, \u4f50\u85e4\u3000\u52c9, \u5c71\u53e3\u552f\u53f2, \u95a2\u5ddd\u5584\u4e8c\u90ce, \u7530\u8fba\u7f8e\u6a39\u5b50, \u570b\u5d0e\u4e3b\u7a0e, \u9060\u85e4\u3000\u683c: \u624b\u8853\u5358\u72ec\u3067\u9577\u671f\u751f\u5b58\u4e2d\u306e\u80c6\u56a2\u539f\u767a\u795e\u7d4c\u5185\u5206\u6ccc\u764c\u306e\u4e00\u4f8b\uff0e\u7b2c43\u56de\u65e5\u672c\u764c\u5c40\u6240\u7642\u6cd5\u7814\u7a76\u4f1a\uff08WEB\u958b\u50ac\uff09,2021\uff0c5.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u304c\u3093\u8a3a\u7642\u5c02\u9580\u75c5\u9662\u306b\u304a\u3051\u308b\u534a\u5c0e\u4f53PET\/CT\u88c5\u7f6e Discovery MI\u306e\u4f7f\u7528\u7d4c\u9a13. \u7b2c61\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a, \u540d\u53e4\u5c4b, 2021, 11.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u30db\u30a6\u7d20\u4e2d\u6027\u5b50\u6355\u6349\u7642\u6cd5\u306b\u304a\u3051\u308b18F-FBPA PET\/CT\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u7b2c49\u56de\u65ad\u5c64\u6620\u50cf\u7814\u7a76\u4f1a, \u9e7f\u5150\u5cf6, 2021, 10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: BNCT\u3068PET\u691c\u67fb\u306b\u3064\u3044\u3066. \u7b2c26\u56de\u6771\u6d77\u816b\u760d\u6838\u533b\u5b66\u7814\u7a76\u4f1a,\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: PET\u6838\u533b\u5b66\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u30bb\u30df\u30ca\u30fc\u81e8\u5e8a\uff13\u3000\u816b\u760d\u305d\u306e\u4ed6. \u7b2c21\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 5.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u6838\u533b\u5b66\u6307\u5c0e\u8005\u30b3\u30fc\u30b9\u816b\u760d\u6838\u533b\u5b66 \uff08\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\uff09. \u7b2c21\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 5.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: Symposium 6 Theranostics \u2013 from PET Imaging to Nuclear Therapy &#8211; An Investigator-initiated Clinical Trial in Patients with Malignant Brain Tumor to Evaluate the Safety and Pharmacokinetics of Radioactive Cu-64 ATSM. \u7b2c80\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a, \u6a2a\u6d5c, 2021, 4.<\/dd>\n<dd>\u5c71\u672c\u5f25\u751f, \u5800\u5ddd\u3000\u6b69, \u65e5\u91ce\u5f69\u5b50, \u5c0f\u5d8b\u5927\u5730, \u571f\u4e95\u5185\u6052\u5b8f, \u6817\u539f\u5b8f\u660e: PET\/CT\u306b\u3066\u4e73\u764c\u306e\u5185\u90e8\u6027\u72b6\u304c\u8a55\u4fa1\u53ef\u80fd\u3067\u3042\u3063\u305f\u4e00\u4f8b. \u7b2c95\u56de\u65e5\u672c\u6838\u533b\u5b66\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 7.<\/dd>\n<dd>\u5800\u5ddd\u3000\u6b69, \u5c71\u672c\u5f25\u751f, \u65e5\u91ce\u5f69\u5b50, \u5c0f\u5d8b\u5927\u5730, \u571f\u4e95\u5185\u6052\u5b8f, \u6817\u539f\u5b8f\u660e: \u539f\u767a\u6027\u80ba\u764c\u306eFDG-PET\/CT\u691c\u67fb\u306b\u3066\u81b5\u306b\u7570\u5e38\u96c6\u7a4d\u3092\u5448\u3057\u305f\u75c7\u4f8b. \u7b2c95\u56de\u65e5\u672c\u6838\u533b\u5b66\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 7.<\/dd>\n<dd>\u5800\u5ddd\u3000\u6b69, \u5c0f\u5d8b\u5927\u5730, \u65e5\u91ce\u5f69\u5b50, \u5c71\u672c\u5f25\u751f, \u571f\u4e95\u5185\u6052\u5b8f, \u6817\u539f\u5b8f\u660e: FDG-PET\/CT\u691c\u67fb\u306b\u3066\u96c6\u7a4d\u306e\u898b\u3089\u308c\u305f\u8910\u8272\u8102\u80aa\u7d44\u7e54\u30fb\u8910\u8272\u8102\u80aa\u816b\u306e\u75c7\u4f8b. \u7b2c381\u56de\u5c0f\u7530\u6025\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u912d\u3000\u4ed5\u582f\uff0c\u5e73\u5c71\u9ebb\u5229\u5b50\uff0c\u9ebb\u751f\u771f\u4e8c\u90ce\uff0c\u5c0f\u6797\u96c4\u4ecb\uff0c\u5c71\u53e3\u552f\u53f2\uff0c\u4e09\u6a4b\u8015\u5e73\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u5bfa\u5185\u3000\u5e79\uff0c\u897f\u4e95\u4fca\u6676\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce: \u5e1d\u738b\u5207\u958b\u5f8c\u5b50\u5bae\u5275\u90e8\u9665\u51f9\u6027\u7622\u75d5\u306b\u767a\u75c7\u3057\u305f\u5b50\u5bae\u5185\u819c\u9593\u8cea\u7d50\u7bc0\u306e\u4e00\u4f8b\uff0e2021\u5e74\u5ea6\u795e\u5948\u5ddd\u770c\u653e\u5c04\u7dda\u533b\u4f1a\u7dcf\u4f1a\u30fb\u7b2c61\u56de\u4f8b\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u67ff\u5185\u3000\u660e, \u963f\u90e8\u3000\u793c, \u5b87\u6d25\u6728\u7fd4\u5e73, \u5b89\u85e4\u548c\u592b, \u9f4a\u85e4\u516c\u5f66, \u7af9\u6797\u8302\u751f: \u7d4c\u6642\u7684\u306aCT\u5024\u306e\u5909\u5316\u3092\u793a\u3057\u305f\u7570\u7269\u306b\u3088\u308b\u6d88\u5316\u7ba1\u7a7f\u5b54\u306e\u4e00\u4f8b.\u7b2c457\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021,3 .<\/dd>\n<dd>\u6c38\u4e95\u4e00\u6bc5, \u677e\u4e38\u514b\u5f66, \u83f1\u6728\u3000\u667a, \u51fa\u6e15\u3000\u4eae, \u5ca9\u57ce\u79c0\u884c, \u9f4a\u85e4\u516c\u5f66, \u5b89\u85e4\u548c\u592b: \u5f53\u9662\u306b\u304a\u3051\u308b\u9ad8IgG4\u8840\u75c7\u306b\u4f34\u3063\u305f\u52d5\u8108\u7624\u306e2\u75c7\u4f8b. \u7b2c83\u56de\u795e\u5948\u5ddd\u770c\u5185\u79d1\u533b\u5b66\u4f1a\u96c6\u8ac7\u4f1a, \u5ddd\u5d0e, 2021, 3.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u68ee\u7530\u6709\u9999\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u4f50\u85e4\u535a\u4fe1: \u4fc2\u7559\u89e3\u9664\u8853\u5f8c\u306b\u6539\u5584\u3057\u305f tethered cord \u3092\u4f34\u3046\u6025\u6027\u8efd\u5ea6\u810a\u9ac4\u640d\u50b7\u306e1\u4f8b. 2021\u5e74\u7b2c50\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a(WEB\u958b\u50ac), 2021, 1.<\/dd>\n<dd>\u4e39\u7fbd\u3000\u5fb9\uff0c\u67f4\u5d0e\u3000\u6df3\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u76f8\u7530\u5178\u5b50: \u65b0\u751f\u5150\u4eee\u6b7b\u306e\u4f4e\u4f53\u6e29\u7642\u6cd5\u306b\u304a\u3051\u308b\u62e1\u6563\u5f37\u8abf\u50cf\u3067\u306e\u64ae\u50cf\u30bf\u30a4\u30df\u30f3\u30b0, \u89e3\u6790\u65b9\u6cd5\u306b\u304a\u3051\u308b\u4e88\u5f8c\u306e\u691c\u8a0e. \u7b2c50\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u5927\u962a, 2021, 2.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u68ee\u7530\u6709\u9999\uff0c\u4f50\u85e4\u535a\u4fe1\uff0c\u76f8\u7530\u5178\u5b50: \u4fc2\u7559\u89e3\u9664\u8853\u5f8c\u306b\u6539\u5584\u3057\u305ftight filum terminale\u3092\u4f34\u3046\u6025\u6027\u8efd\u5ea6\u810a\u9ac4\u640d\u50b7\u306e1\u4f8b. \u7b2c50\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u5927\u962a, 2021, 2.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u7530\u8fba\u4ec1\u5f66\uff0c\u5bcc\u5b89\u3082\u3088\u3053\uff0c\u68ee\u7530\u6709\u9999\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u7d4c\u6642\u7684\u306bMRI spectroscopy\u3092\u64ae\u50cf\u3057\u3048\u305f\u810a\u9ac4\u5c0f\u8133\u5931\u8abf\u75c729\u578b\u306e1\u4f8b. \u7b2c50\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u5927\u962a, 2021, 2.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca, \u4e95\u4e0a\u771f\u898f,\u7530\u4e0a\u5e78\u6cbb\uff0c\u4f50\u85e4\u535a\u4fe1, \u68ee\u7530\u7531\u9999\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u76f8\u7530\u5178\u5b50: \u53cd\u5fa9\u6027\u9ac4\u819c\u708e\u3092\u5408\u4f75\u3057\u305f\u5185\u8033\u5947\u5f62\u306e\u4e00\u4f8b. \u7b2c57\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u57fc\u7389, 2021\uff0c6.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u68ee\u7530\u6709\u9999\uff0c\u76f8\u7530\u5178\u5b50: \u80ce\u5150\u671f\u304b\u3089\u89b3\u5bdf\u3055\u308c\u305fTorcular dural sinus malformation\u306e\u4e00\u4f8b. \u7b2c57\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 6.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff08\u5206\uff09: \u51a0\u52d5\u8108CT\u306b\u304a\u3051\u308b\u6d41\u4f53\u7df4\u6210\u89e3\u6790\u6cd5\u3092\u7528\u3044\u305f\u51a0\u8840\u6d41\u4e88\u5099\u91cf\u6bd4\u306e\u57fa\u790e\u7684\u30fb\u81e8\u5e8a\u7684\u691c\u8a0e\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082018-2021)\uff0c15\u4e07\u5186\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff08\u5206\uff09: \u9020\u5f71CT\u3067\u306e\u30e8\u30fc\u30c9\u5897\u5f37\u52b9\u679c\u304c\u3082\u305f\u3089\u3059\u65b0\u305f\u306a\u7dda\u91cf\u5897\u52a0\u306e\u5f71\u97ff\u306b\u95a2\u3059\u308b\u7814\u7a76\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082018-2022)\uff0c43\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09: \u753b\u9762\u5171\u6709\u30fb\u5bfe\u8a71\u30b3\u30f3\u30b5\u30eb\u30c6\u30fc\u30b7\u30e7\u30f3\u6a5f\u80fd\u3092\u5099\u3048\u305f\u6b21\u4e16\u4ee3\u578b\u9060\u9694\u753b\u50cf\u8a3a\u65ad\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u5b9f\u8a3c\u7814\u7a76. \u79d1\u5b66\u6280\u8853\u632f\u8208\u6a5f\u69cb SCORE\u5927\u5b66\u63a8\u9032\u578b \u62e0\u70b9\u90fd\u5e02\u74b0\u5883\u6574\u5099\u578b \u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30c7\u30b6\u30a4\u30f3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0GAP\u30d5\u30a1\u30f3\u30c9, 592\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09: \u5fc3\u81d3MRI\u306e\u9ad8\u6b21\u5143\u753b\u50cf\u7279\u5fb4\u91cf\u3068\u6a5f\u68b0\u5b66\u7fd2\u3092\u7528\u3044\u305f\u975e\u865a\u8840\u6027\u5fc3\u7b4b\u75c7\u306e\u65b0\u305f\u306a\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u63a2\u7d22. \u4e00\u822c\u8ca1\u56e3\u6cd5\u4eba\u6a2a\u6d5c\u7dcf\u5408\u533b\u5b66\u632f\u8208\u8ca1\u56e3 \u308f\u304b\u3070\u7814\u7a76\u52a9\u6210, 50\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09: \u9ad8\u89e3\u50cf\u5ea6\u9045\u5ef6\u9020\u5f71\uff2d\uff32\uff29\u306b\u3088\u308b\u5de6\u623f\u7dda\u7dad\u5316\u8a55\u4fa1: \u5fc3\u623f\u7d30\u52d5, \u5fc3\u4e0d\u5168\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u610f\u7fa9 \u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d \u82e5\u624b\u7814\u7a76\uff082019-2022)\uff0c143\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u5206\uff09: COVID-19 \u95a2\u9023\u5fc3\u81d3\u969c\u5bb3\u306b\u95a2\u3059\u308b\u8abf\u67fb\u7814\u7a76\uff08TRACE-COVID\uff09. \u539a\u751f\u52b4\u50cd\u884c\u653f\u63a8\u9032\u8abf\u67fb\u4e8b\u696d\u8cbb\u88dc\u52a9\u91d1, 300\u4e07\u5186\uff0e<\/dd>\n<dd>\u77f3\u6e21\u7fa9\u4e4b\uff08\u4ee3\uff09: \u6df1\u5c64\u5b66\u7fd2\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u8133\u6838\u533b\u5b66\u691c\u67fb\u306e\u753b\u8cea\u6539\u5584\u304a\u3088\u3073\u64ae\u50cf\u6642\u9593\u77ed\u7e2e\u306e\u691c\u8a0e.\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\u82e5\u624b\u7814\u7a76\uff082020-2022\uff09, 65\u4e07\u5186.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u4ee3\uff09: \u96e3\u6cbb\u6027\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM \u306b\u3088\u308b\u65b0\u6cbb\u7642\u6cd5\u958b\u767a\uff0d\u65e9\u671f\u627f\u8a8d\u3092\u76ee\u6307\u3059\u7b2cI\u76f8\u62e1\u5927\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u306e\u5b9f\u65bd. AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d, 9509.5\u4e07\u5186.<\/dd>\n<dd>\u5c71\u672c\u5f25\u751f\uff08\u5206\uff09: \u96e3\u6cbb\u6027\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM \u306b\u3088\u308b\u65b0\u6cbb\u7642\u6cd5\u958b\u767a\uff0d\u65e9\u671f\u627f\u8a8d\u3092\u76ee\u6307\u3059\u7b2c I \u76f8\u62e1\u5927\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u306e\u5b9f\u65bd. AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d, 60\u4e07\u5186\uff0e<\/dd>\n<dd>\u65e5\u91ce\u5f69\u5b50\uff08\u5206\uff09: \u96e3\u6cbb\u6027\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM \u306b\u3088\u308b\u65b0\u6cbb\u7642\u6cd5\u958b\u767a\uff0d\u65e9\u671f\u627f\u8a8d\u3092\u76ee\u6307\u3059\u7b2c I \u76f8\u62e1\u5927\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u306e\u5b9f\u65bd. AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d, 60\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c0f\u5d8b\u5927\u5730\uff08\u5206\uff09: \u96e3\u6cbb\u6027\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM \u306b\u3088\u308b\u65b0\u6cbb\u7642\u6cd5\u958b\u767a\uff0d\u65e9\u671f\u627f\u8a8d\u3092\u76ee\u6307\u3059\u7b2c I \u76f8\u62e1\u5927\u30b3\u30db\u30fc\u30c8\u8a66\u9a13\u306e\u5b9f\u65bd. AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d, 60\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u907a\u4f1d\u75c5\u306ethin slice\u64ae\u50cf\u3068\u4eba\u5de5\u77e5\u80fd\u306b\u3088\u308b\u78c1\u6c17\u5171\u9cf4\u753b\u50cf\u8a3a\u65ad\u6cd5\u306e\u6a39\u7acb. \u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082021-2023)\uff0c13\u4e07\u5186.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u547c\u5438\u5668\u7cfb\u5148\u5929\u7570\u5e38\u75be\u60a3\u306e\u8a3a\u7642\u4f53\u5236\u69cb\u7bc9\u3068\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u304a\u3088\u3073\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u3044\u305f\u533b\u7642\u6c34\u6e96\u5411\u4e0a\u306b\u95a2\u3059\u308b\u7814\u7a76. \u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09\uff082020-2022\uff09\uff0c30\u4e07\u5186.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09: \u5c0f\u5150\u304a\u3088\u3073AYA\u4e16\u4ee3\u306e\u6a2a\u7d0b\u7b4b\u8089\u816b\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30ea\u30b9\u30af\u5c64\u5225\u5316\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u306b\u3088\u308b\u6a19\u6e96\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a. AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082020-2022\uff09\uff0c22.1\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u4ee3\uff09: 1H-MRS\u6cd5\u3092\u7528\u3044\u305f\u8133\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76. \u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1, 20\u4e07\u5186.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff08\u5206\uff09: \u982d\u90e8MRI arterial spin labeling(ASL)\u753b\u50cf\u3092\u7528\u3044\u305f\u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76.\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1, 17.3\u4e07\u5186.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff08\u5206\uff09: \u65b0\u6280\u8853\u3092\u7528\u3044\u305f\u5c0f\u5150\u8eaf\u5e79\u90e8MRI\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76. \u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210\u91d1, 21.2\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09: MRS\u306b\u3088\u308b\u5c0f\u5150\u8133\u5185\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u306e\u81ea\u52d5\u8a3a\u65ad\u89e3\u6790\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a. \u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d<\/dd>\n<dd>\uff08\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1\uff09\u57fa\u76e4\u7814\u7a76\uff08C)\u3000(\u4e00\u822c)\uff082019-2021\uff09, 13\u4e07\u5186.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: Dual energy CT\u304c\u3082\u305f\u3089\u3059\u65b0\u305f\u306a\u5faa\u74b0\u5668\u8a3a\u65ad\uff0e\u7b2c372\u56de\u5faa\u74b0\u5668\u753b\u50cf\u6280\u8853\u7814\u7a76\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 2.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u8840\u7ba1\u753b\u50cf\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30de\u30a4\u30d6\u30fc\u30e0: \u3053\u308c\u304b\u3089\u306e\u6d41\u884c\u3092\u8003\u3048\u308b\uff0e\u7b2c41\u56de \u305b\u3068\u3046\u3061\u5fc3\u81d3CT\u30fbMR\u52c9\u5f37\u4f1aWEB, 2021, 4.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u30c8\u30d4\u30c3\u30af\u30b9\uff0eCardiovascular Multimodality Imaging Conference in Kawasaki (CMICK)\uff08WEB\u958b\u50ac\uff09, 2021, 4.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u753b\u50cf\u3067\u5206\u304b\u308b\u75c5\u6c17\u3068\u306f\uff0e\u7b2c12\u56de\u6a2a\u6d5c\u5e02\u533b\u5e2b\u4f1a\u5e02\u6c11\u516c\u958b\u8b1b\u5ea7\uff08WEB\u958b\u50ac\uff09, 2021, 6.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u306f\u3058\u3081\u307e\u3057\u3087\u3046, \u5fc3\u81d3CT\uff5e\u65e5\u5e38\u8a3a\u7642\u306b\u6d3b\u304b\u3059\u3046\u3048\u3067\u306e\u57fa\u790e\u304b\u3089TIPS\u307e\u3067\uff5e\uff0e\u30e1\u30c7\u30a3\u30ab\u30eb\u30b9\u30ad\u30e3\u30cb\u30f3\u30b0\u30fb\u30d0\u30a4\u30a8\u30eb\u5fc3\u8840\u7ba1\u30fb\u9aa8\u8edf\u90e8\u3000WEB\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09, 2021, 6.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u8aad\u5f71\u305d\u3057\u3066\u7814\u7a76\u306b\u5411\u3051\u3066\uff0e\u7b2c11\u56de Advanced Diagnostic Imaging Conference in Hamamatsu\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\u3068MRI\u3092\u81e8\u5e8a\u306b\u6d3b\u304b\u3059\uff0eKowa Online Web Conference\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u80ba\u9ad8\u8840\u5727\u306e\u8a3a\u65ad\u301c\u7279\u306b\u80ba\u8840\u6813\u585e\u6813\u75c7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u65b0\u305f\u306a\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306b\u3064\u3044\u3066\u301c\uff0e\u7b2c4\u56de\u80ba\u9ad8\u8840\u5727\u75c7Network Seminar in Yokohama\uff08WEB\u958b\u50ac\uff09, 2021, 11.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: \u3053\u306e1\u5e74\u306eCT\u306e\u9032\u6b69: \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306e\u8513\u5ef6\u3092\u7d4c\u3066\uff0e\u7b2c6\u56deAdvanced Medical Imaging\u7814\u7a76\u4f1a\uff08SAMI2021\uff09\uff08WEB\u958b\u50ac\uff09, 2021 ,7.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: CT\u642d\u8f09\u8eca\u3092\u7528\u3044\u305fCOVID-19\u5bfe\u7b56: \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u306e\u53d6\u7d44\u307f\uff0e\u7b2c16\u56deImaging Now in Kanagawa\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4: COVID-19\u5bfe\u7b56\u306b\u304a\u3051\u308bCT\u642d\u8f09\u8eca\u306e\u6d3b\u7528: \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u306e\u4e8b\u4f8b\u304b\u3089\uff0e\u611b\u5a9b\u770c\u753b\u50cf\u8a3a\u65adWEB\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09, 2021, 12.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5fc3\u81d3MRI\u306e\u6700\u65b0\u306e\u8a71\u984c. \u7b2c207\u56de\u6a2a\u6d5c\u5fc3\u81d3\u7814\u7a76\u4f1a, \u6a2a\u6d5c, 2021, 3.<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e: \u5faa\u74b0\u5668\u8a3a\u7642\u306b\u304a\u3051\u308b\u5fc3\u81d3MRI. \u795e\u5948\u5ddd\u5faa\u74b0\u5668\u7814\u7a76\u4f1a, \u6a2a\u6d5c, 2021, 5.<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66: \u8edf\u90e8\u816b\u760d\u306e\u753b\u50cf\u8a3a\u65ad\uff5e\u3053\u3053\u307e\u3067\u306f\u753b\u50cf\u3067\u8a3a\u65ad\u3057\u3088\u3046\uff5e\u30e1\u30c7\u30a3\u30ab\u30eb\u30b9\u30ad\u30e3\u30cb\u30f3\u30b0\u30fb\u30d0\u30a4\u30a8\u30eb.\u5fc3\u8840\u7ba1\u30fb\u9aa8\u8edf\u90e8WEB\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09, 2021, 6.<\/dd>\n<dd>\u9752\u6728\u3000\u4eae: \u30d5\u30a3\u30eb\u30e0\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30bb\u30c3\u30b7\u30e7\u30f3\u512a\u79c0\u8cde.\u7b2c57\u56de\u65e5\u672c\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 3.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce: REBOA\u306e\u753b\u50cf\u8a3a\u65ad: \u30dd\u30a4\u30f3\u30c8\u3068\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb.\u6771\u4eac\u30a2\u30f3\u30ae\u30aa\u30fbIVR\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 6.<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce: NBCA. \u30c6\u30eb\u30e2\u30e1\u30c7\u30a3\u30ab\u30eb\u30d7\u30e9\u30cd\u30c3\u30af\u30b9\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0, \u795e\u5948\u5ddd\uff0c2021, 12.<\/dd>\n<dd>\u5bfa\u5185\u3000\u5e79: \u30b3\u30a4\u30ea\u30f3\u30b0. \u30c6\u30eb\u30e2\u30e1\u30c7\u30a3\u30ab\u30eb\u30d7\u30e9\u30cd\u30c3\u30af\u30b9\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0, \u795e\u5948\u5ddd, 2021, 12.<\/dd>\n<dd>\u5bfa\u5185\u3000\u5e79: \u814e\u7d30\u80de\u764c\u306b\u5bfe\u3059\u308b\u51cd\u7d50\u7642\u6cd5\uff5e\u5c0e\u5165\u304b\u30892\u5e74\u306e\u7d4c\u9a13\u3068\u4eca\u5f8c\u306e\u5c55\u671b\uff5e. \u7b2c32\u56de\u6a2a\u6d5c\u5e02\u6ccc\u5c3f\u5668\u79d1\u533b\u4f1a\u30fb\u6a2a\u6d5c\u6ccc\u5c3f\u5668\u79d1\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09, 2021, 4.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u534a\u5c0e\u4f53PET\/CT\u306e\u6709\u7528\u6027. \u6700\u65b0FDG-PET\u30bb\u30df\u30ca\u30fc, \u91d1\u6ca2, 2021, 12.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: PET\/CT\u306b\u304a\u3051\u308b\u8aad\u5f71\u306e\u5de5\u592b\u3068\u6709\u7528\u6027. \u57fc\u7389\u6838\u533b\u5b66\u7814\u7a76\u4f1a, \u57fc\u7389, 2021, 10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u534a\u5c0e\u4f53PET\/CT\u3092\u6700\u5927\u9650\u306b\u6d3b\u304b\u3059\u8aad\u5f71\u3068\u904b\u7528\u65b9\u6cd5. \uff37\uff25\uff22\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 10.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u65b0\u751f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306e\u898b\u9003\u3057\u3092\u9632\u3050\u305f\u3081\u306b\u300c\u65b0\u751f\u5150\u306e\u982d\u90e8MRI\u306e\u8aad\u5f71\u300d. \u7b2c2\u56de\u611b\u77e5\u770c\u65b0\u751f\u5150\u533b\u7642\u30b9\u30ad\u30eb\u30a2\u30c3\u30d7\u7814\u4fee\u4f1a, \u540d\u53e4\u5c4b, 2021, 1.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u305f\u5c0f\u5150\u8650\u5f85. \u6a2a\u6d5cGeneral Pediatrics\u30d5\u30a9\u30fc\u30e9\u30e0\uff08WEB\u958b\u50ac\uff09,2021, 2.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad\u3092\u76ee\u6307\u3057\u3066. \u7b2c57\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u57fc\u7389, 2021, 6.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad\u306e\u8003\u3048\u65b9\u3068\u9032\u3081\u65b9. \u4e00\u822c\u793e\u56e3\u6cd5\u4eba\u5c71\u53e3\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a\u590f\u5b63\u8b1b\u7fd2\u4f1a\uff08WEB\u958b\u50ac\uff09,2021, 7.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u65b0\u751f\u5150\u8133\u75c7\u306e\u753b\u50cf\u8a3a\u65ad,\u5fdc\u7528\u7de8: MRS\u306e\u6709\u7528\u6027. \u7b2c57\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09, 2021, 9.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u5c0f\u5150MRI\u306e\u6d3b\u7528: CT\u3067\u306e\u88ab\u3070\u304f\u3092\u6e1b\u3089\u3059\u305f\u3081\u306b. \u7b2c49\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a(\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u958b\u50ac), 2021, 9.<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Nagayama Y\u201a Tanoue S\u201a Inoue T\u201a Oda S\u201a Nakaura T\u201a Utsunomiya D\u201aYamashita Y: Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma. Eur Radiol\u201a 39\uff081\uff09: 394-403\u201a 2020.<\/dd>\n<dd>Yoshida M\u201a Utsunomiya D\u201a Inoue T\u201a Nakaura T\u201a Sakaino N\u201aHarada K\u201a Sueta D\u201a Tsujita K\u201a Yamashita Y: Prevalence of extracardiac findings in patients undergoing coronary computed tomography and additional low-dose whole-body computed tomography. Jpn J Radiol 38\uff082\uff09: 144-153\u201a 2020.<\/dd>\n<dd>Iwasawa T\u201a Sato M\u201a Yamaya T\u201a Sato Y\u201a Uchida Y\u201a Kitamura H\u201a Hagiwara E\u201a Komatsu S\u201a Utsunomiya D\u201a Ogura T: Ultrahigh-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus \uff08COVID-19\uff09pneumonia. Jpn J Radiol\u201a 38\uff085\uff09: 394-398\u201a 2020.<\/dd>\n<dd>Nakajima K\u201a Kato H\u201a Yamashiro T\u201a Izumi T\u201a Takeuchi I\u201a Nakajima H\u201a Utsunomiya D: COVID-19 pneumonia: infection control protocol inside computed tomography suites. Jpn J Radiol\u201a 38\uff085\uff09: 391-393\u201a 2020.<\/dd>\n<dd>Yoshida M\u201a Nakaura T\u201a Sentaro T\u201a Tanoue S\u201a Inada H\u201a Utsunomiya D\u201a Sakaino N\u201a Harada K\u201a Yamashita Y: Prospective comparison of 70-kVp single-energy CT versus dual-energy CT: which is more suitable for CT angiography with low contrast media dosage? Acad Radiol\u201a 27\uff085\uff09: e116-e122\u201a 2020.<\/dd>\n<dd>Nagamatsu S\u201a Sakamoto K\u201a Yamashita T\u201a Sato R\u201a Tabata N\u201a Motozato K\u201a Yamanaga K\u201a Ito M\u201a Fujisue K\u201a Kanazawa H\u201a Sueta D\u201a Usuku H\u201a Araki S\u201a Arima Y\u201a Takashio S\u201a Suzuki S\u201a Yamamoto E\u201a Izumiya Y\u201a Soejima H\u201a Utsunomiya D\u201a Kaikita K\u201a Yamashita Y\u201a Tsujita K: Impact of hydrostatic pressure on fractional flow reserve: in vivo experimental study of anatomical height difference of coronary arteries. J Cardiol\u201a 76\uff081\uff09: 73-79\u201a 2020.<\/dd>\n<dd>Azuma M\u201a Kato S\u201a Kodama S\u201a Hayakawa K\u201a Kagimoto M\u201a Iguchi K\u201a Fukuoka M\u201a Fukui K\u201a Iwasawa T\u201a Utsunomiya D\u201a Kimura K\u201a Tamura K: Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with nonischemic dilated cardiomyopathy. Magn Reson Imaging\u201a 74: 14-20\u201a 2020.<\/dd>\n<dd>Ishiwata Y\u201a Hieda Y\u201a Kaki S\u201a Aso S\u201a Horie K\u201a Kobayashi Y\u201a Nakamura M\u201a Yamada K\u201a Yamashiro T\u201a Utsunomiya D: Improved diagnostic accuracy of bone metastasis detection by water-HAP associated to non-contrast CT. Diagnostics\u201a 10\uff0810\uff09: 853\u201a 2020.<\/dd>\n<dd>Kato S\u201a Fukui K\u201a Kodama S\u201a Azuma M\u201a Iwasawa T\u201a Kimura K\u201a Tamura K\u201a Utsunomiya D: Incremental prognostic value of coronary flow reserve determined by phase-contrast cine cardiovascular magnetic resonance of the coronary sinus in patients with diabetes mellitus. J Cardiovasc Magn Reson\u201a 22\uff081\uff09: 73\u201a 2020.<\/dd>\n<dd>Kodama S\u201a Kato S\u201a Hayakawa K\u201a Azuma M\u201a Kagimoto M\u201a Iguchi K\u201a Fukuoka M\u201a Fukui K\u201a Iwasawa T\u201a Utsunomiya D\u201a Kosuge M\u201a Kimura K\u201a Tamura K: Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy. Heart Vessels\u201a 35\uff0810\uff09: 1439-1445\u201a 2020.<\/dd>\n<dd>Sakabe D\u201a Fukui T\u201a Oda S\u201a Tominaga O\u201a Okamoto K\u201a Kato S\u201a Yamashiro T\u201a Funama Y\u201a Kidoh M\u201a Ikeda O\u201a Utsunomiya D: Noninvasive flow evaluations of coronary artery bypass grafting using dynamic cardiac CT. Medicine\u201a 99\uff0848\uff09: e23338\u201a 2020.<\/dd>\n<dd>Kawasaki T\u201a Kidoh M\u201a Kido T\u201a Sueta D\u201a Fujimoto S\u201a Kumamaru KK\u201a Uetani T\u201a Tanabe Y\u201a Ueda T\u201a Sakabe D\u201a Oda S\u201a Yamashiro T\u201a Tsujita K\u201a Kato S\u201a Yuki H\u201a Utsunomiya D: Evaluation of significant coronary artery disease based on CT fractional flow reserve and plaque characteristics using random forest analysis in machine learning. Acad Radiol\u201a 27 \uff0812\uff09: 1700-1708\u201a 2020.<\/dd>\n<dd>Tateishi K\u201a Ikegaya N\u201a Udaka N\u201a Sasame J\u201a Hayashi T\u201a Miyake Y\u201a Okabe T\u201a Minamimoto R\u201a Murata H\u201a Utsunomiya D\u201a Yamanaka S\u201a Yamamoto T: BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young. Acta Neuropathol Commun\u201a 8\uff081\uff09: 139\u201a 2020.<\/dd>\n<dd>Yoshida M\u201a Utsunomiya D\u201a Takada S\u201a Komohara Y\u201a Mizoshiri T\u201a Oda S\u201a Harada K\u201a Ikeda O: The imaging findings of peliosis hepatis on gadoxetic acid enhanced MRI.Radiol Case Rep\u201a 15\uff088\uff09: 1261-1265\u201a 2020.<\/dd>\n<dd>Yamashiro T\u201a Kumamaru KK\u201a Kido A\u201a Namoto Matsubayashi R\u201a Ota H\u201a Ida M\u201a Aoki S: Work-style reform and use of information and communication technology among diagnostic radiologists in Japan: Results of the 2018 JRS\/JCR joint survey. Jpn J Radiol\u201a 38\uff087\uff09: 636-642\u201a 2020.<\/dd>\n<dd>Nagatani Y\u201a Yoshigoe M\u201a Tsukagoshi S\u201a Ushio N\u201a Ohashi K\u201a Nitta N\u201a Kimoto T\u201a Uranishi A\u201a Sato S\u201a Mayumi M\u201a Yamashiro T\u201a Moriya H\u201a Murata K\u201a Watanabe Y: Peripheral bronchial luminal conspicuity on dynamic-ventilation computed tomography: association with radiation doses and temporal resolution by using an ex vivo porcine lung phantom. Acta Radiol\u201a 61\uff0812\uff09: 1608-1617\u201a 2020.<\/dd>\n<dd>Morita Y\u201a Yamashiro T\u201a Tsuchiya N\u201a Tsubakimoto M\u201a Murayama S: Automatic bronchial segmentation on ultra-HRCT scans: Advantage of the 1024-matrix size with 0.25-mm slice thickness reconstruction. Jpn J Radiol\u201a 38\uff0810\uff09: 953-959\u201a 2020.<\/dd>\n<dd>Akazawa Y\u201a Ganaha A\u201a Higa T\u201a Kondo S\u201a Oyakawa Y\u201a Hirakawa H\u201a Suzuki M\u201a Yamashiro T: Measurement of stapes footplate thickness in otosclerosis by ultra-highresolution computed tomography. Acta Otolaryngol\u201a 140 \uff0811\uff09: 899-903\u201a 2020.<\/dd>\n<dd>Kitajima K\u201a Kihara T\u201a Kawanaka Y\u201a Kido A\u201a Yoshida K\u201a Mizumoto Y\u201a Tomiyama A\u201a Okuda S\u201a Jinzaki M\u201a Kato F\u201a Takahama J\u201a Takahata A\u201a Fukukura Y\u201a Nakamoto A\u201a Tsujikawa T\u201a Munechika J\u201a Ohgiya Y\u201a Kawai N\u201a Goshima S\u201a Ohya A\u201a Fujinaga Y\u201a Fukunaga T\u201a Fujii S\u201a Tanabe M\u201a Ito K\u201a Tsuboyama T\u201a Kanie Y\u201a Umeoka S\u201a Ichikawa S\u201a Motosugi U\u201a Daido S\u201a Kido A\u201a Tamada T\u201a Matsuki M\u201a Yamashiro T\u201a Yamakado K: Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis &#8211; Japan multicenter study. Oncotarget\u201a 11\uff0840\uff09: 3675-3686\u201a 2020.<\/dd>\n<dd>Koda E\u201a Yamashiro T\u201a Onoe R\u201a Handa H\u201a Azagami S\u201a Matsushita S\u201a Tomita H\u201a Inoue T\u201a Mineshita M: CT texture analysis of mediastinal lymphadenopathy: Combining with US-based elastographic parameter and discrimination between sarcoidosis and lymph node metastasis from small cell lung cancer. PLoS One\u201a 15\uff0812\uff09: e0243181\u201a 2020.<\/dd>\n<dd>Kimura Y\u201a Yamashiro T\u201a Saito Y\u201a Kitsukawa K\u201a Niki H\u201a Mimura H: MRI findings of spring ligament injury: Association with surgical findings and flatfoot deformity. Acta Radiol Open\u201a 9\uff0812\uff09: 2058460120980145\u201a 2020.<\/dd>\n<dd>Sakabe D\u201a Fukui T\u201a Oda S\u201a Tominaga O\u201a Okamoto K\u201a Kato S\u201a Yamashiro T\u201a Funama Y\u201a Kidoh M\u201a Ikeda O\u201a Utsunomiya D: Noninvasive flow evaluations of coronary artery bypass grafting using dynamic cardiac CT. Medicine\u201a 99\uff0848\uff09: e23338\u201a 2020.<\/dd>\n<dd>Kato S\u201a Fukui K\u201a Kodama S\u201a Azuma M\u201a Iwasawa T\u201a Kimura K\u201a Tamura K\u201a Utsunomiya D: Incremental prognostic value of coronary flow reserve determined by phase-contrast cine cardiovascular magnetic resonance of the coronary sinus in patients with diabetes mellitus. Journal of cardiovascular magnetic resonance\u201a 22\uff081\uff09: 73\u201a 2020.<\/dd>\n<dd>Kato S\u201a Fukui K: Successful stent implantation with the use of non contrast whole-heart coronary magnetic resonance angiography and intravascular ultrasound in patient with allergy to iodinated contrast media. Cardiovascular intervention and therapeutics\u201a doi: 10.1007\/s12928-020-<\/dd>\n<dd>00712-z. 2020.<\/dd>\n<dd>Azuma M\u201a Kato S\u201a Kodama S\u201a Hayakawa K\u201a Kagimoto M\u201a Iguchi K\u201a Fukuoka M\u201a Fukui K\u201a Iwasawa T\u201a Utsunomiya D\u201a Kimura K\u201a Tamura K: Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with nonischemic dilated cardiomyopathy. Magnetic resonance imaging\u201a 74: 14-20\u201a 2020.<\/dd>\n<dd>Kodama S\u201a Kato S\u201a Hayakawa K\u201a Azuma M\u201a Kagimoto M\u201a Iguchi K\u201a Fukuoka M\u201a Fukui K\u201a Iwasawa T\u201a Utsunomiya D\u201a Kosuge M\u201a Kimura K\u201a Tamura K: Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for<\/dd>\n<dd>patients with non-ischemic dilated cardiomyopathy. Heart Vessels\u201a 35\uff0810\uff09: 1439-1445\u201a 2020.<\/dd>\n<dd>Yokota Y\u201a Takeda C\u201a Kidoh M\u201a Oda S\u201a Aoki R\u201a Ito K\u201a Morita K\u201a Haraoka K\u201a Yamashita Y\u201a Iizuka H\u201a Kato S\u201a Tsujita K\u201a Ikeda O\u201a Yamashita Y\u201a Utsunomiya D: Effects of Deep Learning Reconstruction Technique in High-Resolution Non-contrast Magnetic Resonance Coronary Angiography at a 3-Tesla Machine. Canadian Association of Radiologists journal\u201a 72 \uff081\uff09: 120-127\u201a 2020.<\/dd>\n<dd>Kawasaki T\u201a Kidoh M\u201a Kido T\u201a Sueta D\u201a Fujimoto S\u201a Kumamaru KK\u201a Uetani T\u201a Tanabe Y\u201a Ueda T\u201a Sakabe D\u201a Oda S\u201a Yamashiro T\u201a Tsujita K\u201a Kato S\u201a Yuki H\u201a Utsunomiya D: Evaluation of Significant Coronary Artery Disease Based on CT Fractional Flow Reserve and Plaque Characteristics Using Random Forest Analysis in Machine Learning. Acad Radiol\u201a 27\uff0812\uff09: 1700-1708\u201a 2020.<\/dd>\n<dd>Miyazaki T\u201a Nakajima W\u201a Hatano M\u201a Shibata Y\u201a Kuroki Y\u201a Arisawa T\u201a Serizawa A\u201a Sano A\u201a Kogami S\u201a Yamanoue T\u201a Kimura K\u201a Hirata Y\u201a Takada Y\u201a Ishiwata Y\u201a Sonoda M\u201a Tokunaga M\u201a Seki C\u201a Nagai Y\u201a Minamimoto T\u201a Kawamura K\u201a Zhang MR\u201a Ikegaya N\u201a Iwasaki M\u201a Kunii N\u201a Kimura Y\u201a Yamashita F\u201a Taguri M\u201a Tani H\u201a Nagai N\u201a Koizumi T\u201a Nakajima S\u201a Mimura M\u201a Yuzaki M\u201a Kato H\u201a Higuchi M\u201a Uchida H\u201a Takahashi T: Visualization of AMPA receptors in living human brain with positron emission tomography. Nat Med\u201a 26\uff082\uff09: 281-288\u201a 2020.<\/dd>\n<dd>Ishiwata Y\u201a Hieda Y\u201a Kaki S\u201a Aso S\u201a Horie K\u201a Kobayashi Y\u201a Nakamura M\u201a Yamada K\u201a Yamashiro T\u201a Utsunomiya D: Improved Diagnostic Accuracy of Bone Metastasis Detection by Water-HAP Associated to Non-contrast CT. Diagnostics\u201a 10\uff0810\uff09: 853\u201a 2020.<\/dd>\n<dd>Yamamoto Y\u201a Mitsunaga S\u201a Horikawa H\u201a Hino A\u201a Kurihara K: Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early. Ann Nucl Med\u201a 34\uff081\uff09: 74-49\u201a 2020.<\/dd>\n<dd>Iwasawa T\u201a Sato M\u201a Yamaya T\u201a Sato Y\u201a Uchida Y\u201a Kitamura H\u201a Hagiwara E\u201a Komatsu S\u201a Utsunomiya D\u201a Ogura T: Ultrahigh-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus \uff08COVID-19\uff09 pneumonia. Jpn J Radiol\u201a 38\uff085\uff09: 394-398\u201a 2020.<\/dd>\n<dd>Kitayama T\u201a Kitamura H\u201a Hagiwara E\u201a Higa K\u201a Okabayashi H\u201a Oda T\u201a Baba T\u201a Komatsu S\u201a Iwasawa T\u201a Ogura T: COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia. Intern Med\u201a 59\uff0824\uff09: 3207-3211\u201a 2020.<\/dd>\n<dd>Tsuchiya N\u201a Iwasawa T\u201a Ogura T\u201a Yamashiro T\u201a Yara S\u201a Fujita J\u201a Murayama S: Pulmonary flow assessment by phasecontrast MRI can predict short-term mortality of fibrosing interstitial lung diseases. Acta Radiol\u201a 61\uff0810\uff09: 1350-1358\u201a 2020.<\/dd>\n<dd>Nishimura N\u201a Kumaki T\u201a Murakami H\u201a Enomoto Y\u201a Tsurusaki Y\u201a Tsuji M\u201a Tsuyusaki Y\u201a Goto T\u201a Aida N\u201a Kurosawa K: Expanding the phenotype of COL4A1-related disorders-Four novel variants. Brain Dev\u201a 42\uff089\uff09: 639-645\u201a 2020.<\/dd>\n<dd>Takizaki N\u201a Tsurusaki Y\u201a Katsumata K\u201a Enomoto Y\u201a Murakami H\u201a Muroya K\u201a Ishikawa H\u201a Aida N\u201a Nishimura G\u201a Kurosawa K: Novel CUL7 biallelic mutations alter the skeletal phenotype of 3M syndrome. Hum Genome Var\u201a 4\uff087\uff09: 1\u201a 2020.<\/dd>\n<dd>Kaneshi Y\u201a Shibasaki J\u201a Aida N\u201a Shimokaze T\u201a Toyoshima K: Indocyanine green lymphography for congenital lymphatic dysplasia with tuberous sclerosis complex: A case report. Pediatr Int\u201a 62\uff082\uff09: 234-236\u201a 2020.<\/dd>\n<dd>Murakami H\u201a Uehara T\u201a Tsurusaki Y\u201a Enomoto Y\u201a Kuroda Y\u201a Aida N\u201a Kosaki K\u201a Kurosawa K: Blended phenotype of AP4E1 deficiency and Angelman syndrome caused by paternal isodisomy of chromosome 15. Brain Dev\u201a 42\uff083\uff09: 289-292\u201a 2020.<\/dd>\n<dd>Taoka T\u201a Aida N\u201a Fujii Y\u201a Ichikawa K\u201a Kawai H\u201a Nakane T\u201a Ito R\u201a Naganawa S: White matter microstructural changes in tuberous sclerosis: Evaluation by neurite orientation dispersion and density imaging \uff08NODDI\uff09 and diffusion tensor images. Sci Rep\u201a 10\uff081\uff09: 436\u201a 2020.<\/dd>\n<dd>Hayashi A\u201a Ito E\u201a Omura M\u201a Aida N\u201a Tanaka M\u201a Tanaka Y\u201a Sato H\u201a Miyagawa N\u201a Yokosuka T\u201a Iwasaki F: Hamanoue S\u201a Goto H: Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma. Pediatr Int\u201a 62\uff081\uff09: 47-51\u201a 2020.<\/dd>\n<dd>\u5927\u6fa4\u7d75\u90fd\u5b50\uff0c\u5317\u6cb3\u5fb3\u5f66\uff0c\u65b0\u958b\u771f\u4eba\uff0c\u671b\u6708\u97ff\u5b50\uff0c\u753a\u7530\u6cbb\u90ce\uff0c\u5c0f\u6797\u771e\u53f8\uff0c\u99ac\u5834\u76f4\u5b50\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u7530\u4e2d\u7950\u5409\uff0c\u7530\u4e2d\u6c34\u7dd2\uff1a Lipoblastoma 51\u4f8b\u306e\u691c\u8a0e\uff0e\u65e5\u672c\u5c0f\u5150\u5916\u79d1\u5b66\u4f1a\u96d1\u8a8c\uff0c56 \uff08 6 \uff09\uff1a906-912\uff0c2020\uff0e<\/dd>\n<dd>\u9ebb\u751f\u771f\u4e8c\u90ce\uff0c\u5800\u6c5f\u6167\u4e00\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff1aCOVID-19\u80ba\u708e\u3068\u6162\u6027\u5fc3\u4e0d\u5168\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c36\uff0811\uff09\uff1a1306-1307\uff0c2020\uff0e<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73\uff0c\u798f\u7530\u5927\u8a18\uff0c\u677e\u4e0b\u5f70\u4e00\u90ce\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c\u5c0f\u5009\u9ad8\u5fd7\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u8d85\u9ad8\u7cbe\u7d30CT\u3092\u7528\u3044\u305f\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u8a55\u4fa1\u306b\u304a\u3051\u308bdeep learning reconstruction \u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u81e8\u5e8a\u653e\u5c04\u7dda\uff0c65\uff08 1 \uff09\uff1a17-24\uff0c2020\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1aCOVID-19\u306e\u4e00\u822c\u7684\u4e8b\u9805\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c36 \uff0811\uff09\uff1a1295\uff0c2020\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff0c\u5cb8\u672c\u771f\u7531\u5b50\uff0c\u4e2d\u6751\u6cf0\u4ecb\uff1a\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662\u306b\u304a\u3051\u308bCT\u64ae\u5f71\uff1a\u300c\u767a\u71b1\u5916\u6765\u300d\u53d7\u8a3a\u60a3\u8005\u3078\u306e\u5bfe\u5fdc\uff0e \u81e8\u5e8a\u753b\u50cf\uff0c36\uff0811\uff09\uff1a1313-1314\uff0c2020\uff0e<\/dd>\n<dd>\u5409\u7530\u5553\u4ecb\uff1a\u5730\u57df\u533b\u7642\u306e\u4e2d\u67a2\u75c5\u9662\u304c\u63a8\u9032\u3059\u308b\u8907\u6570\u65bd\u8a2d\u306e\u30c7\u30fc\u30bf\u7d71\u5408\u306b\u5411\u3051\u305f\u30b7\u30b9\u30c6\u30e0\u904b\u7528\uff0eIT vision\u201a 41\uff1a30-31\uff0c2020\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff0c\u5150\u7389\u3000\u7fd4\uff0c\u65e9\u5ddd\u6e13\u543e\uff0c\u6771\u3000\u771f\u4f0a\uff0c\u9375\u672c\u7f8e\u5948\u5b50\uff0c\u798f\u5ca1\u96c5\u6d69\uff0c\u798f\u4e95\u548c\u6a39\uff0c\u5ca9\u6fa4\u591a\u6075\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff0c\u5c0f\u83c5\u96c5\u7f8e\uff0c\u6728\u6751\u4e00\u96c4\uff0c\u7530\u6751\u529f\u4e00\uff1a\u5fc3\u4e0d\u5168\u8a3a\u7642\u306b\u304a\u3051\u308bMRI\u306e\u6709\u7528\u6027\uff0e\u5faa\u74b0\u5668\u5185\u79d1\uff08Cardioangiology\uff09\uff0c87 \uff08 4 \uff09\uff1a412-418\uff0c2020\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u5faa\u74b0\u5668\u8a3a\u76422020\u3069\u3053\u307e\u3067\u653b\u3081\u3066\uff0c\u3069\u3053\u304b\u3089\u5f15\u304f\u304b\uff1f\u3000\u753b\u50cf\u8a3a\u65ad\u30fb\u305d\u306e\u4ed6MRI\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u75c7\u306e\u9451\u5225\uff0e Medicina\uff0c 57\uff0810\uff09\uff1a1746-1750\uff0c2020\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff0c\u6b66\u6751\u6c11\u5b50\uff1a\u5c0f\u8449\u69cb\u9020\u3068\u9593\u8cea\u6027\u80ba\u708e\u2500\u5c0f\u8449\u30fb\u7d30\u8449\u8fba\u7e01\u3092\u7406\u89e3\u3059\u308b\uff0e\u753b\u50cf\u8a3a\u65ad\u5897\u520a\u53f7\uff0c140\uff0811\uff09\uff1aA140-A153\uff0c2020\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u4eba\u5de5\u77e5\u80fd\u306b\u3088\u308b\u80f8\u90e8CT\u89e3\u6790\u3000\u9593\u8cea\u6027\u80ba\u708e\u306b\u304a\u3051\u308b\u5b9a\u91cf\u8a55\u4fa1\u300cQZIP-ILD\u300d\uff0e\u30a4\u30f3\u30ca\u30fc\u30d3\u30b8\u30e7\u30f3\uff0c35 \uff08 8 \uff09\uff1a74-75\uff0c2020\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u300cMRI\u691c\u67fb\u6642\u306e\u93ae\u9759\u306b\u95a2\u3059\u308b\u5171\u540c\u63d0\u8a00\u300d\u516c\u8868\u5f8c\u306b\u4f55\u304c\u5909\u308f\u3063\u305f\u304b\uff1f\u3000\u653e\u5c04\u7dda\u79d1\u306e\u7acb\u5834\u304b\u3089\uff0e\u5c0f\u5150\u79d1\u8a3a\u7642\uff0c83\uff0812\uff09\uff1a1695-1700\uff0c2020\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1aCOVID-19\u306e\u753b\u50cf\u6240\u898b\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c36\uff0811\uff09\uff1a 1300-1301\uff0c2020\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u8457\u66f8<\/h3>\n<\/dt>\n<dd>Iwasawa T: Principles and Clinical Applications of Respiratory Motion Assessment Using 4D Computed Tomography and Magnetic Resonance Imaging. Pulmonary functional imaging. Y. Ohno\u201a H. Hatabu and H. U. Kauczor. Springer\u201a 92-106\u201a 2020.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u51a0\u52d5\u8108\u72ed\u7a84 \u2500 \u51a0\u52d5\u8108\u30bb\u30b0\u30e1\u30f3\u30c8\u306eAHA\u5206\u985e\u3001SCCT\u5206\u985e\u3092\u4e2d\u5fc3\u306b\uff0e\u3053\u3053\u304b\u3089\u59cb\u3081\u308b\u5faa\u74b0\u5668\u75be\u60a3\u306eCT\u30fbMRI\uff1a\u5fc3\u81d3\u30fb\u9838\u90e8\u8840\u7ba1\u30fb\u80f8\u90e8\u30fb\u8179\u90e8\u30fb\u672b\u68a2\u8840\u7ba1\u75be\u60a3Case Review\uff0e\u79c0\u6f64\u793e\uff0c1\uff0d15\uff0c2020\uff0e<\/dd>\n<dd>\u5409\u7530\u5553\u4ecb\uff1a\u9aa8\u76e4\u8154\u306eCT\u30fbMRI\u8a3a\u65ad\uff0e\u4eca\u65e5\u306e\u8a3a\u65ad\u6307\u91dd\u3000\u7b2c8 \u7248\uff0e\u533b\u5b66\u66f8\u9662\uff0c474-479\uff0c2020\uff0e<\/dd>\n<dd>\u4f0a\u85e4\u8ce2\u4e00\uff0c\u5ca1\u90e8\u54f2\u5f66\uff1a\u795e\u7d4c\u76ae\u819a\u9ed2\u8272\u816b\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c378\uff0c2020\uff0e<\/dd>\n<dd>\u4f0a\u85e4\u8ce2\u4e00\uff0c\u5ca1\u90e8\u54f2\u5f66\uff1aGorlin \u75c7\u5019\u7fa4\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c382-383\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u5c0f\u5150\u671f\u306b\u767a\u75c7\u3059\u308b\u4ee3\u8b1d\u5909\u6027\u75be\u60a3\u7dcf\u8ad6\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c390-391\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1aGM 2 \u2500\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c400-401\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u30e0\u30b3\u591a\u7cd6\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c402-403\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1aAlexander \u75c5\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c424-425\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1aLeigh \u8133\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c450-451\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u6162\u6027\u9032\u884c\u6027\u5916\u773c\u7b4b\u9ebb\u75fa\/Kearns-Sayre\u75c7\u5019\u7fa4\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c454-455\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1aLeukoencephalopathy with brainstem and spinal cord involvement and lactate elevation\uff08 LBSL\uff09\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c458-459\uff0c2020\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u30d4\u30eb\u30d3\u30f3\u9178\u8131\u6c34\u7d20\u9175\u7d20\u8907\u5408\u4f53\u6b20\u640d\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c460-461\uff0c2020\uff0e<\/dd>\n<dd>\u9152\u4e95\u5bb9\u5802\uff0c\u5ca1\u90e8\u54f2\u5f66\uff1a\u5148\u5929\u6027\u30b5\u30a4\u30c8\u30e1\u30ac\u30ed\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c480\uff0c2020\uff0e<\/dd>\n<dd>\u9152\u4e95\u5bb9\u5802\uff0c\u5ca1\u90e8\u54f2\u5f66\uff1a\u5148\u5929\u6027\u30c8\u30ad\u30bd\u30d7\u30e9\u30ba\u30de\u611f\u67d3\u75c7\uff0e\u3088\u304f\u308f\u304b\u308b\u8133MRI\u6539\u8a02\u7b2c4 \u7248\uff0e\u79c0\u6f64\u793e\uff0c481\uff0c2020\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff1a\u3088\u304f\u308f\u304b\u308b\u8133MRI\uff0e\u79c0\u6f64\u793e\uff0c346-347\uff0c466-489\uff0c2020\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u5c0f\u5009\u9ad8\u5fd7 \u7de8\u96c6\u3000COVID-19\u306e\u75c5\u614b\u30fb\u8a3a\u65ad\u30fb\u6cbb\u7642\u3000\u300cCOVID-19\u306e\u753b\u50cf\u8a3a\u65ad\u3000\u4eba\u5de5\u77e5\u80fd\uff08AI\uff09\u3092\u7528\u3044\u305f\u81ea\u52d5\u8a3a\u65ad\u3084\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u3092\u7528\u3044\u305f\u5b9a\u91cf\u8a55\u4fa1\uff0e\u533b\u5b66\u66f8\u9662\uff0c77-78\uff0c2020\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u68ee\u3000\u3000\u58be\uff0c\u5c0f\u5009\u660e\u592b \u7de8\u96c6\u3000\u4eba\u4f53\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u304b\u3089\u5b66\u3076\u753b\u50cf\u8a3a\u65ad\u6280\u8853\u5b66\u300c\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u75c5\u614b\u3068\u753b\u50cf\u300d\u8077\u696d\u6027\u80ba\u75be\u60a3\u306e\u75c5\u614b\u3068\u753b\u50cf\u300d\u300c\u80f8\u819c\u75be\u60a3\u306e\u75c5\u614b\u3068\u753b\u50cf\u300d\u300c\u5faa\u74b0\u969c\u5bb3\u306e\u75c5\u614b\u3068\u753b\u50cf\u300d\u300c\u305d\u306e\u4ed6\u306e\u75be\u60a3\u306e\u75c5\u614b\u3068\u753b\u50cf\u300d\uff0e\u30e1\u30b8\u30ab\u30eb\u30d3\u30e5\u30fc\u793e\uff0c236-282\uff0c2020\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Hieda Y\u201a Ishiwata Y\u201a Kaki S\u201a Yamada K\u201a Iizuka H\u201a Yoshida K\u201a Yamashiro T\u201a Utsunomiya D: Improved diagnostic accuracy for the detection of bone metastasis with 256-row dualenergy computed tomography. European Congress of Radiology\u201a Vienna\u201a 2020\u201a 7.<\/dd>\n<dd>Iizuka H\u201a Aso S\u201a Ishiwata Y\u201a Yoshida K\u201a Utsunomiya D: Birt-Hogg-Dub\u00e9 syndrome: A pictorial review. ECR 2020 \uff08WEB\u958b\u50ac\uff09\u201a 2020\u201a 7.<\/dd>\n<dd>Tomiyasu M\u201a Shibasaki J\u201a Kawai Y\u201a Higashi T\u201a Obata T\u201a Aida N: Brain glycine quantification in an infant with non-ketotic hyperglycemia: a serial proton MRS study. ISMRM 2020 \uff08WEB\u958b\u50ac\uff09\uff0c 2020\u201a 8.<\/dd>\n<dd>Shibasaki J\u201a Niwa T\u201a Tomiyasu M\u201a Morisaki N\u201a Fujii Y\u201a Aida N: Changes in Apparent Diffusion Coefficient Values and Brain Metabolite Levels after Neonatal Hypoxic-Ischemic Encephalopathy. Pediatric Academic Societies \uff08PAS\uff09 Meeting 2020\uff08 WEB\u958b\u50ac\uff09\uff0c 2020\u201a 4-5.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5fc3\u81d3CT\u306e\u81e8\u5e8a\uff1a\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u306b\u3064\u3044\u3066\u8003\u3048\u308b\uff0e\u7b2c30\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a\uff0c\u4ed9\u53f0\uff0c2020\uff0c1\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff1a\u6551\u6025\u753b\u50cf\u8a3a\u65ad\u9818\u57df\u306b\u304a\u3051\u308b\u300c\u3059\u308a\u30ac\u30e9\u30b9\u5f71\u300d\u306e\u9451\u5225\uff0e\u7b2c30\u56de\u65e5\u672c\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76\u4f1aER\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c10\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff1aCT\u3067\u300c\u767d\u3044\u300d\u3068\u306f\u9650\u3089\u306a\u3044\u80ba\u306e\u75c5\u6c17\uff1a\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5165\u9580\uff0e\u6a2a\u6d5c\u5357\u90e8\u5730\u533a\u30e9\u30b8\u30aa\u30ed\u30b8\u30fc\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff1a\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u75c5\u9662CT\u691c\u8a3a\u8eca\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\uff1aCT\u691c\u8a3a\u8eca\u3092\u7528\u3044\u305fCOVID-19\u80ba\u708e\u306e\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u3064\u3044\u3066\uff0e\u5b9f\u8df5\u529b\u3068\u7814\u7a76\u529b\u3092\u5099\u3048\u305f\u6cd5\u533b\u5b66\u8005\u80b2\u6210\u4e8b\u696d\u7b2c4 \u56de\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c12\uff0e<\/dd>\n<dd>Yoshida K\u201a Aso S\u201a Ishiwata Y\u201a Utsunomiya D: Incidental findings on whole body FDG PET\/CT; a guideline for residents and practicing radiologists. ECR 2020\uff08WEB\u958b\u50ac\uff09\uff0c 2020\u201a 3.<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff08\u4e2d\u67a2\u795e\u7d4c\u9818\u57df\uff1a\u4ee3\u8b1d\u5909\u6027\u75be\u60a3\u3092\u4e2d\u5fc3\u306b\uff09\uff0e\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c8\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1a\u865a\u8840\u3068\u306f\u4f55\u304b\uff1f\u3000MRI\u306e\u7acb\u5834\u304b\u3089\uff0e\u7b2c56\u56de\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u4e95\u53e3\u516c\u5e73\uff0c\u5150\u7389\u3000\u7fd4\uff0c\u65e9\u5ddd\u6e13\u543e\uff0c\u6771\u3000\u771f\u4f0a\uff0c\u9375\u672c\u7f8e\u5948\u5b50\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u798f\u5ca1\u96c5\u6d69\uff0c\u798f\u4e95\u548c\u6a39\uff1a\u5de6\u5ba4\u524d\u58c1\u306e\u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9\u90e8\u4f4d\u306b\u5408\u4f75\u3057\u305f\u611f\u67d3\u75c7\u5fc3\u819c\u708e\uff0e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u652f\u90e8\u7b2c657\u56de\u95a2\u6771\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u9375\u672c\u7f8e\u5948\u5b50\uff0c\u4e95\u53e3\u516c\u5e73\uff0c\u5150\u7389\u3000\u7fd4\uff0c\u65e9\u5ddd\u6e13\u543e\uff0c\u6771\u3000\u771f\u4f0a\uff0c\u52a0\u85e4\u771f\u543e\uff0c\u798f\u5ca1\u96c5\u6d69\uff0c\u798f\u4e95\u548c\u6a39\uff0c\u77f3\u5ddd\u5229\u4e4b\uff0c\u6728\u6751\u4e00\u96c4\uff0c\u7530\u6751\u529f\u4e00\uff1a\u80ba\u9759\u8108\u9694\u96e2\u8853\u4e2d\u306bExit block\u306e\u307f\u306e\u4e00\u65b9\u5411\u6027\u30d6\u30ed\u30c3\u30af\u3092\u4ecb\u3057\u305f\u6301\u7d9a\u6027\u306eDouble tachycardia\uff0e\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u5c3e\u5ddd\u677e\u7fa9\uff0c\u897f\u7530\u5e83\u4e4b\uff0c\u4e0b\u7530\u4e09\u51ac\uff0c\u77f3\u6e21\u7fa9\u4e4b\uff0c\u77f3\u5ddd\u6804\u4e8c\uff1a Zr-89\u3092\u7528\u3044\u305f\u56fd\u5185\u521d\u306e\u81e8\u5e8a\u3092\u76ee\u7684\u3068\u3057\u305fBody Phantom\u306e\u57fa\u790e\u7684\u8a55\u4fa1\uff0e\u7b2c60\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c\u795e\u6238\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u7e04\u7530\u664b\u592a\u90ce\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u52a0\u6765\u8061\u4e00\u6717\uff0c\u9752\u6728\u3000\u4eae\uff0c\u5c71\u672c\u3000\u7d71\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u4e0d\u5168\u5b50\u5bae\u7834\u88c2\u306b\u3088\u308b\u5206\u5a29\u5f8c\u51fa\u8840\u306b\u5bfe\u3057\u3066\u5927\u52d5\u8108\u906e\u65ad\u30d0\u30eb\u30fc\u30f3\uff08REBOA\uff09\u633f\u5165\u3068TAE\u306b\u3088\u308a\u6551\u547d\u3057\u5f97\u305f\u4e00\u4f8b\uff0e\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u795e\u6238\uff0c2020\uff0c8\uff0e<\/dd>\n<dd>\u9752\u6728\u3000\u4eae\uff0c\u5c71\u672c\u3000\u7d71\uff0c\u7e04\u7530\u664b\u592a\u90ce\uff0c\u4e0a\u51fa\u6d69\u4e4b\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u5916\u50b7\u6027\u5185\u8178\u9aa8\u52d5\u8108\u9589\u585e\u306e\u4e00\u4f8b\uff0e\u7b2c49\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u795e\u6238\uff0c2020\uff0c8\uff0e<\/dd>\n<dd>\u52a0\u7d0d\u5e0c\u751f\uff0c\u5c71\u672c\u5f25\u751f\uff0c\u65e5\u91ce\u5f69\u5b50\uff0c\u82b9\u6fa4\u6148\u5b50\uff0c\u6bd4\u7559\u9593 \u5fb9\uff0c\u6817\u539f\u5b8f\u660e\uff1a\u9aa8\u8edf\u90e8\u816b\u760d\u306e\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u306b\u7528\u3044\u3089\u308c\u305f\u30b9\u30da\u30fc\u30b5\u30fc\u306eCT\u6240\u898b\uff0e\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c10\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff1a\u5c0f\u5150\u306e\u975e\u5916\u50b7\u6027\u80f8\u9aa8\u5206\u7bc0\u8131\u81fc\u306b\u5bfe\u3057\u4fdd\u5b58\u7684\u7642\u6cd5\u3092\u3068\u3063\u305f\u4e00\u4f8b\uff0e\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c8\uff0e<\/dd>\n<dd>\u5c0f\u53e3\u3000\u7ffc\uff1a\u80f8\u90e8\u7570\u5e38\u5f71\u3092\u5951\u6a5f\u306bFabry \u75c5\u3068\u8a3a\u65ad\u3055\u308c\u305f\u4e00\u4f8b\uff0e\u7b2c49\u56de\u982d\u9838\u90e8\u30fb\u80f8\u90e8\u753b\u50cf\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c12\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u547c\u5438\u5668\u9818\u57df\u306b\u304a\u3051\u308b\u8d85\u9ad8\u7cbe\u7d30CT\u306e\u6709\u7528\u6027\uff0e\u7b2c12\u56de\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c1\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u8d85\u9ad8\u7cbe\u7d30CT\u306b\u3088\u308b\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c39\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u306e\u8a3a\u65ad\uff0e\u7b2c39\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>Iwasawa T\u201a Sato M\u201a Yamaya T\u201a Sato Y\u201a Uchida Y\u201a Kitamura H\u201a Hagiwara E\u201a Komatsu S\u201a Utsunomiya D\u201a Ogura T: Ultrahigh-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus \uff08COVID-19\uff09 pneumonia. \u7b2c79\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\u201a 5.<\/dd>\n<dd>Iwasawa T: Smoking-related lung diseases \uff08COPD\u201a DIP\u201a RBILD\u201a LCH\u201a AEF\uff09. \u7b2c79\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\uff08 WEB\u958b\u50ac\uff09\uff0c 2020\u201a 5.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u4eba\u5de5\u77e5\u80fd\u306b\u3088\u308b\u80f8\u90e8CT\u89e3\u6790\uff0c\u9593\u8cea\u6027\u80ba\u708e\u306b\u304a\u3051\u308b\u5b9a\u91cf\u8a55\u4fa1\uff0e\u7b2c79\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c5\uff0e<\/dd>\n<dd>\u5e83\u5ddd\u5927\u8f14\uff0c\u5bcc\u5b89\u3082\u3088\u3053\uff0c\u5f8c\u85e4\u88d5\u660e\uff0c\u5c71\u672c\u54f2\u54c9\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u306b\u304a\u3051\u308bMethotrexate\uff08MTX\uff09\u6295\u4e0e\u5f8c\u306e\u767d\u8cea\u306b\u95a2\u3059\u308bmagnetic resonance spectroscopy\uff08MRS\uff09\u306e\u691c\u8a0e\uff0e\u7b2c49\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c6-7\uff0e<\/dd>\n<dd>\u6d45\u539f\u6dbc\u5b50\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u4e39\u5185\u5553\u5141\uff0c\u5f8c\u85e4\u88d5\u660e\uff0c\u7530\u4e2d\u7950\u5409\uff0c\u4f50\u85e4\u535a\u4fe1\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u9aa8\u9ac4\u79fb\u690d\u524d\u306e\u5168\u8eab\u7167\u5c04\u304b\u308910\u5e74\u5f8c\u306b\u767a\u75c7\u3057\u305f\u5c0f\u5150\u306e\u653e\u5c04\u7dda\u8a98\u767a\u6027intraosseous meningioma \u306e\u4e00\u4f8b\uff0e\u7b2c49\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c6-7\uff0e<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff1aPURA\u75c7\u5019\u7fa4\u306e2 \u4f8b\uff0e\u7b2c49\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c6-7\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u306e\u975e\u5916\u50b7\u6027\u80f8\u9aa8\u5206\u7bc0\u8131\u81fc\u306b\u5bfe\u3057\u4fdd\u5b58\u7684\u7642\u6cd5\u3092\u3068\u3063\u305f\u4e00\u4f8b\uff0e\u7b2c56\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c8\uff0e<\/dd>\n<dd>\u6d45\u539f\u6dbc\u5b50\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u6c60\u7530\u3000\u6893\uff0c\u4e39\u5185\u5553\u5141\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u5012\u7acb\u8a13\u7df4\u5f8c\u306b\u767a\u75c7\u3057\u305f\u810a\u9ac4\u6897\u585e\u306e\u5c0f\u5150\u4f8b\uff0e\u7b2c56\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c8\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff08\u4ee3\uff09\uff1a\u5fc3\u81d3\u5f01\u819c\u75c7\u304c\u3082\u305f\u3089\u3059\u5fc3\u7b4b\u58c1\u904b\u52d5\u3068\u8840\u6d41\u7570\u5e38\u306b\u95a2\u3059\u308bCT\u30d9\u30af\u30c8\u30eb\u6a5f\u80fd\u89e3\u6790\u3068\u81e8\u5e8a\u5fdc\u7528\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082016\uff0d2020\uff09\uff0c26\u4e07\u5186\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff08\u5206\uff09\uff1a\u51a0\u52d5\u8108CT\u306b\u304a\u3051\u308b\u6d41\u4f53\u7df4\u6210\u89e3\u6790\u6cd5\u3092\u7528\u3044\u305f\u51a0\u8840\u6d41\u4e88\u5099\u91cf\u6bd4\u306e\u57fa\u790e\u7684\u30fb\u81e8\u5e8a\u7684\u691c\u8a0e\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082018\uff0d2021\uff09\uff0c54\u4e07\u5186\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff08\u5206\uff09\uff1a\u9020\u5f71CT\u3067\u306e\u30e8\u30fc\u30c9\u5897\u5f37\u52b9\u679c\u304c\u3082\u305f\u3089\u3059\u65b0\u305f\u306a\u7dda\u91cf\u5897\u52a0\u306e\u5f71\u97ff\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\uff08C\uff09\uff082018\uff0d2022\uff09\uff0c43\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09\uff1a\u9060\u9694\u753b\u50cf\u8a3a\u65ad\u30fb\u975e\u66dd\u9732\u64ae\u5f71\u6a5f\u80fd\u3092\u5b9f\u88c5\u3059\u308bCT\u691c\u8a3a\u8eca\u3092\u7528\u3044\u305f\u9662\u5916\u7642\u990a\u4e2d\u306e\u611f\u67d3\u8005\u306b\u304a\u3051\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u80ba\u708e\u306e\u65e9\u671f\u8a3a\u65ad\u306e\u6709\u7528\u6027\u306b\u95a2\u3059\u308b\u5b9f\u8a3c\u7814\u7a76\uff0e\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\u4ee4\u548c2 \u5e74\u5ea6\u30a6\u30a4\u30eb\u30b9\u7b49\u611f\u67d3\u75c7\u5bfe\u7b56\u6280\u8853\u958b\u767a\u4e8b\u696d\uff08\u5b9f\u8a3c\u30fb\u6539\u826f\u7814\u7a76\u652f\u63f4\uff09\uff082020\uff09\uff0e15\uff0c080\u4e07\u5186\uff0e<\/dd>\n<dd>\u5c71\u57ce\u6052\u96c4\uff08\u4ee3\uff09\uff1a\u30f4\u30a1\u30fc\u30c1\u30e3\u30eb\u30fb\u30ea\u30a2\u30ea\u30c6\u30a3\uff08VR\uff09\u3092\u7528\u3044\u305f\u547c\u5438\u5668\u30fb\u5faa\u74b0\u5668\u52d5\u614b\u753b\u50cf\u306e\u89e3\u6790\uff0e\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\u3000\u82e5\u624b\u7814\u7a76\uff082020\uff0d2021\uff09\uff0c247\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09\uff1a\u9ad8\u89e3\u50cf\u5ea6\u9045\u5ef6\u9020\u5f71MRI\u306b\u3088\u308b\u5de6\u623f\u7dda\u7dad\u5316\u8a55\u4fa1\uff1a\u5fc3\u623f\u7d30\u52d5\uff0c\u5fc3\u4e0d\u5168\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u610f\u7fa9\uff0e\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1\u4e8b\u696d\u57fa\u76e4\u3000\u82e5\u624b\u7814\u7a76\uff082019\uff0d2021\uff09\uff0c130\u4e07\u5186\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff08\u4ee3\uff09\uff1a\u5fc3\u81d3MRI\u306e\u9ad8\u6b21\u5143\u753b\u50cf\u7279\u5fb4\u91cf\u3068\u6a5f\u68b0\u5b66\u7fd2\u3092\u7528\u3044\u305f\u975e\u865a\u8840\u6027\u5fc3\u7b4b\u75c7\u306e\u65b0\u305f\u306a\u30ea\u30b9\u30af\u56e0\u5b50\u306e\u63a2\u7d22\uff0e\u4e00\u822c\u8ca1\u56e3\u6cd5\u4eba\u6a2a\u6d5c\u7dcf\u5408\u533b\u5b66\u632f\u8208\u8ca1\u56e3\u3000\u308f\u304b\u3070\u7814\u7a76\u52a9\u6210\uff0c50\u4e07\u5186\uff0e<\/dd>\n<dd>\u77f3\u6e21\u7fa9\u4e4b\uff08\u4ee3\uff09\uff1a\u6df1\u5c64\u5b66\u7fd2\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u8133\u6838\u533b\u5b66\u691c\u67fb\u306e\u753b\u8cea\u6539\u5584\u304a\u3088\u3073\u64ae\u50cf\u6642\u9593\u77ed\u7e2e\u306e\u691c\u8a0e\uff0e\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\u3000\u82e5\u624b\u7814\u7a76\uff082020\uff0d2022\uff09\uff0c286\u4e07\u5186\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1a1H-MRS\u6cd5\u3092\u7528\u3044\u305f\u8133\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1<\/dd>\n<dd><\/dd>\n<dd>\uff0c263\uff0c000\u5186\uff0e<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff08\u5206\uff09\uff1a\u982d\u90e8MRI arterial spin labeling\uff08ASL\uff09\u753b\u50cf\u3092\u7528\u3044\u305f\u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1<\/dd>\n<dd><\/dd>\n<dd>\uff0c214\uff0c000\u5186\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff08\u5206\uff09\uff1a\u65b0\u6280\u8853\u3092\u7528\u3044\u305f\u5c0f\u5150\u8eaf\u5e79\u90e8MRI\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u795e\u5948\u5ddd\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1<\/dd>\n<dd><\/dd>\n<dd>\uff0c230\uff0c000\u5186\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1aAI\u306b\u3088\u308b\u81e8\u5e8a\u753b\u50cf\u8a3a\u65ad\u3092\u76ee\u6307\u3059\u305f\u3081\u306e\u8907\u5408\u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u958b\u767a\u7814\u7a76\uff0e\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\u3000\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1\u3000\u57fa\u76e4\u7814\u7a76\uff08C\uff09\uff08\u4e00\u822c\uff09\uff082017\uff0d2020\uff09\uff0c97\uff0c845\u5186\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1aMRS\u306b\u3088\u308b\u5c0f\u5150\u8133\u5185\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u306e\u81ea\u52d5\u8a3a\u65ad\u89e3\u6790\u30b7\u30b9\u30c6\u30e0\u306e\u958b\u767a\uff0e\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\uff08\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1\uff09\u57fa\u76e4\u7814\u7a76\uff08C\uff09\uff08\u4e00\u822c\uff09\uff082019\uff0d2021\uff09\uff0c40\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09\uff1a\u547c\u5438\u5668\u7cfb\u5148\u5929\u7570\u5e38\u75be\u60a3\u306e\u8a3a\u7642\u4f53\u5236\u69cb\u7bc9\u3068\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u304a\u3088\u3073\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u3044\u305f\u533b\u7642\u6c34\u6e96\u5411\u4e0a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09\u5fdc\u7528\u7814\u7a76\uff082020\uff0d2022\uff09\uff0c30\u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09\uff1a\u5c0f\u5150\u304a\u3088\u3073AYA\u4e16\u4ee3\u306e\u6a2a\u7d0b\u7b4b\u8089\u816b\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30ea\u30b9\u30af\u5c64\u5225\u5316\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u306b\u3088\u308b\u6a19\u6e96\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0eAMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff082020\uff0d2022\uff09\uff0c20\u4e07\u5186\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5fc3\u81d3CT\u306f\u5faa\u74b0\u5668\u8a3a\u7642\u3092\u3069\u3046\u5909\u3048\u3066\u3044\u304f\u306e\u304b\uff0e\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u3068\u770c\u533b\u5e2b\u4f1a\u5f79\u54e1\u30fb\u533b\u5b66\u4f1a\u5e79\u4e8b\u3068\u306e\u61c7\u8ac7\u4f1a\uff0c\u6a2a\u6d5c\uff0c2020\uff0c1\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306eCT\u3068MRI\u8aad\u5f71\u306e\u57fa\u672c\u3068\u30c8\u30d4\u30c3\u30af\uff0eJCR\u30df\u30c3\u30c9\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc\uff08WEB\u958b\u50ac\uff09\uff0c\u6a2a\u6d5c\uff0c2020\uff0c7\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u7814\u7a76\u3053\u3068\u306f\u3058\u3081\uff0e\u6a2a\u6d5c\u5357\u90e8\u5730\u533a\u30e9\u30b8\u30aa\u30ed\u30b8\u30fc\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c\u6a2a\u6d5c\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14\uff1a\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad \u2500 \u4e3b\u306b\u5fc3\u81d3CT\u3068\u5fc3\u81d3MRI\u306e\u8996\u70b9\u304b\u3089\uff0e\u5317\u6d77\u9053\u5fc3\u81d3\u6838\u533b\u5b66\u30d5\u30a9\u30fc\u30e9\u30e0\uff08WEB\u958b\u50ac\uff09\uff0c\u6771\u4eac\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff1a\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff08\u4e2d\u67a2\u795e\u7d4c\u9818\u57df\uff1a\u4ee3\u8b1d\u5909\u6027\u75be\u60a3\u3092\u4e2d\u5fc3\u306b\uff09\uff0e\u6a2a\u6d5c\u5357\u90e8\u5730\u533a\u30e9\u30b8\u30aa\u30ed\u30b8\u30fc\u8b1b\u6f14\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c\u6a2a\u6d5c\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u85e4\u771f\u543e\uff1aJournal of Cardiovascular Magnetic Resonance Gold Star Reviewer Award\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u653e\u5c04\u7dda\u8a3a\u65ad\u533b\u3068\u306f\uff0e\u307f\u3093\u306a\u306e\u5065\u5eb7\u30e9\u30b8\u30aa\uff0c\u30e9\u30b8\u30aa\u65e5\u672c\uff0c2020\uff0c11\uff0e<\/dd>\n<dd>\u95a2\u5ddd\u5584\u4e8c\u90ce\uff1a\u653e\u5c04\u7dda\u8a3a\u65ad\u533b\u306e\u4ed5\u4e8b\uff0e\u307f\u3093\u306a\u306e\u5065\u5eb7\u30e9\u30b8\u30aa\uff0c\u30e9\u30b8\u30aa\u65e5\u672c\uff0c2020\uff0c12\uff0e<\/dd>\n<dd>\u9752\u6728\u3000\u4eae\uff1a\u30ec\u30f3\u30c8\u30b2\u30f3\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u512a\u79c0\u8cde\uff0e\u7b2c39\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73\uff1a\u79fb\u690d\u5f8c\u30ea\u30f3\u30d1\u5897\u6b96\u6027\u75be\u60a3\u306e1 \u4f8b\uff0e\u5c0f\u7530\u6025X\u7dda\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff0c\u795e\u5948\u5ddd\uff0c2020\uff0c12\uff0e<\/dd>\n<dd>\u5c71\u672c\u5f25\u751f\uff1a\u73cd\u3057\u3044\u7d44\u7e54\u578b\u306e\u4e73\u764c\u306e\u753b\u50cf\u8a3a\u65ad\u3000\u75c5\u7406\u50cf\u3068\u5bfe\u6bd4\u3055\u305b\u3066\uff0e\u6a2a\u6d5c\u4e73\u817a\u753b\u50cf\u8a3a\u65ad\u52c9\u5f37\u4f1a\uff0c\u795e\u5948\u5ddd\uff0c2020\uff0c10\uff0e<\/dd>\n<dd>\u91ce\u6ca2\u4e45\u7f8e\u5b50\uff1a\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff1a\u795e\u7d4c\u82bd\u816b\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c33\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5c02\u9580\u533b\u4f1a\u30fb\u533b\u4f1a\u30df\u30c3\u30c9\u30a6\u30a3\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc\uff0c\u798f\u5ca1\uff0c2020\uff0c1\uff0e<\/dd>\n<dd>\u91ce\u6ca2\u4e45\u7f8e\u5b50\uff1a\u816b\u760d\u6027\u75be\u60a3\u306b\u4f34\u3046\u6551\u6025\u306e\u753b\u50cf\u8a3a\u65ad\uff08Oncologic emergency\uff09\uff0e\u7b2c17\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc\uff0c\u6771\u4eac\uff0c2020\uff0c2\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5b9a\u91cf\u7684\u8a55\u4fa1\u304c\u62d3\u304f\u65b0\u3057\u3044MRI\u8a3a\u65ad\u306e\u53ef\u80fd\u6027\uff0e\u7b2c48\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff08WEB\u958b\u50ac\uff09\uff0c2020\uff0c9-10\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u8133\u306e\u753b\u50cf\u8a3a\u65ad\uff1aPediatric Neuroradiology\u3092\u697d\u3057\u3082\u3046\uff0e\u7b2c188\u56de\u7b51\u5f8cCT\u30fbMRI\u7814\u7a76\u4f1a\uff0c\u4e45\u7559\u7c73\uff0c2020\uff0c11\uff0e<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Iizuka H, Yokota Y, Kidoh M, Oda S, Ikeda O, Tamura Y, Funama Y,\u3000Sakabe D, Nakaura T, Yamashita Y, Utsunomiya D: Contrast Enhancement Boost Technique at Aortic Computed Tomography Angiography: Added Value for the Evaluation of Type II Endoleaks After Endovascular Aortic Aneurysm Repair. Acad Radiol, 26(11): 1435-1440, 2019.<\/dd>\n<dd>Tsurusaki Y, Kuroda Y, Yamanouchi Y, Kondo E, Ouchi K, Kimura Y, Enomoto Y, Aida N, Masuno M, Kurosawa K.Tsurusaki Y, et al\uff1aNovel \/USP9X\/ variants in two patients with X-linked intellectual disability, Hum Genome Var,6:49,2019\uff0e<\/dd>\n<dd>Ohashi I, Enomoto Y, Naruto T, Tsurusaki Y, Kuroda Y, Ishikawa H, Ohyama M, Aida N, Nishimura G, Kurosawa K.Ohashi I, et al: A severe form of Ellis-van Creveld syndrome caused by novel mutations in \/EVC2\/, Hum Genome Var,6:40,2019\uff0e<\/dd>\n<dd>Nozawa K, Niwa T, Aida N.Nozawa K, et al: Imaging of Cystic Lung Lesions in Infants Using Pointwise Encoding Time Reduction with Radial Acquisition (PETRA), Magn Reson Med Sci,18(4):299-300,2019\uff0e<\/dd>\n<dd>Tulyeu J, Tamaura M, Jimbo E, Shimbo H, Takano K, Iai M, Yamashita S, Goto T, Aida N, Tokuhiro E, Yamagata T, Osaka H.Tulyeu J, et al: Aggregate formation analysis of GFAP^R416W found in one case of Alexander disease, Brain Dev. 41(2):195-200,2019\uff0e<\/dd>\n<dd>Ichikawa K, Tsuji M, Tsuyusaki Y, Tomiyasu M, Aida N, Goto T: Serial Magnetic Resonance Imaging and (1)H-Magnetic Resonance Spectroscopy in GABA Transaminase Deficiency, A Case Report. JIMD Rep. 43:7-12,2019\uff0e<\/dd>\n<dd>Nakagawa M, Nakaura T, Namimoto T, Iyama Y, Kidoh M, Hirata K, Nagayama Y, Yuki H, Oda S, Utsunomiya D, Yamashita Y: Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features. Acad Radiol, 26(10): 1390-1399, 2019.<\/dd>\n<dd>Oda S, Nakaura T, Utsunomiya D, Hirakawa K, Takashio S, Izumiya Y, Tsujita K, Kawano Y, Okuno Y, Hata H, Matsuoka M, Yamashita T, Ueda M, Ando Y, Yamashita Y: Clinical potential of dual-energy cardiac CT in cardiac amyloidosis. Amyloid, 26(sup1): 91-92, 2019.<\/dd>\n<dd>Oda S, Takashio S, Nagamatsu S, Yamashita T, Uchimura R, Kidoh M, Utsunomiya D, Nakaura T, Tsujita K, Yamashita Y: Myocardial extracellular volume quantification using CT for the identification of occult cardiac amyloidosis in patients with severe aortic stenosis referred for transcatheter aortic valve replacement. Amyloid, 26(2): 97-98, 2019.<\/dd>\n<dd>Oda S, Takaoka H, Katahira K, Honda K, Nakaura T, Nagayama Y, Taguchi N, Kidoh M, Utsunomiya D, Funama Y, Noda K, Oshima S, Yamashita Y: Low contrast material dose coronary computed tomographic angiography using a dual-layer spectral detector system in patients at risk for contrast-induced nephropathy. Br J Radiol, 92(1094):20180215, 2019.<\/dd>\n<dd>Marume K, Takashio S, Nishi M, Hirakawa K, Yamamoto M, Hanatani S, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Sakamoto K, Yamamoto E, Kaikita K, Izumiya Y, Yamashita Y, Ando Y, Tsujita K: Combination of commonly examined parameters is a useful predictor of positive99 mtc-labeled pyrophosphate scintigraphy findings in elderly patients with suspected transthyretin cardiac amyloidosis. Circ J, 83(8): 1698-1708, 2019.<\/dd>\n<dd>Hirakawa K, Takashio S, Marume K, Yamamoto M, Hanatani S, Yamamoto E, Sakamoto K, Izumiya Y, Kaikita K, Oda S, Utsunomiya D, Shiraishi S, Ueda M, Yamashita T, Yamashita Y, Ando Y, Tsujita K: Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis. ESC Hear Fail, 6(1): 122-130, 2019.<\/dd>\n<dd>Iyama A, Nakaura T, Iyama Y, Kidoh M, Nagayama Y, Oda S, Utsunomiya D, Namimoto T, Morita K, Yuba K, Yamashita Y: Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI. Eur Radiol, 29(4): 2009-2016, 2019.<\/dd>\n<dd>Nagayama Y, Iyama A, Oda S, Taguchi N, Nakaura T, Utsunomiya D, Kikuchi Y, Yamashita Y: Dual-layer dual-energy computed tomography for the assessment of hypovascular hepatic metastases: impact of closing k-edge on image quality and lesion detectability. Eur Radiol, 29(6): 2837-2847, 2019.<\/dd>\n<dd>Nagayama Y, Nakamura N, Itatani R, Oda S, Kusunoki S, Takahashi H, Nakaura T, Utsunomiya D, Yamashita Y: Epicardial fat volume measured on nongated chest CT is a predictor of coronary artery disease. Eur Radiol, 29(7): 3638-3646, 2019.<\/dd>\n<dd>Nagayama Y, Tanoue S, Inoue T, Oda S, Nakaura T, Utsunomiya D, Yamashita Y: Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma. Eur Radiol, 30(1): 394-403, 2019.<\/dd>\n<dd>Kato S, Fukui K, Saigusa Y, Kubota K, Kodama S, Asahina N, Hayakawa K, Iguchi K, Fukuoka M, Iwasawa T, Utsunomiya D, Kosuge M, Kimura K, Tamura K: Coronary Flow Reserve by Cardiac Magnetic Resonance Imaging in Patients With Diabetes Mellitus. JACC Cardiovasc Imaging, 12(12): 2579-2580, 2019.<\/dd>\n<dd>Kato S, Iwasaki A, Kurita Y, Arimoto J, Yamamoto T, Hasegawa S, Sato T, Imajo K, Hosono K, Kobayashi N, Yoneda M, Higurashi T, Kubota K, Utsunomiya D, Nakajima A: Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility. PLoS One, 14(12): e0224921, 2019.<\/dd>\n<dd>Yuki H, Arima Y, Utsunomiya D, Fujisue K, Kidoh M, Oda S, Nakaura T, Yamashita Y, Tsujita K: Coronary arterial microfistulae with meandering dilated coronary arteries and noncompaction-like myocardium. Cardiol J, 26(1): 95-96, 2019.<\/dd>\n<dd>Sueta D, Oda S, Yamamoto E, Nishi M, Kaikita K, Kidoh M, Utsunomiya D, Nakaura T, Yamashita Y, Tsujita K: Takotsubo cardiomyopathy mimicking acute coronary syndrome \u2015 Extracellular volume quantification using cardiac computed tomography \u2015. Circ J, 83(7): 1613, 2019.<\/dd>\n<dd>Sueta D, Oda S, Izumiya Y, Kaikita K, Kidoh M, Utsunomiya D, Yamashita Y, Tsujita K: Comprehensive assessment of takotsubo cardiomyopathy by cardiac computed tomography. Emerg Radiol, 26(1): 109-112, 2019.<\/dd>\n<dd>Kidoh M, Oda S, Utsunomiya D, Emoto T, Nakaura T, Nagayama Y, Yamamoto M, Sakamoto K, Yamamoto E, Kaikita K, Tsujita K, Yamashita Y: Basal septal perforator vein mimicking the \u201clate iodine enhancement\u201d in delayed phase cardiac CT for myocardial scar assessment. Radiol Case Reports, 14(5): 588-590, 2019.<\/dd>\n<dd>Oda S, Kawano Y, Okuno Y, Utsunomiya D, Nakaura T, Tsujita K, Yamashita Y: Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis. Radiol Case Reports, 14(1): 72-74, 2019.<\/dd>\n<dd>Handa A, Nozaki T, Makidono A, Okabe T, Morita Y, Fujita K, Matsusako M, Kono T, Kurihara Y, Hasegawa D, Kumamoto T, Ogawa C, Yuza Y, Manabe A: Pediatric oncologic emergencies: Clinical and imaging review for pediatricians. Pediatr Int, 61(2):122-139, 2019.<\/dd>\n<dd>Iizuka H, Daisaki H, Ogawa M, Yoshida K, Kaneta T: Harmonization of standardized uptake values between two scanners, considering repeatability and magnitude of the values in clinical fluorine-18-fluorodeoxyglucose PET settings: a phantom study. Nucl Med Commun, 40(8):857-864, 2019.<\/dd>\n<dd>Koike Y, Matsui S, Takase K, Tannai H: CT-Guided Percutaneous Needle Biopsy in Patients with Suspected Retroperitoneal Fibrosis: A Retrospective Cohort Study. Cardiovasc Intervent Radiol, 42(10):1434-1440, 2019<\/dd>\n<dd>Koike Y, Kawahara Y, Kiss B, Tannai H, Matsui S: Single-Administration Hepatic Arterial Infusion Chemotherapy Using Steerable Microcatheter Alone through Outer Cannula of 18-Gauge Needle: A Preliminary Study.J Vasc Interv Radiol, 30(3):471-473, 2019<\/dd>\n<dd>Fujisawa, T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, Iwasawa T, Matsushita S, Sugiura H, Hashisako M, Tanaka T, Terasaki Y, Kunugi S, Kitani M, Okuda R, Horiike Y, Enomoto Y, Yasui H, Hozumi H, Suzuki Y, Nakamura Y, Fukuoka J, Johkoh T, Kondoh Y, Ogura T, Inoue Y, Hasegawa Y, Inase N, Homma S, Suda T\uff1aNationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion\uff0eEur Respir J\uff0c53(5)\uff1a1802243\uff0c2019\uff0e\uff44oi\uff1a10.1183\/13993003.02243-2018\uff0e<\/dd>\n<dd>Sekine A, Satoh H, Ikeda S, Oda T, Okudela K, Iwasawa T, Ogura T\uff1aRapid effect of osimertinib re-challenge on brain metastases developing during salvage cytotoxic chemotherapy after osimertinib treatment failure\uff0eA case report Mol Clin Oncol, 10(4)\uff1a451-453\uff0c2019\uff0e\uff44oi\uff1a10.3892\/mco.2019.1818. Epub 2019.<\/dd>\n<dd>Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, and Ogura T\uff1aNegative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis\uff0eBMC Pulm Med\uff0c 19(1)\uff1a78\uff0c2019\uff0e doi: 10.1186\/s12890-019-0841-7.<\/dd>\n<dd>Yamakawa H, Hagiwara E, Ikeda S, Iwasawa T, Otoshi R, Tabata E, Okuda R, Sekine A, Baba T, Iso S, Okudela K, Takemura T, Ogura T\uff1aEvaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia\uff0eRespir Investig\uff0c57(5):422-429\uff0c2019\uff0edoi: 10.1016\/j.resinv.2019.03.006. Epub 2019\uff0e<\/dd>\n<dd>Iwasawa T, Okudela K, Takemura T, Fukuda T, Matsushita S, Baba T, Ogura T, Tajiri M, Yoshizawa A\uff1aComputer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival\uff0eRadiology\uff0c292(2):489-498\uff0c2019\uff0e doi: 10.1148\/radiol.2019182466. Epub 2019\uff0e<\/dd>\n<dd>Chino H, Sekine A, Baba T, Kitamura H, Iwasawa T, Okudela K, Takemura T, Itoh H, Sato S, Suzuki Y, Ogura T\uff1aInterstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity.Intern Med\uff0c58(18)\uff1a2605-2613\uff0c2019\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>Ogura T, Takigawa N, Tomii K, Kishi K, Inoue Y, Ichihara E, Homma S, Takahashi K, Akamatsu H, Ikeda S, Inase N, Iwasawa T, Ohe Y, Ohta H, Onishi H, Okamoto I, Ogawa K, Kasahara K, Karata H, Kishimoto T, Kitamura Y, Gemma A, Kenmotsu H, Sakashita H, Sakamoto S, Sekine K, Takiguchi Y, Tada Y, Toyooka S, Nakayama Y, Nishioka Y, Hagiwara K, Hanibuchi M, Fukuoka J, Minegishi Y, Yanagihara T, Yamamoto N, Yamamoto H, Gaga M, Fong KM, Powell CA, Kiura K\uff1aSummary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia\uff0eDLD\/TOAssemblies of JRS Respir Investig, 57(6):512-533,2019.<\/dd>\n<dd>doi:10.1016\/j.resinv.2019.06.001.Epub 2019.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u9593\u8cea\u6027\u80ba\u708e(IPF\/UIP)\u56fd\u969b\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u6539\u8a02\u306b\u3088\u308b\u753b\u50cf\u5206\u985e\u306e\u5909\u66f4\uff0e\u753b\u50cf\u8a3a\u65ad\uff0c\u300039 (8)\uff1a938-949\uff0c2019\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u9593\u8cea\u6027\u80ba\u708e\uff1a\u8a3a\u65ad\u53ef\u80fd\u306a\u521d\u671f\u50cf\u3092\u3068\u3089\u3048\u308b\uff0e\u81e8\u5e8a\u753b\u50cf\uff0c35 (12) 1384-1394\uff0c2019\uff0e<\/dd>\n<dd>\u65e5\u91ce\u5f69\u5b50\uff1a\u5c0f\u5150\u30fb\u708e\u75c7\u6027\u75be\u60a3\u306b\u304a\u3051\u308bFDG\u2013PET\u306e\u6709\u7528\u6027. \u81e8\u5e8a\u753b\u50cf. 35\uff088\uff09\uff1a918-924, 2019\uff0e<\/dd>\n<dd>\u6afb\u6797\u90c1\u4e4b\u4ecb\uff0c\u96eb\u77f3\u4e00\u4e5f\uff1a\u672a\u75c5\u306e\u898b\u3048\u308b\u5316-\u672a\u75c5\u3092\u8a08\u308b. Cefiro, 30\uff1a45-50, 2019\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Iizuka H, Yoshida K, Okabe T, Terauchi M, Fujita R, Hirai C, Nomura K, Kamide H, Ishiwata Y, Kaneta T: Von Hippel Lindau disease: A pictorial review. ECR 2019\uff0cVienna, 2019, 2.<\/dd>\n<dd>Aida N\uff1a\u00b9H-MRS in neonatal HIE. 2019 Miyazaki Phoenix Neuroimaging Conference, Miyazaki\uff0c2019\uff0c3\uff0e<\/dd>\n<dd>Aida N\uff1a\u00b9H-MR Spectroscopy for the Pediatric brain\uff0eTHE 7th INTERNATIONAL CONGRESS ON MADNETIC RESONANCE IMAGING &amp; 24th ANNUAL SCIENTIFIC MEETING OF KSMRM\uff0c Seoul, 2019\uff0c3\uff0e<\/dd>\n<dd>Aida N\uff1aClinical Application of Neuroradiologic Techniques for Neonates\uff0e The 23th Annual &amp; Scientific Meeting of Taiwan Child Neurology Society\uff0cTaipei\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>Aida N\uff1aMRI\/MRS in Early Development Brain and CNS Disorders\uff0eThe 23th Annual &amp; Scientific Meeting of Taiwan Child Neurology Society\uff0c Taipei\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>Hirose A, Shibasaki J, Tomiyasu M, Kumaki T, Tsuyusaki Y, Goto T, Aida N: Glycine measurement using short and long echo time proton magnetic resonance spectroscopy in a neonate with nonketotic hyperglycinemia. The 20th Annual Meeting of Infantile Seizure Society, Nagoya\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>Aida N\uff1aCortical malformation of the brain:Imaging and topics. 19th Annual Scientific Meeting of Asian and Oceanic Society for Paediatric Radiology, Seoul\uff0c2019\uff0c9\uff0e<\/dd>\n<dd>Aida N\uff1aYour JFR: How to perform pediatric MRI in 2019\u3010Best practices in pediatric brain MRI\u3011\uff0eJournees\u3000Francophones de Radiologie 2019\uff0c Paris\uff0c2019\uff0c10\uff0e<\/dd>\n<dd>Iwasawa T, Ito H, Takemura T, Baba T, and Ogura T\uff1aRadiological-pathological correlation in diffuse lung diseases using ultra-high-resolution computed tomography\uff0eMiller\u2019s to Reid\u2019s lobule\uff0cChicago\uff0c2019\uff0c11-12\uff0e<\/dd>\n<dd>\u77f3\u6e21\u7fa9\u4e4b: \u62bc\u3055\u3048\u3066\u304a\u304d\u305f\u3044\u753b\u50cf\u6240\u898b. \u795e\u5948\u5ddd\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u8853\u8b1b\u7fd2\u4f1a, \u795e\u5948\u5ddd, 2019, 1.<\/dd>\n<dd>\u5b89\u7530\u5c1a\u53f2, \u77f3\u6e21\u7fa9\u4e4b, \u98ef\u585a\u5747, \u4e0a\u51fa\u6d69\u4e4b, \u91ce\u6751\u5e78\u4e00\u90ce, \u5e73\u4e95\u5343\u88d5, \u85e4\u7530\u4eae, \u5bfa\u5185\u5e79, \u5ca1\u90e8\u54f2\u5f66, \u5409\u7530\u5553\u4ecb, \u91d1\u7530\u670b\u6d0b: FDG-PET\/CT\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u795e\u7d4c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\uff11\u4f8b. \u7b2c90\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a, \u6771\u4eac, 2019, 1.<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73, \u5ca9\u6fa4\u591a\u6075, \u8352\u4e95\u5b8f\u96c5, \u7530\u5c3b\u9053\u5f66\uff1a\u80ba\u56a2\u80de\u75c7\u306e4DCT\u306b\u3088\u308b\u89e3\u6790. \u7b2c11\u56de \u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2019, 1.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3MRI\u306e\u53ef\u80fd\u6027\u3068Dual energy CT\u3068\u306eTurf battle. \u7fa4\u99ac\u5fc3\u81d3MRI\u7814\u7a76\u4f1a, \u7fa4\u99ac, 2019, 2.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u9032\u3081\u65b9\uff1a\u5c0f\u5150\u533b\u7642\u306b\u95a2\u308f\u308b\u4eba\u306b\u77e5\u3063\u3066\u3044\u3066\u307b\u3057\u3044\u3053\u3068. \u7b2c16\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc\uff0c\u6771\u4eac\uff0c2019\uff0c2\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u9069\u6b63\u5316\u3068\u30ea\u30b9\u30af\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8\uff0e\u7b2c11\u56de\u653e\u5c04\u7dda\u6280\u5e2b\u533b\u7642\u5b89\u5168\u30bb\u30df\u30ca\u30fc\uff0c\u6771\u4eac\uff0c2019\uff0c2\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u3000\u8a3a\u65ad\u306e\u3059\u309d\u3081\uff5e\u75c7\u4f8b\u304b\u3089\u5b66\u3076\u767a\u751f\u3068\u89e3\u5256\uff0e\u7b2c48\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a\uff0c\u4e45\u7559\u7c73\uff0c2019\uff0c2\uff0e<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u306e\u8a3a\u65ad\uff0e<\/dd>\n<dd>\u6771\u4eac\u30002019\u5e742\u6708<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u718a\u6728\u9054\u90ce\uff0c\u9ed2\u6fa4\u5065\u53f8\uff1a NALCN\u907a\u4f1d\u5b50\u7570\u5e38\u306e2\u4f8b. \u7b2c48\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u4e45\u7559\u7c73, 2019\uff0c2\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u6025\u6027\u8133\u75c7\u30fb\u8133\u708e\u306a\u3069\u3092\u4e2d\u5fc3\u3068\u3059\u308b\u610f\u8b58\u969c\u5bb3\u3092\u304d\u305f\u3059\u75be\u60a3. \u7b2c16\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u6559\u80b2\u30bb\u30df\u30ca\u30fc, \u6771\u4eac, 2019, 2.<\/dd>\n<dd>\u5c0f\u5d8b\u5927\u5730:\u3000PowerPort\u3067\u306e\u9020\u5f71CT\u306e\u5b9f\u969b. \u30e1\u30c7\u30a3\u30b3\u30f3CV\u30dd\u30fc\u30c8\u30bb\u30df\u30ca\u30fc, \u6771\u4eac, 2019, 2.<\/dd>\n<dd>\u5c0f\u5d8b\u5927\u5730:\u3000PowerPort\u306eUS\u30ac\u30a4\u30c9\u4e0b\u7559\u7f6e. \u30e1\u30c7\u30a3\u30b3\u30f3CV\u30dd\u30fc\u30c8\u30bb\u30df\u30ca\u30fc, \u6771\u4eac, 2019, 2.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\u306e\u73fe\u72b6\u3068\u4eca\u5f8c. \u304b\u306a\u304c\u308fCT\u8b1b\u6f14\u4f1a, \u795e\u5948\u5ddd, 2019, 3.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5927\u52d5\u8108\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c38\u56de\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a, \u6771\u4eac, 2019, 3.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u306e\u8a3a\u65ad\uff0e\u65e5\u672c\u753b\u50cf\u533b\u5b66\u4f1a\uff0c\u6771\u4eac\uff0c2019\uff0c3\uff0e<\/dd>\n<dd>\u5c0f\u5d8b\u5927\u5730: \u80c6\u56a2\u764c\u3001\u809d\u6d78\u6f64\u306e\u305f\u3081\u306e\u809d\u90e8\u5206\u5207\u9664\u8853\u5f8c\u3001\u6025\u5909\u306b\u3066\u6b7b\u4ea1\u3057\u305f\u4e00\u4f8b. 2019\u5e74Ai\u51ac\u5b63\u75c7\u4f8b\u691c\u8a0e\u4f1a, \u6771\u4eac, 2019, 3.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u65b0\u305f\u306a\u5c55\u958b\uff08\u5fc3\u81d3CT\uff09. \u7b2c78\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff08\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff09, \u795e\u5948\u5ddd, 2019, 4.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u75c7\u4f8b\u691c\u8a0eACTA2\u7570\u5e38\u75c7. \u7b2c39\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7, \u540d\u8b77\uff0c2019\uff0c4\uff0e<\/dd>\n<dd>\u67f4\u5d0e\u6df3\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u68ee\u5d0e\u83dc\u7a42\uff0c\u5bcc\u5b89\u3082\u3088\u5b50\uff0c\u5c0f\u6fa4\u60a0\u91cc\uff0c\u8c4a\u5cf6\u52dd\u662d\uff1a\u8133\u30c0\u30e1\u30fc\u30b8\u306e\u5b9a\u91cf\uff1aMRS\u306b\u3088\u308b\u4f4e\u9178\u7d20\u6027\u865a\u8840\u6027\u8133\u75c7\u5f8c\u306e\u8133\u5185\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u306e\u7d4c\u6642\u7684\u5909\u5316 Changes in brain metabolite concentrations after HIE. \u7b2c122\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u91d1\u6ca2\uff0c2019\uff0c4\uff0e<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73, \u798f\u7530\u5927\u8a18, \u677e\u4e0b\u5f70\u4e00\u90ce, \u5ca9\u6fa4\u591a\u6075, \u5c0f\u5009\u9ad8\u5fd7\uff1a\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u8d85\u9ad8\u7cbe\u7d30CT\u306b\u304a\u3051\u308bDeep Learning based Reconstruction\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e. \u7b2c78\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a, \u6a2a\u6d5c, 2019, 4\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\uff1aMRI\u3068\u306eturf battle. \u7b2c27\u56de\u672d\u5e4cHeart Imaging Club, \u5317\u6d77\u9053, 2019, 5.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14:\u5fc3\u81d3\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u9032\u6b69 &#8211; \u57fa\u790e\u304b\u3089\u6a5f\u68b0\u5b66\u7fd2\u30fbDeep learning\u306e\u5fdc\u7528\u306b\u3064\u3044\u3066. AIMS Cardiac Imaging 2019, \u6771\u4eac, 2019, 5.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u308b\u5c0f\u5150\u8650\u5f85\uff0e\u718a\u672c\u5927\u5b66\u533b\u5b66\u90e8\u8b1b\u7fa9\uff0c\u718a\u672c\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>\u85e4\u7530\u4eae\uff1a\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1a\u300c\u6b21\u4e16\u4ee3\u306e\u3044\u306e\u3061\u3092\u5b88\u308b\u306b\u306f\u300d\uff0e\u6b7b\u56e0\u7a76\u660e\u5b66\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u300c\u6b21\u4e16\u4ee3\u306e\u3044\u306e\u3061\u3092\u5b88\u308b\uff5e\u30a2\u30ab\u30c7\u30df\u30a2\u304b\u3089\u306e\u6311\u6226\u300d\uff0c\u5927\u962a\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>\u4e39\u5185\u5553\u5141, \u5c0f\u6c60\u7950\u54c9, \u6cb3\u539f\u60a0\u4e00\u90ce, \u677e\u4e95\u9752\u53f2, \u7267\u7530\u5e78\u4e09, \u661f\u91ce\u826f\u670b, \u5ee3\u702c\u73b2, \u6d32\u4e4b\u5185\u5c2d, \u4e45\u4fdd\u6674\u4e38, \u6842\u5ddd\u7fd4, \u5e02\u5ddd\u96c5\u5927, \u4e2d\u4e95\u4e00\u8cb4, \u6edd\u53e3\u670b\u5b50, \u9f4b\u85e4\u6df3: \u8907\u6570\u56de\u306e\u526f\u814e\u9759\u8108\u30b5\u30f3\u30d7\u30ea\u30f3\u30b0\u3092\u8981\u3057\u305f14\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c48\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a,\u798f\u5ca1, 2019, 5.\u512a\u79c0\u30dd\u30b9\u30bf\u30fc\u8cde\uff08\u9285\u8cde\uff09<\/dd>\n<dd>\u9732\ufa11\u60a0\uff0c\u4e95\u5408\u745e\u6c5f\uff0c\u9db4\u5d0e\u7f8e\u5fb3\uff0c\u6751\u4e0a\u535a\u662d\uff0c\u9ed2\u6fa4\u5065\u53f8\uff0c\u65b0\u5b85\u6cbb\u592b\uff0c\u897f\u5c0f\u68ee\u9686\u592a\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u84b2\u3072\u304b\u308a\uff0c\u718a\u6728\u9054\u90ce\uff1a\u3082\u3084\u3082\u3084\u75c5\u3092\u4f34\u3063\u305fIFIH1\u907a\u4f1d\u5b50R720Q\u5909\u7570\u306b\u3088\u308bAicardi Goutieres\u75c7\u5019\u7fa4\u306e1\u4f8b\uff0e\u7b2c61\u56de\u65e5\u672c\u5c0f\u5150\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u540d\u53e4\u5c4b\uff0c2019\uff0c5\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14:\u5fc3\u81d3CT\u306e\u9032\u6b69\uff1a\u5fc3\u81d3MRI\u3068\u306eturf battle. \u7b2c455\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a(\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc), \u795e\u5948\u5ddd, 2019, 6.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u795e\u7d4c\u753b\u50cf\u8a3a\u65ad\u306e\u8003\u3048\u65b9\u3068\u9032\u3081\u65b9. \u5c0f\u5150\u795e\u7d4c\u5916\u79d1\u6559\u80b2\u30bb\u30df\u30ca\u30fc2019\uff0c\u65b0\u6f5f\uff0c2019\uff0c6\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u9032\u3081\u65b9\u3068\u8003\u3048\u65b9\uff0e\u7b2c49\u56de\u4f50\u8cc0CT\u30fbMRI\u7814\u7a76\u4f1a\uff0c\u4f50\u8cc0\uff0c2019\uff0c6\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u653e\u5c04\u7dda\u306e\u4eca\u3068\u672a\u6765\uff0e\u7b2c55\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u795e\u6238\uff0c2019\uff0c6\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u4e2d\u8133\u6c34\u9053\u72ed\u7a84\u3067\u767a\u75c7\u3057\u3001\u6025\u901f\u5897\u5927\u3057\u305f\u7b2c3\u8133\u5ba4\u5185\u80da\u7d30\u80de\u816b\u760d\u306e2\u4f8b. \u7b2c55\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u795e\u6238, 2019, 6.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306b\u304a\u3051\u308b\u533b\u7642\u5b89\u5168\u3000\u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u305f\u5c0f\u5150\u8650\u5f85\uff06\u88ab\u3070\u304f\u4f4e\u6e1b\u5bfe\u7b56\uff0e \u4ee4\u548c\u5143\u5e74\u5ea6\u7b2c1\u56de\u6a2a\u6d5c\u5e02\u533b\u7642\u5b89\u5168\u7814\u4fee\u4f1a\uff0c\u6a2a\u6d5c\uff0c2019\uff0c7\uff0e<\/dd>\n<dd>\u7af9\u7530\u667a\u9999, \u98ef\u585a\u5747, \u9752\u6728\u4eae, \u5c3e\u7530\u6e08\u592a\u90ce, \u6728\u85e4\u96c5\u6587, \u5b87\u90fd\u5bae\u5927\u8f14: \u975e\u9020\u5f713T MRCA\u306b\u304a\u3051\u308bDeep learning reconstruction (DLR): \u6b63\u5e38\u30dc\u30e9\u30f3\u30c6\u30a3\u30a210\u4f8b\u306e\u521d\u671f\u7d4c\u9a13. \u7b2c89\u56de\u5fc3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u6771\u4eac, 2019, 7.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5faa\u74b0\u5668\u75be\u60a3\u306e\u304a\u3055\u3048\u3066\u304a\u304d\u305f\u3044\u75be\u60a3\u3084\u30c6\u30af\u30cb\u30c3\u30af. \u7b2c189\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a\uff08\u7279\u5225\u8b1b\u6f14\uff09, \u798f\u5ca1, 2019, 7.<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5404\u9818\u57df\u7814\u7a76\u306e\u9032\u6b692: \u8108\u7ba1. Society of Advanced Medical Imaging (SAMI) 2019, \u5927\u962a, 2019, 7.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff1a\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\u306e\u57fa\u790e\uff0e\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc\u3000\uff0c\u90a3\u8987\uff0c2019\uff0c7\uff0e<\/dd>\n<dd>\u96eb\u77f3\u4e00\u4e5f\uff1a\u62bc\u3055\u3048\u3066\u304a\u304d\u305f\u3044FDG-PET\/CT\u306e\u57fa\u790e\u77e5\u8b58. JCR\u30df\u30c3\u30c9\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2019, \u795e\u6238, 2019, 7.<\/dd>\n<dd>\u85e4\u7530\u4eae\uff1a\u5973\u6027\u533b\u5e2b\u7b49\u306e\u30ad\u30e3\u30ea\u30a2\u652f\u63f4\u7b56\u306e\u5b9f\u614b\u3068\u30ad\u30e3\u30ea\u30a2\u958b\u767a\u306b\u3064\u3044\u3066\uff0e\u7b2c\uff15\uff11\u56de\u65e5\u672c\u533b\u5b66\u6559\u80b2\u5b66\u4f1a\uff0c\u4eac\u90fd\uff0c2019\uff0c\uff17\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u306e\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff1a\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af\u3092\u542b\u3081\u3066. \u7b2c24\u56de\u90e1\u5c71\u653e\u5c04\u7dda\u79d1\u52c9\u5f37\u4f1a, \u798f\u5cf6, 2019, 9.<\/dd>\n<dd>\u5bcc\u7530\u5f69\u9999\uff0c\u67f4\u5d0e\u6df3\uff0c\u5bcc\u5b89\u3082\u3088\u3053\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u8c4a\u5cf6\u52dd\u662d\uff1a\u65e9\u7523\u5150\u306b\u304a\u3051\u308b\u4e88\u5b9a\u65e5\u76f8\u5f53\u306e\u8133\u5185\u4ee3\u8b1d\u7269\u6fc3\u5ea6\u30686\u6b73\u6642\u77e5\u80fd\u691c\u67fb\uff08WISC-4\uff09\u306e\u95a2\u9023\u6027. \u7b2c47\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff0c\u718a\u672c\uff0c2019\uff0c9\uff0e<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73, \u5ca9\u6fa4\u591a\u6075, \u99ac\u5834\u667a\u5c1a, \u5c0f\u5009\u9ad8\u5fd7, \u6b66\u6751\u6c11\u5b50\uff1a\u80ba\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u3068\u6297ARS\u6297\u4f53\u75c7\u5019\u7fa4\u306e\u9593\u8cea\u6027\u80ba\u708e\u306e\u5408\u4f75\u304c\u7591\u308f\u308c\u305f1\u4f8b. \u7b2c33\u56de \u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u540d\u53e4\u5c4b, 2019, 10\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1a\u5c0f\u5150\u8650\u5f85\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c55\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u611b\u77e5\uff0c2019\uff0c10\uff0e<\/dd>\n<dd>\u4e39\u5185\u5553\u5141\uff0c\u85e4\u4e95\u88d5\u592a\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u7530\u548c\u4fca\uff0c\u4e39\u7fbd\u5fb9\uff0c\u4f50\u85e4\u535a\u4fe1\uff1a\u4e2d\u8133\u6c34\u9053\u72ed\u7a84\u3067\u767a\u75c7\u3057\u3001\u6025\u901f\u5897\u5927\u3057\u305f\u7b2c3\u8133\u5ba4\u5185\u80da\u7d30\u80de\u816b\u760d\u306e2\u4f8b\uff0e\u7b2c14\u56de\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u6771\u4eac\uff0c2019\uff0c10\uff0e<\/dd>\n<dd>\u89d2\u8c37\u5609\u4eae\uff0c\u4e39\u5185\u5553\u5141, \u6e21\u8fba\u6d0b\u5fd7, \u8ca0\u9580\u514b\u5178, \u7530\u4e2d\u5b8f\u5b50, \u677e\u679d\u6e05, \u6587\u654f\u666f, \u5965\u6751\u6804, \u4e8c\u5bae\u6d69\u7bc4, \u77f3\u5ddd\u96c4\u4e00\uff1a\u5145\u5b9f\u6210\u5206\u5185\u306b\u9aa8\u5316\u3092\u5f62\u6210\u3057\u305f\u5fae\u5c11\u6d78\u6f64\u817a\u764c\u306b\u7532\u72b6\u817a\u764c\u8ee2\u79fb\u304c\u816b\u760d\u5185\u7136\u79fb\u3092\u304d\u305f\u3057\u305f1\u4f8b\uff0e\u7b2c55\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u540d\u53e4\u5c4b. 2019, 10\uff0e<\/dd>\n<dd>\u4e39\u5185\u5553\u5141\uff0c\u85e4\u4e95\u88d5\u592a, \u76f8\u7530\u5178\u5b50, \u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u85e4\u7530\u548c\u4fca,\u3000\u4e39\u7fbd\u5fb9, \u4f50\u85e4\u535a\u4fe1\uff1a\u4e2d\u8133\u6c34\u9053\u72ed\u7a84\u3067\u767a\u75c7\u3057\u3001\u6025\u901f\u5897\u5927\u3057\u305f\u7b2c3\u8133\u5ba4\u5185\u80da\u7d30\u80de\u816b\u760d\u306e2\u4f8b\uff0e\u7b2c14\u56de\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff0c\u6771\u4eac, 2019, 10\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3\u306e\u5f62\u614b\u8a3a\u65ad\u3068\u6a5f\u80fd\u8a3a\u65ad\uff1aCT\u306f\u865a\u8840\u8a3a\u65ad\u306b\u3069\u3053\u307e\u3067\u8feb\u308c\u308b\u304b\uff0e\u7b2c59\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a(\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc), \u611b\u5a9b, 2019, 11\uff0e<\/dd>\n<dd>\u5b87\u90fd\u5bae\u5927\u8f14: \u5fc3\u81d3CT\u306e\u81e8\u5e8a\uff1a\u57fa\u790e\u304b\u3089\u6700\u8fd1\u306e\u30c8\u30d4\u30c3\u30af CT-FFR\u3001CT\u9045\u5ef6\u9020\u5f71\u307e\u3067. \u7b2c423\u56de\u795e\u5948\u5ddd\u6838\u533b\u5b66\u7814\u7a76\u4f1a\u5275\u7acb50\u5468\u5e74\u8a18\u5ff5\u5927\u4f1a, \u795e\u5948\u5ddd, 2019, 11\uff0e<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb\uff0c\u5c0f\u6c60\u7e41\u81e3\uff0c\u5cb8\u672c\u771f\u7531\u5b50\uff0c\u9ebb\u751f\u771f\u4e8c\u90ce\uff0c\u5c71\u672c\u7d71\uff0c\u98ef\u585a\u5747\uff0c\u65e5\u6bd4\u8c37\u5b5d\u5fd7\uff0c\u5b87\u90fd\u5bae\u5927\u8f14\uff1aCT\u306b\u3066\u8102\u80aa\u6fc3\u5ea6\u3092\u542b\u3093\u3060\u809d\u7d30\u80de\u764c\u80ba\u8ee2\u79fb\u306e1\u4f8b.\u7b2c456\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2019\uff0c12\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff1aPediatric Neuroradiology is fun!-Advanced MRI\u306e\u81e8\u5e8a\u5fdc\u7528-\uff0e\u5927\u5206\u770c\u653e\u5c04\u7dda\u79d1\u533b\u306e\u4f1a\uff0c \u5927\u5206\uff0c2019\uff0c11\uff0e<\/dd>\n<dd>\u5800\u6c5f\u6167\u4e00, \u963f\u90e8\u793c, \u5b87\u6d25\u6728\u7fd4\u5e73, \u5b89\u85e4\u548c\u592b, \u9f4a\u85e4\u516c\u5f66, \u7af9\u6797\u8302\u751f\uff1a\u4e2d\u8133\u6897\u585e\u69d8\u75c7\u72b6\u3067\u6551\u6025\u5916\u6765\u3092\u53d7\u8a3a\u3057\u3001\u7cbe\u67fb\u306e\u7d50\u679c\u6210\u4eba\u578b\u30a2\u30ec\u30ad\u30b5\u30f3\u30c0\u30fc\u75c5\u3068\u5224\u660e\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c456\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a, \u6771\u4eac, 2019\uff0c12\uff0e<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587\uff1a\u75c7\u4f8b\u5831\u544a\u3092\u542b\u3080<\/h3>\n<\/dt>\n<dd>Okabe T, Nozaki T, Aida N, Starkey J, Enokizono M, Niwa T, Handa A, Numaguchi Y, Kurihara Y: MR imaging findings in some rare neurological complications of paediatric cancer. Insights Imaging, 9(3): 313-324, 2018.<\/dd>\n<dd>Aoki R, Sekikawa Z, Nishii T, Yamamoto T, Miyoshi Y, Takebayashi S: Two cases requiring nephrectomy in long-term follow-up of sporadic angiomyolipoma after transarterial ethanol ablation. Edorium J Radiol 2018, 4: doi:10.5348\/100009R02RA2018CS, 2018.<\/dd>\n<dd>Shibasaki J, Aida N, Morisaki N, Tomiyasu M, Nishi Y, Toyoshima K: Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy. Radiology, 288(3): 840-848, 2018.<\/dd>\n<dd>Sato Y, Shibasaki J, Aida N, Hiiragi K, Kimura Y, Akahira-Azuma M, Enomoto Y, Tsurusaki Y, Kurosawa K: Novel COL4A1 mutation in a fetus with early prenatal onset of schizencephaly. Hum Genome Var, 5(4): doi: 10.1038\/s41439-018-0005-y, 2018.<\/dd>\n<dd>Enomoto Y, Tsurusaki Y, Harada N, Aida N, Kurosawa K: Novel AMER1 frameshift mutation in a girl with osteopathia striata with cranial sclerosis. Congenit Anom (Kyoto), 58(4):145-146, 2018.<\/dd>\n<dd>Ikeda S, Sekine A, Baba T, Katano T, Yamakawa H, Oda T, Iwasawa T, Matsumura M, Takemura T, Ogura T: Secondary pulmonary alveolar proteinosis predominant in the transplanted lung in patients with idiopathic interstitial pneumonia: an autopsy case. J Thorac Dis, 10(5): E351-E354, 2018.<\/dd>\n<dd>Yamakawa H, Hagiwara E, Iwasawa T, Otoshi R, Tabata E, Ikeda S, Okuda R, Baba T, Iso S, Okudela K, Takemura T, Sato S, and Ogura T: Interstitial lung disease associated with anti-citrullinated peptide\/protein antibody-positive anti-synthetase syndrome. J Thorac Dis, 10(10): 5924-5931, 2018.<\/dd>\n<dd>Sekine A, Katano T, Oda T, Ikeda S, Iwasawa T, Satoh H, Kataoka T, Okudela K, Ogura T: Miliary lung metastases from non-small cell lung cancer with Exon 20 insertion: A dismal prognostic entity: A case report. Mol Clin Oncol, 9(6): 673-676, 2018.<\/dd>\n<dd>Yoshimoto M, Honda N, Kurihara H, Hiroi K, Nakamura S, Ito M, Shikano N, Itami J, Fujii H: Non-invasive estimation of 10 B-4-borono-L-phenylalanine-derived boron concentration in tumors by PET using 4-borono-2-18 F-fluoro-phenylalanine. Cancer Sci, 109(5): 1617-1626, 2018.<\/dd>\n<dd>Kurihara H: Integrated 64Cu therapy for the peritoneal dissemination of gastrointestinal cancer. Oncotarget, 9(58): 31165-31166, 2018.<\/dd>\n<dd>Morita T, Kurihara H, Hiroi K, Honda N, Igaki H, Hatazawa J, Arai Y, Itami J: Dynamic changes in 18F-borono-L-phenylalanine uptake in unresectable, advanced, or recurrent squamous cell carcinoma of the head and neck and malignant melanoma during boron neutron capture therapy patient selection. Radiat Oncol, 13(1): 4, 2018.<\/dd>\n<dd>Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T: Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts. Transl Oncol, 11(1): 24-30, 2018.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: 64Cu-ATSM\u3092\u7528\u3044\u305f\u6a19\u7684\u30a2\u30a4\u30bd\u30c8\u30fc\u30d7\u6cbb\u7642\u306e\u56fd\u5185\u958b\u767a. IMMERVISION, 33(11): 52-54, 2018.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>Iwasawa T, Takemura T, Ogura T: Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings. Jpn J Radiol, 36(3): 165-180, 2018.<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66, \u89d2\u7530\u535a\u5b50, \u5bae\u6ca2\u3000\u4eae, \u68ee\u4e0b\u6075\u7f8e\u5b50, \u6cbc\u53e3\u96c4\u6cbb, \u6817\u539f\u6cf0\u4e4b: \u8056\u8def\u52a0\u56fd\u969b\u75c5\u9662\u306b\u304a\u3051\u308b\u4e73\u764c\u773c\u90e8\u8ee2\u79fb11\u4f8b\u306e\u691c\u8a0e. \u81e8\u5e8a\u653e\u5c04\u7dda, 63(4): 443-448, 2018.<\/dd>\n<dd>\u5e73\u4e95\u5343\u88d5: CT\u306b\u3088\u308b\u8178\u9589\u585e\u8a3a\u65ad\u306e\u30dd\u30a4\u30f3\u30c8. \u533b\u5b66\u66f8\u9662, 73(7): 786-789, 2018.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u306e\u753b\u50cf\u691c\u67fb\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u88ab\u3070\u304f\u3092\u6e1b\u3089\u3059\u305f\u3081\u306b. \u81e8\u5e8a\u653e\u5c04\u7dda, 63(7): 747-749, 2018.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: 1H-MR\u30b9\u30da\u30af\u30c8\u30ed\u30b9\u30b3\u30d4\u30fc\uff08MRS). \u5c0f\u5150\u79d1\u8a3a\u7642 \u5225\u5237, 81(8): 975-981,2018.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u306e\u5fa1\u6cd5\u5ea6\u691c\u67fb, \u63a8\u5968\u691c\u67fb. \u753b\u50cf\u8a3a\u65ad, 38(14): 1419-1430, 2018.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca, \u76f8\u7530\u5178\u5b50: \u5927\u8133\u76ae\u8cea\u5f62\u6210\u7570\u5e38\uff08\u6ed1\u8133\u75c7\uff09Barkovich\u3089\u306b\u3088\u308b\u76ae\u8cea\u8133\u56de\u5f62\u6210\u7570\u5e38\u306e\u5206\u985e. \u753b\u50cf\u8a3a\u65ad, 38(\u5897\u520a\u53f711): A38-A41, 2018.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca, \u76f8\u7530\u5178\u5b50: \u305d\u306e\u4ed6\u306e\u5947\u5f62\uff08Chiari\u5947\u5f62, \u982d\u7624\uff09\u2460Chiari\u5947\u5f62\u306e\u5206\u985e\u2461Naidich\u3089\u306e\u982d\u7624\u306e\u5206\u985e. \u753b\u50cf\u8a3a\u65ad, 38(\u5897\u520a\u53f711): A42-A45, 2018.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca: \u5185\u8033\u5947\u5f62\u3000\u2460Jackler\u3089\u306e\u5206\u985e\u2461Sennaroglu\u3089\u306e\u8778\u725b\u524d\u5ead\u5947\u5f62\u306e\u5206\u985e. \u753b\u50cf\u8a3a\u65ad, 38(\u5897\u520a\u53f711): A62-A67, 2018.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u795e\u7d4c\u82bd\u816b\u3000IDRF\uff08INRGSS\u306e\u5206\u985e\uff09. \u753b\u50cf\u8a3a\u65ad, 38(\u5897\u520a\u53f711): A239-A243, 2018.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u7b49\u767a\u8868<\/h3>\n<\/dt>\n<dd>Takehara S, Iwasawa T, Baba T, Ogura T, Mari S: Oba\u00b3 Comparison of ultra-low-dose computed tomography (ULDCT) and standard-dose computed tomography (SDCT) for the detection of interstitial lung disease. European Congress of Radiology, Vienna, 2018, 3.<\/dd>\n<dd>Aida N, Tomiyasu M, Fujii Y, Ichikawa K, Tsuyusaki Y, Tsuji M, Goto T: Brain MRI and MRS finding in GABA metabolism disorders. Asia-Oseania Congress of Radiology Symposium Neuroradiologicum 2018, Taipei, 2018, 3.<\/dd>\n<dd>Ishiwata Y, Kaneta T, Nawata S, Iizuka H, Kamide H, Hirai C, Fujita R, Teruchi M, Okabe T, Hino-shishikura A, Yoshida K, Inoue T: Feasibility of prognosis assessment for cancer of unknown primary (CUP) using texture analysis of 18F-FDG PET\/CT. 12th Congress of the World Federation of Nuclear Medicine and Biology, Melbourne, 2018, 4.<\/dd>\n<dd>Kurihara H: Various accumulations of FBPA in the several kind of tumor pathologies. 12th Congress of the World Federation of Nuclear Medicine and Biology (\u30dd\u30b9\u30bf\u30fc), Melbourne, 2018, 4.<\/dd>\n<dd>Takehara S, Iwasawa T, Matsui K, Tsuchiya N, Murayama S, Ogura T: Computer-based Computed Tomography Analysis for Detecting Interstitial Lung Disease; A prospective study. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a, \u795e\u5948\u5ddd, 2018, 4.<\/dd>\n<dd>Kaki S, Sekikawa Z, Aoki R, Yamamoto T, Furugoori S, Takebayashi S: Huge renal angiomyolipoma with multiple aneurysms treated with staged transcatheter arterial embolization using N-butyl cyanoacrylate and microcoils. The 59th regular meeting of the Kanagawa prefecture general assembly of radiology, Yokohama, 2018, 10.<\/dd>\n<dd>Tannai H, Matsui S, Obara A.D, Kawahara Y, Koike Y, Sugisawa C, Suzuki A, Takiguchi T, Saito J: Segmental adrenal venous sampling is superior to diagnose aldosterone producing adenoma. The Annual meeting of Cardiovascular and Interventional Radiological Society of Europe (CIRSE), Lisbon, 2018, 10.<\/dd>\n<dd>Takehara S, Iwasawa T, Takemura T, Okudela K, Baba T, Ogura T: Computer-Aided Analysis of Progression of Idiopathic Pulmonary Fibrosis: Comparison of Pathological Findings. Scientific Assembly and Annual Meetings of Radiological Society of North America, Chicago, 2018, 11-12.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u304f\u653e\u5c04\u7dda\u79d1\u8a3a\u7642\u300c\u816b\u760d\u8a3a\u65ad\u306b\u304a\u3051\u308bPET\/MRI\u306e\u4f7f\u3044\u65b9\u300d. \u7b2c31\u56deJCR\u30df\u30c3\u30c9\u30a6\u30a3\u30f3\u30bf\u30fc\u30bb\u30df\u30ca\u30fc (\u6559\u80b2\u8b1b\u6f14), \u798f\u5ca1, 2018, 1.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a, \u76f8\u7530\u5178\u5b50, \u91ce\u6fa4\u4e45\u7f8e\u5b50, \u85e4\u7530\u548c\u4fca, \u5e73\u5c71\u9ebb\u5229\u5b50, \u5c71\u672c\u4e9c\u77e2\u5b50, \u5e02\u5ddd\u548c\u5fd7, \u5f8c\u85e4\u77e5\u82f1: \u7279\u5fb4\u7684MRI\u30fbMRS\u6240\u898b\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305fVigabatrin toxicity\u306b\u3088\u308b\u8133\u75c7\u306e1\u4f8b. \u7b2c47\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a, \u7b51\u6ce2, 2018, 2.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \uff23\uff34\u88ab\u3070\u304f\u4f4e\u6e1b\u6280\u8853\u3068\u6a5f\u80fd\u753b\u50cf\u3078\u306e\u5fdc\u7528. \u7b2c10\u56de\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a, \u5927\u962a, 2018, 2.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u65b0\u305f\u306a\u8a3a\u65ad\u57fa\u6e96\u3092\u8e0f\u307e\u3048\u305f\u7279\u767a\u6027\u80ba\u7dda\u7dad\u75c7\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c37\u56de\u753b\u50cf\u533b\u5b66\u4f1a, \u6771\u4eac, 2018, 2.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: New Frontiers of Fusion Imaging \u2013 Oncology. \u7b2c77\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0), \u6a2a\u6d5c, 2018, 4.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u6838\u533b\u5b66\u5c02\u9580\u533b\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u6838\u533b\u5b66\u6307\u5c0e\u8005\u30b3\u30fc\u30b9 \u816b\u760d\u6838\u533b\u5b66\uff08\u672c\u90a6\u306b\u304a\u3051\u308b\u6700\u65b0\u306e\u30c8\u30d4\u30c3\u30af\uff09. \u7b2c18\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a (\u6559\u80b2\u8b1b\u6f14), \u6771\u4eac, 2018, 5.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u6838\u533b\u5b66\u5c02\u9580\u533b\u6559\u80b2\u30bb\u30df\u30ca\u30fcPET\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u30b3\u30fc\u30b9. \u7b2c18\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a (\u6559\u80b2\u8b1b\u6f14), \u6771\u4eac, 2018, 5.<\/dd>\n<dd>\u9752\u6728\u3000\u4eae, \u95a2\u5ddd\u5584\u4e8c\u90ce, \u897f\u4e95\u4fca\u6676, \u5c71\u672c\u3000\u7d71, \u4e09\u597d\u5eb7\u79c0, \u7af9\u6797\u8302\u751f: \u985e\u4e0a\u76ae\u578b\u814e\u8840\u7ba1\u7b4b\u8102\u80aa\u816b\u306b\u5bfe\u3057\u3066transarterial ethanol ablation\u3092\u65bd\u884c\u3057\u305f1\u4f8b. \u7b2c32\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a, \u795e\u5948\u5ddd, 2018, 5.<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73, \u5ca9\u6fa4\u591a\u6075, \u95a2\u6839\u6717\u96c5, \u5c0f\u5009\u9ad8\u5fd7, \u6885\u7530\u8302\u660e: \u30ea\u30f3\u30d1\u816b\u69d8\u8089\u82bd\u816b\u75c7(LYG)\u306e\uff11\u4f8b. \u7b2c47\u56de\u982d\u9838\u90e8\u30fb\u80f8\u90e8\u753b\u50cf\u7814\u7a76\u4f1a, \u6771\u4eac, 2018, 5.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca: de novo\u5909\u7570\u306eNALCN\u907a\u4f1d\u5b50\u7570\u5e38\u306e2\u4f8b. \u7b2c54\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2018, 6.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a, \u5317\u6cb3\u5fb3\u5f66: \u8179\u8154\u5185\u51fa\u8840\u3092\u304d\u305f\u3057\u305f14\u6b73\u7537\u5150. \u7b2c54\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u5ea7\u9577\uff09, \u6771\u4eac, 2018, 6.<\/dd>\n<dd>\u77f3\u6e21\u7fa9\u4e4b, \u5bfa\u5185\u3000\u5e79, \u4e0a\u51fa\u6d69\u4e4b, \u98ef\u585a\u3000\u5747, \u7e04\u7530\u664b\u592a\u90ce, \u5e73\u4e95\u5343\u88d5, \u85e4\u7530\u3000\u4eae, \u5ca1\u90e8\u54f2\u5f66,\u5409\u7530\u5553\u4ecb, \u91d1\u7530\u670b\u6d0b: \u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308bNivolumab\u6295\u4e0e\u5f8c\u306e\u5580\u8840\u306b\u5bfe\u3057\u6c17\u7ba1\u652f\u52d5\u8108\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b. \u7b2c453\u56de\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a, \u5927\u5bae, 2018, 6.<\/dd>\n<dd>\u77f3\u6e21\u7fa9\u4e4b, \u91d1\u7530\u670b\u6d0b, \u4e0a\u51fa\u6d69\u4e4b, \u98ef\u585a\u3000\u5747, \u7e04\u7530\u664b\u592a\u90ce, \u5e73\u4e95\u5343\u88d5, \u85e4\u7530\u3000\u4eae, \u5bfa\u5185\u3000\u5e79, \u5ca1\u90e8\u54f2\u5f66, \u5409\u7530\u5553\u4ecb: 18F-FDG PET\/CT texture analysis\u3092\u7528\u3044\u305f\u539f\u767a\u4e0d\u660e\u764c\u306e\u4e88\u5f8c\u5c64\u5225\u5316\u306e\u53ef\u80fd\u6027. Society of advanced medical imaging (SAMI), \u6771\u4eac, 2018, 7. \u30dd\u30b9\u30bf\u30fc\u512a\u79c0\u8cde.<\/dd>\n<dd>\u4f0a\u85e4\u8ce2\u4e00, \u77f3\u6e21\u7fa9\u4e4b, \u4e0a\u51fa\u6d69\u4e4b, \u98ef\u585a\u3000\u5747, \u5e73\u4e95\u5343\u88d5, \u85e4\u7530\u3000\u4eae, \u5ca1\u90e8\u54f2\u5f66, \u5409\u7530\u5553\u4ecb, \u91d1\u7530\u670b\u6d0b: \u975e\u5178\u578b\u7684\u306a18F-FDG PET\/CT\u6240\u898b\u3092\u5448\u3057,\u539f\u767a\u5de3\u306e\u7279\u5b9a\u306b\u96e3\u6e0b\u3057\u305f\u5341\u4e8c\u6307\u8178\u795e\u7d4c\u5185\u5206\u6ccc\u764c\u306e\u4e00\u4f8b. \u7b2c89\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a, \u6771\u4eac, 2018, 7.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u304c\u3093\u306e\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u3068MRI. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0), \u91d1\u6ca2, 2018, 9\uff0e<\/dd>\n<dd>\u5bfa\u5185\u3000\u5e79, \u77f3\u6e21\u7fa9\u4e4b, \u4f0a\u85e4\u8ce2\u4e00, \u9152\u4e95\u5bb9\u5802, \u4e0a\u51fa\u6d69\u4e4b, \u98ef\u585a\u3000\u5747, \u91ce\u6751\u5e78\u4e00\u90ce, \u85e4\u7530\u3000\u4eae, \u5e73\u4e95\u5343\u88d5, \u5ca1\u90e8\u54f2\u5f66, \u5409\u7530\u5553\u4ecb, \u91d1\u7530\u670b\u6d0b: \u81a8\u6f64\u578b\u30b3\u30a4\u30eb\uff08Azur CX18\uff09\u3092\u4f75\u7528\u3057\u3066\u81b5\u982d\u5341\u4e8c\u6307\u8178\u5207\u9664\u5f8c\u306e\u4eee\u6027\u52d5\u8108\u7624\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u798f\u5ca1, 2018, 10.<\/dd>\n<dd>\u9752\u6728\u3000\u4eae, \u5c71\u672c\u3000\u7d71, \u5e73\u5c71\u9ebb\u5229\u5b50, \u897f\u4e95\u4fca\u6676, \u95a2\u5ddd\u5584\u4e8c\u90ce, \u7af9\u6797\u8302\u751f: \u5b50\u5bae\u8840\u7ba1\u5e73\u6ed1\u7b4b\u816b\u306e1\u4f8b. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u798f\u5ca1, 2018, 10.<\/dd>\n<dd>\u5c71\u53e3\u552f\u53f2, \u85e4\u4e95\u88d5\u592a, \u5bcc\u5b89\u3082\u3088\u3053, \u85e4\u7530\u548c\u4fca, \u91ce\u6fa4\u4e45\u7f8e\u5b50, \u4f50\u85e4\u535a\u4fe1, \u76f8\u7530\u5178\u5b50: \u5178\u578b\u7684\u6240\u898b\u3092\u793a\u3057\u305fdesmoplastic infantile astrocytoma(DIA)\u306e1\u4f8b. \u7b2c13\u56de\u5c0f\u5150\u795e\u7d4c\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u4eac\u90fd, 2018, 10.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u65b0\u305f\u306a\u8a3a\u65ad\u57fa\u6e96\u3092\u8e0f\u307e\u3048\u305f\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u3064\u3044\u3066. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u798f\u5ca1, 2018, 10.<\/dd>\n<dd>\u4e39\u5185\u5553\u5141, \u6cb3\u539f\u60a0\u4e00\u90ce, \u5c0f\u6c60\u7950\u54c9, \u677e\u4e95\u9752\u53f2\uff1a\u5358\u767a\u6027\u30ea\u30f3\u30b0\u72b6\u9670\u5f71\uff08reversed halo sign\uff09\u3092\u5448\u3057\u305f\u80ba\u7d50\u6838\u306e\u4e00\u4f8b. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u798f\u5ca1, 2018,10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: \u653e\u5c04\u6027\u540c\u4f4d\u5143\u7d20\u5185\u7528\u7642\u6cd5\u306e\u73fe\u72b6\u3068\u767a\u5c55. \u7b2c56\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a(\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3), \u6a2a\u6d5c, 2018, 10\uff0e<\/dd>\n<dd>\u4e09\u6a4b\u8015\u5e73, \u5ca9\u6fa4\u591a\u6075, \u99ac\u5834\u667a\u5c1a, \u5c0f\u5009\u9ad8\u5fd7, \u6b66\u6751\u6c11\u5b50: 17\u5e74\u9593\u306e\u7d4c\u904e\u3092\u89b3\u5bdf\u3057\u3048\u305f\u9593\u8cea\u6027\u80ba\u708e\u306e\u4e00\u4f8b. \u7b2c32\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u798f\u5ca1, 2018, 10.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: NET\u306b\u304a\u3051\u308b\u30bd\u30de\u30c8\u30b9\u30bf\u30c1\u30f3\u53d7\u5bb9\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u4f7f\u3044\u65b9. \u7b2c26\u56de\u65e5\u672c\u6d88\u5316\u5668\u95a2\u9023\u5b66\u4f1a\u9031\u9593 (\u30d6\u30ec\u30c3\u30af\u30d5\u30a1\u30fc\u30b9\u30c8\u30bb\u30df\u30ca\u30fc), \u795e\u6238, 2018, 11.<\/dd>\n<dd>\u98ef\u585a\u3000\u5747\uff0c\u5927\ufa11\u6d0b\u5145\uff0c\u5c3e\u5ddd\u677e\u7fa9\uff0c\u5409\u7530\u5553\u4ecb\uff0c\u91d1\u7530\u670b\u6d0b: \u81e8\u5e8a\u6761\u4ef6\u4e0b\u306b\u304a\u3051\u308bSUVmax\u306e\u5909\u52d5\u304a\u3088\u3073\u88c5\u7f6e\u9593\u5dee\u306b\u3064\u3044\u3066\u306ecount-based\u518d\u69cb\u6210\u6cd5\u3092\u7528\u3044\u305f\u691c\u8a0e. \u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c\u6c96\u7e04\uff0c2018, 11\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e: BNCT\u306e\u767a\u5c55\u306b\u8cc7\u3059\u308b\u30db\u30a6\u7d20\u85ac\u5264PET\u306e\u9ad8\u5ea6\u5316. \u7b2c58\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0), \u6c96\u7e04, 2018, 11.<\/dd>\n<dd>\u5c0f\u6797\u96c4\u4ecb, \u5b89\u85e4\u548c\u592b, \u963f\u90e8\u3000\u793c, \u5b87\u6d25\u6728\u7fd4\u5e73, \u9f4a\u85e4\u516c\u5f66: \u8179\u8154\u93e1\u4e0b\u80c6\u56a2\u6458\u51fa\u8853\u5f8c\u306e\u30af\u30ea\u30c3\u30d7\u3092\u6838\u3068\u3057\u305f\u7dcf\u80c6\u7ba1\u7d50\u77f3\u306e\u4e00\u4f8b. \u7b2c454\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a, \u6771\u4eac, 2018,12.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u76f8\u7530\u5178\u5b50: 1H-MRS\u6cd5\u3092\u7528\u3044\u305f\u8133\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff08\u7d99\u7d9a\uff09. \u5e73\u621030\u5e74\u5ea6\u304b\u306a\u304c\u308f\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1, 15\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50(\u5206): AI\u306b\u3088\u308b\u81e8\u5e8a\u753b\u50cf\u8a3a\u65ad\u3092\u76ee\u6307\u3059\u305f\u3081\u306e\u8907\u5408\u30c7\u30a3\u30fc\u30d7\u30e9\u30fc\u30cb\u30f3\u30b0\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u958b\u767a\u7814\u7a76. \u5e73\u621030\u5e74\u5ea6\u6587\u79d1\u7701\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1, 39\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50(\u5206): \u65b0\u751f\u5150\u306e\u8907\u5408\u8133\u753b\u50cf\u8a3a\u65ad\u6cd5\u306e\u78ba\u7acb. \u5e73\u621030\u5e74\u5ea6\u6587\u79d1\u7701\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1, 204,916\u5186\uff08H29\u5e74\u5ea6\u304b\u3089\u306e\u7e70\u308a\u8d8a\u3057\uff09.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50(\u5206): \u30b2\u30ce\u30e0\u85ac\u7406\u5b66\u7684\u89e3\u6790\u3068\u30d7\u30ed\u30c6\u30aa\u30fc\u30e0\u89e3\u6790\u3092\u7528\u3044\u305f\u85ac\u5264\u6027\u4e2d\u67a2\u795e\u7d4c\u969c\u5bb3\u306e\u75c5\u614b\u89e3\u660e. \u5e73\u621030\u5e74\u5ea6\u6587\u79d1\u7701\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1, 13\u4e07\u5186.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: 1H-MRS\u6cd5\u3092\u7528\u3044\u305f\u5185\u81d3\u816b\u760d\u30fb\u9aa8\u8edf\u90e8\u816b\u760d\u5185\u4ee3\u8b1d\u7269\u306e\u6e2c\u5b9a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff08\u7d99\u7d9a\uff09. \u5e73\u621030\u5e74\u5ea6\u304b\u306a\u304c\u308f\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1, 12\u4e07\u5186.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50(\u5206): \u5148\u5929\u6027\u547c\u5438\u5668\u30fb\u80f8\u90ed\u5f62\u6210\u7570\u5e38\u75be\u60a3\u306b\u95a2\u3059\u308b\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u306a\u3089\u3073\u306b\u8a3a\u7642\u4f53\u5236\u306e\u69cb\u7bc9\u30fb\u666e\u53ca\u306b\u95a2\u3059\u308b\u7814\u7a76. \u5e73\u621030\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb, 20\u4e07\u5186.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u65b0\u898f\u6280\u8853\u3092\u7528\u3044\u305f\u5c0f\u5150\u8eaf\u5e79\u90e8MRI\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76. \u5e73\u621030\u5e74\u5ea6\u304b\u306a\u304c\u308f\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1, 12\u4e07\u5186.<\/dd>\n<dd>\u85e4\u7530\u548c\u4fca: \u982d\u90e8MRI\u3000arterial spin labeling(ASL)\u753b\u50cf\u3092\u7528\u3044\u305f\u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76. \u5e73\u621030\u5e74\u5ea6\u304b\u306a\u304c\u308f\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1, 13\u4e07\u5186.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e(\u4ee3): \u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM\u3092\u7528\u3044\u305f\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u7814\u7a76\uff0eAMED\u9769\u65b0\u7684\u533b\u7642\u30b7\u30fc\u30ba\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff08\u5e73\u621029\u5e74\u5ea6-31\u5e74\u5ea6\uff09, 9,997\u4e07\u5186.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u305d\u306e\u4ed6<\/h3>\n<\/dt>\n<dd>\u9752\u6728\u3000\u4eae: \u7b2c28\u56de\u65e5\u672c\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76\u4f1a(\u30d5\u30a3\u30eb\u30e0\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30bb\u30c3\u30b7\u30e7\u30f3)\u512a\u79c0\u8cde, \u798f\u5ca1, 2018, 10.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u8b1b\u6f14<\/h3>\n<\/dt>\n<dd>Niwa T, Aida N: Susceptibility-weighted imaging. 21th Symposium Neuroradiologicum, Taipei, 2018, 3.<\/dd>\n<dd>Aida N: Spinal Abnormalities in Pediatric Systemic Disorders. Asia-Oseania Congress of Radiology Symposium Neuroradiologicum 2018, Taipei, 2018, 3.<\/dd>\n<dd>Aida N: 1H-MR Spectroscopy for Assessment of Pediatric Neurodevelopment and CNS Disorders. The 77th Annual Meeting of the Japan Radiological Society, Yokohama, 2018, 4.<\/dd>\n<dd>Aida N, Tomiyasu M: MRI\/S to Study Metabolic Signatures of Early Brain Development &amp; Disease. JOIN ANNUAL MEETING ISMRM-ESMRMB, Paris, 2018, 6.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u8650\u5f85\u4e8b\u4f8b\u306b\u3064\u3044\u3066. \u65e5\u672c\u5b50\u3069\u3082\u8650\u5f85\u533b\u5b66\u4f1aAHT\u7814\u7a76\u90e8\u7b2c4\u56de\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u9ad8\u69fb, 2018, 1.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u753b\u50cf\u8a3a\u65ad\u304b\u3089\u307f\u305f\u5150\u7ae5\u8650\u5f85. H29\u5e74\u5ea6\u6a2a\u6d5c\u5e02\u7acb\u5e02\u6c11\u75c5\u9662\u5150\u7ae5\u8650\u5f85\u5bfe\u7b56\u7814\u4fee, \u6a2a\u6d5c, 2018, 1.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u810a\u9ac4\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c28\u56de\u95a2\u6771\u5c0f\u5150\u6574\u5f62\u5916\u79d1\u7814\u7a76\u4f1a, \u6771\u4eac, 2018, 2.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u982d\u90e8\u9818\u57df:\u5c0f\u5150\u306e\u6025\u60a3\u5bfe\u5fdc\u306b\u5fc5\u8981\u306a\u77e5\u8b58. Radiology Today in Setouchi 4th, \u5ca1\u5c71, 2018, 2.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: Pediatric Neuroradiology is Fun\uff01 \u7b2c3\u56de\u5bae\u5d0e\u30d5\u30a7\u30cb\u30c3\u30af\u30b9\u795e\u7d4c\u753b\u50cf\u7814\u7a76\u4f1a, \u5bae\u5d0e, 2018, 3.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad:\u5c0f\u5150\u79d1\u533b\u306b\u77e5\u3063\u3066\u3044\u3066\u307b\u3057\u3044\u3053\u3068. \u7b2c121\u56de\u65e5\u672c\u5c0f\u5150\u79d1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u798f\u5ca1,2018, 4.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u795e\u7d4c\u79d1\u533b\u5e2b\u306b\u5fc5\u8981\u306a\u982d\u90e8\u5916\u50b7\u306e\u77e5\u8b58\u3000\u8650\u5f85\u306e\u8996\u70b9\u304b\u3089 \u300c\u753b\u50cf\u8a3a\u65ad\u304b\u3089\u307f\u305f\u5c0f\u5150\u8650\u5f85\u300d. \u7b2c60\u56de\u65e5\u672c\u5c0f\u5150\u795e\u7d4c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u5343\u8449, 2018, 6.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u3053\u3069\u3082\u306b\u512a\u3057\u3044\u753b\u50cf\u8a3a\u65ad-\u5b89\u5168\u306b\u6709\u52b9\u691c\u67fb\u3092-. \u7b2c54\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2018, 6.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u305f\u5c0f\u5150\u8650\u5f85. H30\u5e74\u5ea6\u5c90\u961c\u770c\u7dcf\u5408\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u5150\u7ae5\u8650\u5f85\u4e88\u9632\u59d4\u54e1\u4f1a\u7814\u4fee\u4f1a, \u5c90\u961c, 2018, 7.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u4e8b\u4f8b\u2460, \u4e8b\u4f8b\u2461\u306b\u3064\u3044\u3066\u6307\u5b9a\u767a\u8a00. \u65e5\u672c\u5b50\u3069\u3082\u8650\u5f85\u533b\u5b66\u4f1aAHT\u7814\u7a76\u90e8\u7b2c5\u56de\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u9ad8\u677e, 2018, 8.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u305f\u5c0f\u5150\u8650\u5f85. H30\u5e74\u5ea6\u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u9644\u5c5e\u5e02\u6c11\u7dcf\u5408\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u300c\u5150\u7ae5\u8650\u5f85\u5bfe\u5fdc\u7814\u4fee\u300d, \u6a2a\u6d5c, 2018, 8.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: Pediatric neuroradiology\u3092\u697d\u3057\u3082\u3046\uff01 \u7b2c14\u56de\u5317\u6d77\u9053NR\u61c7\u8a71\u4f1a, \u51fd\u9928, 2018, 8.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: Indication and Safety in Pediatric MR study. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a, \u91d1\u6ca2, 2018, 9.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a: \u5c0f\u5150MRI\u306e\u5b9f\u969b. \u7b2c46\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a, \u91d1\u6ca2, 2018, 9.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\u8ad6\uff1a\u88ab\u3070\u304f\u3068\u30ea\u30b9\u30af\u306e\u4f4e\u6e1b\u306e\u305f\u3081\u306b. \u7b2c54\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a, \u798f\u5ca1, 2018, 10.<\/dd>\n<dd>\u76f8\u7530\u3000\u5178\u5b50: \u5b50\u3069\u3082\u9054\u306e\u305f\u3081\u306e\u753b\u50cf\u8a3a\u65ad\uff1aMRI\u3092\u6d3b\u7528\u3059\u308b\u305f\u3081\u306b\u77e5\u3063\u3066\u3044\u3066\u307b\u3057\u3044\u3053\u3068. \u7b2c47\u56de\u65ad\u5c64\u6620\u50cf\u7814\u7a76\u4f1a, \u672d\u5e4c, 2018, 10.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u753b\u50cf\u8a3a\u65ad\uff1aImage gently and enjoy neuroraiology\uff01 \u7b2c134\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u5bae\u57ce\u795e\u7d4c\u653e\u5c04\u7dda\u7814\u7a76\u4f1a, \u4ed9\u53f0, 2018, 11.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50:\u300c\u65b0\u751f\u5150\u30fb\u80ce\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u300d\u65b0\u751f\u5150\u753b\u50cf\u8a3a\u65ad\uff1a\u7dcf\u8ad6\u3068\u8133\u810a\u9ac4. \u7b2c63\u56de\u65e5\u672c\u65b0\u751f\u5150\u6210\u80b2\u533b\u5b66\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2018, 11.<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50: \u65b0\u751f\u5150\u30fb\u80ce\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u300d\u65b0\u751f\u5150\u80f8\u90e8\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad. \u7b2c63\u56de\u65e5\u672c\u65b0\u751f\u5150\u6210\u80b2\u533b\u5b66\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2018, 11.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt style=\"width: 100%;\">\n<h3>\u8b1b\u7fa9<\/h3>\n<\/dt>\n<dd>\u76f8\u7530\u5178\u5b50: \u753b\u50cf\u8a3a\u65ad\u304b\u3089\u898b\u308b\u5c0f\u5150\u8650\u5f85. \u653e\u5c04\u7dda\u533b\u5b66, \u718a\u672c\u5927\u5b66\u533b\u5b66\u90e8, 2018, 5.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50: \u5c0f\u5150\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66. \u653e\u5c04\u7dda\u533b\u5b66, \u6a2a\u6d5c\u5e02\u5927\u533b\u5b66\u90e8, 2018, 9.<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587<\/h3>\n<\/dt>\n<dd>Hata M, Koike I, Miyagi E, Numazaki R, Asai-Sato M, Kasuya T, Kaizu H, Matsui T, Hirahara F, Inoue T: Radiation therapy for very elderly patients aged 80 years and older with squamous cell carcinoma of the uterine cervix. Am J Clin Oncol, 40\uff082\uff09: 178\uff0d182, 2017.<\/dd>\n<dd>Hata M, Koike I, Miyagi E, Numazaki R, Asai-Sato M, Kaizu H, Mukai Y, Takano S, Ito E, Sugiura M, Inoue T: Radiation therapy for stage IVA uterine cervical cancer: treatment outcomes including prognostic factors and risk of vesicovaginal and rectovaginal fistulas. Oncotarget, 8\uff0868\uff09: 112855\uff0d112866, 2017.<\/dd>\n<dd>Yabuki K, Sano D, Shiono O, Arai Y, Chiba Y, Tanabe T, Nishimura G, Takahashi M, Taguchi T, Kaneta T, Hata M, Oridate N: Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer. Laryngoscope, 127\uff084\uff09: 862\uff0d867, 2017.<\/dd>\n<dd>Hayashi Y, Mitsudo K, Sakuma K, Iida M, Iwai T, Nakashima H, Okamoto Y, Koizumi T, Oguri S, Hirota M, Kioi M, Koike I, Hata M, Tohnai I: Clinical outcomes of retrograde intra-arterial chemotherapy concurrent with radiotherapy for elderly oral squamous cell carcinoma patients aged over 80 years old. Radiat Oncol, 12\uff081\uff09: 112, 2017.<\/dd>\n<dd>Kaneta T, Katsuse O, Hirano T, Ogawa M, Shishikura-Hino A, Yoshida K, Odawara T, Hirayasu Y, Inoue T: Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer&#8217;s disease: a cross-sectional study. BMC Neurol, 17\uff081\uff09: 91, 2017.<\/dd>\n<dd>Kaneta T, Katsuse O, Hirano T, Ogawa M, Yoshida K, Odawara T, Hirayasu Y, Inoue T: Head-to-head visual comparison between brain perfusion SPECT and arterial spin-labeling MRI with different postlabeling delays in Alzheimer disease. AJNR, 38\uff088\uff09: 1562\uff0d1568, 2017.<\/dd>\n<dd>Kaneta T, Ogawa M, Motomura N, Iizuka H, Arisawa T, Hino-Shishikura A, Yoshida K, Inoue T: Initial evaluation of the Celesteion large-bore PET\/CT scanner in accordance with the NEMA NU2\uff0d2012 standard and the Japanese guideline for oncology FDG PET\/CT data acquisition protocol version 2.0. EJNMMI Res, 7\uff081\uff09: 83, 2017.<\/dd>\n<dd>Kaneta T, Sun N, Ogawa M, Iizuka H, Arisawa T, Hino- Shishikura A, Yoshida K, Inoue T: Variation and repeatability of measured standardized uptake values depending on actual values: a phantom study. Am J Nucl Med Mol Imaging, 7\uff085\uff09: 204\uff0d211, 2017.<\/dd>\n<dd>Suzuki-Shibata S, Yamamoto Y, Yoshida T, Mizoguchi N, Nonaka T, Kubota A, Narimatsu H, Miyagi Y, Kobayashi T, Kaneta T, Inoue T: Prognostic value of volumetric FDG PET\/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra- arterial chemoradiotherapy. Jpn J Radiol, 35\uff0812\uff09: 740\uff0d747, 2017.<\/dd>\n<dd>Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T: Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET\/CT. Eur J Nucl Med Mol Imaging, 44\uff089\uff09: 1529\uff0d1537, 2017.<\/dd>\n<dd>Iizuka H, Kaneta T, Ogawa M, Motomura N, Arisawa T, Hino- Shishikura A, Yoshida K, Inoue T: Visual and quantitative assessment of a new anisotropic diffusion filter\uff08statistical transfer with optimizing noise and edge sensing\uff09for positron emission tomography. J Mol Imaging Dynamic, 7: 2, 2017. Nawata S, Kaneta T, Ogawa M, Ishiwata Y, Kobayashi N, Shishikura-Hino A, Yoshida K, Inaba Y, Saito T, Inoue T: Differences in sodium fluoride-18 uptake in the normal skeleton depending on the location and characteristics of the bone. Nuklearmedizin, 56\uff083\uff09: 91\uff0d96, 2017.<\/dd>\n<dd>Shimbo H, Yokoi T, Aida N, Mizuno S, Suzumura H, Nagai J, Ida K, EnomotoY, Hatano C, Kurosawa K: Haploinsufficiency of BCL11A associated with cerebellar abnormalities in 2p15p16.1 deletion syndrome. Mol Genet Genomic Med, 5\uff084\uff09: 429\uff0d437, 2017.<\/dd>\n<dd>Tsurusaki Y, Ohashi I, Enomoto Y, Naruto T, Mitsui J, Aida N, Kurosawa K: A novel UBE2A mutation causes X-linked intellectual disability type Nascimento. Hum Genome Var, 4: 17019, 2017.<\/dd>\n<dd>Enokizono M, Aida N, Niwa T, Osaka H, Naruto T, Kurosawa K, Ohba C, Suzuki T, Saitsu H, Goto T, Matsumoto N: Neuroimaging findings in Joubert syndrome with C5 or f42 gene mutations: a milder form of molar tooth sign and vermian hypoplasia. J Neurol Sci, 376: 7\uff0d12, 2017.<\/dd>\n<dd>Fujii Y, Aida N, Niwa T, Enokizono M, Nozawa K, Inoue T: A small pons as a characteristic finding in Down syndrome: a quantitative MRI study. Brain Dev, 39\uff084\uff09: 298\uff0d305, 2017. Tomiyasu M, Aida N, Shibasaki J, Umeda M, Murata K, Heberlein K, Brown MA, Shimizu E, Tsuji H, Obata T: In vivo estimation of gamma-aminobutyric acid levels in the neonatal brain. NMR Biomed, 30\uff081\uff09, 2017.<\/dd>\n<dd>Niwa T, Nozawa K, Aida N: Visualization of the airway in infants with MRI using pointwise encoding time reduction with radial acquisition\uff08PETRA\uff09. J Magn Reson Imaging, 45\uff083\uff09: 839\uff0d844, 2017.<\/dd>\n<dd>Kitahara H, Maruyama D, Maeshima AM, Makita S, Miyamoto KI, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Tajima K, Terauchi T, Kurihara H, Taniguchi H, Komatsu N, Tobinai K: Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP\/ CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment. Ann Hematol, 96: 411\uff0d420, 2017.<\/dd>\n<dd>Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T: Can 18F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors. Cancer Manag Res, 9: 761\uff0d768, 2017.<\/dd>\n<dd>Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T: Multiple Administrations of 64Cu- ATSM as a novel therapeutic option for glioblastoma: a translational study using mice with xenografts. Transl Oncol, 11\uff081\uff09: 24\uff0d30, 2017.<\/dd>\n<dd>Sasada S, Kurihara H, Kinoshita T, Yoshida M, Honda N, Shimoi T, Shimomura A, Yonemori K, Shimzu C, Hamada A, Kanayama Y, Watanabe Y, Fujiwara Y, Tamura K: Visualization of HER2-specific breast cancer intratumoral<\/dd>\n<dd>heterogeneity using 64Cu-DOTA-trastuzumab PET. Eur J Nucl Med Mol Imaging, 44: 2146\uff0d2147, 2017.<\/dd>\n<dd>Sasada S, Kurihara H, Kinoshita T, Yoshida M, Honda N, Shimoi T, Shimomura A, Yunokawa M, Yonemori K, Shimizu C, Hamada A, Kanayama Y, Watanabe Y, Fujiwara Y, Tamura K: 64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer. Ann Oncol, 28\uff088\uff09: 2028\uff0d2029, 2017.<\/dd>\n<dd>Makita S, Kurihara H, Tobinai K: Intravenacaval invasion of classical Hodgkin lymphoma detected with 18F-fluorodeoxyglucose \uff0818F-FDG\uff09 PET-MRI. Lancet Oncol, 18: e233, 2017.<\/dd>\n<dd>Kono Y, Kurihara H, Kawamoto H, Yasui N, Honda N, Igaki H, Itami J: Radiation absorbed dose estimates for 18F-BPA PET. Acta Radiol, 58: 1094\uff0d1100, 2017.<\/dd>\n<dd>Watanabe Y, Kurihara H, Itami J, Sasaki R, Arai Y, Sugimura K: Relationship between the uptake of 18F-borono-L- phenylalanine and L\uff3b- methyl-11C\uff3dmethionine in head and neck tumors and normal organs. Radiat Oncol, 14: 12\uff0d17, 2017.<\/dd>\n<dd>Kano D, Nakagami Y, Kurihara H, Hosokawa S, Zenda S, Kusumoto M, Fujii H, Kaneta T, Saito S, Uesawa Y, Kagaya H: Development of a double-stranded siRNA labelling method by using 99mTc and single photon emission computed tomography imaging. J Drug Target, 25: 172\uff0d178, 2017.<\/dd>\n<dd>Noritake M, Narui K, Kaneta T, Sugae S, Sakamaki K, Inoue T, Ishikawa T: Evaluation of the response to breast cancer neoadjuvant chemotherapy using 18F-FDG positron emission mammography compared with whole-body 18F-FDG PET: a prospective observational study. Clin Nucl Med, 42\uff083\uff09: 169\uff0d175, 2017.<\/dd>\n<dd>Suzuki-Shibata S, Yamamoto Y\uff0cYoshida T, Mizoguchi N, Nonaka T, Kubota A, Narimatsu H, Miyagi Y, Kobayashi T, Kaneta T, Inoue T: Prognostic value of volumetric FDG PET\/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra- arterial chemoradiotherapy. Japanese Journal of Radiology, 35\uff0812\uff09: 740\uff0d747, 2017.<\/dd>\n<dd>Saito T, Tamura M, Chiba Y, Katsuse O, Suda A, Kamada A, Ikura T, Abe K, Ogawa M, Minegishi K, Yoshimi R, Kirino Y, Ihata A, Hirayasu Y: Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder. J Neurol Sci, 379: 127\uff0d130, 2017.<\/dd>\n<dd>Hayasaka S, Nakamura M, Noda Y, Izuno T, Saeki T, Iwanari H, Hirayasu Y: Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression. Psychiatry Clin Neurosci, 71\uff0811\uff09: 747\uff0d758, 2017.<\/dd>\n<dd>Kaneta T, Katsuse O, Hirano T, Ogawa M, Shihikura-Hino A, Yoshida K, Odawara T, Hirayasu Y, Inoue T: Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer&#8217;s disease: a cross-sectional study. BMC Neurol, 17\uff081\uff09: 91, 2017.<\/dd>\n<dd>Miyauchi M, Kishida I, Suda A, Shiraishi Y, Fujibayashi M, Taguri M, Ishii C, Ishii N, Moritani T, Hirayasu Y: Long term effects of smoking cessation in hospitalized schizophrenia patients. BMC Psychiatry, 17\uff081\uff09: 87, 2017.<\/dd>\n<dd>Ishii M, Okumura Y, Sugiyama N, Hasegawa H, Noda T, Hirayasu Y, Ito H: Feasibility and efficacy of shared decision making for first-admission schizophrenia: a randomized clinical trial. BMC Psychiatry, 17\uff081\uff09: 52, 2017.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>Hata M: Radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma: What is the optimal radiation dose? Ann Radiat Ther Oncol, 1\uff083\uff09: 1012, 2017.<\/dd>\n<dd>\u5e61\u591a\u653f\u6cbb\uff1a\u982d\u90e8\u8840\u7ba1\u8089\u816b\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff0eX \u7dda\u3068\u96fb\u5b50\u7dda\u306b\u3088\u308b\u5168\u982d\u76ae\u7167\u5c04\uff0e\u81e8\u5e8a\u653e\u5c04\u7dda\uff0c62\uff0813\uff09: 1797\uff0d1804\uff0c 2017\uff0e<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50\uff0c\u91d1\u7530\u670b\u6d0b\uff0c\u5c0f\u6797\u4fca\u898f\uff0c\u5e02\u5ddd\u9756\u53f2\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff5e\u4eca\u5f8c\u306e\u5c55\u958b\uff5e\uff0eIsotope News, 750\uff084\uff09: 11\uff0d17\uff0c2017\uff0e<\/dd>\n<dd>\u6817\u539f\u5343\u7d75\u5b50\uff0c\u98ef\u585a \u5747\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d0\u30a4\u30aa\u30de\u30fc\u30ab\u30fc\u306e\u4e16\u754c\u6a19\u6e96\u5316\u306b\u5411\u3051\u3066\uff0e\u81e8\u5e8a\u8a55\u4fa1\uff0c44\uff084\uff09: 785\uff0d812\uff0c2017\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1a\u4e73\u764c\u306e PET\/MRI\uff0eRad Fan, 15: 67\uff0d69, 2017\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dd>\n<h3>\u8457\u66f8<\/h3>\n<\/dd>\n<dd>Hata M: Proton beam therapy. Encyclopedia of Cancer, 4th Edition. Springer-Verlag Berlin Heidelberg, New York, 2017.<\/dd>\n<dd>Kurihara H: Personalized Pathway-Activated Systems Imaging in Oncology, Chapter 11 Cpper-Labeled Radiopharmaceuticals in Oncology. Springer, 195\uff0d211, 2017.<\/dd>\n<dd>\u592a\u7530\u5149\u6cf0\uff0c\u5e61\u591a\u653f\u6cbb\uff1a\u30de\u30a4\u30e4\u30fc\u30b9\u8179\u90e8\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\u2500\u767a \u751f\u5b66\u7684\u30fb\u89e3\u5256\u5b66\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\uff0e\u533b\u5b66\u66f8\u9662\uff0c2017\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u65b0\u751f\u5150\u8133\u75c7\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u753b\u50cf\u8a3a\u65ad\uff0e \u5b66\u7814\u30e1\u30c7\u30a3\u30ab\u30eb\u79c0\u6f64\u793e\uff0c37\uff083\uff09: 329\uff0d341\uff0c2017\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1a\u6d88\u5316\u5668\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d \u85ac\u7269\u7642\u6cd5\u306e\u30b1\u30fc\u30b9\u30d5\u30a1\u30a4\u30ea\u30f3\u30b0\uff0c\u30bd\u30de\u30c8\u30b9\u30bf\u30c1\u30f3\u53d7\u5bb9\u4f53\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\uff08SRS\uff09\u3068\u306f\uff0e\u533b\u5b66\u3068\u770b\u8b77\u793e\uff0c107\uff0c2017\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1a\u6838\u533b\u5b66\u878d\u5408\u753b\u50cf \u57fa\u790e\u3068\u81e8\u5e8a\uff0e\u91d1\u539f\u51fa\u7248\uff0c67\uff0d 73\uff0c2017\uff0e<\/dd>\n<dd>\u68ee\u7530\u656c\u88d5\uff0c\u6817\u539f\u5b8f\u660e\uff1aFDG-PET\/MRI \u2500 MRI \u304c\u6709\u7528\u3067\u3042\u3063\u305f\u75c7\u4f8b\uff081\uff09\u9ac4\u819c\u5185\u64ad\u7a2e\uff0e\u91d1\u539f\u51fa\u7248\uff0c126\uff0d129\uff0c 2017\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff0c\u68ee\u7530\u656c\u88d5\uff1aFDG-PET\/MRI \u2500 MRI \u304c\u6709\u7528\u3067\u3042\u3063\u305f\u75c7\u4f8b\uff082\uff09\u4e73\u623f\uff0e\u91d1\u539f\u51fa\u7248\uff0c130\uff0d133\uff0c2017\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u767a\u8868<\/h3>\n<\/dt>\n<dd>Hata M, Koike I, Miyagi E, Numazaki R, Asai-Sato M, Kaizu H, Mukai Y, Takano S, Ito E, Sugiura M, Inoue T: Safety and efficacy of radiation therapy for very elderly patients aged 80 years or older with uterine cervical cancer. The 59th Annual Scientific Meeting of the American Society for Radiation Oncology\uff08ASTRO\uff09, San Diego, 2017, 9.<\/dd>\n<dd>Ishiwata Y, Kaneta T, Yoshida K, Hino A, Inoue T: Feasibility of prognosis development for cancer of unknown primary \uff08CUP\uff09using 18F-FDG PET\/CT to determine intratumoral heterogeneity and total lesion glycolysis \uff08TLG\uff09. SNMMI \uff08Society of Nuclear Medicine and Molecular Imaging\uff09, Denver, 2017, 6.<\/dd>\n<dd>Fujita R\uff08E poster presentation\uff09: Improvement in the diagnosis of interstitial pulmonary fibrosis with a computer-aided diagnosis system for computed tomography images. 8th International Workshop on Pulmonary Function Imaging, Seoul, 2017, 3.<\/dd>\n<dd>Kurihara H: The accumulation correlation of FDG and FBPA malignant tumors by PET\/CT. European Congress of Radiology, Vienna, 2017, 3.<\/dd>\n<dd>Kurihara H: Session \u2161 Anti-HER2 immuno-PET study. Federation of Asian Societies for Molecular Imaging Conference, Seoul, 2017, 8.<\/dd>\n<dd>\u5e61\u591a\u653f\u6cbb\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u548c\u7530\u79c0\u6587\uff0c\u5bae\u57ce\u60a6\u5b50\uff0c\u6d77\u6d25 \u4e45\uff0c\u5411\u4e95\u4f51\u5e0c\uff0c\u9ad8\u91ce\u7965\u5b50\uff0c\u4f0a\u85e4\u82f1\u5b50\uff0c\u6749\u6d66 \u5186\uff0c\u76f8\u539f\u9053\u5b50\uff0c \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u4e73\u623f\u5916 Paget \u75c5\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff1a\u6cbb\u7642\u6210\u7e3e\u3068\u4e88\u5f8c\u56e0\u5b50\u306e\u89e3\u6790\uff0c\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e\u6ce8\u76ee\u6f14\u984c\u8cde\u53d7\u8cde\uff0e<\/dd>\n<dd>\u91d1\u7530\u670b\u6d0b\uff1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 2 \u300cPET \u306b\u3088\u308b\u304c\u3093\u306e\u75c5\u614b\u8a55\u4fa1\u3068\u6cbb\u7642\u6226\u7565\u3078\u306e\u5fdc\u7528\u300d\uff08\u82f1\u8a9e\uff09\u201cApplication of Cu-62\/64 ATSM PET for the treatment of glioma\u201d\uff0e\u7b2c76\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c4\uff0e<\/dd>\n<dd>\u5c0f\u6c60 \u6cc9\uff1a\u306f\u3058\u3081\u307e\u3057\u3087\u3046\uff0cRI \u6cbb\u7642 \uff5e\u30be\u30fc\u30d5\u30a3\u30b4 \u00ae \u6295\u4e0e\u306e\u57fa\u790e\uff5e\u300f\uff0e\u795e\u5948\u5ddd\u524d\u7acb\u817a\u764c\u9aa8\u8ee2\u79fb\u6cbb\u7642\u3092\u8003\u3048\u308b\u4f1a\u57fa\u8abf\u8b1b\u6f14\uff0c\u6a2a\u6d5c\uff0c2017\uff0c12\uff0e<\/dd>\n<dd>\u6d77\u6d25 \u4e45\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u6cbb\u7684\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u3092\u65bd\u884c\u3057\u305f\u5b50\u5bae\u981a\u90e8\u5c0f\u7d30\u80de\u764c\u306e 1 \u4f8b\uff0e\u7b2c451 \u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6a2a\u6d5c\uff0c 2017\uff0c6\uff0e<\/dd>\n<dd>\u4f0a\u85e4\u82f1\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u5ca9\u5d0e\u53f2\u8a18\uff0c\u5f8c\u85e4\u88d5\u660e\uff0c \u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1aDiffuse intrinsic pontine glioma \u306b\u5bfe\u3059\u308b\u5be1\u5206\u5272\u7167\u5c04\uff0e\u7b2c53\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u5411\u4e95\u4f51\u5e0c\uff0c\u7cdf\u8c37\u5065\u592b\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u5f37\u76ae\u75c7\u5408\u4f75\u60a3\u8005\u3067\u80ba\u764c\u306e\u6e96\u6839\u6cbb\u7167\u5c04\u3092\u884c\u3063\u305f 1 \u4f8b\uff0e\u7b2c451\u56de\u65e5\u672c \u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e \u6749\u6d66 \u5186\uff0c\u6d77\u6d25 \u4e45\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u591a\u767a\u5de8\u5927\u518d\u767a\u75c5\u5909\u3092\u6709\u3059\u308b\u7de9\u5f90\u767a\u80b2\u6027\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306b\u5bfe\u3059\u308b\u4f4e\u7dda\u91cf\u653e\u5c04\u7dda\u6cbb\u7642\u304c\u8457\u52b9\u3057\u305f 1 \u4f8b\uff0e\u7b2c451\u56de\u65e5 \u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u98ef\u585a \u5747\uff0c\u91d1\u7530\u670b\u6d0b\uff0c\u672c\u6751\u4fe1\u7be4\uff0c\u5c3e\u5ddd\u677e\u7fa9\uff0c\u65e5\u91ce\u5f69\u5b50\uff0c \u5409\u7530\u5553\u4ecb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u65b0\u3057\u3044 PET \u753b\u50cf\u30d5\u30a3\u30eb\u30bf\u30fc\u201cStatistical Transfer with Optimizing Noise and Edge Sensing\uff08STONES\uff09\u201d \u306e\u5b9f\u7528\u5316\u306b\u5411\u3051\u305f\u691c\u8a0e\uff0e\u7b2c86\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2017\uff0c1\uff0e<\/dd>\n<dd>\u98ef\u585a \u5747\uff0c\u65e5\u91ce\u5f69\u5b50\uff0c\u5c0f\u6fa4\u5e78\u5f66\uff0c\u5b87\u9ad8\u76f4\u5b50\uff0c\u5c71\u4e2d\u6b63\u4e8c\uff0c \u5409\u7530\u5553\u4ecb\uff0c\u91d1\u7530\u670b\u6d0b\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1aFDG-PET\/CT \u3092\u65bd\u884c\u3055\u308c\u305f\u809d\u5305\u866b\u75c7\u306e\u4e00\u4f8b\uff0e\u7b2c87\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff0c\u6771\u4eac\uff0c2017\uff0c7\uff0e<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50\uff0c\u5c0f\u6797\u898f\u4fca\uff0c\u6749\u6d66 \u5186\uff0c\u6709\u6fa4 \u54f2\uff0c\u9ad8\u7530\u7531\u8cb4\uff0c \u5c3e\u5ddd\u677e\u7fa9\uff0c\u91d1\u7530\u670b\u6d0b\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u5e02\u5ddd\u9756\u53f2\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1aPeptide receptor radionuclide therapy\uff08PRRT\uff09\u306b\u95a2\u3059\u308b\u5f53\u9662\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u56fd\u5185\u5916\u306e\u52d5\u5411\uff0e\u7b2c 5 \u56de\u65e5\u672c\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u4ed9\u53f0\uff0c2017\uff0c9\uff0e<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50\uff0c\u6749\u6d66 \u5186\uff0c\u9ad8\u7530\u7531\u8cb4\uff0c\u6709\u6fa4 \u54f2\uff0c\u91d1\u7530\u670b\u6d0b\uff0c \u5e61\u591a\u653f\u6cbb\uff0c\u5c0f\u6797\u898f\u4fca\uff0c\u5e02\u5ddd\u9756\u53f2\uff0c\u5c3e\u5ddd\u677e\u7fa9 , \u81fc\u4e95\u6df3\u4e4b\uff0c \u5927\u6cbc\u6559\u5b50\uff0c\u7acb\u77f3\u7531\u4f73\uff0c\u6728\u85e4\u7406\u6075\uff0c\u5c71\u4e2d\u7af9\u6625\uff0c\u4e95\u4e0a\u767b\u7f8e \u592b\uff1a\u65b0\u898f RI \u5185\u7528\u7642\u6cd5\u85ac\u5264\u306e\u5c0e\u5165\u3068\u591a\u8077\u7a2e\u9023\u643a\uff5e\u5f53\u9662\u306e\u53d6\u308a\u7d44\u307f\uff5e\uff0e\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u30fb\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u5408\u540c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff0c\u6a2a\u6d5c\uff0c2017\uff0c10\uff0e<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50\uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u6838\u533b\u5b66\u5185\u7528\u7642\u6cd5\uff5e\u5f53\u9662\u306e\u6cbb \u7642\u6210\u7e3e\u3068\u56fd\u5185\u5916\u306e\u52d5\u5411\uff5e\uff0e\u7b2c906\u56de\u653e\u5c04\u7dda\u8a3a\u7642\u7814\u7a76\u4f1a\uff0c \u65b0\u5bbf\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u52a0\u6765\u8061\u4e00\u6717\uff1a\u6c34\u982d\u75c7\u3092\u4f34\u3063\u305f\u795e\u7d4c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u4f8b\uff0e\u5c0f\u7530\u6025 X \u7dda\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\uff0c\u76f8\u6a21\u5927\u91ce\uff0c2017\uff0c12\uff0e<\/dd>\n<dd>\u7530\u5c71\u7531\u7f8e\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u677e\u4e95\u8b19\u543e\uff0c\u4f50\u85e4\u6676\u5b50\uff0c\u672c\u90f7\u79c0\u5e78\uff0c \u767d\u7530\u4eae\u4ecb\uff0c\u4e09\u6d66\u4e00\u90ce\uff0c\u6751\u7530\u61b2\u5f66\uff0c\u6a4b\u672c\u6674\u6e80\uff0c\u5e61\u591a\u653f\u6cbb\uff0c \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u624b\u8853\u4e0d\u80fd\u5c3f\u7ba1\u764c\u304a\u3088\u3073\u5c3f\u7ba1\u764c\u8853\u5f8c\u5c40\u6240\u518d \u767a\u306b\u5bfe\u3059\u308b\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642\uff08IMRT\uff09\u306e\u691c\u8a0e\uff0eThe outcome of intensity-modulated radiation therapy for inoperable ureter cancer and local recurrence after nephroureterectomy\uff0e\u7b2c55\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c \u6a2a\u6d5c\uff0c2017\uff0c10\uff0e<\/dd>\n<dd>\u6749\u6d66 \u5186\uff0c\u6d77\u6d25 \u4e45\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a \u5316\u5b66\u7642\u6cd5\u62b5\u6297\u6027\u6ffe\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306b\u5bfe\u3057\u3066\u4f4e\u7dda\u91cf\u653e\u5c04\u7dda\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f\u4e00\u4f8b\uff0e\u7b2c63\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a\uff0c \u6a2a\u6d5c\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u4f0a\u85e4\u82f1\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u5ca9\u5d0e\u53f2\u8a18\uff0c\u5f8c\u85e4\u88d5\u660e\uff0c \u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u3073\u307e\u3093\u6027\u6a4b\u81a0\u816b\u306b\u5bfe\u3059\u308b\u5be1\u5206\u5272\u7167\u5c04\uff0e\u7b2c63\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a\uff0c \u6a2a\u6d5c\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u6d77\u6d25 \u4e45\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u5149\u85e4\u5065\u53f8\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u5c0f\u6cc9\u654f\u4e4b\uff0c \u5411\u4e95\u4f51\u5e0c\uff0c\u9ad8\u91ce\u7965\u5b50\uff0c\u4f0a\u85e4\u82f1\u5b50\uff0c\u6749\u6d66 \u5186\uff0c\u85e4\u5185 \u795d\uff0c \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u53e3\u8154\u764c\u306b\u5bfe\u3059\u308b\u8d85\u9078\u629e\u7684\u52d5\u6ce8\u5316\u5b66\u653e\u5c04\u7dda \u7642\u6cd5\uff1a\u7dcf\u7dda\u91cf60Gy \u672a\u6e80\u3067\u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u5411\u4e95\u4f51\u5e0c\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u6797 \u6210\u5f66\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u5c0f\u6c60 \u6cc9\uff0c \u6d77\u6d25 \u4e45\uff0c\u9ad8\u91ce\u7965\u5b50\uff0c\u6749\u6d66 \u5186\uff0c\u4f0a\u85e4\u82f1\u5b50\uff0c\u77e2\u5c3e\u6b63\u7950\uff0c \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u524d\u7acb\u817a\u764c\u306e125\u2160\u30b7\u30fc\u30c9\u6cbb\u7642\u306b\u4f75\u7528\u3055\u308c \u308b3DCRT \u3068 IMRT \u306e\u6bd4\u8f03\u691c\u8a0e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff0c\u91ce\u5d0e\u592a\u5e0c\uff0c\u6817\u539f\u6cf0\u4e4b\uff0c\u53f3\u7530\u7f8e\u91cc\uff0c\u677e\u85e4 \u51e1\uff1a \u4f1a\u9670\u90e8\u4e73\u5150\u8840\u7ba1\u816b\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305f PELVIS \u75c7\u5019\u7fa4\u306e 2 \u75c7\u4f8b\uff0e\u7b2c53\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0c\u6a2a\u6d5c\uff0c 2017\uff0c6\uff0e<\/dd>\n<dd>\u5ca1\u90e8\u54f2\u5f66\uff0c\u76f8\u7530\u5178\u5b50\uff1a\u5148\u5929\u4ee3\u8b1d\u75c5\u306e\u753b\u50cf\u8a3a\u65ad\uff0e\u7b2c53\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a\uff0c\u677e\u5c71\uff0c2017\uff0c9\uff0e<\/dd>\n<dd>\u4f50\u85e4\u745e\u5e0c\uff0c\u5c0f\u7530\u5207\u4e00\u5c06\uff0c\u6749\u6d66 \u5186\uff0c\u592a\u7530\u7d14\u4e00\uff0c\u5c0f\u677e\u5f18\u4e00\uff0c \u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u524d\u7acb\u817a\u764c3D-CRT \u5f8c\u306e\u76f4\u8178\u51fa\u8840\u767a\u751f\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u4f50\u85e4\u745e\u5e0c\uff0c\u6749\u6d66 \u5186\uff0c\u5c0f\u7530\u5207\u4e00\u5c06\uff1a\u524d\u7acb\u817a\u764c3D-CRT \u306b\u304a\u3051\u308b\u76f4\u8178\u51fa\u8840\u767a\u751f\u983b\u5ea6\u306b\u95a2\u3059\u308b\u691c\u8a0e\uff0e\u7b2c61\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c3\uff0e<\/dd>\n<dd>\u9752\u6728 \u4eae\uff0c\u5b87\u6d25\u6728\u7fd4\u5e73\uff0c\u897f\u4e95\u4fca\u6676\uff1aPleuropulmonary paragonimus westermani in human\uff0cdiagnosed by pleural biopsy\uff0e\u7b2c451\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u9752\u6728 \u4eae\uff0c\u5c71\u672c \u7d71\uff0c\u53e4\u90e1\u614e\u592a\u90ce\uff0c\u897f\u4e95\u4fca\u660c\uff0c\u95a2\u5ddd\u5584\u4e8c\u90ce\uff0c\u7af9\u6797\u8302\u751f\uff1a\u30d0\u30eb\u30fc\u30f3\u88dc\u52a9\u306b\u3088\u308b\u8840\u7ba1\u9078\u629e\u3067\u52d5\u8108\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u5f97\u305f\u8179\u76f4\u7b4b\u8840\u816b\u306e 1 \u4f8b\uff0e\u6551\u6025\u30fb\u5916\u50b7 IVR \u75c7\u4f8b\u691c\u8a0e\u4f1a\uff0c\u6771\u4eac\uff0c2017\uff0c12\uff0e<\/dd>\n<dd>\u5927\u6751\u7d20\u5b50\uff1a\u5c0f\u5150\u56fa\u5f62\u816b\u760d\u306e\u653e\u5c04\u7dda\u6cbb\u7642\uff0e\u7b2c76\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\u6559\u80b2\u8b1b\u6f14\uff0c\u6a2a\u6d5c\uff0c2017\uff0c4\uff0e<\/dd>\n<dd>\u5927\u6751\u7d20\u5b50\uff1a\u5c0f\u5150\u56fa\u5f62\u60aa\u6027\u816b\u760d\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u8a08\u753b\uff0e\u653e\u5c04\u7dda\u816b\u760d\u533b\u304c\u753b\u50cf\u8a3a\u65ad\u533b\u306b\u671f\u5f85\u3059\u308b\u3053\u3068\uff0e\u7b2c53\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a \u5c0f\u5150\u6838\u533b\u5b66\u7814\u7a76\u4f1a \u5408\u540c\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u5c0f\u5150\u56fa\u5f62\u304c\u3093\u3078\u306e\u6311\u6226 : \u8a3a\u65ad\u3068\u6cbb\u7642\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1a\u6838\u533b\u5b66\u5c02\u9580\u533b\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u6838\u533b\u5b66\u6307\u5c0e\u8005\u30b3\u30fc\u30b9 \u816b\u760d\u6838\u533b\u5b66\uff08\u672c\u90a6\u306b\u304a\u3051\u308b\u6700\u65b0\u306e\u30c8\u30d4\u30c3\u30af\uff09\uff0e\u7b2c17\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a\uff0c\u6771\u4eac\uff0c2017\uff0c4\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1aSymposium 1 \u304c\u3093\u8a3a\u7642\u306b\u304a\u3051\u308b\u6297\u4f53 PET \u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff0e\u7b2c12\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c5\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff1aPET \u6838\u533b\u5b66\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\u300cPET \u65b0\u898f\u6280\u8853\u306e\u81e8\u5e8a\u5c0e\u5165\u306b\u5411\u3051\u305f\u74b0\u5883\u6574\u5099\u300d\u4e2d\u6027\u5b50\u6355\u7372\u7642\u6cd5\u306b\u304a\u3051\u308b FBPA \u306e\u5229\u7528\uff0e\u7b2c57\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c10\uff0e<\/dd>\n<dd>\u5c0f\u7530\u5207\u4e00\u5c06\uff0c\u4f50\u85e4\u745e\u5e0c\uff1a\u30a2\u30d6\u30b9\u30b3\u30d1\u30eb\u52b9\u679c\u3068\u601d\u308f\u308c\u308b\u6cbb\u7642\u7d4c\u904e\u3092\u793a\u3057\u305f\u5b50\u5bae\u9838\u764c\u306e\u4e00\u4f8b\uff0e\u7b2c61\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c3\uff0e<\/dd>\n<dd>\u5c0f\u7530\u5207\u4e00\u5c06\uff0c\u4f50\u85e4\u745e\u5e0c\uff0c\u8302\u7530\u535a\u884c\uff0c\u6797 \u5b8f\u884c\uff0c\u6749\u6d66 \u5186\uff0c \u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u30a2\u30d6\u30b9\u30b3\u30d1\u30eb\u52b9\u679c\u3068\u601d\u308f\u308c\u308b \u6cbb\u7642\u7d4c\u904e\u3092\u793a\u3057\u305f\u5b50\u5bae\u9838\u764c\u306e\u4e00\u4f8b\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff0c\u76f8\u7530\u5178\u5b50\uff0c\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff0c\u5e73\u5c71\u9ebb\u5229\u5b50\uff1a5\uff0c10- \u30e1\u30c1\u30ec\u30f3\u30c6\u30c8\u30e9\u30d2\u30c9\u30ed\u8449\u9178\u9084\u5143\u9175\u7d20\uff08MTHFR\uff09\u6b20\u640d\u75c7\u306e\u4e00\u4f8b\uff0e\u7b2c37\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7\uff0c\u5c90\u961c\uff0c 2017\uff0c6\uff0e<\/dd>\n<dd>\u7530\u5c71\u7531\u7f8e\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u677e\u4e95\u8b19\u543e\uff0c\u4f50\u85e4\u6676\u5b50\uff0c\u672c\u90f7\u79c0\u5e78\uff0c \u767d\u7530\u4eae\u4ecb\uff0c\u6a4b\u672c\u6674\u6e80\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u653e\u5c04\u7dda \u6cbb\u7642\u671f\u9593\u4e2d\u306e\u814e\u81d3\u306e\u4f4d\u7f6e\u5909\u5316\u306b\u3088\u308a\u7167\u5c04\u306b\u96e3\u6e0b\u3057\u305f\u508d \u5927\u52d5\u8108\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u306e 1 \u4f8b\uff0e\u7b2c451\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u7530\u5c71\u7531\u7f8e\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u677e\u4e95\u8b19\u543e\uff0c\u4f50\u85e4\u6676\u5b50\uff0c\u672c\u90f7\u79c0\u5e78\uff0c \u767d\u7530\u4eae\u4ecb\uff0c\u7530\u4e2d\u6c5f\u91cc\uff0c\u7389\u4e95\u6d0b\u592a\u90ce\uff0c\u6a4b\u672c\u6674\u6e80\uff0c\u5e61\u591a\u653f \u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u8840\u6db2\u75be\u60a3\u306b\u3088\u308b\u810a\u9ac4\u5727\u8feb\u75c7\u5019\u7fa4\u306b\u5bfe \u3059\u308b\u7dca\u6025\u7167\u5c04\u306e\u691c\u8a0e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u4f50\u85e4\u6676\u5b50\uff0c\u5927\u6751\u7d20\u5b50\uff0c\u677e\u4e95\u8b19\u543e\uff0c\u7530\u5c71\u7531\u7f8e\u5b50\uff0c\u672c\u90f7\u79c0\u5e78\uff0c \u767d\u7530\u4eae\u4ecb\uff0c\u5c71\u4e0b\u90e8 \u4e98\uff0c\u658e\u85e4\u304b\u304a\u308a\uff0c\u6a4b\u672c\u6674\u6e80\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642\uff08IMRT\uff09\u3092\u7528\u3044 \u305f oligo-recurrence \u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u77f3\u6a4b\u76f4\u4e5f\uff0c\u526f\u5cf6\u4fca\u5178\uff0c\u5ddd\u53e3\u5f18\u6bc5\uff0c\u79cb\u5ead\u5065\u5fd7\uff0c\u9577\u8c37\u5ddd\u6b63\u4fca\uff0c \u78ef\u90e8\u516c\u4e00\uff0c\u4f0a\u85e4 \u4ec1\uff0c\u4eca\u4e95\u7f8e\u667a\u5b50\uff0c\u6c5f\u5cf6\u6cf0\u751f\uff0c\u7b39\u4e95\u5553\u8cc7\uff0c\u4e0b\u7530\u7d75\u7f8e\u5b50\uff0c\u5c0f\u53e3\u6b63\u5f66\uff0c\u79cb\u5143\u54f2\u592b\uff0c\u5e61\u591a\u653f\u6cbb\uff0c\u524d \u6797\u4fca\u4e5f\uff1a\u9aa8\u9ac4\u7834\u58ca\u7684\u524d\u51e6\u7f6e\u3068\u3057\u3066\u306e\u5168\u8eab\u7167\u5c04\uff08TBI\uff09 \u306e\u5168\u56fd\u8abf\u67fb\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u6a2a\u6e9d\u7531\u7f8e\u5b50\uff0c\u4e0a\u6751\u535a\u53f8\uff0c\u65b0\u5800\u840c\u9999\uff0c\u8352\u6728\u3042\u305a\u307f\uff0c\u9022\u5742\u516c\u4eba\uff0c\u84ee\u898b\u58fd\u53f2\uff0c\u6797 \u6210\u5f66\uff0c\u69d9\u5c71\u548c\u79c0\uff0c\u8fd1\u85e4\u6176\u4e00\uff0c\u4e2d\u4e95\u5ddd \u6607\uff0c\u77e2\u5c3e\u6b63\u7950\uff0c\u7cdf\u8c37\u5065\u592b\uff0c\u5e61\u591a\u653f\u6cbb\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u30cf\u30a4\u30ea\u30b9\u30af\u524d\u7acb\u817a\u764c\u306b\u5bfe\u3059\u308b\u5185\u5206\u6ccc\u7642\u6cd5\u4f75\u7528 IMRT \u306e\u6cbb\u7642\u6210\u7e3e\uff0e\u7b2c105\u56de\u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u9e7f\u5150\u5cf6\uff0c 2017\uff0c4\uff0e<\/dd>\n<dd>\u5c0f\u539f\u5927\u5730\uff1a\u4e21\u5074\u4e0a\u90e8\u5c3f\u8def\u3092\u4e3b\u4f53\u3068\u3059\u308b\u60aa\u6027\u30ea\u30f3\u30d1\u816b\uff0e\u7b2c451\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5b9a\u671f\u5927\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c6\uff0e<\/dd>\n<dd>\u592a\u7530\u8aa0\u5fd7\uff0c\u5e2f\u5200\u5149\u53f2\uff0c\u5ca9\u6e15\u5b66\u8af8\uff0c\u65e5\u66ae\u96c5\u4e00\uff0c\u6a2a\u7530\u5c1a\u6a39\uff0c \u6751\u4e95\u592a\u90ce\uff0c\u5c0f\u6c60 \u6cc9\uff0c\u4e95\u4e0a\u5149\u5e83\uff1a\u9ac4\u819c\u816b\u306b\u5bfe\u3059\u308b\u30b5\u30a4\u30d0\u30fc\u30ca\u30a4\u30d5\u3092\u7528\u3044\u305f\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\uff0e\u65e5\u672c\u8133\u795e\u7d4c\u5916\u79d1\u5b66\u4f1a\u7b2c76\u56de\u5b66\u8853\u7dcf\u4f1a\uff0c\u540d\u53e4\u5c4b\uff0c2017\uff0c10\uff0e<\/dd>\n<dd>\u4e95\u4e0a\u5149\u5e83\uff0c\u5927\u5ddd\u6d69\u5e73\uff0c\u5ee3\u7530\u4f73\u53f2\uff0c\u7530\u53e3\u7d14\u4e00\uff0c\u5c0f\u6c60 \u6cc9\uff0c \u5ca9\u6e15\u5b66\u7dd2\uff0c\u5e2f\u5200\u5149\u53f2\uff0c\u592a\u7530\u8aa0\u5fd7\uff1aCyberKnife \u306b\u3088\u308b\u52d5\u4f53\u8ffd\u5c3e\u7167\u5c04\u306e\u8ffd\u5c3e\u7cbe\u5ea6\u306b\u5bfe\u3057\u3066\u816b\u760d\u3068\u4f53\u8868\u306e\u4f4d\u76f8\u5dee\u304c\u4e0e\u3048\u308b\u5f71\u97ff\uff0e\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c30\u56de\u5b66\u8853\u5927\u4f1a\uff0c\u5927\u653e\u5c04\u7dda\u533b\u5b66\uff0c\u7cbe\u795e\u533b\u5b66\u962a\uff0c2017\uff0c11\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u4e95\u4e0a\u767b\u7f8e\u592b\uff08\u5206\uff09\uff1aPET-CT \u7b49\u306b\u3088\u308b\u5b9a\u91cf\u7684\u533b\u5b66\u753b\u50cf\u8a3a\u65ad\u624b\u6cd5\u306e\u78ba\u7acb\u3068\u30b3\u30f3\u30d1\u30cb\u30aa\u30f3\u8a3a\u65ad\u3078\u306e\u5fdc\u7528\uff0e\u5e73\u621029\u5e74\u5ea6\u79d1\u5b66\u7814\u7a76\u88dc\u52a9\u91d1 \u57fa\u76e4\u7814\u7a76\uff08B\uff09\uff0c30\u4e07\u5186\uff0e<\/dd>\n<dd>\u4e95\u4e0a\u767b\u7f8e\u592b\uff08\u5206\uff09\uff1a\u30b2\u30ce\u30e0\u7de8\u96c6\u6280\u8853\u3092\u5fdc\u7528\u3057\u305f\u65b0\u898f\u907a\u4f1d\u5b50\u767a\u73fe\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u6cd5\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u5e73\u621029\u5e74\u5ea6\u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1 \u6311\u6226\u7684\u840c\u82bd\u7814\u7a76\uff0c10\u4e07\u5186\uff0e \u5e61\u591a\u653f\u6cbb\uff08\u4ee3\uff09\uff1a\u4f53\u5e79\u90e8\u653e\u5c04\u7dda\u6cbb\u7642\u306b\u304a\u3051\u308b\u547c\u5438\u6027\u79fb\u52d5\u2500\u56db\u6b21\u5143\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u89e3\u6790\u3068\u6cbb\u7642\u6cd5\u306e\u6a19\u6e96\u5316\u2500\uff0e\u6587\u90e8\u79d1\u5b66\u7701\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1\u57fa\u76e4\u7814\u7a76\uff08C\uff09\uff08\u5e73\u621029\uff0d31\u5e74\u5ea6\uff09\uff0c260\u4e07\u5186\uff08416\u4e07\u5186\uff09\uff0e<\/dd>\n<dd>\u91d1\u7530\u670b\u6d0b\uff08\u5206\uff09\uff1a\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u306e\u305f\u3081\u306e\u65b0\u305f\u306a PET \u85ac\u5264\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u5e73\u621029\u5e74\u5ea6\u56fd\u7acb\u304c\u3093\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u7814\u7a76\u958b\u767a\u8cbb \u98db\u5185\u73ed\uff08\u5bfa\u5185\u5c0f\u73ed\uff09\u5206\u62c5\u7814\u7a76\u8005\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u5206\uff09\uff1a\u5148\u5929\u6027\u547c\u5438\u5668\u30fb\u80f8\u90ed\u5f62\u6210\u7570\u5e38\u75be\u60a3\u306b\u95a2\u3059\u308b\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u306a\u3089\u3073\u306b\u8a3a\u7642\u4f53\u5236\u306e\u69cb\u7bc9\u30fb\u666e\u53ca\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u5927\u962a\u5e9c\u7acb\u6bcd\u5b50\u4fdd\u5065\u7dcf\u5408\u533b\u7642\u30bb\u30f3\u30bf\u30fc \u96e3\u6cbb\u6027\u75be\u60a3\u7b49\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09\uff0c16\u4e07\u5186\uff0e<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u4ee3\uff09\uff1a3T \u88c5\u7f6e MRS \u306b\u3088\u308b\u5c0f\u5150\u8133\u5185\u4ee3\u8b1d\u7269\u30fb\u795e\u7d4c\u4f1d\u9054\u7269\u8cea\u306e\u5927\u8133\u30fb\u5c0f\u8133\u3067\u306e\u5b9a\u91cf\uff0e\u5e73\u621029\u5e74\u5ea6\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1\uff08\u6587\u90e8\u79d1\u7814\uff09\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d\uff0c331,490\u5186\uff0e<\/dd>\n<dd>\u81fc\u4e95\u898f\u6717\uff0c\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1a\u8133\u30af\u30ec\u30a2\u30c1\u30f3\u6b20\u4e4f\u75c7\u5019\u7fa4\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u6cbb\u7642\u53ef\u80fd\u306a\u77e5\u7684\u969c\u5bb3\u75c7\u5019\u7fa4\u306e\u81e8\u5e8a\u7814\u7a76\uff0e\u4eac\u90fd\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7814\u7a76\u79d1 \u51c6\u6559\u6388 \u548c\u7530\u656c\u4ec1\uff0c5 \u4e07\u5186\uff0e<\/dd>\n<dd>\u91ce\u6fa4\u4e45\u7f8e\u5b50\uff08\u7814\u7a76\u5354\u529b\u8005\uff09\uff1a\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\u5c0f\u5150\u304a\u3088\u3073 AYA \u4e16\u4ee3\u306e\u6a2a\u7d0b\u7b4b\u8089\u816b\u304a\u3088\u3073\u30e6\u30fc\u30a4 \u30f3\u30b0\u8089\u816b\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30ea\u30b9\u30af\u5c64\u5225\u5316\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u306b\u3088\u308b\u6a19\u6e96\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a\uff0e\u5e73\u621029\u5e74\u5ea6 AMED \u59d4\u8a17\u8cbb\uff0c\u4eac\u90fd\u5e9c\u7acb\u533b\u79d1\u5927\u5b66\u5927\u5b66\u9662\u7814\u7a76\u79d1\u5c0f\u5150\u79d1\u5b66 \u7d30\u4e95 \u5275\uff0e \u6817\u539f\u5b8f\u660e\uff08\u4ee3\uff09\uff1a\u304c\u3093\u306e\u65e9\u671f\u767a\u898b\u3068\u9069\u683c\u6cbb\u7642\u306e\u65e9\u671f\u8a3a\u65ad\u306b\u8cc7\u3059\u308b PET \u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u958b\u767a\uff0e\u5e73\u621029\u5e74\u5ea6 AMED\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff0c1\uff0c989\u4e07\u5186\uff0e<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u4ee3\uff09\uff1a\u65e5\u672c\u767a\u653e\u5c04\u6027\u85ac\u526464Cu-ATSM \u3092\u7528\u3044\u305f\u60aa\u6027\u8133\u816b\u760d\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u7814\u7a76\uff0e\u9769\u65b0\u7684\u533b\u7642\u30b7\u30fc\u30ba\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff0c9\uff0c997\u4e07\u5186\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u305d\u306e\u4ed6\u8b1b\u6f14<\/h3>\n<\/dt>\n<dd>Hata M: Radiation therapy for breast cancer. Project for improvement of the national program for early detection of breast cancer in Serbia\uff08JICA\uff09, Yokohama, 2017, 6.<\/dd>\n<dd>Kaneta T\uff1a SPECT and PET imaging for the diagnosis of dementia. 2nd Cognitive Impairment Symposium, Shanghai, 2017, 5.<\/dd>\n<dd>\u91d1\u7530\u670b\u6d0b\uff1a\u6838\u533b\u5b66\u7dcf\u8ad6\u30fbRI \u5185\u7528\u7642\u6cd5\uff0e\u30ec\u30b8\u30c7\u30f3\u30c8\u30bb\u30df\u30ca\u30fc\uff0c\u6771\u4eac\uff0c2017\uff0c11\uff0e<\/dd>\n<dd>\u91d1\u7530\u670b\u6d0b\uff1aPET \u691c\u67fb\u306b\u304a\u3051\u308b18F \u5229\u7528\uff0eJSPS \u7b2c155\u59d4\u54e1\u4f1a\u4e3b\u50ac\u8b1b\u6f14\u4f1a\u300c\u30d5\u30c3\u7d20\u3068\u533b\u7642\u306e\u7814\u7a76\u6700\u524d\u7dda\u300d\uff0c\u6850\u751f\uff0c 2017\uff0c12\uff0e<\/dd>\n<dd>\u6749\u6d66 \u5186\uff0c\u5c3e\u5ddd\u677e\u7fa9\uff1a\u30b8\u30e5\u30cb\u30a2\u30bb\u30df\u30ca\u30fcin \u6a2a\u6d5c\u300e\u6559\u3048\u3066\uff01\u5b87\u5b99\u3067\u6d3b\u52d5\u3059\u308b\u6280\u8853\uff0c\u653e\u5c04\u7dda\u304c\u898b\u305b\u308b\u4e16\u754c\u300f\uff0e\u7b2c57 \u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2017\uff0c10\uff0e<\/dd>\n<dd>Hata M: Top Reviewers Award. The Outstanding Reviewer of the International Journal of Radiation Oncology, Biology, Physics. American Society for Radiation Oncology\uff08ASTRO\uff09, 2017, 7.<\/dd>\n<dd>Hata M: Publons Peer Review Awards. The top peer reviewers. Publons, 2017, 9.<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<div class=\"change_elem_panel\">\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u539f\u8457\u8ad6\u6587<\/h3>\n<\/dt>\n<dd>Shimizu M, Mitsudo K, Koike I, Taguri M, Iwai T, Koizumi T, Oguri S, Kioi M, Hirota M, Inoue T, Tohnai I: Prognostic value of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography for patients with oral squamous cell carcinoma treated with retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy. Oral and Maxillofacial surgery, 121(3): 239-247, 2016.<\/dd>\n<dd>Kaneta T, Ogawa M, Daisaki H, Nawata S, Yoshida K, Inoue T:SUV measurement of normal vertebrae using SPECT\/CT with Tc-99m methylene diphosphonate. Am J Nucl Med Mol Imaging, 6(5): 262-268, 2016.<\/dd>\n<dd>Nishimura G, Komatsu M, Hata M, Yabuki K, Taguchi T, Takahashi M, Shiono O, Sano D, Arai Y, Takahashi H, Chiba Y, Oridate N: Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy. Int J Clin Oncol, 21(2): 224-230, 2016.<\/dd>\n<dd>Nishimura G, Taguchi T, Takahashi M, Shiono O, Komatsu M, Sano D, Yabuki K, Arai Y, Takahashi H, Hata M, Oridate N: Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma. Cancer Chemother Pharmacol, 77(6): 1315-1319, 2016.<\/dd>\n<dd>Nishimura G, Yabuki K, Hata M, Komatsu M, Taguchi T, Takahashi M, Shiono O, Sano D, Arai Y, Takahashi H, Chiba Y, Oridate N: Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma. Int J Clin Oncol, 21(4): 658-667, 2016.<\/dd>\n<dd>Ishibashi N, Hata M, Mochizuki T, Ogawa K, Sugiura H, Takekawa Y, Maebayashi T, Aizawa T, Sakaguchi M, Abe O: Radiation therapy for primary breast lymphoma in male gynecomastia: a rare case report and review of the literature. Int J Hematol, 104(4): 519-524, 2016.<\/dd>\n<dd>Yabuki K, Sano D, Shiono O, Arai Y, Takahashi H, Chiba Y, Tanabe T, Nishimura G, Takahashi M, Taguchi T, Kaneta T, Hata M, Oridate N: Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapy. Head Neck, 38(11): 1666-1671, 2016.<\/dd>\n<dd>Yoshida K, Kaneta T, Takano S, Sugiura M, Kawano T, Hino A, Yamamoto T, Shizukuishi K, Kaneko M, Zurth C, Inoue T :Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases. Ann Nucl Med, 30(7): 453-460, 2016.<\/dd>\n<dd>Kobayashi K, Kurihara H, Watanabe Y, Murakami N, Inaba K, Nakamura S, Wakita A, Okamoto H, Umezawa R, Takahashi K, Igaki H, Ito Y, Yoshimoto S, Shigematsu N, Itami J: In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer. Appl Radiat Isot, 115: 138-146, 2016.<\/dd>\n<dd>Gobara H, Arai Y, Kobayashi T, Yamakado K, Inaba Y, Kodama Y, Yamagami T, Sone M, Watanabe H, Okumura Y, Shinya T, Kurihara H, Kanazawa S: Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702). Jpn J Radiol, 34: 556-563, 2016.<\/dd>\n<dd>Kurihara H, Shimizu C, Miyakita Y, Yoshida M, Hamada A, Kanayama Y, Yonemori K, Hashimoto J, Tani H, Kodaira M, Yunokawa M, Yamamoto H, Watanabe Y, Fujiwara Y, Tamura K: Molecular imaging using PET for breast cancer. Breast Cancer, 23(1): 24-32, 2016.<\/dd>\n<dd>Iwasawa T, Kanauchi T, Hoshi T, Ogura T, Baba T, Gotoh T, Oba MS: Multicenter study of quantitative computed tomography analysis using a computer-aided three-dimensional system in patients with idiopathic pulmonary fibrosis. Jpn J Radiol, 34(1): 16-27, 2016.<\/dd>\n<dd>Hosoda C, Baba T, Hagiwara E, Ito H, Matsuo N, Kitamura H, Iwasawa T, Okudela K, Takemura T, Ogura T: Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis. Respirology, 21(5): 920-926, 2016.<\/dd>\n<dd>Yamakawa H, hagiwara E, Kitamura H, Yamanaka Y, Ikeda S, Sekine A, Baba T, Iso S, Okudela K, Iwasawa T, Takemura T, Kuwano K, and Ogura T: Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis. PLoS One, 11(8): e0161908129, 2016.<\/dd>\n<dd>Tomiyasu M, Aida N, Shibasaki J, Tachibana Y, Endo M, Nozawa K, Shimizu E, Tsuji H, Obata T: Normal lactate concentration range in the neonatal brain. Magn Reson Imaging, 34(9): 1269-1273, 2016.<\/dd>\n<dd>Tsujimoto S, Yanagimachi M, Tanoshima R, Urayama KY, Tanaka F, Aida N, Goto H, Ito S: Influence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignancies. Pediatr Blood Cancer, 63(11): 1983-1989, 2016.<\/dd>\n<dd>Aida N, Niwa T, Fujii Y, Nozawa K, Enokizono M, Murata K, Obata T: Quiet T1-Weighted Pointwise Encoding Time Reduction with Radial Acquisition for Assessing Myelination in the Pediatric Brain. AJNR Am J Neuroradiol, 37(8): 1528-1534, 2016.<\/dd>\n<dd>Nakashima M, Takano K, Tsuyusaki Y, Yoshitomi S, Shimono M, Aoki Y, Kato M, Aida N, Mizuguchi T, Miyatake S, Miyake N, Osaka H, Saitsu H, Matsumoto N: WDR45 mutations in three male patients with West syndrome. J Hum Genet, 61(7): 653-661, 2016.<\/dd>\n<dd>Niwa T, de Vries LS, Manten GT, Lequin M, Cuppen I, Shibasaki J, Aida N: Interhemispheric Lipoma, Callosal Anomaly, and Malformations of Cortical Development: A Case Series. Neuropediatrics, 47(2): 115-118, 2016.<\/dd>\n<dd>Tomotaki S, Shibasaki J, Yunoki Y, Kishigami M, Imagawa T, Aida N, Toyoshima K, Itani Y: Effectiveness of Corticosteroid Therapy for Acute Neurological Symptoms in Incontinentia Pigmenti. Pediatr Neurol, 56: 55-58, 2016.<\/dd>\n<dd>Takano K, Shiba N, Wakui K, Yamaguchi T, Aida N, Inaba Y, Fukushima Y, Kosho T: Elevation of neuron specific enolase and brain iron deposition on susceptibility-weighted imaging as diagnostic clues for beta-propeller protein-associated neurodegeneration in early childhood: Additional case report and review of the literature. Am J Med Genet A, 170A(2): 322-328, 2016.<\/dd>\n<dd>\u4e95\u4e0a\u5149\u5e83, \u7a32\u7530\u8015\u4f5c, \u7530\u53e3\u7d14\u4e00, \u5927\u5ddd\u6d69\u5e73, \u5c0f\u6c60\u6cc9, \u5ca9\u6e15\u5b66\u8af8, \u65e5\u66ae\u96c5\u4e00, \u5e2f\u5200\u5149\u53f2, \u592a\u7530\u8aa0\u5fd7: \u80ba\u304c\u3093\u6cbb\u7642\u306b\u304a\u3051\u308bCyberKnife (Fiducial-free lung tracking) \u306e\u816b\u760d\u4f4d\u7f6e\u8a8d\u8b58\u7cbe\u5ea6\u306b\u3064\u3044\u3066 Accuracy of the Fiducial-free lung tracking with CyberKnife in the treatment of lung cancer. \u5b9a\u4f4d\u7684\u653e\u5c04\u7dda\u6cbb\u7642, 20: 119-124, 2016.<\/dd>\n<dd>\u65e5\u91ce\u5f69\u5b50, \u91d1\u7530\u670b\u6d0b, \u5409\u7530\uff4d\u5553\u4ecb, \u7c73\u5c71\u667a\u5553, \u5ddd\u91ce\u525b, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a \u5168\u8eab\u578b\u82e5\u5e74\u6027\u7279\u767a\u6027\u95a2\u7bc0\u708e\u306b\u304a\u3051\u308bFDG\uff0dPET\u3092\u7528\u3044\u305f\u75be\u60a3\u6d3b\u52d5\u6027\u8a55\u4fa1\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u81e8\u5e8a\u653e\u5c04\u7dda, 61(7): 921-927, 2016.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7dcf\u8aac<\/h3>\n<\/dt>\n<dd>\u5c0f\u6c60\u3000\u6cc9, \u5e61\u591a\u653f\u6cbb, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u6ccc\u5c3f\u5668\u79d1\u533b\u306e\u305f\u3081\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u8b1b\u5ea7\u300c\u653e\u5c04\u7dda\u306e\u57fa\u790e\uff1a\u6838\u533b\u5b66\u5206\u91ce\u300d. \u81e8\u5e8a\u6ccc\u5c3f\u5668\u79d1, 70(9): 650-654, 2016.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075 : \u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306e\uff23\uff21\uff24, \u65e5\u672c\u80f8\u90e8\u81e8\u5e8a, 75(4): 366-382, 2016.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u8efd\u5ea6\u306e\u9593\u8cea\u6027\u9670\u5f71,\u753b\u50cf\u3067\u307f\u304b\u3051\u308b\u5076\u767a\u7684\u6240\u898b\u306e\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8. \u753b\u50cf\u8a3a\u65ad, 36 (9): 864-865, 2016.<\/dd>\n<dd>\u4e8c\u6728\u5c06\u660e, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u8ee2\u79fb\u6027\u809d\u816b\u760d\u306e\u753b\u50cf\u8a3a\u65ad. \u81e8\u5e8a\u5916\u79d1, 71(12): 1338-1342, 2016.<\/dd>\n<dd>\u6e21\u90e8\u6210\u5ba3, \u837b\u91ce\u4f0a\u77e5\u6717, \u570b\u5d0e\u4e3b\u7a0e, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u98df\u9053\u304c\u3093\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306b\u767a\u751f\u3057\u305f\u653e\u5c04\u6027\u80ba\u969c\u5bb3. \u81e8\u5e8a\u653e\u5c04\u7dda, 61(8): 1001-1011, 2016.<\/dd>\n<dd>\u98ef\u585a \u5747\uff0c\u91d1\u7530 \u670b\u6d0b\uff0c\u4e95\u4e0a \u767b\u7f8e\u592b\uff1a\u6700\u65b0\u578bPET\/CT\u88c5\u7f6eCelesteion\u306b\u671f\u5f85\u3055\u308c\u308b\u767a\u5c55\u6027\u3092\u8003\u3048\u308b\uff0e\u6708\u520a\u65b0\u533b\u7642\uff0c43(3): 33-35\uff0c2016\uff0e<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u8457\u66f8<\/h3>\n<\/dt>\n<dd>\u5ca9\u6fa4\u591a\u6075(\u5206\u62c5\u57f7\u7b46): \u753b\u50cf\u8a3a\u65ad\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3 2016\u5e74\u7248. \u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a \u65e5\u672c\u653e\u5c04\u7dda\u79d1\u5c02\u9580\u533b\u4f1a\u30fb\u533b\u4f1a\u7de8, 170-171, 2016.<\/dd>\n<dd>\u65e5\u91ce\u5f69\u5b50,\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u65b0\u7248 \u653e\u5c04\u7dda\u533b\u79d1\u5b66 \u2500\u751f\u4f53\u3068\u653e\u5c04\u7dda\u30fb\u96fb\u78c1\u6ce2\u30fb\u8d85\u97f3\u6ce2\u2500. \u533b\u7642\u79d1\u5b66\u793e, 91-93, 2016.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u5b66\u4f1a\u767a\u8868<\/h3>\n<\/dt>\n<dd>Hata M, Wada H, Ogino I, Omura M, Koike I, Tayama Y, Odagiri K, Kasuya T, Aihara M, Inoue T: Radiation therapy for angiosarcoma of the scalp: total scalp irradiation with X-rays and electrons. The 35th European Society for Radiotherapy and Oncology (ESTRO), Turin, 2016, 4.<\/dd>\n<dd>Kaneta T: SUV measurement of normal vertebrae using SPECT\/CT with Tc-99m methylenediphosphonate . Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016, San Deigo, 2016, 6.<\/dd>\n<dd>Mukai Y\uff1aLocal control and intermediate term cosmetic outcome following IMRT for nasal tumors. AHNS 9th International Conference on Head and Neck Cancer, Seattle, 2016, 7.<\/dd>\n<dd>Ishiwata Y, Kaneta T, Kamide H, Hino A, Yoshida K, Yoneyama T, Kawano T, Inoue T: The maximum blood-subtracted 18F-NaF activity (bsNaFmax) is a good predictor of calcified atherosclerotic plaque growth in the aorta. SNMMI, San Diego, 2016, 6.<\/dd>\n<dd>Iwasawa T, Takemura T, Baba T, Ogura T, and Gotoh T: Certificate of Merit\u53d7\u8cde,Smoking related interstitial lung disease A puzzling problem in interstitial pneumonias. Scientific Assembly and Annual Meetings of Radiological Society of North America, Chicago, 2016, 11.<\/dd>\n<dd>Iwasawa T, Sekine A, Shinohara T, Ogura T, and Gotoh T: The minimum lung area during tidal breathing on Magnetic Resonance Imaging (MRI) correlates with the prognosis of the patients with chronic obstructive pulmonary disease (COPD). Scientific Assembly and Annual Meetings of Radiological Society of North America, Chicago, 2016, 11.<\/dd>\n<dd>Iwasawa T: Magnetic Resonance Imaging for Chronic obstructive lung disease phenotyping. 1st Asia Oceania Workshop of Pulmonary Functional Imaging, \u795e\u6238, 2016, 1.<\/dd>\n<dd>Iwasawa T:\u3000Smoking related lung interstitial pneumonias (DIP, RBILD, and other CT findings in smokers). \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a, \u6a2a\u6d5c, 2016, 4.<\/dd>\n<dd>Fujii Y, Aida N, Niwa T, Enokizono M, Nozawa K, Inoue T: \u512a\u79c0\u6f14\u984c\u8cde\uff08\u540c\u4e0a\uff09. The brainstem in Down syndrome: A Quantitative MRI Study. The 52nd annual meeting of the Japanese Society of Pediatric Radiology 2016, Tokyo, 2016, 6.<\/dd>\n<dd>\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u6838\u533b\u5b66\u753b\u50cf\u8a3a\u65ad. \u7b2c95\u56de\u307f\u3061\u306e\u304f\u6838\u533b\u5b66\u306e\u4f1a, \u4ed9\u53f0, 2016, 2.<\/dd>\n<dd>\u5e61\u591a\u653f\u6cbb, \u5c0f\u6c60\u3000\u6cc9, \u5bae\u57ce\u60a6\u5b50, \u7cdf\u8c37\u5065\u592b, \u6d77\u6d25\u3000\u4e45, \u9ad8\u91ce\u7965\u5b50, \u4f0a\u85e4\u82f1\u5b50, \u6749\u6d66\u3000\u5186, \u6c60\u7530\u5f26\u5927, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a80\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u5b50\u5bae\u9838\u764c\u60a3\u8005\u306e\u653e\u5c04\u7dda\u6cbb\u7642. \u7b2c59\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a, \u6a2a\u6d5c, 2016, 7.<\/dd>\n<dd>\u5e61\u591a\u653f\u6cbb, \u548c\u7530\u79c0\u6587, \u837b\u91ce\u4f0a\u77e5\u6717, \u5927\u6751\u7d20\u5b50, \u5c0f\u6c60\u3000\u6cc9, \u7530\u5c71\u82b3\u53f2, \u5c0f\u7530\u5207\u4e00\u5c06, \u7cdf\u8c37\u5065\u592b, \u6d77\u6d25\u3000\u4e45, \u76f8\u539f\u9053\u5b50, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aRadiation therapy for angiosarcoma of the scalp: total scalp irradiation with X-rays and electrons. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u5c0f\u6c60\u3000\u6cc9, \u5e61\u591a\u653f\u6cbb, \u7cdf\u8c37\u5065\u592b, \u6d77\u6d25\u3000\u4e45, \u9ad8\u91ce\u7965\u5b50, \u4f0a\u85e4\u82f1\u5b50, \u6749\u6d66\u3000\u5186, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aThree cases of primary cutaneous anaplastic large-cell lymphoma treated with EBRT. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u5411\u4e95\u4f51\u5e0c, \u5e61\u591a\u653f\u6cbb, \u5c0f\u6c60\u3000\u6cc9, \u5bae\u57ce\u60a6\u5b50, \u7cdf\u8c37\u5065\u592b, \u6d77\u6d25\u3000\u4e45, \u9ad8\u91ce\u7965\u5b50, \u4f0a\u85e4\u82f1\u5b50, \u6749\u6d66\u3000\u5186, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aThe outcome of radiation therapy for vulvar carcinoma: a single center, 1993-2013. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u4f0a\u85e4\u82f1\u5b50, \u5927\u6751\u7d20\u5b50, \u5e61\u591a\u653f\u6cbb, \u5ca9\u5d0e\u53f2\u8a18, \u5f8c\u85e4\u88d5\u660e, \u91ce\u6fa4\u4e45\u7f8e\u5b50, \u76f8\u7530\u5178\u5b50, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aA trial of hypofractionated radiation therapy for diffuse intrinsic pontine glioma. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u6749\u6d66\u3000\u5186, \u6d77\u6d25\u3000\u4e45, \u4f0a\u85e4\u82f1\u5b50, \u9ad8\u91ce\u7965\u5b50, \u7cdf\u8c37\u5065\u592b, \u5c0f\u6c60\u3000\u6cc9, \u5e61\u591a\u653f\u6cbb, \u5fb3\u4e45\u5143\u5f66, \u4f50\u91ce\u5927\u4ecb, \u6298\u8218\u4f38\u5f66, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aRadiation therapy for massive hypopharyngeal cancer following administration of anti-PD-1 antibody. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50, \u5c0f\u6797\u898f\u4fca, \u5e02\u5ddd\u9756\u53f2, \u5c3e\u5ddd\u677e\u7fa9, \u6751\u4e0a\u670b\u53f2, \u4e2d\u6751\u5eb7\u5f66, \u81fc\u4e95\u6df3\u4e4b, \u9ad8\u7530\u7531\u8cb4, \u6709\u6fa4\u3000\u54f2, \u6c60\u7530\u5f26\u5927, \u4f0a\u85e4\u82f1\u5b50, \u6749\u6d66\u3000\u5186, \u7cdf\u8c37\u5065\u592b, \u6d77\u6d25\u3000\u30fbv, \u5c0f\u6c60\u3000\u6cc9, \u5e61\u591a\u653f\u6cbb, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306b\u5bfe\u3059\u308b\u6838\u533b\u5b66\u5185\u7528\u7642\u6cd5\uff08Peptide Receptor Radionuclide Therapy\uff09\uff5e\u5f53\u9662\u306e\u53d6\u308a\u7d44\u307f\uff5e. \u7b2c59\u56de\u6a2a\u6d5c\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a, \u6a2a\u6d5c, 2016, 7.<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50\uff1aPeptide Receptor Radionuclide Therapy \uff5e\u56fd\u5185\u5c0e\u5165\u306b\u5411\u3051\u305f\u53d6\u308a\u7d44\u307f\uff5e. \u5168\u56fd\u304c\u3093\u30d7\u30ed\u6210\u679c\u5831\u544a\u5e02\u6c11\u516c\u958b\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0, \u6771\u4eac, 2016, 6.<\/dd>\n<dd>\u9ad8\u91ce\u7965\u5b50,\u6749\u6d66\u5186,\u5c3e\u5ddd\u677e\u7fa9,\u6751\u4e0a\u670b\u53f2,\u4e2d\u6751\u5eb7\u5f66,\u81fc\u4e95\u6df3\u4e4b,\u9ad8\u7530\u7531\u8cb4,\u6709\u6fa4\u54f2,\u5c0f\u6797\u5247\u4fca,\u5e02\u5ddd\u9756\u53f2,\u5e61\u591a\u653f\u6cbb\u4e95\u4e0a\u767b\u7f8e\u592b \uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u306e\u56fd\u5185\u52d5\u5411\uff5e\u5f53\u9662\u306e\u53d6\u308a\u7d44\u307f\uff5e. \u962a\u795eTheranostics\u7814\u7a76\u4f1a, \u5175\u5eab, 2016, 9.<\/dd>\n<dd>\u7e04\u7530\u664b\u592a\u90ce\uff0c\u91d1\u7530\u670b\u6d0b\uff0c\u5ddd\u91ce\u3000\u525b\uff0c\u5409\u7530\u5553\u4ecb\uff0c\u5c0f\u6797\u76f4\u5b9f\uff0c\u7a32\u8449\u3000\u88d5\uff0c\u658e\u85e4\u77e5\u4e4b\uff0c\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u6b63\u5e38\u9aa8\u306b\u304a\u3051\u308bNaF\u96c6\u7a4d\u306e\u7a0b\u5ea6\u3068\u5206\u5e03\u306e\u691c\u8a0e\uff0e\u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0c\u6a2a\u6d5c\uff0c2016\uff0c4\uff0e<\/dd>\n<dd>\u5927\u6751\u7d20\u5b50\uff1a\u76f4\u8178\u764c\u8853\u5f8c\u306e\u524d\u7acb\u817a\u764c\u60a3\u8005\u306b\u5bfe\u3059\u308bIMRT\u306e\u6709\u5bb3\u4e8b\u8c61. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u306e\uff23\uff34\u753b\u50cf\u306e\u5b9a\u91cf\u8a55\u4fa1.\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u7814\u7a76\u4f1a \u7b2c2\u56de\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc, \u798f\u5ca1, 2016, 9.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075: \u9593\u8cea\u6027\u80ba\u708e\u306e\u547c\u5438\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3068\u81e8\u5e8a\u5fdc\u7528.\u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a \u30ea\u30d5\u30ec\u30c3\u30b7\u30e3\u30fc\u30b3\u30fc\u30b9, \u6771\u4eac, 2016, 9.<\/dd>\n<dd>\u7530\u5c71\u7531\u7f8e\u5b50, \u5927\u6751\u7d20\u5b50, \u677e\u4e95\u8b19\u543e, \u672c\u90f7\u79c0\u5e78, \u6c38\u7530\u5f18\u5178, \u5409\u7530\u7f8e\u4fdd, \u5c71\u4e0b\u90e8\u4e98, \u658e\u85e4\u304b\u304a\u308a, \u5409\u7530\u3044\u305a\u307f, \u7530\u4e2d\u6c5f\u91cc, \u4e0b\u5c71\u30e9\u30a4, \u6a4b\u672c\u6674\u6e80, \u5e61\u591a\u653f\u6cbb, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u810a\u9ac4\u5727\u8feb\u75c7\u5019\u7fa4\u306b\u5bfe\u3059\u308b\u7dca\u6025\u7167\u5c04\u306e\u691c\u8a0e. \u7b2c54\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6a2a\u6d5c, 2016, 10.<\/dd>\n<dd>\u7530\u5c71\u7531\u7f8e\u5b50, \u5927\u6751\u7d20\u5b50, \u677e\u4e95\u8b19\u543e, \u672c\u90f7\u79c0\u5e78, \u6c38\u7530\u5f18\u5178, \u5409\u7530\u7f8e\u4fdd, \u5c71\u4e0b\u90e8\u4e98, \u658e\u85e4\u304b\u304a\u308a, \u6a4b\u672c\u6674\u6e80, \u5e61\u591a\u653f\u6cbb, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1aDiagnostic process previous to radiotherapy for metastatic spinal cord compression. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a, \u4eac\u90fd, 2016, 11.<\/dd>\n<dd>\u4e8c\u6728\u5c06\u660e, \u5ca9\u6fa4\u591a\u6075, \u95a2\u6839\u6717\u96c5, \u99ac\u5834\u667a\u5c1a, \u5c0f\u5009\u9ad8\u5fd7\uff1a\u9593\u8cea\u6027\u80ba\u708e\u306b\u304a\u3051\u308b\u7d50\u7bc0\u691c\u51fa\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u652f\u63f4\u8a3a\u65ad\u30b7\u30b9\u30c6\u30e0\u306e\u6709\u7528\u6027. \u7b2c45\u56de \u982d\u9838\u90e8\u30fb\u80f8\u90e8\u753b\u50cf\u7814\u7a76\u4f1a, \u6771\u4eac, 2016, 5.<\/dd>\n<dd>\u4e8c\u6728\u5c06\u660e, \u65e5\u91ce\u5f69\u5b50, \u91d1\u7530\u670b\u6d0b, \u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u6162\u6027\u53cd\u5fa9\u6027\u591a\u767a\u6027\u9aa8\u9ac4\u708e\uff08CRMO\uff09\u306b\u9593\u8cea\u6027\u7b4b\u708e\u3092\u5408\u4f75\u3057\u3001\u6838\u533b\u5b66\u691c\u67fb\u304c\u65bd\u884c\u3055\u308c\u305f1\u4f8b. \u7b2c 85 \u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a, \u6771\u4eac, 2016, 7.<\/dd>\n<dd>\u5e73\u5c71\u9ebb\u5229\u5b50, \u9f4b\u85e4\u516c\u5f66, \u963f\u90e8\u793c, \u4e45\u4fdd\u7530\u662d\u5f66, \u5b89\u85e4\u548c\u592b, \u4e2d\u5c71\u5d07, \u9234\u6728\u5eb7\u592a\u90ce\uff1a\u9aa8\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u3067\u539f\u767a\u5de3\u306b\u96c6\u7a4d\u3057\u305f\u8180\u80f1\u764c\u306e2\u4f8b.\u3000\u7b2c450\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a, \u6771\u4eac, 2016, 12.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u7814\u7a76\u52a9\u6210\u91d1<\/h3>\n<\/dt>\n<dd>\u6817\u539f\u5b8f\u660e(\u4ee3)\uff1a\u304c\u3093\u306e\u65e9\u671f\u8a3a\u65ad\u306b\u8cc7\u3059\u308b\u65b0\u898f\u306ePET\u85ac\u5264\u6a19\u8b58\u6280\u8853\u958b\u767a\u3068\u666e\u53ca\u306b\u5411\u3051\u305f\u81ea\u52d5\u5408\u6210\u88c5\u7f6e\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u7814\u7a76\uff0e\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u59d4\u8a17\u8cbb, 2,170\u4e07\u5186.<\/dd>\n<dd>\u6817\u539f\u5b8f\u660e\uff08\u5206\uff09\uff1aF-BPA PET\u691c\u67fb\u306b\u3088\u308bBPA\u4f53\u5185\u5206\u5e03\u8a55\u4fa1\u304a\u3088\u3073\u305d\u306e\u96c6\u7a4d\u5909\u5316\u306e\u7814\u7a76\uff0e\u79d1\u5b66\u7814\u7a76\u8cbb\u52a9\u6210\u4e8b\u696d \u57fa\u76e4\u7814\u7a76\uff08\uff23\uff09, 124\u4e07\u5186.<\/dd>\n<dd>\u5ca9\u6fa4\u591a\u6075\uff08\u4ee3\uff09: \u9593\u8cea\u6027\u80ba\u708e\u306eCT\u753b\u50cf\u89e3\u6790\u306e\u305f\u3081\u306e\u30d5\u30a1\u30f3\u30c8\u30e0\u4f5c\u6210.\u795e\u5948\u5ddd\u770c\u304c\u3093\u7814\u7a76\u57fa\u91d1, 7.8\u4e07\u5186.<\/dd>\n<dd>\u85e4\u4e95\u88d5\u592a\uff08\u4ee3\uff09: \u9759\u97f3\u5316MRI\u201cPETRA\u201d\u3092\u7528\u3044\u305f\u5c0f\u5150\u306e\u753b\u50cf\u8a3a\u65ad\u306b\u95a2\u3059\u308b\u7814\u7a76. \u5e73\u621028\u5e74\u5ea6\u304b\u306a\u304c\u308f\u770c\u7acb\u75c5\u9662\u5c0f\u5150\u533b\u7642\u57fa\u91d1\u7814\u7a76\u52a9\u6210, 33\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u4ee3\uff09\uff1a3T\u88c5\u7f6eMRS\u306b\u3088\u308b\u5c0f\u5150\u8133\u5185\u4ee3\u8b1d\u7269\u30fb\u795e\u7d4c\u4f1d\u9054\u7269\u8cea\u306e\u5927\u8133\u30fb\u5c0f\u8133\u3067\u306e\u5b9a\u91cf. \u5e73\u621028\u5e74\u5ea6\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1, 78\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1a\u65b0\u751f\u5150\u306e\u8907\u5408\u8133\u753b\u50cf\u8a3a\u65ad\u6cd5\u306e\u78ba\u7acb. \u5e73\u621028\u5e74\u5ea6\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a \u5b66\u8853\u7814\u7a76\u52a9\u6210\u57fa\u91d1\u52a9\u6210\u91d1, 52\u4e07\u5186.<\/dd>\n<dd>\u76f8\u7530\u5178\u5b50\uff08\u5206\uff09\uff1a\u8133\u30af\u30ec\u30a2\u30c1\u30f3\u6b20\u4e4f\u75c7\u5019\u7fa4\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u6cbb\u7642\u53ef\u80fd\u306a\u77e5\u7684\u969c\u5bb3\u75c7\u5019\u7fa4\u306e\u81e8\u5e8a\u7814\u7a76. \u5e73\u621028\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1 \u96e3\u6cbb\u6027\u75be\u60a3\u7b49\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09, 10\u4e07\u5186.<\/dd>\n<dd>\u91ce\u5d0e\u4e45\u7f8e\u5b50\uff08\u5206\uff09\uff1a\u5c0f\u5150\u547c\u5438\u5668\u5f62\u6210\u7570\u5e38\u30fb\u4f4e\u5f62\u6210\u75be\u60a3\u306b\u95a2\u3059\u308b\u5b9f\u614b\u8abf\u67fb\u306a\u3089\u3073\u306b\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u306b\u95a2\u3059\u308b\u7814\u7a76. \u5e73\u621028\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\u88dc\u52a9\u91d1 \u96e3\u6cbb\u6027\u75be\u60a3\u7b49\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u653f\u7b56\u7814\u7a76\u4e8b\u696d\uff09, 10\u4e07\u5186.<\/dd>\n<\/dl>\n<dl class=\"contents_list flex_box\">\n<dt>\n<h3>\u305d\u306e\u4ed6\u8b1b\u6f14<\/h3>\n<\/dt>\n<dd>Hata M\uff1aRadiation therapy for breast cancer. Project for improvement of the national program for early detection of breast cancer in Serbia (JICA), Yokohama, 2016, 7.<\/dd>\n<dd>Kaneta T: Image Diagnosis of Dementia using SPECT and PET. 1st Cognitive Impairment Symposium, \u62db\u5f85\u8b1b\u6f14, \u4e0a\u6d77, 2016, 5.<\/dd>\n<dd>Kaneta T: Radionuclide therapy in Japan. Satellite meeting of China-Japan-Korea nuclear medicine congress, \u62db\u5f85\u8b1b\u6f14, \u700b\u967d, 2016, 7.<\/dd>\n<dd>\u91d1\u7530\u670b\u6d0b\uff1a\u653e\u5c04\u7dda\u95a2\u9023\u533b\u85ac\u54c1\u306e\u65b0\u77e5\u898b\u300c\u30aa\u30af\u30c8\u30ec\u30aa\u30b9\u30ad\u30e3\u30f3\u306e\u65b0\u5c55\u958b\u300d. Advanced Medical Imaging \u7814\u7a76\u4f1a\uff08SAMI\uff09, \u6771\u4eac, 2016, 7.<\/dd>\n<dd>\u4e95\u4e0a\u767b\u7f8e\u592b\uff1a\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u306b\u304a\u3051\u308b\u30bd\u30de\u30c8\u30b9\u30bf\u30c1\u30f3\u53d7\u5bb9\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3068RI\u5185\u7528\u7642\u6cd5. \u7b2c4\u56de\u65e5\u672c\u795e\u7d4c\u5185\u5206\u6ccc\u816b\u760d\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a, \u6771\u4eac, 2016, 9.<\/dd>\n<\/dl>\n<\/div>\n\n\n\n<p><!--change_elem_panel--><\/p>\n\n\n\n<p><style>\n    @media screen and (max-width: 768px) {<br \/>\n        .changeElem_btn_content {<br \/>\n            flex-flow: wrap;<br \/>\n        }<br \/>\n        .changeElem_btn_content .change_elem_btn {<br \/>\n            margin-bottom: 20px;<br \/>\n        }<br \/>\n    }<br \/>\n<\/style><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u81e8\u5e8a\u7814\u7a76 \u6a2a\u6d5c\u5e02\u7acb\u5927\u5b66\u653e\u5c04\u7dda\u8a3a\u65ad\u5b66\u6559\u5ba4\u3067\u306f\u3001\u4ee5\u4e0b\u306e\u9818\u57df\u3092\u7814\u7a76\u306e\u67f1\u3068\u3057\u3066\u6d3b\u52d5\u3057\u3066\u3044\u308b\u3002 \u52a0\u3048\u3066\u3001\u672c\u6559\u5ba4\u3067\u306f\u5927\u5b66\u9662\u751f\u306e\u5b66\u4f4d\u53d6\u5f97\u306b\u5411\u3051\u305f\u7814\u7a76\u6307\u5c0e\u3092\u884c\u3063\u3066\u304a\u308a\u3001 \u533b\u5b66\u90e84\u5e74\u751f\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30ea\u30b5\u30fc\u30c1\u30af\u30e9\u30fc\u30af\u30b7\u30c3\u30d7\u3082\u6bce\u5e74\u53d7\u3051\u5165\u308c\u3066\u3044\u308b [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-12","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/pages\/12","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/comments?post=12"}],"version-history":[{"count":119,"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/pages\/12\/revisions"}],"predecessor-version":[{"id":1907,"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/pages\/12\/revisions\/1907"}],"wp:attachment":[{"href":"https:\/\/www-user.yokohama-cu.ac.jp\/~diagrad\/wp-json\/wp\/v2\/media?parent=12"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}